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Executive Summary  
Exponential	   data	   growth	   in	   life	   sciences	   demands	   cross	   discipline	   work	   that	   brings	  
together	  computing	  and	  life	  sciences	  in	  a	  usable	  manner	  that	  can	  enhance	  knowledge	  
and	   understanding	   in	   both	   fields.	   High	   throughput	   approaches,	   advances	   in	  
instrumentation	   and	   overall	   complexity	   of	   mass	   spectrometry	   data	   have	   made	   it	  
impossible	  for	  researchers	  to	  manually	  analyse	  data	  using	  existing	  market	  tools.	  	  
By	   applying	   a	   user-­‐centred	   approach	   to	   effectively	   capture	   domain	   knowledge	   and	  
experience	   of	   biologists,	   this	   thesis	   has	   bridged	   the	   gap	   between	   computation	   and	  
biology	   through	   software,	   PepTracker	   (http://www.peptracker.com).	   This	   software	  
provides	  a	  framework	  for	  the	  systematic	  detection	  and	  analysis	  of	  proteins	  that	  can	  be	  
correlated	   with	   biological	   properties	   to	   expand	   the	   functional	   annotation	   of	   the	  
genome.	  
The	  tools	  created	   in	  this	  study	  aim	  to	  place	  analysis	  capabilities	  back	   in	  the	  hands	  of	  
biologists,	  who	   are	   expert	   in	   evaluating	   their	   data.	   Another	  major	   advantage	   of	   the	  
PepTracker	   suite	   is	   the	   implementation	   of	   a	   data	   warehouse,	   which	   manages	   and	  
collates	  highly	  annotated	  experimental	  data	   from	  numerous	  experiments	  carried	  out	  
by	   many	   researchers.	   This	   repository	   captures	   the	   collective	   experience	   of	   a	  
laboratory,	  which	  can	  be	  accessed	  via	  user-­‐friendly	  interfaces.	  	  
Rather	  than	  viewing	  datasets	  as	  isolated	  components,	  this	  thesis	  explores	  the	  potential	  
that	  can	  be	  gained	  from	  collating	  datasets	  in	  a	  “super-­‐experiment”	  ideology,	  leading	  to	  
formation	   of	   broad	   ranging	   questions	   and	   promoting	   biology	   driven	   lines	   of	  
questioning.	  This	  has	  been	  uniquely	  implemented	  by	  integrating	  tools	  and	  techniques	  
from	  the	  field	  of	  Business	  Intelligence	  with	  Life	  Sciences	  and	  successfully	  shown	  to	  aid	  
in	  the	  analysis	  of	  proteomic	  interaction	  experiments.	  
Having	  conquered	  a	  means	  of	  documenting	  a	  static	  proteomics	  snapshot	  of	  cells,	  the	  
proteomics	  field	   is	  progressing	  towards	  understanding	  the	  extremely	  complex	  nature	  
of	   cell	   dynamics.	   PepTracker	   facilitates	   this	   by	   providing	   the	   means	   to	   gather	   and	  
analyse	  many	  protein	  properties	  to	  generate	  new	  biological	   insight,	  as	  demonstrated	  
by	  the	  identification	  of	  novel	  protein	  isoforms.	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Abbreviations 
1NF/2NF/3NF	   First/Second/Third	  Normal	  Form	  
AJAX	   	   Asynchronous	  JavaScript	  &	  XML	  
API	   	   Application	  Programming	  Interface	  
BI	   	   Business	  Intelligence	  	  
CRUD	   	   CReate,	  Update	  and	  Delete	  	  
CSV	   	   Comma	  Separated	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DMEM	  	   	   Dulbeccos’s	  Modified	  Eagle	  Medium	  
DNA	   	   DeoxyriboNucleic	  Acid	  	  
DPMDB	   	   Global	  Proteome	  Machine	  DataBase	  
EBI	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  Bioinformatics	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   Extract,	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  and	  Load	  
GFP	   	  	   Green	  Fluorescent	  Protein	  
GUI	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  User	  Interface	  
GO	   	   Gene	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   Google	  Web	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HCI	   	   Human	  Computer	  Interaction	  
HTML	   	   HyperText	  Markup	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HTTP	   	   HyperText	  Transfer	  Protocol	  
HUPO	   	   HUman	  Proteome	  Organisation	  
IDE	   	   Integrated	  Development	  Environment	  
IPI	   	   International	  Protein	  Index	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  Management	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  About	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   Mass	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   Model	  View	  Controller	  
NOPdb	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  DataBase	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   OnLine	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  Processing	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   Protein	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  Identifier	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   Post	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   Web	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Introduction 
Biology	   is	  a	  broad	   ranging	   field,	   spanning	   the	   study	  of	  whole	   living	  organisms	   to	   the	  
molecular	  scale	  of	  the	  cell,	  hence	  defining	  a	  variety	  of	  sub	  disciplines.	  Cellular	  biology	  
focuses	   on	   examining	   the	   building	   blocks	   of	   life	   in	   order	   to	   further	   understand	   the	  
structure,	  function,	  growth,	  origin,	  evolution,	  distribution	  and	  taxonomy	  of	  life.	  Thanks	  
to	  technical	  and	  experimental	  innovations	  it	  is	  now	  possible	  to	  make	  high	  throughput,	  
quantitative	   measurements	   of	   cellular	   DNA,	   RNA	   and	   protein	   molecules	   on	   an	  
unparalleled	   scale.	   This	   allows	   researchers	   to	   design	   experiments	   in	   new	  ways	   that	  
promise	   major	   insights	   into	   the	   mechanisms	   of	   cell	   growth	   and	   the	   relationships	  
between	  gene	  function	  and	  human	  disease.	  	  
The	  main	   role	   of	   genes	   is	   to	   instruct	   a	   cell	   on	   how	   to	  make	   the	   different	   types	   of	  
proteins	   that	   control	   cellular	   metabolism	   and	   make	   up	   the	   fabric	   of	   subcellular	  
structures.	   Whereas	   biologists	   previously	   concentrated	   on	   studying	   one	   or	   two	  
proteins	  in	  isolation,	  it	  is	  now	  possible	  to	  detect	  and	  measure	  changes	  in	  the	  levels	  and	  
properties	   of	   thousands,	   or	   even	   tens	   of	   thousands,	   of	   genes	   and	   their	   protein	  
products	   in	   a	   single	   experiment.	   This	   field	   is	   known	   as	   “proteomics”	   or	   “functional	  
genomics”.	  	  
Proteomics	   is	   continuously	   evolving,	   with	   better	   instrumentation	   available	   year	   on	  
year	  and	   improvements	   in	  experimental	   techniques	  and	  protocols.	   Laboratories	  now	  
have	   easier	   access	   to	  mass	   spectrometry	   instrumentation	   and	   are	   able	   to	   carry	   out	  
high	  throughput	  research.	  The	  corollary	  of	  large-­‐scale	  modern	  proteomics	  is	  resulting	  
in	   the	   generation	   of	   big	   volumes	   of	   data	   that	   represent	   the	   quantitative	  
measurements	   of	   proteins	   residing	   in	   cells.	   For	   example,	   current	   experiments	   can	  
already	   generate	   in	   the	   order	   of	   600GBytes	   of	   raw	   data	   and	   it	   is	   envisioned	   future	  
experiments	  will	  generate	  even	  larger	  datasets	  at	  a	  more	  granular	  level.	  
This	  exponential	   increase	   in	  the	  volumes	  of	  mass	  spectrometry	  data	   is	  not	   limited	  to	  
the	   proteomics	   domain.	   Data	   growth	   has	   been	   experienced	   across	   many	   fields,	  
including	   genomics,	   complex	   physics	   simulations,	   finance	   and	   retail.	   This	   trend	   of	  
larger	  datasets	  has	  raised	  issues	  surrounding	  the	  capture,	  management	  and	  processing	  
of	  data	  within	  acceptable	  time	  frames	  and	  is	  now	  termed	  as	  the	  field	  of	  ‘Big	  Data’.	  Big	  
data	  sizes	  are	  a	  constantly	  moving	  goalpost,	  with	  current	  big	  data	  being	  ranging	  from	  a	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few	  dozen	  Terabytes	  to	  many	  Petabytes.	  This	  definition	  puts	  proteomics	  in	  the	  arena	  
of	  Big	  Data	  and	  opens	  up	  the	  possibility	  of	  using	  Big	  Data	  technologies	  to	  help	  manage	  
data	  sets	  in	  a	  collective	  manner.	  
Existing	   tools	   in	   the	  proteomics	   domain,	   such	   as	   the	   Trans	   Proteomic	   Pipeline,	   have	  
made	  significant	  efforts	  to	  make	  the	  analysis	  process	  of	  mass	  spectrometry	  data	  more	  
straightforward.	   However,	   to	   date,	   none	   of	   the	   software’	   created	   provide	   data	  
warehouse	  and	  complex	  downstream	  analytic	  capabilities	  for	  quantitative	  proteomics	  
data.	   Furthermore,	  many	   software	   focus	   on	   a	   single	   user,	   single	  machine	  workflow,	  
which	  is	  restrictive	  in	  terms	  of	  the	  size	  of	  datasets	  that	  can	  be	  handled	  and	  fails	  to	  take	  
advantage	  of	  the	  experience	  captured	  in	  previous	  datasets.	  	  
Traditionally,	   biologists	   perform	   experiments	   serially	   and	   analyse	   the	   resulting	   data	  
from	  a	  single	  experiment	  largely	  in	  isolation	  from	  other	  datasets.	  Primarily	  researchers	  
will	  concentrate	  on	  the	  follow	  up	  analysis	  of	  only	  a	  small	  subset	  of	  the	  resulting	  data,	  
resulting	  in	  most	  of	  the	  obtained	  information	  being	  effectively	  discarded	  and	  its	  value	  
lost.	   In	   the	   absence	   of	   dedicated	   software	   tools,	   designed	   specifically	   to	   handle	  
proteomics	   data,	   the	   value	   of	   information	   generated	   is	   further	   reduced	   due	   to	  
limitations	  with	   the	   available	   analysis	   tools	   (e.g.	   Excel),	   which	   are	   not	   suited	   to	   the	  
scale	  and	  complexity	  of	  these	  new	  types	  of	  data.	  	  
Furthermore,	   the	   data	   are	   often	   not	   annotated	   with	   well-­‐structured	   and	  
comprehensive	   metadata	   describing	   experimental	   protocols	   applied	   during	  
generation,	  which	  limits	  the	  amount	  of	  automated	  analysis	  that	  can	  take	  place	  across	  
datasets.	   If	  datasets	  could	  be	  collated	  and	  stored,	   it	   is	  envisioned	  that	  all	  of	  the	  data	  
generated	   in	   every	   experiment	   could	   be	   collectively	   used	   to	   aid	   in	   future	   analysis,	  
rather	   than	   discarding	   them	   as	   irrelevant	   based	   on	   the	   narrow	   interests	   of	   the	  
researcher	  seeking	  to	  test	  a	  specific,	  often	  narrow	  hypothesis.	  
Another	  challenge	  resulting	  from	  the	  lack	  of	  suitable	  software	  tools	  has	  been	  that	  the	  
experimentalists,	   who	   best	   understand	   the	   design	   and	   meaning	   of	   their	   studies,	  
however	   can	   not	   perform	   the	   analysis	   of	   their	   data	   because	   they	   lack	   the	   required	  
computing	   skills.	   Instead,	   the	   large	   datasets	   are	   passed	   over	   to	   specialised	  
Biocomputing	  groups,	  who	  do	  not	  perform	  experiments	   themselves,	   for	  analysis	  and	  
interpretation.	   This	   separation	   of	   data	   analysis	   from	   data	   generation	   can	   lead	   to	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misunderstandings	   on	   both	   sides	   and	   can	   complicate	   and	   hinder	   an	   efficient	  
knowledge	  discovery	  process.	  It	  can	  also	  contribute	  to	  a	  rather	  piecemeal	  approach	  for	  
analysing	  biological	  data.	  Software	  created	  by	  specialist	  Biocomputing	  groups	  can	  be	  
difficult	   to	   setup	   and	   utilise,	   as	   these	   software	   are	   often	   not	   designed	   for	   non-­‐
computational	  experts.	  This	  can	   lead	  to	  frustration	  on	  the	  part	  of	  researchers	  whose	  
expertise	  lie	  in	  biology	  rather	  than	  computing.	  	  
In	   order	   to	   bridge	   this	   gap	   between	   life	   sciences	   and	   computing,	   well-­‐designed	  
interfaces	   are	   required	   that	   can	   hide	   the	   underlying	   complexity	   in	   algorithms	   and	  
computation,	  to	  provide	  researchers	  with	  the	  ability	  to	  carry	  out	  their	  own	  analysis.	  In	  
order	  to	  implement	  such	  interfaces	  a	  user-­‐centred	  design	  philosophy	  can	  be	  employed	  
which	  focuses	  on	  the	  needs,	  wants	  and	  limitations	  of	  end	  users.	  At	  each	  stage	  of	  the	  
software	   development,	   specific	   focus	   is	   placed	   on	   involving	   users	   in	   design	   and	  
usability	  evaluations.	  The	  feedback	  from	  informal	  interviews,	  focus	  groups	  and	  one-­‐to-­‐
one	  discussions	  can	  then	  be	  fed	  back	  into	  the	  software	  development	  cycle	  to	  improve	  
the	   outcome.	   This	   increases	   the	   likelihood	   of	   user	   acceptance	   and	   aids	   in	   the	  
identification	  of	  problems	  and	  issues	  early,	  which	  would	  otherwise	  take	  a	   lot	  of	  time	  
and	  effort	  to	  resolve	  later	  in	  the	  design	  and	  development	  process.	  
By	  focusing	  on	  users,	  the	  opportunities	  arising	  from	  the	  challenges	  in	  proteomics	  have	  
been	  identified	  and	  embraced	  to	  build	  a	  new	  approach	  for	  extracting	  maximum	  value	  
from	  proteomics	  data.	  It	  has	  been	  recognised	  that	  a	  custom	  data	  environment	  must	  be	  
developed	  for	  management	  and	  analysis	  of	  quantitative	  proteomics	  data.	  The	  aim	  of	  
this	  is	  twofold;	  first	  to	  ensure	  that	  researchers	  can	  make	  best	  use	  of	  all	  data	  resulting	  
from	  every	  experiment	  carried	  out	  in	  the	  laboratory	  and	  second,	  to	  place	  the	  ability	  to	  
carry	   out	   sophisticated	   data	   analysis	   and	   mining	   back	   into	   the	   hands	   of	   the	  
experimentalists	  who	  generate	  the	  data.	  	  
This	  thesis	  describes	  the	  development	  of	  new	  software	  tools	  that	  facilitate	  the	  ability	  
of	   researchers	   to	  manage	   and	   intuitively	   analyse	   their	   own	   data	   and	   convert	   it	   into	  
information.	  This	  in	  turn	  translates	  to	  biological	  knowledge	  and	  understanding,	  which	  
not	  only	  furthers	  the	  field	  but	  can	  also	  be	  reapplied	  to	  follow-­‐up	  experiments	  and	  used	  
to	  design	  and	  test	  hypotheses.	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Chapter 1: Literature Review 
Chapter	  1	  provides	  a	  background	  to	  cell	  biology	  and	  proteomics,	  describing	  the	  use	  of	  
mass	   spectrometry	   and	   various	   experimental	   techniques	   as	   well	   as	   describing	   the	  
challenges	  faced	  by	  the	  field	  in	  moving	  forward	  (section	  1.1).	  These	  challenges	  can	  be	  
summarised	  as	  data	  management,	  visualisation	  and	  analysis	  (sections	  1.2-­‐1.4).	  
1.1 Cell Biology & Proteomics 
1.1.1 Genomics & Proteomics 
The	  Human	  Genome	  Project	  was	  a	  major	  international	  endeavour	  aimed	  at	  identifying	  
and	  mapping	  all	  genes,	  which	  control	  hereditary	  characteristics	   in	   living	  organisms.	  A	  
gene	  is	  any	  given	  segment	  along	  a	  DNA	  strand	  that	  encodes	  instructions	  allowing	  a	  cell	  
to	  produce	  a	  specific	  product	   -­‐	   typically	  a	  protein.	  However,	   since	   the	  completion	  of	  
the	  human	  genome	  project	  (2003)	  (Lander	  et	  al.,	  2001,	  Venter	  et	  al.,	  2001)	  the	  focus	  of	  
research	   has	   changed	   from	   working	   at	   the	   genome	   level,	   identifying	   and	   mapping	  
genes,	   to	   documenting	   the	   function	   of	   genes	   and	   realising	   how	   changes	   in	   the	  
sequence	   relate	   to	  health	  and	  disease	  at	   the	   cellular	   level.	  Genes,	  while	  holding	   the	  
code	  to	  build	  proteins,	  are	  functionally	  non-­‐descript,	  as	  the	  regulation	  and	  expression	  
of	   the	  gene	   is	  a	  result	  of	  proteins	   in	  the	  cell	   reacting	  to	  environmental	  and	  chemical	  
stimuli.	  Additionally,	  splicing	  and	  processing	  and	  modification	  variants,	  which	  arise	  at	  
the	   protein	   level,	  may	   alter	   the	   structure	   and	   function	   of	   the	   proteins	   from	   a	   given	  
gene.	   By	   researching	   the	   proteins	   expressed	   by	   genes	   under	   various	   conditions,	   the	  
field	  of	   life	   sciences	  has	  made	   significant	   contributions	   to	   the	  understanding	  of	  how	  
the	   human	   body	   functions.	   This	   research	   has	   led	   to	   the	   definition	   of	   a	   new	   field:	  
proteomics,	  which	  aims	  to	  discover,	  annotate	  and	  describe	  the	  properties	  of	  proteins	  
in	  living	  organisms.	  The	  field	  of	  proteomics	  is	  vast,	  covering	  the	  analysis	  of	  all	  proteins	  
encoded	  by	  a	  genome.	  Typically	  there	  are	  multiple	  proteins	  associated	  with	  each	  gene,	  
resulting	  in	  the	  total	  number	  of	  protein	  products	  extending	  far	  beyond	  the	  estimated	  
20,000-­‐25,000	  genes	  in	  the	  human	  genome.	  	  
The	  molecular	  basis	   of	   genes	   is	  DNA	   (DeoxyriboNucleic	  Acid),	  which	   consists	  of	   long	  
polymer	   chains	   that	   are	   composed	  of	   four	   subunits,	   known	  as	   nucleotides	   or	   bases.	  
These	  four	  nucleotides	  are:	  adenine	  (A),	  cytosine	  (C),	  guanine	  (G),	  and	  thymine	  (T).	  The	  
order	   in	   which	   the	   nucleotides	   appear	   in	   a	   DNA	   strand	   determines	   the	   biological	  
information	  encoded	  by	  the	  strand.	  	  The	  chemical	  attractions	  between	  the	  nucleotides	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result	   in	   the	   appearance	   of	   molecule	   pairs,	   such	   that	   adenine	   always	   pairs	   with	  
thymine	   and	   guanine	   pairs	   with	   cytosine.	   This	   base-­‐pairing	   characteristic	   makes	   it	  
straightforward	   to	   work	   out	   the	   complementary	   DNA	   strand	   of	   any	   single-­‐stranded	  
DNA	  sequence.	  These	  two	  DNA	  strands	  together	  form	  a	  structure	  with	  the	  well-­‐known	  
double-­‐helix	  shape	  and	  tightly	  bind	  to	  form	  chromosomes.	  It	  is	  this	  DNA	  structure	  that	  
forms	  the	  physical	  basis	  of	  inheritance	  in	  a	  living	  organism.	  
When	  a	  cell	  reproduces	  it	  divides	  into	  multiple	  cells,	  passing	  on	  genetic	  information	  via	  
DNA	  strands.	  It	  is	  these	  DNA	  strands	  that	  are	  used	  by	  the	  cell	  during	  protein	  synthesis,	  
the	  process	  by	  which	   cells	  build	  new	  proteins.	   This	  process	   requires	   the	  use	  of	  DNA	  
from	  within	   the	  cell	  nucleus.	  Each	  DNA	  strand	  within	  a	  chromosome	  contains	  genes,	  
which	  each	  hold	  a	  genetic	  ‘blueprint’	  required	  to	  build	  a	  protein	  molecule.	  Depending	  
on	   which	   genes	   are	   active	   or	   inactive	   will	   directly	   influence	   the	   proteins	   that	   are	  
synthesised	  within	  a	  cell.	  	  
Similar	  to	  DNA	  and	  RNA,	  proteins	  are	  linear	  structures,	  which	  can	  be	  represented	  by	  a	  
text	   string.	  Whereas	  DNA	  and	  RNA	  use	  a	   four-­‐character	  alphabet,	  proteins	   require	  a	  
twenty-­‐character	   alphabet	   to	   represent	   each	   possible	   amino	   acid	   in	   a	   protein	  
sequence.	  When	  amino	  acids	   join	  together,	  they	  form	  polypeptides	  and	  each	  protein	  
can	   consist	   of	  one	  or	  more	  polypeptides.	   The	  amino	  acid	   sequence	  of	   a	  protein	   can	  
vary	   in	   length	   from	   typically	   50	   to	   2000	   amino	   acid	   residues	   and	   is	   known	   as	   the	  
primary	   structure.	   The	   attraction	   between	   amino	   acids	   can	   cause	   a	   protein	   primary	  
sequence	   to	  coil	  or	   fold,	   forming	  a	  secondary	  structure.	  Finally	   the	   tertiary	  structure	  
describes	   the	   overall	   3D	   protein	  molecule,	   which	   is	   the	   secondary	   structure	   further	  
folded	  back	  on	  itself	  (see	  Figure	  1).	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Figure	  1:	  Protein	  primary,	  secondary,	  tertiary	  and	  quaternary	  structures.	  
(http://en.wikipedia.org/wiki/File:Main_protein_structure_levels_en.svg)	  
During	   protein	   synthesis,	   or	   directly	   following	   synthesis,	   proteins	   can	   undergo	   a	  
process	  of	  posttranslational	  modification.	  This	  modification	  is	  a	  chemical	  alteration	  of	  
the	   protein,	   which	   can	   alter	   the	   physical	   and	   chemical	   properties,	   folding,	   stability,	  
activity	  and	  function	  of	  the	  protein.	  	  
Whilst	   genetic	   information	   is	   static,	   the	   protein	   complement	   of	   a	   cell	   is	   dynamic.	  
Proteins	  play	  a	  pivotal	  role	   in	  the	  life	  of	  an	  organism,	  they	  are	  the	  elements	  within	  a	  
cell	   that	   provide	   structure,	   produce	   energy,	   as	   well	   as	   allow	   communication,	  
movement,	  and	  reproduction	  (Cho,	  2007).	  Proteins	  are	  the	  main	  macromolecules	  of	  an	  
organism	   hence,	   when	   studying	   an	   organism	   biologists	   usually	   either	   investigate	  
proteins,	  or	  molecules	  that	  have	  been	  made	  from,	  or	  by,	  proteins.	  Due	  to	  the	  pivotal	  
role	  played	  by	  proteins	  in	  providing	  the	  basic	  functional	  and	  structural	  framework	  for	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cellular	   life,	   it	   is	   imperative	  for	  researchers	  to	  be	  able	  to	  understand	  the	   life	  cycle	  of	  
proteins.	  	  
The	  study	  of	  functional	  and	  behavioural	  proteomics	  aims	  to	  answer	  questions	  such	  as	  
which	   form	   of	   a	   protein	   has	   been	   found	   in	   a	   cell	   (isoform)	   (Neubauer	   et	   al.,	   1998,	  
Rappsilber	  and	  Mann,	  2002b,	  Ahmad	  et	  al.,	  2011),	  how	  much	  of	  a	  protein	   is	   in	  a	  cell	  
(intensity	   and	   abundance),	   where	   it	   is	   located	   in	   a	   cell	   (spatial	   localisation),	   who	   it	  
communicates	   with	   (interactions),	   what	   structural	   conformation	   it	   may	   have	  
(structure),	  binding	  surfaces	  or	  locations	  (Nett	  et	  al.,	  2010,	  Rappsilber,	  2011)	  and	  what	  
chemical	   modifications	   it	   may	   gain	   or	   lose.	   Protein	   characterisation	   has	   allowed	  
investigation	  of	  potential	  pathogen	  species	  (Wilson	  et	  al.,	  1999).	  These	  questions	  can	  
be	   answered	   through	   a	   variety	   of	   experimental	   techniques.	   Localisation	   of	   proteins	  
can	   be	   studied	   through	   cellular	   fractionation	   techniques	   that	   allow	  measurement	   of	  
proteins	  within	  different	  sub-­‐cellular	  compartments	  (Boisvert	  et	  al.,	  2010,	  Boisvert	  et	  
al.,	   2011).	   Protein-­‐protein	   interactions	   can	   be	   studied	   using	   methods	   such	   as	  
immunoprecipitation	  (Trinkle-­‐Mulcahy	  et	  al.,	  2008c,	  Boulon	  et	  al.,	  2010a,	  Boulon	  et	  al.,	  
2010b),	   involving	   the	   use	   of	   an	   antibody	   bound	   to	   the	   protein	   of	   interest	   to	   isolate	  
interaction	   partners,	   or	   cross	   linking	   (Rappsilber	   et	   al.,	   2000,	   Maiolica	   et	   al.,	   2007,	  
Rappsilber,	   2011),	   which	   covalently	   binds	   together	   interacting	   proteins.	   It	   has	   been	  
shown	   that	   these	   approaches	   to	   studying	   protein-­‐protein	   interactions	   also	   require	  
adequate	   bioinformatics	   software	   (Maiolica	   et	   al.,	   2007).	   Furthermore,	   protein	  
modification	   can	   be	   identified	   via	   enrichment	   of	   modifications	   within	   a	   biological	  
sample	   and	   novel	   in-­‐machine	   selection	   processes	   to	   analyse	   specific	   ions	   which	  
characterise	  peptide	  modifications	  (Macrae	  and	  Ferguson,	  2005,	  Vertegaal	  et	  al.,	  2006,	  
Matic	  et	  al.,	  2008,	  Westman	  et	  al.,	  2010,	  Ahmad	  et	  al.,	  2011).	  
The	   Lamond	  Laboratory,	  based	   in	   the	  Wellcome	  Trust	  Centre	   for	  Gene	  Regulation	  &	  
Expression,	   is	   playing	   a	   prominent	   role	   in	   the	   development	   and	   application	   of	   new	  
quantitative	  and	  high	  throughput	  methods	  for	  the	  analysis	  of	  gene	  expression	  and	  cell	  
biology.	   In	  particular	  the	  Lamond	  group	  focus	  on	  how	  cancer	  and	  other	  diseases	  can	  
result	  in	  changes	  in	  the	  spatial	  distribution,	  stability	  and	  function	  of	  proteins	  in	  human	  
cell	   lines.	   Rather	   than	   analysing	   the	   cellular	   proteome	   as	   a	   static	   snapshot	   in	   time,	  
advanced	   studies	   are	   now	   looking	   at	   the	   function	   and	   dynamics	   of	   proteins	   on	   a	  
proteome-­‐wide	   scale	   involving	   large-­‐scale	   use	   of	   proteomics	   technologies.	   The	  most	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accurate	   and	   high	   throughput	   method	   for	   protein	   analysis	   used	   in	   science	   today	   is	  
Mass	  Spectrometry	  (MS).	  	  
1.1.2 Mass Spectrometry 
Mass	   Spectrometry	   relies	   on	   highly	   accurate	   mass	   measurements	   of	   peptide	  
preparations	   -­‐	   typically	   tryptic	   digests	   of	   proteins,	   where	   a	   protein	   sequence	   is	   cut	  
after	   every	   Lysine	   and	   Arginine	   amino	   acid	   resulting	   in	   computationally	   predictable	  
pieces	  of	   protein,	   namely	  peptides.	   These	  pieces	  of	   protein	   are	  measured	   in	   a	  mass	  
spectrometer,	   which	   distinguishes	   between	   ions	   based	   on	   mass-­‐to-­‐charge	   (m/z)	  
measurements.	  A	  mass	  spectrometer	  has	  three	  main	  components:	  an	  ion	  source,	  m/z	  
analyser	  and	  a	  detector	  (see	  Figure	  2).	  	  
	  
Figure	  2:	  Mass	  spectrometer	  overview.	  
In	  order	  to	  make	  mass-­‐to-­‐charge	  measurements	  of	  ions,	  each	  molecule	  is	  ionised	  and	  
the	  ion	  is	  propelled	  into	  a	  mass	  analyser	  by	  an	  electric	  field.	  In	  order	  to	  allow	  accurate	  
measurements	   to	   be	   taken,	   the	   ions	   are	   released	   from	   the	   ioniser	   over	   a	   period	   of	  
time.	   Popular	   types	   of	   ionisation	   include	   electrospray	   ionisation	   (ESI)	   (Fenn	   et	   al.,	  
1989)	  and	  matrix-­‐assisted	  laser	  desorption/ionisation	  (MALDI)	  (Karas	  and	  Hillenkamp,	  
1988),	  due	   to	   the	   little	  or	  no	   fragmentation	  of	   the	  molecules	   that	  occurs	  during	   the	  
ionisation	  and	  desorption	  process.	  When	  the	  ions	  reach	  the	  mass	  analyser	  they	  must	  
be	  sorted	  depending	  on	  their	  mass-­‐to-­‐charge	  ratio.	  There	  are	  two	  main	  types	  of	  mass	  
analyser:	   those	   that	  use	  an	  electric	   field	  and	   those	   that	  employ	   the	  use	  of	  magnetic	  
fields.	   There	   are	   four	   commonly	   used	  mass	   analysers:	   ion	   trap,	   time-­‐of-­‐flight	   (TOF),	  
quadrupole	   and	   Fourier	   transform	   ion	   cyclotron	   (FT-­‐MS)	   analysers	   (Aebersold	   and	  
Mann,	  2003).	   The	   choice	  of	   analyser	  depends	  on	  a	  number	  of	   factors	   related	   to	   the	  
design	  and	  performance	  of	  each.	  The	  analysers	  can	  be	  used	   individually	  or	  placed	   in	  
tandem	   with	   one	   another	   to	   take	   advantage	   of	   the	   strengths	   of	   each.	   Finally,	   the	  
detector	  (usually	  a	  specific	  type	  of	  electron	  multiplier)	  takes	  readings	  by	  producing	  an	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electric	  charge	  each	  time	  it	  is	  struck	  by	  an	  ion.	  The	  goal	  of	  the	  detector	  is	  to	  record	  the	  
abundance	  of	  each	  mass-­‐to-­‐charge	  ion.	  
The	  Fingerprint	  Proteomics	  Facility	  and	  the	  Lamond	  Laboratory,	   in	  the	  College	  of	  Life	  
Sciences,	   have	   a	   variety	  of	   instruments	   from	  Thermo	  Scientific	   Fisher.	   These	   include	  
the	  LTQ	  Orbitrap	  XL,	  LTQ	  Orbitrap	  VELOS	  and	  Q	  Exactive	  (see	  Figure	  3).	  The	  Orbitrap	  
instruments	  are	  based	  on	  technology	  developed	  by	  Alexander	  Makarov.	  They	  include	  a	  
special	   type	  of	   ion	   trap	  where	   ions	  are	  electrostatically	   trapped	   in	  an	  orbit	  around	  a	  
central,	   spindle	   shaped	  electrode.	   The	  electrode	   confines	   the	   ions	   so	   that	   they	  both	  
orbit	   around	   the	   central	   electrode	   and	   oscillate	   back	   and	   forth	   along	   the	   central	  
electrode's	  long	  axis.	  This	  oscillation	  generates	  a	  current	  in	  the	  detector	  plates,	  which	  
is	  recorded	  by	  the	  instrument.	  The	  frequency	  of	  the	  oscillations	  is	  directly	  dependant	  
on	  the	  mass-­‐to-­‐charge	  of	  the	  ions.	  
	  
Figure	  3:	  Mass	  spectrometry	  instruments.	  
The	   output	   of	   the	   mass	   spectrometer	   is	   a	   spectrum	   that	   can	   be	   used	   to	   match	  
detected	   ions	   to	   masses	   of	   predicted	   tryptic	   peptide	   sequences,	   which	   can	   be	  
calculated	  due	  to	  the	  known	  chemistry	  of	  amino	  acids.	  High	  throughput	  technologies,	  
such	  as	  MS,	  have	  made	  it	  possible	  for	  researchers	  to	  identify	  hundreds	  of	  thousands	  of	  
peptides,	   leading	   to	   thousands	   of	   protein	   identifications	   in	   a	   single	   analysis.	   This	   is	  
known	  as	  ‘bottom	  up’	  proteomics	  as	  the	  process	  works	  from	  the	  peptide	  level	  back	  up	  
to	  the	  complete	  protein.	  
The	   great	   advance	   seen	   in	   the	   mass	   spectrometers	   of	   today	   comes	   from	   many	  
innovators.	  Even	  though	  MS	  is	  now	  popular	  in	  cell	  biology	  its	  roots	  lie	  in	  physics,	  where	  
it	  was	  first	  conceived	  by	  inventor	  Joseph	  John	  Thomson	  who	  received	  a	  Nobel	  Prize	  for	  
Physics	  in	  1906	  for	  his	  work	  on	  the	  existence	  and	  properties	  of	  ions	  (Thomson,	  2010).	  
Francis	  Aston	  carried	  on	  the	  work	  of	  Thomson	  and	  won	  his	  own	  Nobel	  Prize	  in	  1922	  for	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Chemistry	  and	  is	  credited	  for	  building	  the	  first	  mass	  spectrometer	  that	  could	  measure	  
the	   masses	   of	   atoms	   (Squires,	   1998).	   	   The	   instrument	   was	   then	   modified	   and	  
continuously	   improved	  until	   the	  end	  of	   the	  1930's	  by	  which	  time	  mass	  spectrometry	  
had	   become	   an	   established	   technique	   for	   the	   separation	   of	   atomic	   ions	   by	   mass.	  
However,	   there	   still	   remained	   the	   challenge	   of	  moving	   large	  molecules	   into	   the	   gas	  
phase	   without	   extensive	   fragmentation	   and	   decomposition.	   The	   next	   major	  
development	   came	   in	   the	   form	  of	  Wolfgang	   Paul’s	   invention	   of	   the	   quadrupole	   and	  
quadrupole	   ion	   trap	   (Paul,	   1990),	   which	   earned	   him	   the	   Nobel	   Prize	   in	   1989	   for	  
Physics.	   Then,	   in	   1988,	   the	   ESI	   and	   MALDI	   ionisation	   techniques	   appeared	   almost	  
simultaneously	   and	   revolutionised	   biological	  MS.	   John	   Fenn	   received	   a	   shared	   2002	  
Nobel	   Prize	   in	   Chemistry	   for	   his	   development	   of	   ESI	   (Fenn,	   2002)	   along	  with	   Koichi	  
Tanaka	  for	  his	  development	  of	  a	  laser	  desorption	  method	  of	  protein	  ionization	  (Tanaka	  
et	   al.,	   1988).	   Both	   of	   these	   techniques	   opened	   up	   the	   world	   of	  mass	   spectrometry	  
analysis	  to	  biological	  macromolecules,	  such	  as	  proteins.	  
Mass	   spectrometry-­‐based	   proteomics	   can	   now	   be	   applied	   to	   samples	   from	   various	  
model	  organisms,	  including	  human	  (Nilsson	  et	  al.,	  2010),	  yeast	  (de	  Godoy	  et	  al.,	  2008),	  
nematodes	  (Larance	  et	  al.,	  2011),	  trypanosomes	  (Nett	  et	  al.,	  2009b,	  Nett	  et	  al.,	  2009a)	  
and	  drosophila	  (Brunner	  et	  al.,	  2007).	  Multiple	  samples	  from	  both	  the	  same	  organism	  
and	   different	   organisms	   can	   be	   compared	   using	   mass	   spectrometry	   combined	   with	  
stable	  isotope	  labelling.	  This	   involves	  labelling	  samples	  with	  different	  stable	  isotopes,	  
after	  which	  the	  proteins	  and	  peptides	  in	  different	  samples	  are	  still	  chemically	  (almost)	  
identical	  but	  have	  a	  different	  mass.	  This	  shift	  in	  mass	  can	  be	  used	  to	  compare	  the	  same	  
proteins	  in	  multiple	  samples	  of	  generated	  under	  different	  conditions.	  
There	  are	  many	  isotope-­‐labelling	  methods,	  the	  most	  popular	  techniques	  include:	  	  
• Isotope	   Coded	   Affinity	   Tags	   (ICAT)	   (Gygi	   et	   al.,	   1999a)	   is	   one	   of	   the	   first	  
methods	   developed	   to	   differentially	   label	   peptides.	   This	   technique	   uses	   a	  
reagent	  that	  can	  carry	  either	  a	  light	  or	  heavy	  tag	  that	  covalently	  attaches	  to	  a	  
protein.	   Labelling	   two	   samples	   with	   either	   the	   light	   or	   heavy	   tag	   allows	  
comparison	  between	  two	  conditions.	  The	  samples	  are	   then	  combined,	  before	  
digesting	  and	  analysing	  by	  mass	  spectrometry.	   ICAT	  has	  a	  dependence	  on	  the	  
occurrence	  of	  cysteine’s	  in	  the	  proteins	  of	  interest	  and	  the	  number	  of	  cysteine	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residues	   as	   this	   can	   negatively	   affect	   the	   sequence	   coverage	   of	   a	   protein	  
identification.	  
• Isobaric	   Tags	   for	   Relative	   and	   Absolute	   Quantification	   (iTRAQ)	   (Ross	   et	   al.,	  
2004)	  uses	  covalent	  labelling	  of	  N-­‐terminus	  side	  chains	  of	  peptides	  with	  tags	  of	  
varying	   size.	   This	   approach	   differs	   from	   ICAT	   as	   peptides	   are	   fractionated	  
before	  labelling	  takes	  place.	  Final	  database	  searching	  on	  the	  output	  of	  the	  mass	  
spectrometry	   can	   match	   fragmentation	   data	   of	   the	   peptides	   and	   tags	   to	  
identify	   and	   quantify	   the	   peptides	   and	   hence	   proteins	   from	   which	   they	  
originate.	  An	  advantage	  of	  iTRAQ	  over	  ICAT	  is	  that	  protein	  sequence	  coverage	  
is	  higher	  as	  all	  peptides	  are	  labelled	  and	  available	  for	  analysis.	  
• Stable	  Isotope	  Labelling	  By	  Amino	  Acids	  (SILAC)	  (Ong	  et	  al.,	  2002)	  differs	  from	  
both	   iTRAQ	   and	   ICAT	   as	   it	   metabolically	   labels	   proteins	   via	   incorporation	   of	  
labelled	   arginine,	   lysine	   or	   both.	   This	   gives	   rise	   to	   the	   possibility	   of	   four	  
different	   samples,	   also	   considering	   an	   unlabelled	   sample.	   This	   tag	   less	  
approach	   provides	   benefits	   over	   other	   labelling	   strategies	   as	   it	   alleviates	  
potential	   issues	   with	   liquid	   chromatography,	   for	   example	   co-­‐elution,	   and	  
reduces	  proteomic	  complexity,	  as	   the	  cells	  analysed	  are	  usually	  homogenous.	  	  
This	   approach	   is	   described	   in	   detail	   in	   1.1.3	   Stable	   Isotope	   Labelling	   using	  
Amino	  Acids	  in	  Cell	  Culture.	  
1.1.3 Stable Isotope Labelling using Amino Acids in Cell Culture 
Advanced	  techniques,	  including	  MS	  combined	  with	  Stable	  Isotope	  Labelling	  by	  Amino	  
acids	   in	  Cell	   culture	   (SILAC)	   (Ong	  et	  al.,	   2002),	   are	  being	  used	   to	  not	  only	  accurately	  
identify	   but	   also	   quantify	   proteins	   within	   biological	   samples.	   SILAC	   protocols	   obtain	  
quantitative	   measurements	   through	   comparison	   of	   light	   and	   heavier	   forms	   of	   the	  
same	  peptide,	  arising	  from	  the	  presence	  of	  heavier,	  stable	  isotopes	  such	  as	  13C,	  2H	  and	  
15N.	   These	   stable	   isotopes	   are	   incorporated	   into	   proteins	   by	   in	   vivo	   labelling,	   i.e.	  
growing	   the	   cells	   in	   specialised	  media	  where	   specific	   amino	   acids,	   typically	   arginine	  
and	  lysine,	  are	  replaced	  with	  corresponding	  heavy	  isotope-­‐substituted	  forms	  in	  which	  
either	  all	  carbons,	  or	  combinations	  of	  carbon’s,	  hydrogen’s	  or	  nitrogen’s	  are	   isotope-­‐
labelled.	  This	  labelling	  of	  peptides,	  using	  isotopes,	  produces	  a	  mass	  shift,	  which	  can	  be	  
measured	  by	  the	  mass	  spectrometer	  and	  appears	  in	  the	  mass	  spectra.	  SILAC	  not	  only	  
aids	  with	   quantification	   of	   proteins	   but	   also	   allows	   researchers	   to	   compare	   samples	  
using	  differential	  labelling.	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Figure	  4:	  Typical	  SILAC	  experiment	  involving	  light	  and	  heavy	  labelled	  samples.	  
The	   advent	   of	   techniques	   such	   as	   SILAC,	   combined	   with	   the	   advancements	   in	  
instrumentation	   have	   allowed	   the	   use	   of	   mass	   spectrometry	   not	   only	   for	   protein	  
identification	   and	   study	   of	   modifications,	   but	   also	   made	   it	   possible	   to	   study	  
quantitative	  expression	  of	  proteomes	   (Rappsilber	   and	  Mann,	  2002a,	  Ong	  and	  Mann,	  
2005).	  
1.1.4 Challenges in the Proteomics Field 
When	  attempting	  to	  identify	  proteins	  from	  peptide	  identifications,	  there	  are	  a	  number	  
of	  problems	  faced	  by	  researchers.	  Theses	  challenges	  are	  two	  fold,	  related	  to	  either	  the	  
experimental	   method	   or	   the	   computation.	   The	   experimental	   problems	   can	   be	  
summarised	  as:	  	  
• difficulty	   in	   detection	   of	   low-­‐abundance	   proteins	   due	   to	   the	   large	   dynamic	  
range	  of	  protein	  abundances	  found	  in	  cells,	  
• loss	  of	  proteins	  during	  enrichment	  strategies	  due	  to	  their	  fragility,	  
• the	   volatile	   nature	   of	   some	   proteins	   in	   certain	   environments,	   making	   them	  
highly	  unstable,	  
• selective	  MS/MS,	  which	   is	  pre-­‐set	  to	  usually	  the	  top	  10	  highest	   intensity	   ions,	  
resulting	  in	  not	  all	  peptides	  being	  selected	  for	  MS/MS	  and	  placing	  bias	  towards	  
high	  abundance	  peptides,	  and	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• the	  lack	  of	  reproducibility	  between	  separate	  mass	  spectrometry	  runs.	  	  
Due	   to	   these	   problems,	   and	   the	   range	   of	   tasks	   and	   objectives	   in	   proteomics,	   it	   has	  
been	   stated	   that	   finding	   a	   universal	   technology	   “that	   enables	   you	   to	   identify	   all	  
proteins,	   in	   all	   samples,	   all	   of	   the	   time”	   is	   near	   impossible	   (Kevin	   Auton,	   Chief	  
Executive,	   Proteomics	   Technology	  Developers,	  NextGen	   Sciences	  of	  Huntingdon,	  UK)	  
(cited	   in	   (Gershon,	   2003)).	   Due	   to	   this,	   over	   recent	   years,	  much	   emphasis	   has	   been	  
placed	   on	   trying	   to	   make	   scientific	   protocols	   and	   experimentation	   more	   accurate	  
through	  advancements	  in	  instrumental,	  experimental	  and	  computational	  methods.	  
Using	   improved	   scientific	   protocols	   coupled	   with	   MS,	   biologists	   are	   now	   able	   to	  
generate	  larger	  volumes	  of	  data	  related	  to	  a	  greater	  number	  of	  proteins	  and	  peptides.	  
The	  improvements	  in	  MS	  equipment	  make	  it	  possible	  to	  sample	  more	  ions,	  resulting	  in	  
a	   greater	   number	   of	   spectra	   obtained	   per	   unit	   of	   time.	   Currently	   each	   mass	  
spectrometer	   is	   able	   to	   generate	   hundreds	   to	   tens	   of	   thousands,	   of	   fragment	   ion	  
spectra	  per	  hour	  of	  data	  (Nesvizhskii	  et	  al.,	  2007).	  However,	  scientists	  are	  not	  yet	  able	  
to	   benefit	   fully	   from	   the	   discoveries	   that	   can	   be	  made	   from	   these	   data,	   due	   to	   the	  
computational	   and	   statistical	   challenges	   that	   have	   arisen.	   These	   problems	   can	   be	  
summarised	  as:	  
• cost	  of	  data	  storage,	  
• data	   management	   issues	   that	   are	   simply	   not	   addressed	   by	   storing	   data	   but	  
require	  storage	  of	  metadata	  related	  to	  the	  raw	  data,	  	  
• MS/MS	   spectral	   algorithms	   mostly	   report	   a	   significance	   of	   a	   match,	   these	  
algorithms	   can	   not	   report	   an	   absolute	   measure,	   which	   means	   there	   is	  
ambiguity	   in	   the	   interpretation	   of	   the	   output	   and	   confidence	   can	   only	   be	  
gained	  through	  finding	  the	  same	  protein	  identification	  in	  multiple,	  separate	  MS	  
experiments,	  
• large	   numbers	   of	   spectra	   are	   difficult	   to	   combine	   and	   analyse,	   resulting	   in	  
experiments	  being	  analysed	  individually	  rather	  than	  part	  of	  a	  larger	  goal,	  
• complexity	   of	   the	   proteomics	   experiments	   resulting	   even	   more	   complex	  
datasets	   that	   are	   impossible	   to	   visualise	   and	   analyse	   with	   existing,	   popular	  
scientific	  tools	  such	  as	  Excel,	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• the	  lack	  of	  consensus	  on	  data	  formats	  and	  data	  standards	  leading	  to	  problems	  
with	  sharing	  of	  data,	  	  
• majority	   of	   MS/MS	   spectra	   represent	   the	   noise	   or	   minor	   contaminants	   and	  
therefore	   have	   no	   value	   to	   the	   aim	   of	   the	   experiment	   and	   should	   not	   be	  
included	  within	  the	  analysis	  process,	  
• contamination	   and	   noise	   detected	   between	   samples	   is	   likely	   to	   overlap,	  
however	   to	   build	   a	   baseline	   a	   large	   number	   of	   experimental	   datasets	   would	  
have	  to	  be	  compared	  for	  which	  there	  is	  no	  current	  infrastructure	  and	  
• existence	  of	  proteins	  as	  multiple	   isoforms	  or	  post	   translational	   states	  make	   it	  
difficult	  to	  experimentally	  and	  algorithmically	  detect	  and	  differentiate	  between	  
these.	  
In	  the	  early	  days,	  the	  main	  goal	  of	  MS	  based	  proteomics	  may	  have	  been	  to	  identify	  and	  
analyse	   proteins	   faster,	   with	   increased	   sensitivity	   and	   reliability,	   however	   this	   focus	  
has	   changed.	   On	   its	   own	   MS	   is	   inefficient,	   especially	   in	   the	   processing	   of	   data	  
(Aebersold	   and	   Goodlett,	   2001).	   An	   appropriate	   proteome	   analysis	   platform	   is	  
required	  to	  convert	  data,	  obtained	  during	  experiments,	  into	  useful	  knowledge	  that	  can	  
be	  applied	  to	  make	  biological	  discoveries	  of	  significance.	  	  
It	   has	   already	   been	   shown	   that	   combining	   computing	   with	   biology	   in	   the	   field	   of	  
bioinformatics	  can	  be	  very	  useful.	  The	  creation	  of	  niche	  tools	  combined	  with	  databases	  
can	   help	   in	   the	   analysis	   of	   mass	   spectrometry	   data	   within	   a	   variety	   of	   situations,	  
including	   the	   investigation	   of	   structural	   proteomics	   (Rappsilber,	   2011)	   and	   post-­‐
translational	  modifications	  of	  proteins	  (Martin	  et	  al.,	  2010).	  
1.2 Data Management Technology 
1.2.2 Current Data Management in Life Sciences 
It	  has	  been	  recognised	  that	  manual	  methods	  of	  inspection	  and	  analysis	  are	  no	  longer	  
viable	   and	   instead	   tools	   are	   required	   for	   computational	   analysis	   of	   these	   MS	   data	  
(Kumar	   and	  Mann,	   2009).	   To	  date	   there	   is	   no	  method	   to	   routinely	   capture,	  manage	  
and	  archive	  datasets	  from	  such	  studies.	  A	  proteomics	  consultant,	  Sara	  Ten	  Have,	  has	  
described	  this	  problem:	  “despite	  our	  reliance	  on	  computation,	  most	  scientists	  are	  not	  
capable	   of	   complex	   data	   storage	   and	   analysis	   computing,	   and	   therefore	   rely	   on	  
computer	   programmers	   to	   do	   this	   for	   us”.	  Advances	   in	   technology	  have	   allowed	   for	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more	  sophisticated	  proteomics	  experiments,	  which	  have	  resulted	  in	  the	  generation	  of	  
an	   increased	  volume	  and	  complexity	  of	  data	   that	  demands	   the	  development	  of	  new	  
tools	  due	  to	  the	  non-­‐existence	  or	  inadequacy	  of	  current	  tools,	  such	  as	  Excel.	  In	  these	  
situations,	   biological	   researchers	   have	   been	   forced	   to	   carry	   out	   minimal	   analysis	  
manually	  and	  then	  hand-­‐over	  their	  datasets	  to	  bioinformaticians	  (typically	  external	  to	  
the	  laboratory)	  who	  have	  the	  necessary	  computing	  skills	  to	  handle	  these	  data.	  This	  is	  
frustrating	  for	  the	  biologists	  who	  are	  experts	  in	  how	  the	  data	  are	  generated	  and	  who	  
understand	  the	  meaning	  and	  limitations	  of	  the	  data.	  Having	  driven	  the	  formulation	  of	  
the	   initial	  hypothesis	   that	   led	  to	   the	  experiments	  and	  data	  generation,	   the	  biologists	  
are	  more	  acutely	  aware	  of	  how	   they	  would	   like	   to	  question	   the	  data	   further	  and	   its	  
potential.	   Furthermore,	   there	   can	   be	   limited	   contact	   between	  bioinformaticians	   and	  
biologists	  resulting	  in	  minimal	  information	  exchange	  regarding	  the	  context	  of	  the	  data	  
and	   the	   processes	   involved	   in	   generating	   the	   data,	   potentially	   leading	   to	   errors	   in	  
analysis.	  
Despite	   the	  many	   development	   projects	   that	   have	   taken	   place	   by	   bioinformaticians	  
and	   software	   developers,	   an	   evident	   gap	   remains	   in	   the	   uptake	   of	   new	   software	  
solutions.	  Furthermore,	  some	  systems	  that	  were	  developed	  for	  MS-­‐based	  proteomics	  
are	  no	  longer	  maintained	  or	  available,	  including:	  	  
• Rosetta	  Biosoftware	  (support	  discontinued	  in	  July	  2011)	  –	  this	  technology	  and	  
corresponding	   assets	   were	   bought	   by	   Microsoft	   in	   2009	   and	   sale	   of	   the	  
software	  was	  discontinued.	  Support	  for	  existing	  customers	  was	  stopped	  in	  July	  
2011.	   Microsoft	   used	   the	   assets	   to	   drive	   progress	   on	   their	   own	   Microsoft	  
Amalga	  Life	  Sciences	  platform.	  
• PeptideSearch	   (last	   update	   was	   September	   2007)	   –	   this	   peptide	   search	  
software	   was	   created	   by	   the	  Mann	   group	   while	   he	   was	   at	   the	   Bioanalytical	  
Research	   Group	   in	   EMBL-­‐Heidelberg.	   Once	  Matthias	  Mann	   left	   this	   research	  
institute	  the	  software	  was	  left	  to	  be	  maintained	  by	  the	  next	  group	  leader	  but	  is	  
no	  longer	  maintained	  or	  available.	  
• Sherpa	   (last	   reported	   release	   in	   2000)	   –	   this	   software	  was	   developed	   by	   the	  
Ken	   Walsh	   Laboratory	   (Biochemistry	   Department,	   University	   of	   Washington,	  
Seattle,	  WA)	  to	  aid	  in	  the	  correlation	  and	  interpretation	  of	  LC/MS	  and	  MS/MS	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spectra,	   however	   it	   was	   never	   developed	   beyond	   a	   beta	   release.	   The	  
programmer	  discontinued	  development	  and	  support	  of	  the	  software.	  	  	  
The	  main	  factors	  attributing	  to	  software	  becoming	  unavailable	  include:	  	  
• software	  developers	  moving	  onto	  new	  projects	  or	  moving	  institutes,	  	  
• unusable	  nature	  of	  many	  systems,	  	  
• software	  becoming	  out-­‐dated,	  	  
• inadequate	  support	  for	  end	  users,	  	  
• complex	   nature	   of	   the	   science	   resulting	   in	   software	   that	   does	   not	   meet	  
requirements,	  	  
• software	  groups	  being	  bought	  over	  by	  companies,	  	  
• new	  instrumentation,	  
• evolving	  standards	  (see	  1.2.9	  Data	  Standards)	  and	  	  
• high	  licensing	  costs	  of	  commercial	  software.	  	  
Researchers,	  with	  a	  background	  in	  life	  sciences,	  often	  come	  across	  complex	  analytical	  
needs,	  which	  drive	  them	  to	  create	  custom	  software	  in	  laboratories.	  This	  results	  in	  the	  
researcher	  choosing	  to	   learn	  the	  necessary	  computing	  skills	  that	  can	  help	  them	  build	  
scripts,	  which	   later	  become	   tools.	  However,	   this	   strategy	  often	   results	   in	   these	   tools	  
becoming	   out	   of	   date	   and	   unavailable	   due	   to	   the	   researcher	   moving	   onto	   another	  
institute	  and	  leaving	  behind	  software	  that	  is	  no	  longer	  maintained.	  	  
On	   the	   other	   hand,	   successful	   software	   projects,	   like	   the	   Rosetta	   Biosoftware,	   have	  
suffered	  due	  to	  the	  success	  of	  their	  software	  developers.	  The	  Rosetta	  Biosoftware	  was	  
bought	   over	   by	   a	   company	   (Microsoft),	   who	   wanted	   to	   access	   the	   talent	   of	   the	  
software	   developer	   team	   for	   other	   projects,	   which	   led	   to	   the	   software	   being	  
discontinued.	  	  
The	  success	  of	  a	  piece	  of	  software	   is	  not	  always	  attributed	  to	   its	   functionality,	  but	   is	  
also	   dependant	   on	   how	   this	   functionality	   is	   implemented.	   To	   use	  many	   of	   the	   tools	  
that	  are	  currently	  available	  on	  the	  market,	  computer	  expertise	  is	  required	  (Mead	  et	  al.,	  
2007).	  Scientists	  trained	  in	  biology	  generally	  do	  not	  hold	  such	  expertise	  and	  should	  not	  
be	  expected	  to	  learn	  complex	  computer	  skills	  to	  be	  able	  to	  use	  the	  tools.	  Instead,	  the	  
onus	  should	  be	  on	  developers	  to	  create	  usable,	  accessible	  software	  that	  can	  be	  utilised	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with	   minimal	   effort	   from	   researchers.	   Often	   developers	   neglect	   the	   interface	   and	  
hence	   neglect	   to	   understand	   the	   importance	   of	   effective	   design	   in	   the	   success	   of	  
software.	  	  
Not	   only	   should	   software	   be	   usable,	   it	   should	   also	   be	   supported	   by	   adequate	   user	  
documentation,	   video	   tutorials	   and/or	  workshops.	   As	   the	   functionality	   of	   a	   piece	   of	  
software	   increases,	   it	   inherently	  becomes	  more	  complex	  and	  so	  user	  documentation	  
and	   support	   becomes	   imperative.	  Many	   successful	   projects,	   such	   as	  MaxQuant	   and	  
Skyline,	  have	  created	  user	  groups.	  These	  user	  groups	  aid	  in	  establishing	  a	  community	  
of	  users	  who	  can	  help	  one	  another	  and	  answer	  questions,	   removing	  the	  pressure	  on	  
developers	   to	   answer	   all	   questions.	   Furthermore,	   having	   workshops	   at	   conferences	  
and	   holding	   dedicated	   user	   group	   gatherings,	   like	   the	   MaxQuant	   Summer	   School,	  
provide	  opportunities	  for	  users	  to	  speak	  with	  developers	  and	  gain	  hands-­‐on	  training.	  	  
Integrating	   computing	   with	   ‘wet’	   experiments	   is	   another	   challenge	   that	   is	   often	  
underestimated.	   The	   complex	   nature	   of	   the	   research,	   carried	   out	   by	   biologists,	   is	  
difficult	   to	   communicate	   and	   can	   act	   to	   hinder	   collaborations	   between	   the	   two	  
disciplines.	   Establishing	   effective	   communication	   is	   pertinent,	   as	   a	   software	  
development	  project	   cannot	   succeed	  without	  effective	   two-­‐way	  communication	   that	  
allows	  focused	  and	  well	  articulated	  requirements	  to	  be	  elicited	  and	  implemented.	  	  
Another	   major	   challenge	   for	   laboratories	   is	   the	   high	   licensing	   costs	   of	   software,	  
especially	  for	  tailor	  made	  applications.	  As	  seen	  from	  Table	  3,	  software	  entails	  multiple	  
costs	  in	  terms	  of	  purchase	  and	  paying	  for	  support,	  which	  often	  comes	  as	  an	  additional,	  
yearly	  subscription	  fee.	  Even	  if	  a	  laboratory	  decides	  to	  opt	  for	  an	  open-­‐source	  software	  
package,	  they	  are	  then	  reliant	  on	  the	  software	  developers	  to	  maintain	  the	  solution	  and	  
keep	   it	   up-­‐to-­‐date	  and	   compatible	  with	  other	   analysis	   software	   that	   the	   researchers	  
either	  must,	  or	  may	  want	  to	  use	  in	  parallel.	  	  
Where	   there	   is	   an	   evident	   gap	   in	   the	  market	   for	   software	   with	   novel	   functionality,	  
there	   is	   a	   case	   for	   biological	   research	   laboratories	   to	   commission	   research	   and	   to	  
create	  tailor	  made	  software	  tools	  that	  can	  meet	  the	  demands	  of	  their	  research	   in	   its	  
advanced	   state.	   However,	   it	   should	   be	   understood	   that	   under	   these	   circumstances,	  
considerable	  thought	  and	  effort	  is	  required	  to	  establish	  a	  team	  of	  software	  developers	  
that	   will	   be	   responsible	   for	   implementing	   functionality,	   as	   well	   as	   continuing	   to	  
47	  
maintain	   and	   support	   the	   software.	   Table	   1	   lists	   successful	   software	   developed	   in	  
research	   laboratories.	   From	   the	  details	  of	   the	   software	  development,	   it	   is	  evidenced	  
that	  these	  laboratories	  view	  this	  software	  as	  a	  major	  resource	  that	  requires	  significant	  
development	   effort.	   Furthermore,	   these	   software	   are	   supported	   through	   multiple	  
methods,	  including	  videos,	  tutorials	  and	  workshops.	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Yates	  Laboratory	  (http://fields.scripps.edu/researchtools.php)	  
DTASelect	  organizes	  and	  filters	  SEQUEST	  identifications,	  
reducing	  the	  time	  required	  to	  interpret	  the	  results	  for	  each	  
sample.	  Contrast	  differentiates	  multiple	  samples	  and	  
comprises	  a	  powerful	  meta-­‐analytical	  tool.	  
2	  
Tutorial,	  Manual,	  Email	  Address	  
Freeware	  






Mann	  Laboratory	  (http://maxquant.org/)	  
Quantitative	  proteomics	  software	  package	  designed	  for	  
analysing	  large	  mass-­‐spectrometric	  data	  sets.	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Aebersold	  Laboratory,	  Institute	  for	  Systems	  Biology	  
(http://peptideprophet.sourceforge.net/)	  
(http://proteinprophet.sourceforge.net/)	  
Automatic	  validation	  of	  peptide	  assignments	  from	  database	  
search	  programs,	  such	  as	  SEQUEST,	  to	  MS/MS	  spectra.	  
4	  
Video	  Tutorial,	  Written	  Tutorial,	  Workshops,	  Forum,	  Mailing	  
List	  	  
Open	  Source	  








MacCoss	  Lab	  Software	  
(https://skyline.gs.washington.edu/labkey)	  	  
Windows	  client	  application	  for	  building	  Selected	  Reaction	  
Monitoring	  (SRM)	  /	  Multiple	  Reaction	  Monitoring	  (MRM)	  and	  
Full-­‐Scan	  (MS1	  and	  MS/MS)	  quantitative	  methods	  and	  
analysing	  the	  resulting	  mass	  spectrometer	  data.	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Pacific	  Northwest	  National	  Laboratory	  
(http://omics.pnl.gov/software/)	  
Multiple	  tools	  to	  aid	  with	  the	  analysis	  of	  mass	  spectrometry	  
data,	  including	  Fasta	  File/Protein	  Sequence/Protein	  Database	  
related	  tools,	  MS	  &	  MS/MS	  Analysis,	  Data	  Analysis	  &	  Data	  
Presentation,	  MS	  Data	  File	  Utilities	  and	  Mass	  Spectrometry	  
Auxiliary	  tools.	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Written	  Tutorials/Help	  Guides,	  Workshops	  
Open	  Source	  
Table	  1:	  Successful	  Research	  Laboratory	  Software.	  
In	   research	   laboratories,	   not	   all	   requirements	  will	   be	  well	   defined	  and,	   furthermore,	  
these	   requirements	   will	   continuously	   evolve.	   Hence	   the	   task	   of	   creating	   software	  
should	  be	  viewed	  as	  an	  on-­‐going	  effort	  as	  opposed	  to	  a	  short-­‐term	  project.	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For	   successful	   uptake,	   software	   development	   in	   proteomics	   requires	   the	  
implementation	   of	   novel	   software	   that	   is	   automated,	   robust	   and	   user-­‐friendly	  
(Gershon,	   2003).	   The	   above	   challenges	   should	   all	   be	   considered	   to	   ensure	   a	  
sustainable	  solution.	  
1.2.3 Comparison of Existing Software 
Shown	  below	  is	  a	  table	  summarising	  the	  main	  downstream	  analysis	  software	  available	  
for	  analysing	  quantitative	  mass	  spectrometry	  datasets.	  These	  software	  contain	  a	  suite	  
of	   tools	   that	   work	   collectively	   to	   allow	   full	   analysis	   of	   mass	   spectrometry	   datasets.	  
There	   are	  many	   other	   tools	   developed	   by	   research	   laboratories	   that	   have	   not	   been	  
included	   in	  the	  comparison	  below	  as	  these	  tools	  carry	  out	  specific	   tasks	  that	  are	  not	  
comparative	   to	  enterprise	   level	  applications.	  Table	  3	  shows	  a	   review	  of	   the	  different	  
software.	  	  
Software	   Supplier	  
MaxQuant	   Mann	  Laboratory	  
http://maxquant.org/	  
PepTracker	   Lamond	  Laboratory	  
http://www.peptracker.com/moreInformation/	  

















Skyline	   MacCoss	  Lab	  Software	  	  
https://skyline.gs.washington.edu/labkey	  
Table	  2:	  Major	  Mass	  Spectrometry	  Data	  Analysis	  Software.	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MaxQuant	   Desktop	   No	   Quant.	   Yes	   -­‐	   No	   Thermo	  
PepTracker	   Web	  &	  
Desktop	  
Yes	   External	  
Tools,	  e.g.	  
MaxQuant	  
Yes	   -­‐	   Yes	   *	  




No	   Various	  
ProteinScape	   Desktop	   Yes	   Quant.	  
(WARP-­‐LC	  
Module)	  
Yes	   Yes	   No	   Bruker	  





No	   *	  
Proteome	  
Discoverer	  
Desktop	   No	   Quant.	   Yes	   £10,000	   No	   Thermo	  
Scaffold	  3	  Q+	   Desktop	   No	   Quant.	   ITRAQ	  
Labelled	  
$5,995	   No	   *	  
Skyline	   Desktop	   No	   Quant.	   Label-­‐Free	  
Only	  
-­‐	   No	   Various	  
*	  Software	  does	  not	  deal	  with	  raw	  data,	  instead	  takes	  data	  from	  external	  search	  engines.	  
Table	  3:	  Comparison	  of	  Major	  Mass	  Spectrometry	  Data	  Analysis	  Software.	  
Table	  3	  shows	  that,	  besides	  PepTracker	  (the	  software	  developed	  during	  this	  research),	  
all	  of	  the	  software	  are	  desktop	  based,	  not	  making	  use	  of	  a	  web	  platform.	  Furthermore,	  
some	  of	  the	  software,	  namely	  Progenesis,	  Scaffold	  3	  Q+	  and	  Skyline,	  limit	  themselves	  
to	   work	   with	   data	   generated	   from	   label-­‐free	   or	   labelled	   samples	   only.	   None	   of	   the	  
other	  software	  incorporate	  a	  LIMS,	  apart	  from	  ProteinScape,	  which	  couples	  their	  LIMS	  
closely	  with	  Bruker	  instruments.	  Another	  feature	  lacking	  in	  the	  software	  is	  the	  ability	  
to	  warehouse	  data	  from	  multiple	  researchers	  and	  experiments,	  which	  would	  allow	  for	  
further	   extensive	   analysis.	   In	   addition,	   commercial	   companies	   were	   behind	   the	  
development	  of	  all	   software	  with	   the	  exception	  of	  MaxQuant,	  which	  often	   results	   in	  
the	   development	   of	   software	   being	   displaced	   from	   the	   actual	   science	   carried	   out	   in	  
research	  laboratories.	  PepTracker’s	  unique	  focus	  on	  downstream	  analysis	  coupled	  with	  
data	  warehousing	  sets	  it	  apart	  from	  the	  other	  software	  reviewed,	  this	  is	  evident	  by	  the	  
built-­‐in,	   centralised,	   data	   warehouse	   in	   PepTracker.	   Rather	   than	   duplicating	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functionality	   already	   available	   in	   other	   software,	   PepTracker	   in	   fact	   makes	   use	   of	  
MaxQuant	  for	  quantitation	  of	  mass	  spectrometry	  data	  in	  its	  workflow.	  
1.2.3 Experimental Data Workflow 
Solutions	   are	   needed	   that	   can	   transparently	   take	   the	   data	   being	   generated	   by	   MS	  
instruments	  and	  interpret	  it	  so	  that	  it	  may	  be	  stored	  in	  a	  manner	  that	  facilitates	  future	  
analysis	   and	   processing.	   This	   is	   not	   a	   simple	   task	   due	   to	   the	   large	   variety	   of	   MS	  
instrument	   platforms,	   such	   as	   ion	   traps,	   quadrupole/time-­‐of-­‐flight,	   ion	   cyclotron	  
resonance	  and	  time-­‐of-­‐flight/time-­‐of-­‐flight,	  which	  have	  caused	  a	  number	  of	  different	  
proprietary	  data	  formats	  and	  incompatible	  systems	  to	  be	  developed,	  adhering	  to	  their	  
own	  rules	  and	  structures.	  Often	  tools	  that	  are	  developed	  for	  data	  processing	  are	  tied-­‐
in	  with	   instruments,	   such	  as	   the	  WARP-­‐LC	  module	  developed	  by	  Bruker	   for	  use	  with	  
data	  produced	  from	  Bruker	  instruments,	  making	  the	  task	  of	  comparable	  data	  analysis	  
near	  impossible.	  The	  various	  file	  formats	  associated	  with	  the	  range	  of	  instrumentation	  
include	   XCalibur/RAW	   (Thermo	   Electron),	   Analyst/WIFF	   (ABI	   and	   MDS	   Sciex),	  
MassLynx/RAW	   (Waters)	   or	   BAF	   (Bruker).	   This	   tactic	   of	   coupling	   data	   formats	   to	  
instruments	   ensures	   that	   researchers	   are	   restricted	   to	   using	   hardware	   and	   software	  
from	  one	   instrument	   provider,	   hence	   benefitting	   companies.	  Due	   to	   the	   proprietary	  
nature	  of	  such	  software,	  they	  are	  not	  developed	  or	  documented	  extensively	  because	  
the	   companies	   creating	   them	   have	   a	   greater	   emphasis	   on	   the	   development	   of	  
instrumentation,	  which	  is	  the	  core	  focus	  of	  their	  business	  model.	  Due	  to	  these	  reasons,	  
writing	  software	  to	  be	  vendor	  neutral	  is	  very	  important.	  This	  issue	  has	  been	  tackled	  by	  
third	  party	  software,	  such	  as	  RAW2msm	  and	  the	  Trans	  Proteomic	  Pipeline	  (TPP),	  which	  
convert	   mass	   spectrometer	   files	   to	   readable	   file	   formats	   that	   can	   be	   passed	   into	  
proteomic	   search	   engines	   for	   further	   processing.	   In	   order	   to	   carry	   out	   database	  
searching,	   search	  engines,	   such	  as	  MASCOT	   (www.matrixscience.com)	   (Perkins	  et	  al.,	  
1999),	   SEQUEST	   (Eng	   et	   al.,	   1994)	   or	   X!Tandem	   (Fenyo	   and	   Beavis,	   2003),	   require	  
proprietary	   data	   formats	   to	   be	   converted	   into	   common	   text	   file	   formats,	   such	   as	  
mzXML	   or	   mzML,	   and,	   in	   some	   cases,	   to	   mgf	   (MASCOT),	   dta	   (SEQUEST)	   or	   pkl	  
(ProteinLynx,	  Micromass)	  (Nesvizhskii	  and	  Aebersold,	  2004).	  
Once	  search	  engines	  have	  the	  data	  in	  a	  readable	  format	  they	  have	  the	  capabilities	  to	  
convert	   the	  mass	  spectral	  data	   into	  peak	   lists	  with	  associated	   intensity	  values.	  Using	  
these	  peak	  lists	  the	  software	  then	  carry	  out	  the	  task	  of	  identification,	  using	  externally	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available	  sequence	  databases,	  which	  involves	  mapping	  the	  mass	  spectra	  produced	  by	  
an	   MS	   instrument	   to	   identified	   peptides	   and	   thereby	   map	   to	   genome-­‐encoded	  
proteins.	  	  They	  are	  also	  responsible	  for	  filtering	  out	  less	  reliable	  identifications.	  This	  is	  
one	   of	   the	   most	   important	   phases	   of	   high-­‐level	   data	   processing	   in	   a	   proteomics	  
pipeline.	   After	   protein	   and	   peptide	   identifications	   have	   been	   made,	   quantification	  
software,	  such	  as	  MsQuant	  (Schulze	  and	  Mann,	  2004)	  and	  MaxQuant	  (Cox	  and	  Mann,	  
2008),	  can	  be	  used	  to	  extract	  meaningful	  ratios	  (for	  labelled	  protein/peptide	  scenarios)	  
or	   intensity	   (for	   label-­‐free	   scenarios)	   values	   from	  multiple	  mass	   spectra.	  This	   further	  
processing	  is	  carried	  out	  in	  quantitative	  experiments	  to	  determine	  protein	  expression	  
levels.	  The	  outcome	  of	  this	  upstream	  processing	  is	  a	  set	  of	  textual	  data	  that	  should	  be	  
easier	   to	   handle.	   However,	   further	   complications	   arise,	   as	   only	   specific	   versions	   of	  
Microsoft	  Excel,	  the	  choice	  tool	  for	  analysis	  by	  scientists,	  can	  open	  these	  large	  files	  and	  
in	   some	  cases	   the	   files	   are	   too	  big	   to	  be	  opened	   in	  all	   versions	  of	   Excel	   and	   require	  
either	  command	  line	  access,	  or	  a	  more	  basic	  application,	  such	  as	  Notepad.	  
	  
Figure	  5:	  Mass	  spectrometry	  data	  workflow.	  
1.2.4 Workflow Management Systems 
As	   described	   above,	   the	   processing	   involved	   with	   proteomics	   data	   is	   a	   multi-­‐step	  
procedure	  (Kearney	  and	  Thibault,	  2003,	  Baldwin,	  2004).	  	  Due	  to	  the	  various	  tools	  that	  
have	  been	  developed,	  each	  performing	  specialised	  tasks,	  there	   is	  an	  obvious	  need	  to	  
create	  technologies	  that	  can	  connect	  data	  and	  tools.	  However,	  when	  trying	  to	  achieve	  
this	   task,	   the	   issue	  of	   interoperability	  arises,	  whereby	   the	  appropriate	  standards	  and	  
infrastructure	  are	  not	  available	   leading	   to	   inter-­‐application	  communication	  problems	  
(Neerincx	  and	  Leunissen,	  2005).	  The	  lack	  of	  standard	  data	  formats	  and	  definitions	  has	  
been	  a	  major	  problem	  for	  a	  long	  time.	  It	  has	  been	  suggested	  that	  the	  issues	  related	  to	  
inter-­‐application	   communication	   can	   be	   overcome	   through	   implementation	   of	   an	  
automated	  linear	  pipeline	  (Domon	  and	  Aebersold,	  2006).	  The	  Workflow	  Management	  
Coalition	   (WfMC)	   describes	   this	   as	   a	   Workflow	   Management	   System	   (WMS)	   and	  
provides	  the	  following	  definition:	  “[A	  WMS]	  defines,	  manages	  and	  executes	  workflows	  
through	  the	  execution	  of	  software	  whose	  order	  of	  execution	  is	  driven	  by	  a	  computer	  
representation	   of	   the	   workflow	   logic”.	   A	   number	   of	   attempts	   have	   been	   made	   to	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represent	   the	   daily	   work	   of	   scientists	   within	   an	   automated	   pipeline	   using	   a	   WMS.	  
Some	  examples	  of	  these	  include:	  
• Trans-­‐Proteomic	  Pipeline	  (TPP)	  (Keller	  et	  al.,	  2005)	  
• Taverna	  (Oinn	  et	  al.,	  2004)	  
• Biopipe	  (Hoon	  et	  al.,	  2003)	  
• BioWMS	  	  (Bartocci	  et	  al.,	  2007)	  
• Wildfire	  (Tang	  et	  al.,	  2005)	  
• Pegasys	  (Shah	  et	  al.,	  2004).	  
The	   generation	   of	   automated	   workflows	   can	   involve	   the	   creation	   of	   a	   central	   data	  
repository,	  which	   is	  often	  a	  Relational	  DataBase	  Management	  System	  (RDBMS).	  Data	  
from	   the	  multiple	   software	   packages	   in	   the	   pipeline	   feed	   into	   this	   central	   database.	  
Often,	  the	  software	  fitting	  into	  the	  pipeline	  can	  also	  be	  customised.	  However,	  many	  of	  
the	   pipelines	  mentioned	   above	   are	   restricted	   to	  working	  with	   specific	   software	   that	  
have	  an	  accessible	   interface	  and	  new	  pieces	  of	   software	   that	  do	  not	  conform	  to	   the	  
standards	  defined	  by	  the	  WMS	  can	  not	  be	  incorporated	  into	  the	  pipeline.	  	  
Another	   issue	   that	   arises	   in	   the	   creation	   of	   pipelines	   in	   life	   sciences	   research	   is	  
transparency.	  Analysis	  of	  use	  cases	  from	  the	  BioMOBY	  (Wilkinson	  et	  al.,	  2003)	  project	  
have	  shown	  that	  scientists	  often	  want	  to	  view	  intermediate	  results	  to	  understand	  why	  
an	   automated	   pipeline	   produced	   certain	   results.	   This	   is	   not	   always	   apparent	   in	  
workflows,	  which	   simply	   take	   an	   input	   and	  produce	   a	   set	   of	   results	   as	   a	   standalone	  
output.	   Developers	   should	   thus	   maximise	   the	   traceability,	   reproducibility	   and	   a	  
compositional	   nature	   within	   an	   automated	   workflow	   (Bartocci	   et	   al.,	   2007).	   Other	  
challenges	   within	   existing	   workflows	   include	   the	   cost	   and	   effort	   involved	   in	  
maintaining	   solutions.	   These	   issues	   are	  enhanced	  due	   to	  data	   and	   software	   changes	  
that	  occur	  frequently	  in	  a	  rapidly	  advancing	  research	  field,	  such	  as	  proteomics.	  	  
1.2.5 Potential for Collective Data Analysis  
When	   new	   techniques	   became	   available	   for	   large-­‐scale	   protein	   identification,	   many	  
people	   involved	   themselves	   in	   the	   production	   of	   large	   quantities	   of	   data	   that	   were	  
poorly	   organised	   and	   quickly	   became	   impossible	   to	   manage.	   Developing	   a	   well-­‐
documented	   data	   store	   means	   that	   analysis	   tools	   can	   be	   built	   to	   process	   the	   data	  
without	   being	   concerned	   with	   the	   disparities	   in	   data	   formats	   of	   the	   original	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instruments	   or	   upstream	   processing	   software.	   The	   development	   of	   software,	   to	  
analyse	   data,	   can	   allow	   scientists	   to	   make	   new	   discoveries	   that	   would	   otherwise	  
require	  great	  effort.	  The	  tools	  created	  must	  produce	  accurate	  and	  reproducible	  results	  
through	   a	   transparent	   analysis	   process	   (Nesvizhskii	   et	   al.,	   2007).	   An	   analysis	   of	   the	  
results	   can	   be	   presented	   in	   various	   forms	   due	   to	   the	   variety	   of	   questions	   that	  
biologists	  may	  want	  answered.	  Hence,	  it	  makes	  sense	  for	  analysis	  software	  to	  consist	  
of	   separate	  components	   that	  can	  each	   retrieve	  and	  examine	  specific	  data	   in	  defined	  
ways.	  Individual	  researchers,	  generating	  data,	  will	  currently	  carry	  out	  the	  downstream	  
analysis	   of	   their	   quantitative	   proteomics	   data.	   Due	   to	   the	   lack	   of	   structure	   and	  
organisation	   of	   quantitative	   data	   there	   has	   been	   very	   little	   work	   on	   developing	  
applications	   to	   carry	   out	   automated	   analysis.	   Automated	   analysis	   could	   potentially	  
reveal	   data	   contained	   within	   the	   spectra	   that	   may	   be	   missed	   on	   a	   first	   targeted	  
investigation.	   This	   is	   a	   potential	   goldmine	  which	   presents	   an	   untapped	   avenue	   that	  
could	   answer	   many	   biological	   questions	   that	   are	   simply	   too	   difficult	   to	   tackle	   in	   a	  
manual	  effort.	  	  
1.2.6 Data Recording & Collection  
In	   order	   to	   ensure	   successful	   analysis,	   it	   is	   also	   imperative	   to	   record	   the	   metadata	  
describing	  the	  experiment	  and	  conditions	  used	  to	  generate	  the	  data	  being	  analysed.	  In	  
addition,	   it	   is	   essential	   for	   researchers	   to	   share	   knowledge	   regarding	   the	   data	  
processing	   parameters	   and	   quality	   (Domon	   and	   Aebersold,	   2006).	   These	   metadata	  
must	  be	  readily	  available	  in	  a	  common	  format,	  especially	  for	  comparative	  data	  studies.	  
Having	   an	   agreed	   standard	   data	   definition	   allows	   researchers	   to	   directly	   compare	  
related	  experiments	  and	  come	  to	   logical	  conclusions.	  Without	  this	   information,	  using	  
pre-­‐existing	   datasets	   can	   be	   questionable	   as	   their	   reliability	   cannot	   be	   guaranteed.	  
Without	  actual	  metadata,	  scientists	  must	  make	  assumptions	  that	  can	  be	  incorrect	  and	  
lead	   to	   false	   discoveries.	   Hence,	   the	   inclusion	   of	   metadata,	   both	   annotation	   and	  
protocol	   information,	  must	  be	   included	  within	   standards	   relating	   to	  high	   throughput	  
proteomics	  data.	   Published	  guidelines	   (Bradshaw,	  2005,	  Bradshaw	  et	   al.,	   2006)	  have	  
provided	   direction	   on	   what	   this	   metadata	   should	   consist	   of.	   These	   guidelines	  
specifically	  mention	  the	  inclusion	  of	  the	  parameters	  used	  when	  running	  software	  that	  
carries	  out	  database	  searching.	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Research	   has	   shown	   that	   traditional	   approaches	   to	   metadata	   collation	   and	  
management,	   i.e.	   laboratory	   notebooks	   (lab	   books),	   are	   no	   longer	   meeting	   the	  
demands	  of	  multi-­‐user,	  multi-­‐tasking	  labs	  (Piggee,	  2008).	  The	  problems	  with	  lab	  books	  
can	   be	   summarized	   into	   two	   main	   features:	   they	   are	   paper	   based	   and	   difficult	   to	  
search.	  Paper	  based	  solutions	  require	  greater	  space	  to	  store	  and	  are	  therefore	  often	  
locked	   away	   in	   locations	   that	   are	   not	   easily	   accessible.	   Furthermore,	   finding	   the	  
correct	   lab	   book	   can	   be	   impossible	   and	   attempting	   to	   read	   the	   handwriting	   in	   the	  
book,	  even	  more	  difficult.	   Problems	  also	  arise	  with	   issues	  of	   security	  and	   in	   keeping	  
reliable	  and	  archived	  copies.	  In	  contrast,	  computers	  are	  ideal	  tools	  for	  providing	  quick	  
access	  to	  large	  quantities	  of	  data.	  Automation	  of	  such	  activities	  has	  proven	  to	  increase	  
productivity	   as	   well	   as	   aid	   in	   the	   advancement	   of	   research	   (Smallmon	   and	   Ganjei,	  
2004).	  	  
By	   recording	   the	   various	   steps	   of	   an	   end-­‐to-­‐end	   experiment	   and	   analysis	  
computationally,	  it	  is	  possible	  to	  collect	  extensive	  metadata	  that	  can	  play	  a	  pivotal	  role	  
when	  revisiting	  experiments	  and	  analyses	  carried	  out	  in	  the	  past	  or	  when	  attempting	  
to	   use	   previous	   data	   in	   new	  analyses.	   This	   includes	   documenting	  where	   the	  original	  
raw	  files	  are	  stored	  during	  the	  MS	  instrument	  analysis	  so	  that	  the	  original	  data	  can	  be	  
re-­‐processed	  using	  newer	  versions	  of	  software.	  Scientists	  often	  carry	  out	  this	  type	  of	  
data	  management	  locally,	  on	  their	  own	  workstation,	  which	  makes	  tracking	  of	  samples	  
from	  the	  mass	  spectrometer	  to	  raw	  mass	  spectra	  and	  finally	  to	  the	  protein	  and	  peptide	  
identifications	   impossible.	   Further	   problems	   arise	   when	   the	   researcher	   leaves	   the	  
laboratory,	   taking	   a	   whole	   host	   of	   data	   with	   them	   and	   rendering	   the	   re-­‐analysis	   of	  
their	  data	  impossible.	  	  
1.2.7 Data Dissemination  
On	   a	   wider	   scale,	   further	   technological	   improvements,	   organisation	   of	   international	  
proteomics	  projects	  and	  open	  access	  to	  results	  are	  needed	  for	  proteomics	  to	  fulfil	   its	  
potential	   (Tyers	  and	  Mann,	  2003).	  Modern	   life	   sciences	   research	   laboratories	  are	  no	  
longer	  environments	  in	  which	  scientists	  work	  alone,	  they	  have	  progressed	  to	  carrying	  
out	  work,	  often	  with	  global	  ties,	  that	   is	  more	  quantitative	  and	  comparative	   in	  nature	  
(Domon	  and	  Aebersold,	  2006).	  	  The	  lack	  of	  common	  data	  formats	  and	  standards	  makes	  
it	   near	   impossible	   for	   researchers,	   from	   multiple	   laboratories,	   to	   compare	   their	  
datasets	   generated	   using	   various	   instruments	   and	   platforms.	   In	   fact,	   data	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dissemination	  has	  been	  described	  as	  the	  weakest	  area	  in	  proteomics	  research	  (Prince	  
et	   al.,	   2004,	   Rohlff,	   2004).	   The	   reasons	   for	   this	   are	   two-­‐fold,	   lack	   of	   technology	   to	  
accomplish	   dissemination	   of	   data	   and	   the	   attitudes	   of	   researchers.	   Attitudes	   of	  
researchers	   play	   a	   significant	   role	   due	   to	   the	   competitive	   nature	   of	   many	   scientific	  
fields,	   and	   issues	   of	   both	   psychology	   and	   peer-­‐review	   based	   funding	   mechanisms,	  
whereby	   free	   scientific	   communication	  of	   results	   is	  often	  not	  encouraged	   to	  provide	  
the	  originators	  of	  the	  data	  with	  a	  perceived	  competitive	  advantage	  and	  possibly	  help	  
them	  to	  obtain	  further	  funding.	  	  
Apart	   from	   the	   sociological	   reasons,	   there	   are	   also	   many	   logistical	   reasons,	   which	  
make	   it	   difficult	   to	   share	   data.	   These	   reasons	   relate	   to	   local	   data	   management,	  
standardisation	  and	  availability	  of	  public	  repositories	  (Martens,	  2006).	  In	  cases	  where	  
researchers	  do	  make	  their	  data	  available,	  it	  is	  commonly	  in	  the	  form	  of	  published	  lists	  
of	   proteins	   in	   a	   PDF.	   This	  makes	   the	   task	   of	   comparing	   data	   extremely	   tedious	   and	  
difficult	   for	   any	   substantial	   datasets.	   Not	   only	   is	   extracting	   data	   from	   a	   PDF	  
problematic	  but	  also	  the	  data	  are	  formatted	  differently	  from	  one	  PDF	  to	  another,	  for	  
example	  different	   accession	   systems	  may	  be	  used	   in	   datasets	   produced	  by	  different	  
users.	  Furthermore,	   in	   the	   field	  of	  proteomics,	  data	  age	  quickly,	  as	   illustrated	  by	   the	  
frequently	  changing	  protein	  accession	  numbers,	  resulting	  in	  published	  data	  becoming	  
out-­‐of-­‐date	  and	  inaccessible	  almost	  as	  soon	  as	  it	  is	  produced.	  Hence,	  there	  is	  a	  need	  to	  
archive	  these	  data	  in	  accessible	  repositories	  that	  can	  handle	  changing	  data	  over	  time	  
to	  promote	  sharing	  of	  data.	  This	  requires	  the	  use	  of	  common	  formats	  and	  standards	  to	  
ensure	   the	   data	   are	   easily	   readable	   and	   can	   be	   shared.	   Currently	   researchers	   are	  
unable	   to	   share	  datasets	  unless	   they	   are	   running	   samples	  on	   the	   same	  MS	  machine	  
and	  then	  using	  the	  same	  database-­‐searching	  program.	  
It	   is	   imperative	   that	  data	  dissemination	   issues	  are	  overcome	   to	   create	  a	   transparent	  
process	  of	  data	  communication	  that	  can	  benefit	   the	  global	   research	  community.	  The	  
benefits	   this	   would	   bring	   include	   consistent	   and	   more	   efficient	   assessment	   by	  
reviewers,	   additional	   citations	   and	  most	   importantly,	   the	   potential	   to	   generate	   new	  
results	   that	  will	   advance	   the	   field.	   	   In	   recent	  years,	  one	  of	   the	  efforts	   to	   try	  and	  aid	  
with	  sharing	  large	  datasets	  is	  Tranche	  (https://trancheproject.org).	  Tranche	  consists	  of	  
a	  network	  of	  computers,	  to	  which	  users	  can	  upload	  files	  and	  download	  files.	  Files	  can	  
be	  of	  any	  type,	  size	  and	  with	  encryption	  if	  required.	  However,	  Tranche	  acts	  only	  as	  a	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file	  storage	  and	  dissemination	  system,	  without	  focus	  on	  the	  content	  of	  files.	  Without	  
knowing	  which	  file	  you	  are	  looking	  for	  and	  the	  meaning	  of	  the	  data	  defined	  in	  the	  file	  
it	  is	  impossible	  to	  make	  use	  of	  the	  data	  –	  Tranche	  is	  designed	  only	  as	  an	  ideal	  solution	  
for	  sharing	  of	  large	  files.	  Hence	  data	  management	  solutions	  are	  required	  to	  hold	  data	  
in	  a	  searchable	  manner	  and	  provide	  a	  suitable	  format	  for	  sharing	  these	  data.	  	  
1.2.8 Public Data Repositories 
	  
Figure	  6:	  Abstract	  from	  Nature	  Biotechnology.	  
Based	  on	  the	  continuing	  realisation	  that	  data	  should	  be	  shared	  and	  openly	  available	  in	  
the	   life	  sciences	  community,	   journals	  are	  now	  recommending	  that	  data	  be	  deposited	  
in	  public	  repositories	  that	  are	  publicly	  available	  (see	  Figure	  6).	  Repositories	  have	  been	  
created	  to	  capture	  data	  and	  fill	  the	  gap	  that	  has	  become	  evident.	  Public	  repositories,	  
such	  as	   the	  PeptideAtlas	   (Institute	   for	  Systems	  Biology)	   (Desiere	  et	  al.,	  2005),	  Global	  
Proteome	  Machine	  Database	  (GPMDB)	  (Beavis	  Informatics)	  (Craig	  et	  al.,	  2004)	  and	  the	  
PRoteomics	   IDEntifications	   (PRIDE)	   Database	   (European	   Bioinformatics	   Institute)	  
(Jones	   et	   al.,	   2006),	   have	   all	   developed	   due	   to	   the	   needs	   of	   the	   constantly	   evolving	  
experiments	   and	   datasets.	   Even	   though	   these	   repositories	   have	   been	   extended	   and	  
expanded	  to	   include	  original	  spectra,	   links	  to	  associated	  proteins	  and	  genomics	  data,	  
they	   are	   still	   unable	   to	   handle	   quantitative	   proteomics	   data.	   In	   addition,	   these	  
repositories	   are	   mainly	   aimed	   at	   capturing	   published	   data	   as	   opposed	   to	   the	  
immediate	   data	   that	   researchers	   are	   working	   with.	   This	   raises	   the	   need	   for	   the	  
creation	  of	  local	  repositories	  for	  use	  within	  laboratories.	  
Public	   repositories	   often	   suffer	   from	   problems	   related	   to	   standards.	   If	   public	  
repositories	  are	   following	  specific	   standards	   then	   it	  becomes	  difficult	   for	   researchers	  
to	   understand	   and	   use	   the	   data	   for	   their	   own	   purposes.	   Furthermore,	   public	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repositories	   often	   accept	   data	  of	   varying	  quality	   from	  a	  wide	   range	  of	   authors	   from	  
different	   laboratories.	   It	   cannot	   be	   guaranteed	   that	   all	   of	   these	   sources	   will	   be	  
producing	   data	   of	   similar	   quality	   and	   reliability,	   as	   would	   be	   preferred	   or	   required	  
when	  documenting	  new	  discoveries.	  Hence,	  this	  leads	  to	  the	  need	  for	  privately	  owned	  
repositories,	   managed	   by	   laboratories,	   that	   link	   into	   external	   repositories	   for	  
supplementary	   data.	   These	   types	   of	   repositories	   must	   also	   be	   well	   maintained	   and	  
extendible	  to	  allow	  them	  to	  cope	  with	  the	  fast	  paced	  development	  of	  the	  proteomics	  
field	  and	  provide	  data	  to	  researchers	  in	  a	  readable	  format	  that	  is	  easily	  understandable	  
and	  usable.	  
1.2.9 Data Standards 
To	  make	  data	  accessible,	   laboratories	  must	  decide	  how	   to	   structure	  data	  when	   they	  
are	   making	   it	   available	   to	   others.	   However,	   either	   creating	   their	   own	   standards	   or	  
using	  specialised	  protocols	  often	  adds	  to	  the	  problem,	  as	  other	  researchers	  will	  not	  be	  
motivated	  or	  have	  the	  time	  or	  resources	  to	  incorporate	  data	  into	  an	  analysis	   if	  these	  
data	  differ	  in	  format	  to	  their	  own.	  Thus,	  researchers	  must	  design	  and	  develop	  common	  
standards	  that	  are	  universally	  readable.	  This	  situation	  is	  being	  tackled	  by	  organisations	  
such	   as	   the	   international	   HUman	   Proteome	  Organisation	   (HUPO)	   (Hanash	   and	   Celis,	  
2002).	  In	  2001,	  HUPO	  launched	  a	  project	  to	  involve	  the	  entire	  international	  community	  
in	   discussions	   to	   enable	   reaching	   a	   consensus	   over	   standards.	   In	   order	   to	   aid	   with	  
tackling	   standardisation	   issues,	   HUPO	   have	   developed	   the	   Proteomics	   Standards	  
Initiative	   (PSI)	   (Orchard	   et	   al.,	   2005).	   Standards	   and	   guidelines	   are	   already	   under	  
development	  in	  the	  form	  of	  the	  Minimal	  Information	  About	  a	  Proteomics	  Experiment	  
(MIAPE),	  the	  format	  for	  mass	  spectrometry	  data	  (mzData)	  as	  well	  as	  the	  standard	  for	  
analysis	   data	   (analysisXML).	   Further	   published	   standards	   (McDonald	   et	   al.,	   2004,	  
Pedrioli	   et	   al.,	   2004)	   and	   guidelines	   are	   available	   for	   those	   aiming	   to	   set	   standards	  
(Carr	  et	  al.,	  2004,	  Bradshaw,	  2005,	  Wilkins	  et	  al.,	  2006).	  In	  all	  of	  these	  efforts,	  one	  of	  
the	   most	   important	   issues	   highlighted	   is	   the	   reasoning	   that	   standards	   imply	   that	  
everyone	   conforms	   to	   a	   specific	   format,	   hence	   all	   attempts	   at	   creating	   proteomics	  
data	  standards	  must	  converge	  at	  some	  point,	  otherwise	  researchers	  shall	  be	  left	  with	  a	  
number	   of	   so-­‐called	   standards	   to	   choose	   from.	   When	   creating	   standards	   it	   is	  
imperative	  to	  involve	  all	  relevant	  parties	  in	  the	  discussions,	  including	  manufacturers	  of	  
instruments,	   the	   researchers	   carrying	   out	   ‘wet’	   laboratory	   experiments	   and	   the	  
software	  developers	  creating	  the	  processing	  and	  analysis	  software.	  It	  is	  encouraging	  to	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know	  that	  two	  of	  the	  main	  proteomics	  standards	  (mzXML,	  developed	  by	  the	  Institute	  
of	   Systems	  Biology	   in	   Seattle	   and	  mzData)	   are	  being	  merged	   into	  one	  new	   standard	  
mzML.	  MzML	   is	   a	   data	   format	   for	   the	   exchange	   and	   storage	   of	  mass	   spectrometer	  
files.	  The	  generation	  of	  these	  new	  standards	  has	  been	  an	  arduous	  process	  as	  there	  are	  
many	   sources	   and	   types	   of	   data	   generation	   in	   the	   proteomics	   field.	   At	   the	   time	   of	  
writing	  there	  are	  no	  agreed	  standards,	  draft	  or	  final,	  for	  quantitative	  proteomics	  data	  
generated	  during	  analysis	  of	  MS	  data.	  
Creating	  standards	  for	  data	  in	  the	  proteomics	  field	  is	  far	  from	  simple.	  The	  complexity	  
of	   proteomics	   leads	   to	   many	   issues	   when	   setting	   up	   new	   software,	   much	   of	   this	  
centring	  on	   the	  data	  being	   stored.	  An	  example	  of	   this	  would	  be	  protein	   annotation.	  
Despite	  the	  major	  advances	  made	   in	  documentation	  of	  metadata	  regarding	  proteins,	  
there	  are	   still	  many	  disagreements.	  One	  of	   the	  dominant	   issues	   surrounding	  protein	  
annotation	   is	   agreement	   on	   accession	   numbers.	   This	   stems	   from	   the	   varying	  
definitions	  of	  a	  protein	  in	  the	  highly	  dynamic	  environment	  of	  the	  cell.	  For	  example,	  a	  
researcher	  looking	  at	  a	  specific	  pathway	  in	  the	  cell	  will	   identify	  and	  publish	  a	  protein	  
under	   a	  new	  name	  and	  hence	  a	  new	  protein	  will	   be	  defined.	  However,	   at	   the	   same	  
time	   the	   set	   of	   amino	   acids	   making	   up	   the	   protein	   may	   be	   identified	   by	   another	  
researcher	  looking	  at	  the	  structure	  of	  a	  protein	  complex,	  hence	  the	  second	  researcher	  
would	  also	  rightly	  define	  this	  as	  an	  entirely	  new	  protein.	  These	  two	  instances	  that	  are	  
resultant	  from	  this	  scenario	  are	  in	  fact	  the	  same	  protein.	  As	  time	  goes	  on,	  with	  further	  
investigation,	  understanding	  of	  the	  two	  documented	  proteins	  is	  likely	  to	  be	  merged	  to	  
one	   novel	   protein.	   However,	   this	   type	   of	   scenario	  means	   that	   any	   database	   system	  
must	  be	  able	  to	  deal	  with	  this	  constantly	  changing	  data	  description	  and	  redundancy.	  
To	   tackle	   this	   issue,	   various	   data	   sources	   have	   developed	   their	   own	   accession	  
numbering	   system,	   which	   users	   are	   then	   forced	   to	   translate	   between.	   A	   further	  
complication	   of	   these	   varied	   accession	   systems	   arises	   due	   to	   the	   redundancy	   in	   the	  
accession	  numbers	  making	  them	  highly	  unstable,	  likely	  to	  be	  updated	  and	  occasionally	  
deleted.	   As	   well	   as	   changing	   continuously,	   multiple	   identifiers	   within	   one	   source	  
database	   may	   actually	   refer	   to	   a	   single	   protein.	   This	   form	   of	   redundancy	   is	   very	  
common	  and	  expected	  in	  data	  sources	  related	  to	  proteomics.	  	  
Without	   a	   common	   accession	   number	   for	   proteins,	   software	   developers	   have	   the	  
challenging	   task	  of	   continuously	   converting	  between	  accession	  numbers	   to	  carry	  out	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comparisons	   and	   retrieve	   information	   from	   different	   sources.	   To	   aid	   in	   this	   task,	   a	  
number	  of	  protein	  mapping	  services	  have	  been	  created	  to	  simplify	  the	  task	  of	  finding	  
proteins	   in	   multiple	   data	   sources.	   The	   Protein	   Identifier	   Cross-­‐Referencing	   (PICR)	  
Service	  (Cote	  et	  al.,	  2007)	  is	  one	  such	  tool.	  It	  provides	  an	  interactive	  web	  interface	  and	  
a	   Simple	  Object	   Access	   Protocol	   (SOAP)	  web	   service	   to	   translate	   between	   accession	  
systems.	  It	  has	  the	  capabilities	  to	  access	  identifiers	  from	  over	  60	  source	  databases	  and	  
is	   built	   around	   the	   UniProt	   Archive	   (UniParc),	   a	   non-­‐redundant	   source	   of	   protein	  
sequences.	  
The	  life	  sciences	  community	  have	  to	  address	  the	  issues	  described	  above	  in	  relation	  to	  
data	   acquisition	   and	   integration,	   processing,	   analysis	   and	   dissemination	   to	   make	  
progress	   in	   the	   field.	   The	   recent	   developments	   in	   instrumentation	   and	   scientific	  
protocols	  have	   led	   to	  data	   generation	  on	  a	   scale	  previously	  unknown	   to	   the	   field	  of	  
proteomics	  and	  almost	  unique	  in	  life	  sciences,	  with	  gene	  sequencing	  as	  one	  of	  the	  only	  
other	   examples	   of	   large-­‐scale,	   singular	   data	   generation	   endeavours.	   The	   problems	  
described	   make	   it	   evident	   that	   advancements	   in	   science	   have	   to	   be	   supported	   by	  
adequate	  developments	   in	   the	   field	  of	   computing.	  There	  are	  many	  new	  and	  exciting	  
discoveries	   to	   be	  made	   through	   cross-­‐disciplinary	  work	   that	   brings	   together	   science	  
and	  computing	  in	  a	  usable	  fashion	  that	  can	  enhance	  knowledge	  and	  understanding	  in	  
both	   fields.	   With	   the	   right	   support	   and	   development,	   the	   way	   in	   which	   data	  
management	  and	  analysis	   is	   tackled	   in	   laboratories	   can	  be	   revolutionised	   to	   support	  
novel	  avenues	  of	  analysis	  that	  were	  previously	  impossible.	  This	  opens	  up	  the	  possibility	  
to	   formulate	   and	   evaluate	   biological	   hypotheses	   that	   could	   lead	   to	   new	   biological	  
discoveries.	  	  
1.3 Data Visualisation Approaches 
1.3.1 Origins of Data Visualisation 
Data	  visualisation	  is	  an	  interdisciplinary	  subject	  area	  being	  investigated	  and	  applied	  to	  
heterogeneous	  data	  sources	  across	  many	  applications.	  Even	  though	  data	  visualisation	  
has	  mainly	  developed	  over	  the	  past	  30	  years,	  its	  origins	  come	  from	  2nd	  Century	  Egypt	  
where	  astronomical	  measurements	  were	  first	  recorded	  in	  table	  format	  (see	  Figure	  7)	  
(Few,	   2007).	   Current	   age	   data	   visualisation	   unites	   two	   sub-­‐areas,	   namely	   scientific	  
visualisation	  and	   information	  visualisation	  (Post	  et	  al.,	  2003).	  Card	  et	  al.	  describe	  the	  
difference	   between	   scientific	   visualization	   and	   information	   visualization	   as	   primarily	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based	  on	  the	  difference	  in	  input	  data.	  Scientific	  visualisation	  is	  applied	  to	  physical	  data	  
that	  often	  has	  a	  natural	  spatial	  mapping	  whereas	  information	  visualisation	  techniques	  
apply	  to	  abstract	  data	  without	  inherent	  spatial	  mappings	  (Card	  et	  al.,	  1999).	  However,	  
this	  distinction	  between	  the	  fields	  has	  been	  challenged	  by	   interest	   in	  visualisation	  by	  
the	   bioinformatics	   community	   for	   genomic	   data	   (Rhyne,	   2003).	   It	   has	   been	   rightly	  
identified	  that	  “information	  visualization	  is	  not	  unscientific,	  and	  scientific	  visualization	  
is	  not	  uninformative”	  (Munzner,	  2000).	  
	  
Figure	  7:	  Egyptian	  astronomical	  measurement	  table.	  
In	  1983	  Edward	  Tufte,	  described	  as	  the	  “Leonardo	  da	  Vinci	  of	  Data”,	  by	  The	  New	  York	  
Times,	   noted	   that	   “At	   their	   best,	   graphics	   are	   instruments	   for	   reasoning	   about	  
quantitative	   information.	   Often	   the	   most	   effective	   way	   to	   describe,	   explore,	   and	  
summarize	  a	  set	  of	  numbers	  -­‐-­‐	  even	  a	  very	   large	  set	  -­‐-­‐	   is	  to	   look	  at	  pictures	  of	  those	  
numbers.	   Furthermore,	   of	   all	   methods	   for	   analyzing	   and	   communicating	   statistical	  
information,	  well-­‐designed	  data	  graphics	  are	  usually	  the	  simplest	  and	  at	  the	  same	  time	  
the	  most	   powerful.”	   (Tufte,	   1983).	   In	   1987,	   a	   report	   was	   compiled	   by	   the	   National	  
Science	   Foundation	   (McCormick	   et	   al.,	   1987)	   describing	   visualisation	   as	   "the	   use	   of	  
computer	   graphics	   to	   create	   visual	   images	   which	   aid	   in	   understanding	   of	   complex,	  
often	  massive	   numerical	   representation	   of	   scientific	   concepts	   or	   results".	  Neither	   of	  
these	  prominent	  publications	   stated	   a	  difference	  between	   scientific	   and	   information	  
visualisation	   (Rhyne,	   2003).	   Both	   of	   these	   sub-­‐domains	   aim	   to	   use	   visual	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representation	   to	   facilitate	   knowledge	   discovery	   by	   taking	   advantage	   of	   the	   human	  
ability	  to	  spot	  patterns,	  trends	  and	  outliers.	  	  
1.3.2 Types of Data Visualisations 
Visualisations	   centre	   on	   displaying	   data	   using	   coordinate	   systems,	   colours,	   lines,	  
points,	   shading,	   numbers,	   symbols	   and	  words	   (Tufte,	   1983).	   The	   various	   reasons	   for	  
data	   visualisation	  have	  prompted	  a	  number	  of	  different	   visualisation	   components	   to	  
be	   developed.	   One	   class	   of	   visualisations	   is	   graphs,	   tables	   and	   diagrams,	   which	  
collectively	  fall	  under	  the	  category	  of	  charts.	  Even	  though	  the	  traditional	  table	  of	  data	  
is	  overlooked	  as	  a	  visualisation,	  the	  way	  in	  which	  data	  are	  visually	  arranged	  into	  rows	  
and	  columns	  make	  it	  one	  of	  the	  most	  popular	  and	  effective	  ways	  of	  presenting	  data.	  
Graphs,	  with	  their	  organisation	  of	  data	  using	  two-­‐dimensional	  coordinates,	  came	  much	  
later	   and	   researchers	   now	   commonly	   use	   charts,	   such	   as	   pie	   and	   bar,	   to	   convey	  
information.	  	  
Data	  features	  coupled	  with	  the	  way	  data	   is	  to	  be	  used	  and	  the	  context	  play	  a	  role	   in	  
how	   a	   visualisation	   is	   designed.	   The	   type	   of	   data	   involved	   will	   influence	   how	   it	   is	  
presented	  and	  mined.	  Data	  can	  vary	  from	  being:	  	  
• Hierarchical:	  organisation	  of	  data	  into	  several	  levels	  where	  each	  level	  is	  linked	  
to	  the	  one	  above	  and	  below	  it,	  for	  example	  cells	  can	  be	  classified	  into	  species,	  
organism,	  organ,	  tissue	  and	  so	  on,	  	  
• Spatial:	  where	  data	   is	   separated	  by	   location,	   for	   example	  data	   at	   the	   cellular	  
level	   can	   be	   collated	   for	   different	   cellular	   compartments	   such	   as	   cytoplasm,	  
nucleus,	  nucleolus	  etc.	  and/or	  	  
• Multi-­‐dimensional:	   data	   is	   defined	   by	   several	   dimensions,	   for	   example	   an	  
experiment	   can	   be	   described	   by	   many	   dimensions,	   for	   example	   cell	   type,	  
organism,	  treatment,	  date	  etc.	  	  
There	   are	   three	   main	   purposes	   for	   visualisations:	   data	   exploration,	   hypothesis	  
confirmation	  and	  visual	  presentation	  (Yeh,	  2006).	  John	  Tukey	  defined	  data	  exploration	  
as	   exploring	   data	   where	   the	   researcher	   does	   not	   know	   what	   they	   are	   looking	   for	  
(Tukey,	   1977).	   It	   has	   been	   found	   that	   spatial	   visualisations	   are	   the	  most	   effective	   in	  
this	  case	  as	  they	  allow	  unconstrained	  searching	  and	  undirected	  navigation	  to	  uncover	  
trends	  and	  anomalies.	  This	  is	  often	  carried	  out	  as	  a	  first	  stage	  in	  analysis	  and	  can	  lead	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to	  hypothesis	  generation.	  When	  a	  researcher	  would	  like	  to	  confirm	  a	  hypothesis	  they	  
believe	   to	  be	   true	   they	  need	   to	  be	   able	   to	   see	   relationships	   in	   data	   clearly.	   For	   this	  
task,	   traditional	  2D	   scatter	  plot	   representations	  of	  data	   can	  be	  very	   informative.	   For	  
visual	  presentation	  of	  data,	  the	  most	   important	  consideration	  should	  be	  the	  ease-­‐of-­‐
perception	  for	  unfamiliar	  viewers.	  	  
In	   recent	   years	   the	   web	   has	   become	   a	   viable	   medium	   for	   visualisation,	   which	   has	  
prompted	   design	   of	   new	   components	   that	   have	   built-­‐in	   interaction,	   animation	   and	  
graphics.	   The	   popularity	   of	   web-­‐based	   visualisation	   has	   been	   further	   enhanced	  
through	   larger	   companies	   becoming	   involved	   in	   the	   development	   of	   libraries	   of	  
visualisations.	  Google	  Finance	  is	  an	  example	  of	  a	  web-­‐based	  tool	  that	  has	  developed	  a	  
standard	  for	  interactive	  timeline	  charts	  and	  Google	  Maps	  has	  defined	  how	  interactive	  
maps	   should	   be	   used.	   	   Furthermore,	   Google	   have	   created	   Application	   Programming	  
Interfaces	   (APIs)	   such	   as	   the	   Google	   Chart	   API	   (see	   Figure	   8)	   and	   the	   Google	  
Visualisation	  API	  to	  allow	  software	  developers	  to	  quickly	  and	  easily	  incorporate	  Google	  
style	  charts	  into	  their	  own	  web	  applications.	  IBM	  is	  another	  company	  delving	  into	  the	  
world	   of	   visualisation	   through	   their	   offering:	  Many	   Eyes,	  which	   is	   an	   internet	   based	  
tool	   allowing	   users	   to	   upload	   their	   data	   and	   view	   it	   in	   a	   serious	   of	   pre-­‐defined	  
visualisations	   that	   are	   interactive.	   The	  Many	   Eyes	   visualisations	   can	   then	   be	   shared	  
through	  embedding	  into	  web	  pages	  etc.	  
	  
Figure	  8:	  Examples	  of	  charts	  available	  using	  the	  Google	  Chart	  API.	  	  
1.3.3 Potential for Data Visualisation in Life Sciences 
The	   main	   driving	   force	   behind	   data	   visualisation	   is	   the	   desire	   to	   make	   it	   easier	   to	  
reveal	  important	  information	  in	  complex	  data	  and	  accessing	  the	  ability	  to	  interact	  with	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data	   in	   novel	   ways.	   Furthermore,	   visualisations	   are	   an	   invaluable	   tool	   for	  
communication	   of	   results	   in	   research	   environments.	   Visualisations	   provide	   an	  
alternative	   interface	   for	   working	   with	   data	   that	   make	   use	   of	   human	   perception	  
abilities,	   for	   example	   researchers	   can	   gain	   insight	   and	   spot	   visual	   anomalies	   more	  
intuitively	  in	  graphical	  representations	  compared	  with	  lists	  of	  numbers.	  
Within	   life	   sciences	   many	   research	   laboratories	   follow	   the	   traditional	   route	   of	  
analysing	   data,	   which	   primarily	   revolves	   around	   an	   ‘Excel	   culture’,	   whereby	  
researchers	  extract	  data	  from	  multiple	  software	  and	  load	  them	  into	  spreadsheets	  and	  
perform	  their	  own	  calculations,	  making	  use	  of	  in-­‐built	  Excel	  functions	  and	  charts.	  This	  
raises	  the	  possibility	  of	  researchers	  failing	  to	  identify	  interesting	  discoveries,	  especially	  
in	  cases	  where	  a	  researcher	  has	  limited	  experience	  of	  analysing	  and	  manipulating	  the	  
type	  of	  data	  they	  are	  currently	  handling.	  By	  implementing	  standard	  visualisations	  that	  
are	  transparent,	  researchers	  could	  benefit	  both	  in	  scientific	  productivity	  and	  raise	  the	  
potential	   for	   major	   science	   breakthroughs,	   described	   as	   being	   on	   par	   with	  
supercomputers	  (McCormick	  et	  al.,	  1987).	  	  
The	  complexity	  of	  proteomics	  data	  makes	  it	  more	  difficult	  to	  understand	  if	  only	  viewed	  
as	   data	   in	   tabular	   format.	   In	   comparison	   to	   tabular	   data	   the	   human	   brain	   is	   more	  
susceptible	   to	   intuitively	   recognising	   patterns	   in	   visual	   displays.	   The	   best	   pattern	  
matching	  algorithm	  available,	  as	  well	  as	  the	  final	  decision	  making	  authority,	  is	  still	  the	  
mind.	  Researchers	  rely	  on	  their	  experience	  and	  knowledge	  to	  draw	  reliable	  and	  well-­‐
informed	   conclusions,	   which	   is	   difficult	   if	   not	   impossible	   to	   capture	   in	   a	   computer	  
system.	   Hence,	   using	   visualisations	   to	   complement	   automated	   data	   mining	   and	  
knowledge	  discovery	  can	  aid	  to	  uncover	  useful	  knowledge.	  	  
“Information	  visualization	  is	  becoming	  more	  than	  a	  set	  of	  tools	  and	  technologies	  and	  
techniques	  to	  understand	  large	  datasets.	   It	   is	  emerging	  as	  a	  medium	  in	  its	  own	  right,	  
with	   a	   wide	   range	   of	   expressive	   potential.”	   (Eric	   Rodenbeck,	   Founder	   &	   Creative	  
Director	  of	  Stamen	  Design).	  	  
Data	  visualisation	  provides	  researchers	  with	  another	  tool	  in	  their	  analysis	  of	  often	  very	  
complex	   and	   increasingly	   large	   volumes	   of	   data.	   This	   was	   realised	   in	   the	   National	  
Science	   Foundation	   report	   which	   described	   the	   problem	   and	   potential	   role	   of	  
visualisations	   in	   science	   stating	   “Users	   from	   industry,	   universities,	   medicine	   and	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government	   are	   largely	   unable	   to	   comprehend	   or	   influence	   the	   ‘fire	   hoses’	   of	   data,	  
produced	  by	  contemporary	  sources	  such	  as	  supercomputers	  and	  satellites,	  because	  of	  
inadequate	  Visualization	  in	  Scientific	  Computing	  tools”.	  Shared	  data	  visualizations	  can	  
further	  help	  with	  collaboration	  between	  researchers	  in	  science.	  
Visualisations	  have	  extended	   in	   recent	  years,	   from	  basic	  2D	  and	  3D	  environments	   to	  
dynamic	   multi-­‐dimensional	   environments.	   Multi-­‐dimensional	   data,	   which	   describe	  
data	   entities	   with	   more	   than	   three	   attributes,	   is	   becoming	   more	   popular	   in	   data	  
visualisation.	   There	   are	   some	   excellent	   examples	   of	   commercial	   multi-­‐dimensional	  
software	   in	   industry,	   including	   an	   in	   memory	   multi-­‐dimensional	   analytics	   tool	  
developed	   by	   Spotfire	   (http://spotfire.tibco.com/).	   The	   Spotfire	   DecisionSite	   is	   a	  
decision-­‐making	   software	   tool	   that	   helps	  users	   identify	   relationships	   and	  patterns	   in	  
data	   through	   interactive,	   visual	   approaches.	   With	   the	   generation	   of	   more	   complex	  
data	   and	   emergence	   of	   data	   warehousing	   and	   data	   mining,	   the	   application	   of	  
visualisation	  to	  high	  dimensionality	  datasets	  has	  become	  more	  relevant	  and	  required.	  	  
It	   should	   not	   be	   underestimated	   how	   useful	   static	   graphs,	   both	   on	   paper	   and	   in	  
electronic	  form,	  are	  in	  communicating	  a	  great	  deal	  of	  information.	  However,	  the	  layer	  
of	   interaction	   between	   researcher	   and	   data	   also	   plays	   a	   significant	   role	   when	  
researchers	   are	   at	   the	   exploration	   and	   analytics	   phase.	   This	   has	   prompted	   further	  
research	   and	   developments	   in	   the	   Human	   Computer	   Interaction	   (HCI)	   field,	   which	  
looks	  at	  the	   interaction	  between	  user	  and	  graphical	  user	   interface.	  The	  development	  
of	   interactive	   interfaces,	   such	   as	   the	   point-­‐and-­‐click	  mouse	   interface,	   the	  what-­‐you-­‐
see-­‐is-­‐what-­‐you-­‐get	   (WYSIWYG)	   interface,	   drag-­‐and-­‐drop	   interfaces	   and	   hierarchical	  
file	  browsers,	  have	  pushed	  visualisations	  to	  evolve	  to	  provide	  increased	  interactivity	  in	  
intuitive	  ways.	  By	  providing	  a	  more	  immersive	  environment	  with	  suitable	  interactivity,	  
researchers	   have	   the	   ability	   to	   quickly	   assimilate	   and	   interact	   with	   their	   data	   and	  
generate	  hypotheses.	  	  	  
1.3.4 Problems with Data Visualisations 
Data	   visualisation	   is	   often	   greatly	   under	   estimated	   due	   to	   lack	   of	   understanding.	  
Current	   visualisation	   tools	   in	   life	   sciences	   suffer	   from	   problems	   making	   them	   less	  
efficient	   in	  meeting	   their	   full	   potential	   in	   the	   scientific	   analysis	  pathway.	  The	   lack	  of	  
real-­‐time	   interactivity	   with	   simple	   charts	   can	   be	   frustrating	   for	   researchers.	   On	   the	  
other	   hand,	   making	   visualisations	   very	   complex	   can	   also	   make	   them	   more	   of	   a	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hindrance.	   In	   these	  situations,	   researchers	  will	  opt	   to	  discard	  and	   fail	   to	  adopt	   these	  
visualisations	  into	  their	  standard	  analysis	  workflow.	  This	  can	  lead	  to	  researchers	  being	  
disillusioned	  as	  to	  the	  full	  advantage	  of	  effective	  visualisations	  in	  exploration,	  analysis	  
and	   communication	   of	   their	   data.	   A	   successful	   visualisation	   should	   initially	   translate	  
understanding	   of	   data	   to	   a	   researcher	   through	   immediate	   perception	   of	   outliers,	  
clusters	   and/or	   trends.	   Follow	   up	   interactivity	   with	   the	   visualisation	   should	   provide	  
researchers	   with	   the	   ability	   to	   delve	   into	   their	   data.	   Superfluous	   functionality	   that	  
simply	  makes	  visualisations	  look	  good	  should	  not	  interfere	  with	  exploration	  of	  data	  for	  
useful	  research.	  	  
It	  is	  imperative	  to	  keep	  sight	  of	  the	  primary	  goal	  of	  data	  visualisations	  in	  life	  sciences	  
research,	  which	  is	  biological	  insight.	  Often	  developers	  will	  focus	  on	  the	  development	  of	  
impressive	  visualisations	  and	  fail	   to	  meet	  the	  aims	  of	   the	  scientific	  discovery	  process	  
(Bethel	  et	  al.,	  2009).	  It	  is	  also	  important	  to	  consider	  how	  users	  will	   interact	  with	  data	  
and	  then	  create	  an	  appropriate	  human	  computer	   interface.	   In	  order	  to	  ensure	  this	   is	  
implemented	  well,	   interactions	  with	  visualisations	   should	  be	   tested	  with	   researchers	  
to	  ensure	   they	  add	  benefit	   to	  analysis,	   rather	   than	  act	  as	  a	  distraction	  or	  hindrance.	  
However,	   objectively	   evaluating	   visualisations	   remains	   a	   fundamental	   issue	   that	   is	  
challenging	   to	   address	   due	   to	   the	   difficulty	   in	   defining	   objective	   criteria	   (Johnson,	  
2004).	  The	  phrase:	  “overview	  first,	  zoom	  and	  filter,	  then	  details-­‐on-­‐demand”	  from	  The	  
Visual	   Information-­‐Seeking	   Mantra	   (Shneiderman,	   1996),	   is	   a	   basic	   principle	  
summarising	  an	  excellent	   framework	   for	  designing	  visual	  data	  applications.	   Scientific	  
analysis	  centres	  around	  “What-­‐if”	  type	  of	  analysis,	  which	  makes	  the	  interactive	  nature	  
of	  visualisations	  a	  valuable	  tool	  for	  investigation	  of	  data	  to	  answer	  questions	  efficiently	  
and	  effectively	  (Johnson,	  2004).	  
When	  creating	  visualisations	  it	  is	  also	  important	  to	  consider	  screen	  sizes	  on	  which	  the	  
end-­‐visualisations	  will	  be	  viewed.	  It	  is	  key	  for	  researchers	  to	  have	  the	  ability	  to	  view	  a	  
complete	  visualisation	  on	  screen	  when	  attempting	   to	  determine	   trends	  and	  patterns	  
effectively.	   If	   a	   researcher	   is	   unable	   to	   view	   all	   data	   points	   then	   they	   are	   unable	   to	  
perceive	  the	  potential	  relationships	  that	  could	  lead	  to	  interesting	  discoveries.	  
Hans	  Rosling,	  who	   is	   a	  world	  health	   expert	   and	  data	   visionary,	   believes	   that	  making	  
information	  more	  accessible	  has	  the	  potential	  to	  change	  the	  quality	  of	  the	  information	  
itself.	   Rosling	   has	   demonstrated	   his	   belief	   in	   a	   series	   of	   TED	   talks	   using	   specially	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designed	  software,	  GapMinder	  (see	  Figure	  9),	  to	  show	  how	  statistics	  and	  data	  can	  be	  
made	   more	   accessible	   and	   lively.	   His	   talks	   have	   given	   him	   global	   prominence	   as	   a	  
visionary	  in	  the	  field.	  	  	  
	  
Figure	  9:	  Screenshot	  of	  GapMinder	  (http://www.gapminder.org).	  
In	  order	  to	  make	  accurate	  hypotheses	  and	  publish	  data	  in	  peer-­‐reviewed	  journals	  it	  is	  
important	  to	  ensure	  data	  are	  of	  a	  high	  standard,	  however	  many	  visualisations	  do	  not	  
take	  this	  into	  account	  and	  do	  not	  let	  researchers	  manipulate	  the	  data	  being	  displayed.	  
Data	  quality	  issues	  are	  ubiquitous	  within	  scientific	  measurements.	  It	  can	  be	  difficult	  to	  
comprehend	   their	   impact	   when	   viewing	   quality	   parameters	   as	   numbers	   in	   a	   list.	  
However,	  by	  visually	  seeing	  the	  data	  quality	  measurements	  researchers	  are	  less	  likely	  
to	  base	  hypotheses	  founded	  on	  irrelevant,	  incomplete	  or	  questionable	  data.	  This	  was	  
realised	  early	  on	  in	  the	  visualisation	  world	  with	  the	  National	  Science	  Foundation	  report	  
on	  visualisations	  stating	  “Scientists	  need	  an	  alternative	  to	  numbers	   .	   .	   .	  The	  ability	  of	  
scientists	  to	  visualize	  complex	  computations	  and	  simulations	  is	  absolutely	  essential	  to	  
insure	  the	  integrity	  of	  analyses,	  to	  provoke	  insights	  and	  to	  communicate	  those	  insights	  
with	  others.”	  (McCormick	  et	  al.,	  1987).	  This	  is	  very	  much	  true	  in	  the	  proteomics	  field,	  
as	   having	   a	   good	   understanding	   of	   data	   can	   lead	   to	   more	   reliable	   hypotheses	   and	  
follow	  up	  studies.	  One	  example	  of	  visualising	  data	  quality	  is	  through	  dynamic	  filtering	  
of	  values	  on	  a	  graph.	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Often	   developers	   of	   visualisations	   fail	   to	   spend	   adequate	   time	   considering	   and	  
understanding	  the	  underlying	  scientific	  data.	  This	  can	  be	  achieved	  by	  working	  directly	  
with	  researchers	  generating	  the	  data.	  It	  has	  been	  reported	  that	  there	  is	  no	  substitute	  
to	  working	  side-­‐by-­‐side	  with	  end	  users	  (Brooks,	  1996,	  Johnson,	  2004).	  It	  was	  predicted	  
early	  on,	  in	  the	  National	  Science	  Foundation’s	  report,	  that	  visualisations	  would	  be	  the	  
mechanism	  that	  would	  bring	  researchers	   into	   the	  computing	   loop	   (McCormick	  et	  al.,	  
1987).	  The	  report	  insisted	  that	  in	  order	  to	  develop	  successful	  visualisations	  it	  would	  be	  
important	   to	   foster	   interactions	   between	   researchers	   and	   visualisation	   experts.	  
Interdisciplinary	  teams	  are	  highly	  recommended	  as	  researchers	  have	  a	  unique	  insight	  
of	   the	   important	   factors	   in	   the	   underlying	   scientific	   data	   they	   have	   generated	   and	  
visualisation	  experts	  have	  the	  skills	  to	  implement	  high	  quality	  visual	  tools.	  
1.3.5 Web-Based Visualisation Technologies 
With	   the	   web	   increasingly	   being	   used	   for	   data	   accumulation,	   analysis	   and	  
dissemination,	  a	  number	  of	  technologies	  have	  arisen	  to	  allow	  programmers	  to	  create	  
rich	   interactive	   applications	   (RIAs).	   These	   types	   of	   applications	   benefit	   from	  a	   state-­‐
based	  client	  environment,	  whereby	   the	   researcher	  does	  not	  have	   to	   reload	  pages	  or	  
move	  between	  many	  pages.	  Technologies	  such	  as	  SilverLight	  (Microsoft),	  Flex	  (Adobe	  
Systems)	  and	  Google	  Web	  Toolkit	  (GWT)	  have	  the	  ability	  to	  send	  and	  receive	  data	  from	  
servers	   dynamically,	   without	   the	   need	   to	   reload	   the	   browser.	   Furthermore,	   these	  
technologies	   come	   with	   a	   collection	   of	   rich	   libraries	   that	   can	   be	   used	   to	   build	  
visualisations.	   A	   report	   by	   Gartner	   predicted	   that	   “Interactive	   visualisation	   will	   be	  
quickly	   accepted	   during	   the	   next	   two	   years	   as	   a	   common	   front	   end	   to	   analytical	  
application,	  driven	  by	  the	  ubiquity	  of	  rich	  Internet	  applications.”	  (Schlegel,	  2008).	  
The	  main	  difference	  between	  the	   three	  popular	  RIA’s	   is	   their	  mode	  of	  development,	  
with	  GWT	  compiling	   Java	  code	  to	   JavaScript,	  Silverlight	  compiling	  XAML	  to	  a	  XAP	  file	  
that	  runs	   in	   the	  Silverlight	  plug-­‐in	  and	  Adobe	  Flex	  compiling	  a	  combination	  of	  MZML	  
and	  Actionscript	  to	  a	  Flash	  swf	  file.	  Adobe	  Flex	  has	  more	  components,	  both	  built	  in	  and	  
available	   from	   the	   open	   source	   community,	   as	   compared	   to	   GWT	   and	   Silverlight.	  
Another	  major	  benefit	   of	  Adobe	  Flex	   is	   its	  partner	  product,	  Adobe	  Air,	  which	  allows	  
deployment	  of	  Adobe	  Flex	  applications	  on	  both	  web	  and	  desktop	  platforms.	  Compared	  
with	  GWT,	   Adobe	   Flex	   also	   has	   the	   upper	   hand	  with	   regards	   to	   its	  multimedia	   user	  
interfaces,	   with	   Flash	   Player	   providing	   a	   much	   more	   enhanced	   user	   experience	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compared	   to	   a	   web	   browser.	   Silverlight	   requires	   users	   to	   download	   and	   install	   a	  
custom	  Silverlight	  plug-­‐in	  to	  run	  their	  content.	  	  
In	   recent	   years	   developments	   such	   as	   HTML5	   are	   emerging	   as	   alternatives	   to	  
interactive,	   flash	   based	   web	   solutions.	   HTML5	   implements	   a	   canvas	   element	   and	  
Scalable	   Vector	   Graphics	   (SVG),	   providing	   interactivity	   within	   a	   supporting	   web	  
browser.	  In	  addition,	  Javascript	  libraries	  like	  WebGL	  (Web	  Graphics	  Library)	  can	  make	  
use	   of	   the	   HTML5	   canvas	   element	   to	   provide	   an	   API	   for	   rendering	   interactive	   3D	  
graphics.	  
However,	  unlike	  HTML5,	  tried	  and	  tested	  RIA	  technologies,	  such	  as	  Adobe	  Flex,	  work	  in	  
a	  well-­‐known	  and	  predictable	  run-­‐time	  environment,	  i.e.	  the	  Flash	  Player.	  Adobe	  Flex	  
has	  good	  performance,	   testing	  tools	  and	   internationalisation	  support.	  More	  recently,	  
Adobe	  Flex	  has	  also	  been	  donated	  by	  Adobe	  to	  the	  open	  source	  Apache	  Foundation,	  
which	  opens	  up	  the	  potential	  for	  the	  technology	  to	  grow	  with	  many	  developers	  able	  to	  
contribute	  directly	   to	   its	   rich	   libraries.	  Furthermore	   there	  are	  many	  convenient	   tools	  
for	   the	   development	   of	   Adobe	   Flex	   applications,	   including	   integrated	   development	  
environments	   (IDEs),	   compilers,	   debuggers	   and	   profilers.	   These	   tools	   make	   the	  
development	  and	  testing	  of	  web	  based	  applications	  much	  simpler	  than	  attempting	  to	  
accomplish	   the	   same	   functionality	   with	   a	   combination	   of	   HTML5	   and	   several	   other	  
technologies,	  including	  AJAX,	  JavaScript,	  CSS	  and	  the	  XMLHttpRequest	  object.	  The	  use	  
of	  several	  separate	  technologies	  results	  in	  the	  need	  for	  additional	  developer	  time	  and	  
extensive,	   in	   depth	   testing	   to	   ensure	   the	   additional	   interfaces	   between	   the	  
technologies	  work	  appropriately.	  Often,	  this	  added	  complexity	  involved	  in	  developing	  
HTML5	  applications	  results	   in	  a	  much	  lower	  functional	  specification	  for	  most	  HTML5-­‐
based	   web	   applications,	   due	   to	   the	   extensive	   developer	   time	   required	   for	   testing	  
under	  several	  browsers.	  
1.4 Software Approaches for Biological Data Analysis 
1.4.1 Super-Experiment Data Analysis 
As	  mentioned	  in	  section	  1.2.5	  Potential	  for	  Collective	  Data	  Analysis,	  typical	  analysis	  of	  
data	   in	   proteomics	   is	   carried	   out	   manually	   by	   researchers	   on	   a	   single	   experiment,	  
single	   dataset	   level.	   However,	   collection	   of	   datasets	   into	   a	   single	   data	   repository	  
provides	  an	  ideal	  target	  data	  source	  that	  is	  large	  enough	  to	  be	  used	  as	  a	  baseline	  for	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identifying	  global	  patterns	  and	  trends.	  Through	  the	  use	  of	  Knowledge	  Discovery	   (KD)	  
techniques	   it	   is	   possible	   to	   provide	   automated	   analysis	   to	   extract	   implicit,	   unknown	  
and	   potentially	   useful	   information	   from	   a	   target	   collection	   of	   datasets.	   These	  
techniques	  can	  only	  uncover	  patterns	  and	  trends	  that	  exist	  in	  the	  data	  already,	  hence	  
it	   is	   reliant	   on	   a	   data	   environment	   containing	   a	   large	   and	   continually	   expanding	  
collection	   of	   consistently	   annotated	   MS	   datasets	   that	   are	   normalised	   and	  
implemented	   in	   an	   n-­‐dimensional	   database	   for	   classification,	   visualisation,	  
probabilistic	  and	  statistical	  analysis	  approaches.	  
With	   this	   approach	   datasets	   could	   be	   linked	   and	   studied	   together	   to	   generate	   new	  
hypotheses	   spanning	   broader	   questions.	   This	   approach	   has	   been	   termed	   as	   ‘super-­‐
experiment’	   analysis.	   A	   super-­‐experiment	   can	   be	   understood	   as	   analysis	   involving	  
multiple	  independent	  datasets	  in	  which	  each	  dataset	  provides	  value	  to	  the	  analysis	  of	  
every	  other	  dataset	  in	  the	  collection.	  By	  integrating	  the	  datasets	  in	  such	  a	  way,	  novel	  
research	  can	  be	  carried	  out	  to	  identify	  patterns	  or	  trends	  that	  cannot	  be	  elicited	  from	  
a	  single	  dataset.	  This	  analysis	  does	  not	  necessarily	  have	  to	  come	  from	  multiple	  related	  
datasets,	   generated	   to	   answer	   specific	   questions,	   in	   fact	   it	   is	   envisioned	   that	   by	  
analysing	  unrelated	  datasets	  it	  will	  be	  possible	  to	  extract	  further	  knowledge	  that	  was	  
not	  hypothesised.	  In	  this	  way,	  each	  dataset	  has	  the	  potential	  of	  informing	  the	  analysis	  
of	  existing	  and	  future	  datasets.	  This	  novel	  pathway	  of	  analysis	  necessitates	  tools	  that	  
can	   collate	   a	   large	  number	  of	  organised	  and	  well-­‐documented	  experiments	   that	   can	  
then	   provide	   the	   opportunity	   to	   carry	   out	   super-­‐experiments	   to	   extend	   into	   new	  
biological	  analyses.	  	  
1.4.2 Applying Business Intelligence for Super-Experiment Analysis 
The	  world	  of	   proteomics	   research	   is	   very	   knowledge	   centric.	   In	   order	   to	  make	   good	  
research	  decisions	  and	  plans	  it	  is	  imperative	  for	  researchers	  to	  manage	  the	  data	  they	  
are	   generating	   and	   maximise	   the	   information	   gleaned	   from	   the	   data.	   This	   is	   not	  
dissimilar	  to	  the	  business	  world,	  which	  has	  been	  encountering	  and	  attempting	  to	  solve	  
the	  same	  sorts	  of	  problems.	  Within	  the	  business	  world	  much	  research	  and	  effort	  has	  
gone	  into	  the	  development	  of	  a	  field	  known	  as	  Business	  Intelligence	  (BI).	  	  
The	   term	  Business	   Intelligence	  was	   first	  used	  by	  an	   IBM	  researcher	  Hans	  Peter	   Luhn	  
(Luhn,	   1958).	   Luhn	   defined	   intelligence	   as	   “the	   ability	   to	   apprehend	   the	  
interrelationships	  of	  presented	  facts	  in	  such	  a	  way	  as	  to	  guide	  action	  towards	  a	  desired	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goal”.	  The	  field	  of	  Business	  Intelligence	  is	  primarily	  concerned	  with	  the	  development	  of	  
tools	  and	  techniques	  to	  aid	  with	  the	  identification,	  extraction	  and	  analysis	  of	  business	  
data.	   The	   aim	  of	   the	   computational	   techniques	   is	   to	   help	   businesses	   use	   their	   data,	  
such	   as	   sales	   revenues,	   to	   support	   good	   decision-­‐making.	   BI	   applications	   perform	  
various	   tasks	   such	   as	   data	   integration,	   data	   quality,	   data	   warehousing,	   master	   data	  
management,	  text	  and	  content	  analytics.	  	  
The	  role	  of	  BI	  in	  various	  companies	  usually	  involves	  the	  conversion	  of	  customer	  related	  
data	  to	  information,	  which	  is	  then	  interpreted	  by	  analysts	  to	  produce	  knowledge	  that	  
can	  be	  used	  to	  action	  improvements	   in	  the	  company.	  Even	  though	  BI	  strategies	  have	  
been	  developed	  in	  the	  commercial	  arena	  and	  primarily	  used	  by	  businesses,	  there	  is	  no	  
reason	  why	   these	   strategies	   could	   not	   be	   applied	   to	   data	  with	   different	  meaning	   in	  
other	  fields,	  such	  as	  research.	  The	  types	  of	  processes	  involved	  in	  BI	  could	  also	  apply	  in	  
the	   life	   sciences	   field	   where	   researchers	   want	   to	   convert	   their	   biological	   data	   into	  
information	  that	  can	  then	  reveal	  useful	  knowledge.	  This	  knowledge	  could	  then	  be	  fed	  
back	   into	   the	   experimental	   workflow,	   either	   through	   follow	   up	   experiments,	   or	   by	  
improving	  existing	  experiments.	  Hence,	  it	  is	  hypothesised	  that	  BI	  could	  have	  a	  positive	  
impact	  in	  the	  field	  of	  life	  sciences.	  	  
This	   has	   been	   demonstrated	   previously	   in	   an	   academic	   study	   carried	   out	   to	   analyse	  
historical	  science	  data,	  which	  has	  enhanced	  understanding	  of	  how	  Darwin	  developed	  
the	   theory	   of	   Evolution	   by	   natural	   selection	   (Kohn	   et	   al.,	   2005).	   Previously,	   this	  
approach	  has	  not	  been	  used	  in	  an	  academic	  proteomics	  laboratory.	  It	  is	  hypothesised	  
that	  wider	  application	  of	  these	  techniques	  will	  be	  of	  great	  utility,	  not	  only	  for	  academic	  
proteomics	   research,	   but	   also	   for	   other	   research	   areas	   involving	   the	   collection	   and	  
mining	  of	  very	  large	  datasets,	  as	  is	  now	  common	  in	  biomedical	  science.	  
BI	   deals	   incredibly	   well	   with	   the	   efficient	   analysis	   of	   large	   datasets.	   In	   particular	   BI	  
principles	  have	  been	  designed	  with	  the	  aid	  of	  data	  warehouses	  that	  often	  contain	  data	  
collated	   from	   many	   sources.	   If	   proteomics	   datasets	   could	   be	   arranged	   in	   a	   data	  
warehouse,	  the	  use	  of	  BI	  could	  be	  made	  more	  straightforward.	  The	  core	  concept	  of	  BI	  
revolves	   around	   understanding	   and	   modelling	   data	   in	   an	   appropriate	   format	   that	  
makes	  analysis	  easier	  and	  more	   intuitive	   for	  end-­‐users.	  BI	   technology	   is	  designed	  for	  
rapid	   interactive	   response	   and	   works	   particularly	   well	   for	   train-­‐of-­‐thought	   analysis,	  
whereby	  response	  times	  from	  queries	  are	  rapid	  enough	  (one	  to	  two	  seconds	  or	  less)	  to	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allow	   a	   user	   to	   follow	   a	   sequence	   of	   ideas	  where	   each	   answer	   can	   prompt	   another	  
question.	   The	   advantages	   of	   rapid	   response	   times	   on	   productivity	   have	   been	   well	  
understood	   for	   many	   years	   (Lambert,	   1984).	   BI	   techniques	   facilitate	   the	   analysis	   of	  
complex	  data	  and	  are	  essentially	  discipline	  agnostic.	  	  
The	  BI	  method	  of	  analysing	  data	   includes	  OnLine	  Analytical	  Processing	   (OLAP).	  OLAP	  
works	   alongside	   a	   data	   warehouse,	   which	   can	   be	   structured	   using	   a	   relational	   or	  
multidimensional	   structure.	   The	   data	   warehouse	   is	   a	   vital	   component	   that	   must	  
contain	   the	   required	   data	   in	   a	   consistent	   format.	   The	   data	   warehouse	   can	   be	  
populated	  from	  various	  source	  systems	  to	  provide	  a	  comprehensive	  coverage	  of	  data	  
needed	  to	  answer	  the	  questions	  of	  researchers.	  Data	   in	   life	  sciences	   is	  spread	  across	  
many	  databases,	  hosted	  by	   institutions	  around	   the	  world	   that	  are	  specialists	   in	   their	  
own	   areas.	   However,	   researchers	   would	   greatly	   benefit	   from	   being	   able	   to	   access	  
differing	   data	   from	   one	   location,	   for	   example	   localisation,	   post	   translational	  
modifications	  (PTMs)	  and	  domain	  information.	  Furthermore,	  researchers	  would	  ideally	  
like	  to	  collate	  this	  information	  with	  their	  own	  datasets	  to	  draw	  conclusions.	  Searches	  
to	   find	   these	   data	   are	   very	   time	   consuming.	   Some	  of	   the	   global	   databases	   available	  
provide	  web	  access	  to	  data	  (O'Donovan	  et	  al.,	  2002),	  which	  can	  be	  used	  to	  make	  local	  
copies	  of	  databases.	  To	  load	  data	  into	  the	  warehouse,	   it	  must	  go	  through	  an	  extract,	  
transform	   and	   load	   (ETL)	   process	   to	   catch	   any	   variations	   in	   data	   schemas	   and	   data	  
values.	  Once	  all	  data	  have	  been	  loaded	  into	  the	  data	  warehouse,	  OLAP	  can	  be	  used	  to	  
transform	   the	   data	   into	   an	   OLAP	   cube,	   which	   is	   a	   multidimensional	   structure	   for	  
querying	  and	  analysis.	  
1.4.3 Relational versus Multi-Dimensional Databases 
A	   database	   is	   an	   electronic	   data	   store	   defined	   by	   a	   data	   dictionary,	   describing	   the	  
fields	  and	  the	  various	  parameters	  associated	  with	  each	  field,	  such	  as	  data	  type	  and	  any	  
constraints.	   Databases	   can	   be	   designed	   in	   a	   number	   of	   ways	   with	   two	   of	   the	  most	  
popular	   being	   a	   relational	   and	   dimensional	   structure.	   A	   relational	   database	   models	  
data	  by	  analysing	  the	  relationships	  between	  different	  data	  entities	  and	  defining	  those	  
relationships.	  For	  example	  proteins	  are	  related	  to	  peptides	  as	  one	  protein	  is	  made	  up	  
of	  multiple	  peptides.	  In	  comparison,	  a	  multidimensional	  database	  structure	  views	  data	  
as	  a	   series	  of	  measures,	   typically	   values	   that	  are	  of	   interest,	   such	  as	   ion	   intensity	  of	  
73	  
peptides,	  and	  dimensions,	  i.e.	  the	  parameters	  used	  to	  extract	  specific	  data,	  such	  as	  cell	  
type	  or	  date	  etc.	  	  
	  
Figure	  10:	  Relational	  versus	  dimensional	  database	  structure.	  
A	   relational	   database	   is	   inherently	   designed	   to	   handle	   transactional	   data.	   CReate,	  
Update	  and	  Delete	   (CRUD)	  operations	  are	  handled	  very	  well	  by	  relational	  structures.	  
Structured	  Query	  Language	  (SQL),	  a	  programming	  language,	  can	  be	  used	  to	  construct	  
queries	   to	   extract	   data	   from	   tables	   in	   the	   database.	   There	   are	   many	   commercial	  
relational	  database	  providers,	  such	  as	  Teradata,	  Microsoft,	  Oracle	  and	  IBM,	  as	  well	  as	  
open	   source	   solutions,	   such	   as	  MySQL,	   SQLite	   and	   PostgresSQL.	  Within	   a	   relational	  
engine	   data	   are	   not	   structured	   particularly	  well	   for	   analytics,	   as	   data	   can	   be	   spread	  
across	   many	   tables,	   which	   have	   to	   be	   joined	   together	   before	   having	   the	   ability	   to	  
extract	  the	  data	  of	  interest.	  	  
In	   comparison	   a	   multidimensional	   structure	   supports	   analytics	   in	   a	   more	   intuitive	  
manner.	  A	  multidimensional	  data	  model	  can	  alleviate	  problems	  inherent	  in	  a	  relational	  
database	   by	  making	   it	   easier	   to	   select,	   navigate	   and	   explore	   data.	   It	   is	   also	   able	   to	  
provide	   increased	  query	  performance	   in	  comparison	   to	  a	   relational	  database,	  due	   to	  
the	  way	  that	   it	  holds	  pre-­‐aggregated	  data.	  Almost	  all	  query	  result	  times	  benefit	  from	  
this	   type	   of	   pre-­‐computation.	   However	   multi-­‐dimensional	   databases	   are	   not	  
particularly	   good	   for	   transactional,	   CRUD	   operations.	   MultiDimensional	   eXpressions	  
(MDX)	   is	   a	   programming	   language	   allowing	   programmers	   to	   query	  multidimensional	  
database	   structures.	   Commercial	   multi-­‐dimensional	   database	   providers	   include	  
Microsoft,	  Hyperion,	  Cognos	  and	  Oracle.	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Chapter 2: Methodology 
This	   thesis	   has	   resulted	   in	   the	   creation	   of	   an	   environment,	   PepTracker,	   for	  
management	   and	  mining	   of	   cell	   biology	   data	   produced	   by	   scientists	   working	   in	   the	  
specialised	   field	   of	   proteomics.	   The	   suite	   of	   tools	   within	   this	   software	   incorporates	  
automated	  visualisation	  and	  analysis	  tools	  to	  handle	  quantitative	  data	  produced	  from	  
proteomics	  studies.	  The	  creation	  of	  this	  software	  involved	  a	  heavy	  focus	  on	  involving	  
users	  to	  drive	  the	  development	  aims	  and	  outcomes.	  Described	  in	  this	  section	  are	  the	  
technologies	   and	   user-­‐centred	   techniques	   that	   were	   applied	   to	   create	   this	   novel	  
software	  in	  the	  expert	  proteomics	  field	  (section	  2.1).	  
2.1 Software Development Approach 
2.1.1 Developer Environment 
During	   the	   creation	   of	   PepTracker,	  my	   location	   as	   the	   developer	  was	   thought	   to	   be	  
very	   important.	   I	  was	   therefore	   embedded	   in	   the	   Lamond	   laboratory.	   This	   provided	  
continuous	  contact	  with	  researchers	  and	  allowed	  me	  to	  gain	  insight	  into	  the	  needs	  and	  
problems	  of	   the	   researchers	   from	  everyday	   contact.	   It	   also	  provided	  opportunity	   for	  
passive	   ethnography	   to	   take	   place,	   for	   example	   lunch-­‐time	   conversations	   led	   to	   the	  
identification	   of	   issues	   that	   could	   be	   tackled	   easily	   via	   PepTracker,	   e.g.	   moving	   an	  
external	  database	  (holding	  data	  about	  the	  components	  and	  solutions	  acquired	  by	  the	  
laboratory)	   into	   the	   PepTracker	   system	   for	   easier	   management	   and	   linkage	   to	  
experimental	   metadata.	   The	   researchers	   in	   the	   laboratory	   responded	   well	   to	   this	  
approach	   with	   one	   proteomics	   researcher	   reporting	   “[Researcher]	   is	   constantly	   in	  
touch	  and	  checking	  requirements	  of	   the	   individuals	  who	  use	  the	  data,	   is	  seated	  with	  
them	   in	  a	   lab	  on	  a	  daily	  basis,	   and	   is	   acutely	  aware	  of	  our	   capability	  and	   limitations	  
with	  regard	  to	  computing”.	  
2.1.2 Ethnographic Observation 
Ethnographic	   approaches	  were	   used	   to	   observe	   researcher	   tasks,	   carry	   out	   iterative	  
evaluation	   and	   testing.	   These	   approaches	   focused	   attention	   on	   researchers	   and	  
allowed	   for	   continuous	   refinement	   based	   on	   observations,	   for	   example,	   watching	  
researchers	  enter	  experimental	  metadata	  helped	  identify	  a	  better	  database	  model	  to	  
reflect	  the	  variations	  in	  experimental	  procedures.	  Furthermore,	  analysing	  researchers	  
in	   their	  working	  environment	   is	   vital	  when	  creating	  visualisation	   tools	   that	  meet	   the	  
needs	  of	  users.	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2.1.3 New Ideas and Inspiration 
Fostering	  an	  environment	   that	  encourages	  new	   ideas	  and	   inspiration	   is	   important	   to	  
get	   researchers	   excited	   about	   the	   development.	   During	   the	   creation	   of	   PepTracker,	  
there	  were	  many	  meetings	  that	  involved	  researchers	  describing	  complex	  user	  interface	  
ideas	   that	   would	   improve	   their	   interaction	   with	   the	   charting	   components	   within	  
PepTracker.	  Rather	  than	  refusing	  to	  consider	  these	  ideas	  because	  the	  code	  base	  would	  
not	   allow	   for	   such	   developments,	   these	   requests	  were	  monitored.	   Feature	   requests	  
included	   tasks	   like	   scrollable	   and	   zoomable	   charts.	   After	   realising	   the	   importance	   of	  
these	   features	   to	   researchers,	   a	   new	   technology	   was	   incorporated	   into	   the	  
architecture,	   i.e.	  Adobe	  Flex,	   to	   implement	  an	   interface	   that	  provided	   this	   increased	  
charting	   interactivity.	   Furthermore,	   encouraging	   and	   allowing	   extensive	   ‘thinking’	  
about	  problems	  and	  data	  during	   researcher	  meetings,	  pushed	   the	  boundaries	  of	   the	  
development	  to	  continue	  and	  explore	  new	  avenues,	  such	  as	  BI.	  
2.1.4 Domain Knowledge  
Developing	   software	   for	   research	   laboratories	   is	   further	   complicated	   as	   research	  
laboratories	   are	   at	   the	   forefront	   of	   discovery,	   hence	   their	   needs	   are	   often	   novel,	  
specialised	  frequently	  changing.	  In	  order	  to	  understand	  how	  to	  deal	  with	  the	  changing	  
needs	   of	   researchers	   of	   the	   PepTracker	   system,	   it	   was	   important	   to	   gain	   extensive	  
domain	   knowledge.	  Within	   a	   scientific	   environment,	   this	   domain	   knowledge	  may	  be	  
obtained	   by	   carrying	   out	   experiments.	   The	   tedious	   nature	   and	   steps	   involved	   in	  
proteomics	   experiments	  was	  not	   fully	   understood	  until	   time	  was	   spent	   shadowing	  a	  
biologist	  carrying	  out	  an	  experiment	  and	  also	  by	  taking	  part	  in	  tasks,	  such	  as	  pipetting	  
etc.,	  in	  the	  laboratory.	  From	  getting	  involved	  I	  was	  able	  to	  understand	  the	  data	  being	  
processed	  and	  why	  there	  may	  be	  variability	   in	   the	  resulting	  data,	  e.g.	   from	  pipetting	  
errors.	   In	  addition,	  observing	  researchers	  was	   imperative	  for	  the	  development	  of	  the	  
PepTracker	   system,	   in	   order	   to	   fully	   understand	   and	   automate	   the	   workflow	   of	   a	  
researcher	  studying	  proteomics.	  
2.1.5 Understanding Users 
Involving	  highly	  intelligent	  researchers	  in	  software	  development	  can	  be	  challenging	  as	  
researchers	  often	  find	  it	  difficult	  to	  translate	  their	  science	  into	  a	  set	  of	  requirements.	  
The	  creation	  of	  PepTracker	  required	  an	  in-­‐depth	  understanding	  of	  the	  problems	  faced	  
by	  researchers	   in	  order	  to	  help	  them	  identify	  potential	  computational	  solutions.	  One	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such	  problem	  involved	  developing	  a	  method	  of	  annotating	  proteins	  as	  contaminants	  in	  
protein-­‐protein	   interaction	   studies,	   by	   analysing	   very	   large	   sets	   of	   experiments.	   The	  
overall	  solution	  to	  this	  problem	  was	  the	  use	  of	  BI	  principles	  to	  provide	  pre-­‐aggregation	  
of	  data	   for	   rapid	   response.	  Despite	  being	  new	  to	   the	   field	  of	  business	   intelligence,	   it	  
was	  possible	  to	  implement	  the	  techniques	  by	  describing	  and	  helping	  researchers	  think	  
of	   their	   problem	   in	   terms	   of	   ‘measures’,	   i.e.	   the	   values	   they	   are	   interested	   in,	   and	  
‘dimensions’,	  i.e.	  the	  fields	  on	  which	  they	  would	  like	  to	  query.	  Following	  on	  from	  this	  it	  
was	   possible	   to	   create	   a	   Sun	   Model	   diagram,	   which	   describes	   a	   researcher’s	  
perception	   and	   understanding	   of	   their	   data,	   and	   then	   convert	   this	   into	   a	   physical	  
implementation.	  This	   is	   the	  process	  used	   in	   the	  generation	  of	   the	  Protein	  Frequency	  
Library	  (see	  Chapter	  5:	  Multidimensional	  Analysis	  with	  IP	  Experiments).	  
Furthermore,	  by	  becoming	  involved	  in	  the	  biology	  of	  the	  project,	  it	  was	  possible	  to	  get	  
in	   the	   role	   of	   a	   biology	   researcher	   and,	   therefore,	   consider	   the	   problems	   from	   a	  
different	  point	  of	  view	  and	  have	  an	  increased	  motivation	  to	  solve	  the	  problem.	  It	  was	  
also	   felt	   that	   this	   promoted	   the	   biologists	   to	   have	   a	   vested	   interest	   in	   making	   the	  
development	  of	  the	  BI	  tool	  a	  success.	  This	  is	  evidenced	  in	  feedback	  received	  and	  by	  the	  
willingness	  of	  researchers	  to	  take	  technical	  drawings,	  such	  as	  the	  Sun	  Model,	  and	  use	  
these	  within	  presentations	  of	  their	  own	  projects.	  	  
2.1.6 Researcher Expectations 
In	  order	  to	  manage	  the	  expectations	  from	  researchers,	  small	  iterations	  were	  delivered	  
frequently.	  This	  allowed	  researchers	  to	  witness	  the	  development	  as	   it	  happened	  and	  
to	   understand	   better	   the	   timescales	   involved	   in	   creating	   certain	   features.	   Also,	   the	  
researchers	  were	  asked	   to	  prioritise	   requirements	  and	  hence	  help	  define	  a	   schedule	  
based	  on	  a	   set	  of	   features	   they	  had	   requested,	   along	  with	   the	  projected	   timescales.	  
This	   scheduling	  meant	   that	   researchers	  were	  more	  aware	  of	  what	   they	  could	  expect	  
from	  the	  software	  and	  developer	  in	  a	  given	  timeframe.	  
2.1.7 Function and Form 
It	   was	   also	   found	   that	   focusing	   on	   how	   a	   researcher	   achieved	   a	   task	   was	   just	   as	  
important	   as	  what	   the	   task	   end-­‐goal	   involved.	  Within	   PepTracker,	   identifying	   trends	  
and	   patterns	   in	   data	   was	   a	   vital	   component.	   However,	   many	   of	   the	   meetings	   with	  
users	  centred,	  not	  on	  what	  these	  trends	  and	  patters	  were,	  but	  rather	  on	  the	  process	  
by	  which	  researchers	  would	  discover	  these	  insights	  and	  how	  tools	  could	  be	  developed	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to	   facilitate	   this	  process.	  For	  example,	  a	  variety	  of	  chart	   features,	   such	  as	  overlaying	  
groups	  of	  data,	  filtering	  of	  datasets	  and	  selecting	  ranges	  of	  data,	  were	  implemented	  as	  
they	  helped	  improve	  user	  perception	  of	  the	  data	  being	  viewed	  and	  analysed.	  	  	  
2.1.8 Leadership 
Software	  development	  can	  further	  be	  hampered	  due	  to	  a	  drive	  for	  productivity	  alone.	  
Within	  a	  research	  area,	  it	  is	  important	  to	  understand	  the	  use	  of	  spending	  quality	  time	  
simply	   talking	   about	   problems	   and	   data.	   For	   a	   project	   like	   PepTracker,	  where	   there	  
was	  no	  existing	  similar	  software	  design,	  it	  was	  difficult	  for	  researchers	  to	  define	  what	  
they	  wanted	  and	  for	  the	  developer	  to	  ask	  the	  right	  questions,	  hence	  emphasis	  had	  to	  
be	  placed	  on	  the	  need	  to	  refine	  the	  questions	  until	  cohesive	  ideas	  could	  be	  obtained.	  
Having	  leadership	  that	  allowed	  for	  the	  necessary	  scope	  and	  flexibility	  to	  explore	  new	  
ideas,	   such	   as	   the	   use	   of	   BI,	   rather	   than	   placing	   pressure	   on	   output	   in	   terms	   of	  
functionality,	   inspired	   innovation	   and	   novel	   interface	   design.	   In	   terms	   of	   the	  
PepTracker	   system	   this	   came	   from	   the	   head	   of	   the	   Lamond	   Laboratory,	   Professor	  
Angus	   Lamond,	   who	   is	   not	   a	   computer	   scientist	   and	   hence	   was	   interested	   by	   the	  
biological	   significance	   of	   the	   work,	   yet	   was	   driven	   throughout	   the	   development	   to	  
push	   for	   innovative	   ideas	  of	   tackling	  problems	   rather	   than	  measuring	  success	  by	   the	  
number	  of	  papers	  released	  through	  the	  use	  of	  the	  software. 
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Chapter 3: Nucleolar Proteomics Database 
3.1 Summary 
An	  experimental	  data	  handling	  system	  has	  been	  created	  as	  an	  update	  to	  the	  previous	  
Nucleolar	   Proteome	   Database	   (NOPdb3.0:	   http://www.lamondlab.com/NOPdb3.0/).	  
This	   updated	   system	   is	   able	   to	   manage	   large	   datasets	   identified	   by	   multiple	   MS	  
experiments	   and	   has	   been	   used	   to	   analyse	   highly	   purified	   preparations	   of	   human	  
nucleoli	   from	   different	   cell	   lines.	   The	   newly	   created	   application	   includes	   a	   dynamic	  
relational	  database,	  which	   is	  kept	  up	  to	  date	  by	   laboratory	  researchers.	  The	  data	  are	  
further	   annotated	   with	   information	   from	   specific	   external	   sources	   on	   the	   web,	  
including	   the	   IPI	   and	   Gene	   Ontology	   databases.	   In	   addition,	   an	   Application	  
Programming	   Interface	   (API)	   provides	   external	   users	   with	   a	   portal	   to	   link	   into	   the	  
nucleolar	   proteome	   database	   and	   hence	   gain	   access	   to	   continually	   updated	   results.	  
From	  the	  initial	  ~700	  human	  proteins	  identified	  in	  the	  previous	  iteration	  of	  the	  NOPdb,	  
there	  are	  now	  over	  50,000	  identified	  peptides	  contained	  in	  over	  4,500	  human	  proteins	  
from	  purified	  nucleoli,	  providing	  enhanced	  coverage	  of	  the	  nucleolar	  proteome.	  
Chapter	   3	   describes	   the	   NOPdb	   software,	   focusing	   first	   on	   the	   history	   of	   previous	  
versions	  of	  the	  NOPdb	  (section	  3.2),	  following	  with	  a	  description	  of	  NOPdb	  version	  3.0	  
(section	  3.3),	   its	   implementation	   (sections	  3.4)	  and	   finally	  a	  discussion	  on	   the	  use	  of	  
NOPdb3.0	  (section	  3.5).	  	  	  
3.2 Background 
The	   nucleolus	   is	   a	   highly	   conserved	   nuclear	   organelle	   whose	   main	   function	   is	   to	  
coordinate	   the	   synthesis	   and	   assembly	   of	   ribosome	   subunits	   (Boisvert	   et	   al.,	   2007).	  
Previously,	   a	   Nucleolar	   Proteome	   Database	   (NOPdb2.0:	  
http://www.lamondlab.com/NOPdb)	   was	   described	   that	   archived	   data	   on	   over	   700	  
proteins	   that	   were	   identified	   by	   multiple	   mass	   spectrometry	   analyses	   from	   highly	  
purified	  preparations	  of	  human	  nucleoli	   (Leung	  et	  al.,	   2006).	   Each	  protein	  entry	  was	  
annotated	  with	   information	  about	   its	   corresponding	  gene,	   its	  domain	   structures	  and	  
relevant	   protein	   homologues	   across	   species,	   as	   well	   as	   documenting	   its	   MS	  
identification	   history,	   including	   all	   of	   the	   peptides	   sequenced	   by	   tandem	   MS/MS.	  
Moreover,	   data	   showing	   the	   quantitative	   changes	   in	   the	   relative	   levels	   of	  
approximately	   500	   nucleolar	   proteins	  were	   compared	   at	   different	   time	   points	   upon	  
transcriptional	  inhibition	  (Andersen	  et	  al.,	  2005).	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The	   data	   presented	   by	   the	   previous	   NOPdb,	   version	   2.0,	   was	   held	   in	   a	   flat	   file	  
database.	   Due	   to	   the	   aggregated	   nature	   of	   the	   data,	   results	   from	   individual	  
experiments	   could	   not	   be	   extracted.	   The	   peptide	   data	   for	   a	   single	   protein	   were	  
merged	  within	  this	  database	  rather	  than	  stored	  separately.	  The	  client	  interface	  to	  this	  
database	  consisted	  of	  Perl	  CGI	  scripts.	  These	  scripts	  were	  able	  to	  extract	  the	  relevant	  
data	  from	  the	  flat	  file	  database	  to	  create	  static	  html	  pages.	  After	  running	  the	  scripts,	  a	  
page	   was	   created	   on	   the	   server	   for	   each	   protein.	   The	   html	   pages	   were	   then	  made	  
available	  to	  the	  global	  community	  via	  the	  Internet.	  Each	  time	  data	  were	  updated	  in	  the	  
flat	   files,	   the	   Perl	   scripts	   had	   to	   be	   run	   again	   in	   order	   to	   reproduce	   the	   static	   html	  
pages.	   This	   process	   of	   having	   to	   reproduce	   the	   static	   html	   protein	   pages	   after	   each	  
database	  update	  was	  highly	  inefficient	  and	  time	  consuming.	  A	  more	  efficient	  approach	  
is	  to	  produce	  dynamic	  html	  pages	  upon	  user	  request.	  Furthermore,	  the	  capabilities	  of	  
the	  NOPdb	   version	   2.0	   database	  were	   limited	  with	   respect	   to	   security,	   ease	   of	   use,	  
accessibility,	   maintainability	   and	   expandability.	   For	   example,	   a	   number	   of	   security	  
concerns	  arose	  regarding	  the	  Perl	  scripts,	  which	  proved	  very	  difficult	  to	  resolve	  due	  to	  
limited	  documentation.	  
3.3 Nucleolar Proteome Database v 3.0 
The	  new	  version	  of	  the	  NOPdb3.0	  (http://www.lamondlab.com/NOPdb3.0/)	  consists	  of	  
a	   unique,	   secure,	   extendable	   content	   management	   system,	   holding	   advanced	  
nucleolar	   proteomics	   data.	   The	   created	   application	   includes	   a	   dynamic	   relational	  
database,	   which	   is	   kept	   up	   to	   date	   by	   members	   of	   the	   Lamond	   Laboratory.	   It	   also	  
allows	  the	  query	  of	  protein	  data	  hosted	  within	  the	  database	  by	  external	  users,	  either	  
using	  the	  custom	  built	  graphical	  user	  interfaces,	  or	  by	  building	  custom	  web	  tools	  that	  
access	  data	  via	  the	  custom	  API.	  In	  addition	  to	  the	  dynamic	  interfaces	  provided	  by	  the	  
new	   content	  management	   system,	   the	   data	   included	   in	   the	   nucleolar	   proteome	   are	  
also	   dynamically	   updated	   with	   proteins	   identified	   from	   several	   different	   cell	   lines,	  
using	  various	  instruments,	  by	  members	  of	  the	  laboratory.	  	  
The	  new	  version	  of	  the	  Nucleolar	  Proteome	  Database	  (NOPdb3.0)	  archives	  all	  human	  
nucleolar	  proteins	  identified	  to	  date	  by	  the	  Lamond	  Laboratory	  and	  their	  collaborators	  
using	  MS	  analyses	  (Andersen	  et	  al.,	  2005,	  Leung	  et	  al.,	  2006,	  Boisvert	  et	  al.,	  2007).	  The	  
current	   version	   3.0	   of	   the	   database	   is	   available	   at	  
http://www.lamondlab.com/NOPdb3.0/	   and	   is	   searchable	   either	   by	   protein	   name,	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protein	   sequence,	   motif	   (Mulder	   et	   al.,	   2003,	   Bateman	   et	   al.,	   2004,	   Letunic	   et	   al.,	  
2004),	   Gene	   Ontology	   (GO)	   (describe	   gene	   products	   in	   terms	   of	   their	   associated	  
biological	   processes,	   cellular	   components	   and	   molecular	   functions	   in	   a	   species-­‐
independent	  manner)	   (Ashburner	   et	   al.,	   2000)	   terms	   or	   by	   setting	   the	   range	   of	   the	  
predicted	  isoelectric	  point	  and/or	  molecular	  weight	  (see	  Figure	  11).	  	  
	  
Figure	  11:	  Snapshots	  of	  the	  NOPdb3.0	  (http://www.lamondlab.com/NOPdb3.0/).	  	  
For	  illustration,	  the	  database	  was	  searched	  to	  identify	  a	  protein:	  Phosphatase	  1	  (PP1)	  
isoform	  and	  here	  is	  shown	  an	  overview	  page	  for	  this	  protein	  documenting	  its	  sequence,	  
peptides	  identified,	  etc.	  
The	  NOPdb3.0	  provides	   information	  on	  multiple	  parameters,	   including	  protein	  name,	  
accession	  number,	  gene	  symbol,	  gene	  name,	   sequence,	  molecular	  weight,	   isoelectric	  
point	  (PI),	  peptides	  identified,	  experiments	  in	  which	  the	  protein	  was	  identified,	  motifs	  
and	  gene	  ontology	  annotation.	  	  
3.4 Technical Implementation 
The	   new	   NOPdb3.0	   application	   consists	   of	   a	   multi-­‐tier	   architecture,	   with	   the	   data	  
storage,	  business	  logic	  and	  client	  interface	  as	  separate	  components.	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3.4.1 NOPdb3.0 Databases 
Version	   3.0	   of	   the	  NOPdb	   is	   an	   entirely	   new	   implementation	   using	   a	   fully	   relational	  
design	  with	  major	   improvements	  over	  previous	  versions	  and	  additional	   functionality.	  
The	   newly	   created	   database	   holds	   data	   of	   higher	   granularity,	   storing	   data	   at	   the	  
peptide	   level	   as	   opposed	   to	   collated	   data	   on	   proteins.	   This	   higher	   granularity	   also	  
means	   that	   results	   from	  new	  experiments	   can	  be	  directly	   uploaded	   to	   the	  database	  
without	  prior	  processing,	  as	   the	  direct	  output	   from	  MS-­‐based	  proteomics	  analyses	   is	  
peptide	  data.	  	  
The	   data	   storage	   is	   implemented	   via	   a	   relational	  MySQL	   database.	   The	   database	   is	  
structured	  (see	  Figure	  12)	  to	  allow	  easy	  extendibility	  and	  maintenance	  in	  the	  future.	  	  
 
Figure	  12:	  Entity-­‐Relationship	  (ER)	  diagram	  for	  NOPdb3.0.	  	  
E-­‐R	  diagram	  depicting	  the	  relationships	  between	  the	  tables	  present	  in	  the	  MySQL	  
database	  implemented	  for	  the	  NOPdb3.0	  Content	  Management	  System.	  
A	  number	  of	  database	  features	  were	  employed	  to	  ensure	  the	  security	  of	  data	  and	  to	  
prevent	  SQL	  injection	  attacks.	  One	  of	  these	  features	  involved	  the	  use	  of	  Views	  that	  sit	  
in	   a	   layer	   above	   tables.	  Access	   to	   the	  database	  was	  only	  permitted	   via	   these	  Views.	  
Some	  of	   the	  View	   tables	   consist	  of	  aggregation	  of	   common	  queries,	  which	   increases	  
the	   speed	   of	   querying,	   hence	   providing	   better	   performance	   to	   users.	   In	   conjunction	  
with	   the	   View	   tables,	   specialised	   users	   were	   set	   up	   on	   the	   database.	   The	   database	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users	   were	   granted	   restricted	   privileges	   to	   carry	   out	   specific	   operations	   on	   certain	  
tables.	  
Normalisation	   of	   the	   database	   fields	   was	   carried	   out	   using	   the	   three	   normal	   forms	  
defined	  by	   Edgar	   F.	   Codd	   (Codd	  et	   al.,	   1971),	   i.e.	   1NF,	   2NF	   and	  3NF.	   This	   technique	  
helped	   to	   eliminate	   anomalies	   from	   the	   database	   design	   and	   hence	   avoid	   any	  
structural	  or	  logical	  problems.	  A	  definition	  for	  1NF,	  2NF	  and	  3NF	  is	  provided	  below:	  
• 1NF:	  A	  relation	  in	  which	  intersection	  of	  each	  row	  and	  column	  contains	  one	  and	  
only	  one	  value.	  
• 2NF:	   A	   relation	   that	   is	   in	   1NF	   and	   every	   non-­‐primary-­‐key	   attribute	   is	   fully	  
functionally	  dependent	  on	  the	  primary	  key	  (no	  partial	  dependency).	  
• 3NF:	   A	   relation	   that	   is	   in	   1NF	   and	   2NF	   and	   in	   which	   no	   non-­‐primary-­‐key	  
attribute	  is	  transitively	  dependent	  on	  the	  primary	  key.	  
The	  purpose	  of	  the	  business	  logic	  layer	  is	  to	  act	  as	  an	  interface	  between	  the	  client-­‐side	  
application	   and	   database.	   In	   order	   to	   extract	   useful	   data	   from	   the	   database,	   the	  
business	  logic	  employs	  complex	  SQL	  queries.	  	  
A	  further	  two	  databases	  were	  also	  set	  up	  to	  store	  a	   local	  copy	  of	  the	  additional	  data	  
from	   the	   International	   Protein	   Index	   (IPI)	   and	   Gene	   Ontology	   databases.	   The	  
information	   required	   from	   these	   databases	   was	   found	   in	   file	   formats	   from	   the	  
respective	  database	  websites.	  Scripts	  were	  then	  written	  to	  parse	  the	  data	  and	  store	  it	  
in	  a	  relational	   format,	  which	   is	   linked	  to	  the	  NOPdb3.0	  database.	  These	  data	  provide	  
useful,	  further	  annotation	  to	  complement	  the	  data	  within	  the	  NOPdb3.0.	  
3.4.2 Application Programming Interface 
All	   communication	  between	   the	  database	   and	   application	  has	   been	   implemented	   to	  
pass	  through	  the	  custom	  made	  Application	  Programming	  Interface	  (API)	  to	  create	  data	  
pages	   ‘on	   the	   fly’	   using	   the	   custom	   API	   rather	   than	   serving	   static	   data	   pages,	   as	   in	  
previous	  versions.	  The	  API	  acts	  as	  a	  security	  blanket	  around	  the	  database.	  All	  requests	  
to	  carry	  out	  CRUD	  operations	  have	  to	  pass	  via	  the	  API,	  which	  ensures	  that	  the	  user	  has	  
the	   appropriate	   privileges,	   via	   a	   unique	   API	   key	   supplied	   to	   each	   user.	   The	   API	   is	  
implemented	   using	   the	   REST	   (Representational	   State	   Transfer)	   approach.	   REST	   is	   an	  
"architectural	   style"	   that	   exploits	   the	   existing	   technology	   and	   protocols	   of	   the	  Web,	  
including	  HTTP	  (Hypertext	  Transfer	  Protocol)	  and	  XML	  (Extensible	  Markup	  Language).	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REST	   is	   simpler	   to	   use	   than	   the	   well-­‐known	   SOAP	   (Simple	   Object	   Access	   Protocol)	  
approach,	  which	   requires	  writing	  or	  using	  a	  provided	  server	  program	   (to	   serve	  data)	  
and	   a	   client	   program	   (to	   request	   data).	   Within	   the	   NOPdb	   application,	   the	   REST	  
technology	   is	   used	   to	   retrieve	   data	   and	   allow	   it	   to	   be	   read	   through	   a	   series	   of	  
designated	  web	  pages	   that	   hold	   and	  describe	   the	   content	   in	   XML.	   Furthermore,	   the	  
API	   to	   the	  NOPdb	  has	   the	  potential	   to	  allow	  the	  global	   science	  community	   to	  access	  
the	   data	   held	   within	   the	   database,	   whilst	   still	   ensuring	   high	   security.	   It	   does	   so	   by	  
providing	  a	  series	  of	  functions	  that	  cover	  a	  broad	  range	  of	  tasks	  that	  a	  user	  may	  like	  to	  
carry	   out.	   These	   are	   planned	   out	   using	   the	   API	   design	   specification.	   Using	   these	  
functions,	  external	  users	  are	  able	  to	  utilise	  the	  REST	  web	  service	  to	  create	  applications	  
and/or	  websites	  that	  subscribe	  to	  data	  held	  within	  the	  NOPdb.	  Users	  require	  the	  URL	  
(Uniform	  Resource	  Locator)	  for	  the	  page	  where	  the	  XML	  is	   located.	  They	  receive	  this	  
information	  after	  they	  request	  access	  to	  the	  API	  and	  are	  then	  supplied	  with	  a	  unique	  
API	  key	  and	  documentation.	  Users	  can	  then	  interpret	  the	  content	  data	  using	  the	  XML	  
information	  and	  reformat	  it	  appropriately.	  	  
The	  API	  was	  coded	  to	  accept	  an	  API	  key	  from	  users	  and	  compare	  this	  to	  the	  database	  
to	   determine	  which	   scripts	   a	   user	   can	   execute.	   Furthermore,	   the	   URL	   access	   to	   API	  
scripts	  was	  implemented	  to	  use	  the	  mod_rewrite	  Apache	  server	  module.	  This	  module	  
allows	   users	   to	   request	   data	   from	   user-­‐friendly	   URLs,	   which	   are	   translated	   on	   the	  
server	  side,	  using	  mod_rewrite,	  into	  a	  format	  that	  is	  more	  acceptable	  by	  the	  technical	  
scripts.	  
3.4.3 Application Security 
Increased	   security	   was	   a	   core	   focus	   of	   this	   development.	   The	   application	   itself	   is	  
designed	   with	   three	   levels	   of	   access,	   to	   facilitate	   management	   and	   to	   prevent	  
unauthorised	   use	   of	   the	   system.	   Users	   are	   provided	   with	   different	   levels	   of	   access	  
according	   to	   their	   needs,	   which	   are	   seamlessly	   enforced	   by	   the	   application.	   This	  
security	   ensures	   that	   the	   data	   remain	   accurate	   and	   the	   quality	   of	   the	   data	   is	   not	  
compromised.	  Furthermore,	  this	  application	  creates	  a	  platform	  for	  the	  Lamond	  group	  
to	  share	  their	  data	  with	  the	  wider	  cell	  biology	  community.	  	  
3.4.4 Client Side Interfaces 
The	  application	  has	  the	  ability	  to	  interpret	  data	  and	  therefore	  aggregate	  it	  to	  provide	  
metadata	  for	  proteins	  on	  a	  usable,	  graphical	  interface.	  The	  structure	  of	  the	  application	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has	   been	   designed	   using	   the	   Model-­‐View-­‐Controller	   (MVC)	   design	   pattern,	   thus	  
meaning	   that	   the	   functionality	   is	   separated	   from	   the	   overall	   look	   and	   feel	   of	   the	  
application	  to	  ensure	  a	  more	  customisable	  solution.	  	  
The	   business	   logic	   and	   client	   interface	   can	   both	   reside	   on	   any	   Apache	   web	   server	  
capable	  of	   serving	  PHP	   classes	   and	   the	   client	   interface,	  which	   is	   built	   in	  Adobe	  Flex.	  
The	  Apache	   server	   had	   to	   be	   configured	   to	   allow	   scripts	   to	   run	   for	   a	   greater	   length	  
than	  the	  standard	  of	  30	  seconds	  and	  to	  be	  able	  to	  handle	  larger	  file	  uploads.	  This	  was	  
required	   to	   ensure	   the	   server	   could	   handle	   the	   processing	   of	   the	   large	   result	   files	  
produced	   in	   the	   Lamond	   Laboratory.	   Furthermore,	   a	   cross-­‐domain	   policy	   had	   to	   be	  
added	  to	  the	  server	  to	  ensure	  that	  a	  flash	  player,	  running	  the	  client	  side	  application,	  
could	   communicate	   with	   the	   PHP	   scripts	   residing	   on	   the	   server.	   	   Adobe	   Flex	   was	  
chosen	  as	  it	  allows	  RIAs	  to	  be	  prototyped	  and	  developed	  rapidly,	  with	  the	  end	  product	  
running	  across	  a	  wide	  range	  of	  client	  browsers.	  	  
Implementation	   began	   with	   the	   electronic	   prototype,	   used	   as	   a	   basis	   for	   further	  
implementation.	  The	  mock	  functionality	  was	  periodically	  changed	  over	  to	  become	  fully	  
functional	  with	  the	  API	  and	  database.	  During	  the	  implementation	  phase	  there	  were	  a	  
number	   of	   features	   that	   required	   extensive	   thought,	   research	   and	   planning	   to	  
implement	   in	  the	  best	  possible	  way	  –	  optimised	  for	  quick	  and	  efficient	  performance.	  
Furthermore,	   a	   number	   of	   algorithms	   were	   developed	   to	   carry	   out	   common	  
functionality	   in	   a	   well	   thought	   out	   sequence	   of	   steps.	   Some	   notable	   technical	  
achievements	  include:	  	  
• An	  efficient	  searching	  algorithm	  to	  allow	  a	  user	  to	  carry	  out	  a	  generic	  search	  for	  
specific	  proteins	  based	  upon	  a	  set	  of	  search	  criteria.	  This	  algorithm	  is	  used	  for	  
the	   main	   search	   that	   is	   available	   in	   the	   application.	   The	   search	   algorithm	  
created	   is	   intuitive	   as	   it	   is	   able	   to	   speed	   up	   the	   search,	   based	   on	   the	   search	  
criteria	  provided.	  Some	  of	  the	  information	  provided	  in	  the	  search	  criteria	  spans	  
multiple	   tables	   or	   even	  multiple	   databases.	   In	   order	   to	   ensure	   that	   minimal	  
queries	   are	   carried	   out,	   the	   search	   algorithm	   uses	   different	   database	   views	  
depending	  on	  which	  tables	  and	  databases	  need	  to	  be	  queried.	  Furthermore,	  if	  
proteins	   have	   been	   eliminated	   from	   initial	   search	   queries,	   the	   algorithm	  will	  
ignore	   these	   proteins	   when	   looking	   for	   matches	   with	   the	   remainder	   of	   the	  
search	  criteria	  identified.	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• The	   implementation	  of	  an	  API	   function	  that	  references	  a	  number	  of	  database	  
tables	  to	  collate	  an	  amalgamated	  set	  of	  data	  based	  on	  one	  protein.	  It	  achieves	  
this	  by	  referencing	  multiple	  views	  from	  different	  databases.	  
• The	   creation	   of	   a	   script	   that	   can	   efficiently	   process	   large	   result	   files	   (tens	   of	  
thousands	   of	   lines)	   produced	   from	   lab	   instruments.	   These	   result	   files	   are	  
provided	   in	   comma	   separated	   variable	   format	   (csv).	   The	   script	   is	   able	   to	  
identify	   both	   errors	   and	   omissions	   in	   the	   data,	   which	   it	   then	   reports	   to	   the	  
calling	  script	  in	  detail.	  	  
The	  application	  facilitates	  mining	  of	  stored	  data,	  with	  data	  being	  stored	  in	  a	  relational	  
structure	  that	  is	  well	  documented.	  Thus	  tools	  can	  be	  built	  to	  search,	  analyse,	  read	  and	  
understand	  the	  data.	  This	  mining	  capability	  is	  evident	  within	  the	  application	  interfaces,	  
with	   the	   database	   being	   searchable	   by	   multiple	   parameters,	   including	   gene	   names,	  
amino	   acid	   or	   nucleotide	   sequences,	   sequence	   motifs,	   or	   by	   limiting	   the	   range	   of	  
isoelectric	   points	   and/or	   molecular	   weights.	   The	   database	   is	   also	   searchable	   by	  
Interpro	  motif	   numbers	   (database	   of	   protein	   families,	   domains	   and	   functional	   sites)	  
(Mulder	  et	  al.,	  2003,	  Bateman	  et	  al.,	  2004,	  Letunic	  et	  al.,	  2004)	  and	  by	  Gene	  Ontology	  
terms	   (describe	   gene	   products	   in	   terms	   of	   their	   associated	   biological	   processes,	  
cellular	   components	   and	   molecular	   functions	   in	   a	   species-­‐independent	   manner)	  
(Ashburner	   et	   al.,	   2000).	   Furthermore,	   the	   NOPdb3.0	   application	   allows	   the	  
researchers	   to	   visualise	   the	   data	   produced	   from	   experiments	   and	   enables	   cross	  
analysis	  between	  experiments.	  
3.5 Discussion 
Through	  investigating	  an	  existing	  application,	  used	  for	  archiving	  basic	  data	  on	  proteins,	  
this	   study	   was	   able	   to	   create	   a	   unique,	   secure,	   extendable	   content	   management	  
system,	   holding	   advanced	   nucleolar	   proteomics	   data.	   The	   newly	   created	   application	  
includes	  a	  dynamic	   relational	  database,	  which	   is	  kept	  up	   to	  date	  by	  members	  of	   the	  
Lamond	   Laboratory.	   The	   data	   are	   further	   annotated	  with	   information	   from	   reliable,	  
recognised	   external	   sources	   on	   the	   web.	   The	   database	   and	   application	   have	   been	  
implemented	   to	   communicate	   via	   a	   custom	   made	   API.	   This	   API	   acts	   as	   a	   security	  
blanket	  around	  the	  database.	  In	  addition,	  an	  API	  provides	  external	  users	  with	  a	  portal	  
to	   link	   into	   the	   Lamond	   Laboratory	   database	   and	   hence	   gain	   access	   to	   cutting	   edge	  
research	   and	   results.	   This	   API	   provides	   the	   ability	   for	   users	   to	   create	   their	   own	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websites	  and/or	  applications	   that	   represent	   the	  data	  being	   stored	   in	   the	  proteomics	  
database.	  	  
The	   NOPdb3.0	   allows	   secure	   access	   to	   the	   data,	   via	   three	   user	   levels.	   Users	   have	  
control	  to	  enter	  new	  data	  into	  the	  system	  and	  carry	  out	  on-­‐going	  management	  of	  the	  
data.	  Furthermore,	  this	  application	  allows	  the	  Lamond	  Laboratory	  to	  share	  their	  data	  
with	   the	   wider	   biology	   community,	   who	   can	   then	   benefit	   from	   access	   to	   the	   latest	  
research	   results.	   The	   application	   also	   makes	   data	   mining	   a	   reality.	   The	   specialist	  
techniques	   used	   to	   design	   and	   create	   the	   client	   interface	   enable	   it	   to	   dynamically	  
generate	   layouts	   for	   content	   and	   allow	   easy	   access	   to	   data	   for	   Lamond	   Laboratory	  
biologists.	   Through	   the	   interfaces,	   researchers	   can	   visualise	   the	   data	   produced	   from	  
experiments,	   which	   allows	   for	   easier	   cross	   analysis	   between	   experiments	   to	   be	  
achieved.	  
The	   database	   has	   been	   populated	   with	   different	   sets	   of	   experiments	   that	   identify	  
proteins	   in	   purified	   preparations	   of	   human	   nucleoli.	   From	   the	   initial	   ~700	   proteins	  
identified	   in	   the	   previous	   iteration	   of	   the	   NOPdb,	   over	   50,000	   peptides	   have	   been	  
identified	   contained	   in	   over	   4,500	  human	  proteins	   from	  purified	   nucleoli	   verified	   by	  
multiple	  MS	  analyses	   in	  different	  cell	   lines,	  providing	  significantly	  enhanced	  coverage	  
of	  the	  nucleolar	  proteome.	  The	  increased	  coverage	  of	  the	  human	  nucleolar	  proteome	  
is	  illustrated	  by	  the	  fact	  that	  NOPdb3.0	  now	  includes	  over	  80%	  of	  ribosomal	  proteins,	  
as	   opposed	   to	   the	   	   ~28%	   described	   in	   NOPdb	   version	   2.0.	   It	   is	   estimated	   that	  
NOPdb3.0	  contains	  over	  80%	  of	   the	  main	  human	  nucleolus	  proteins.	  The	  proteins	   in	  
the	   database	   will	   be	   regularly	   updated	   as	   more	   experiments	   are	   performed	   in	   the	  
Lamond	  Laboratory.	  
The	   continuous	   collaboration	  with	   the	   researchers	   from	   the	   Lamond	   Laboratory	   has	  
resulted	   in	   the	   creation	   of	   a	   usable	   piece	   of	   software.	   The	   user-­‐centred	   approach	  
employed	  during	  this	  work	   involved	  closely	  working	  with	  researchers	  to	  continuously	  
evaluate	  and	  obtain	  feedback	  on	  the	  software	  being	  created.	  Using	  this	  approach,	  user	  
responses	   could	   be	   quickly	   incorporated	   into	   early	   prototypes	   resulting	   in	   fewer	  
changes	   towards	   the	   end	   of	   the	   development.	   Feedback	   from	   the	   researchers	  
suggested	   that	   previous	   experience	   of	   software	   development	   had	   not	   involved	   this	  
user-­‐centred	   approach,	   which	   they	   attributed	   to	   the	   success	   of	   this	   project.	  
Furthermore,	   sessions	   with	   the	   researchers	   revealed	   that	   this	   project	   was	   simply	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opening	  the	  doors	  and	  highlighting	  the	  possibility	  of	  many	  more	  developments	  in	  this	  
field.	  	  
The	  nucleolar	  proteome	  database	  provides	  a	  basis	  for	  further	  work	  in	  creating	  a	  larger	  
repository	   and	   interfaces	   that	   can	   handle	   all	   types	   of	   MS	   experiments,	   not	   only	  
nucleolar	  datasets.	  Furthermore,	  the	  NOPdb3.0	  highlights	  the	  potential	  of	  automating	  
the	   storage	   of	   data	   in	   an	   electronic	   database	   and	   using	   it	   in	   conjunction	   with	  
experimental	  metadata	  to	  carry	  out	  analysis.	  These	  concepts	  were	  explored	  to	  create	  
new	   software	   described	   in	   Chapter	   4:	   PepTracker	   -­‐	   A	   Tool	   for	   Proteomics	   Data	  
Management	  &	  Analysis.  
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Chapter 4: PepTracker - A Tool for Proteomics Data 
Management & Analysis 
4.1 Summary 
To	  date,	  biological	   science	  has	   relied	  heavily	  on	   the	  manual	  analysis	  of	  experimental	  
datasets	  to	  interpret	  results.	  However,	  the	  combination	  of	  fast	  paced	  advances	  in	  both	  
instrumentation	   and	   experimental	   techniques	   has	   resulted	   in	   the	   availability	   of	  
complete	  genomes	  and	  the	  production	  of	  large	  datasets,	  for	  which	  manual	  analysis	  is	  
no	   longer	   feasible.	   With	   the	   advent	   of	   high	   throughput	   methods	   for	   protein	  
identification,	   huge	   volumes	   of	   data	   are	   being	   created	   via	   mass	   spectrometry.	   The	  
volume	  and	  complexity	  of	   these	  data	  make	   it	   impossible	   to	  analyse	   them	  by	  manual	  
inspection.	  These	  data	  are	  a	  major	  resource	  that	  requires	  new	  approaches	  to	  manage,	  
analyse	  and	  store	  efficiently,	   for	  researchers	  working	  within	  the	  same	  institution	  and	  
collaborating	  institutes.	  These	  problems	  are	  further	  enhanced	  by	  the	  complexity	  of	  the	  
data,	   the	  non-­‐consensus	  on	  data	   formats	  and	  absence	  of	  data	   standards.	   The	   issues	  
mentioned	  here	  are	  outlined	  in	  detail	  within	  Chapter	  1:	  Literature	  Review.	  Researchers	  
are	   now	  heavily	   reliant	   on	   computer-­‐based	   analysis	   and	   visualisation	   techniques	   for	  
large	  datasets.	  	  
The	   Lamond	   Laboratory	   is	   one	   such	   group	   requiring	   new	   methodologies	   for	   the	  
collection,	   storage,	   analysis,	   and	   visualisation	   of	   large	   datasets	   from	   proteomics	  
experiments.	   The	   Principal	   Investigator	   of	   the	   Lamond	   Laboratory,	   Professor	   Angus	  
Lamond,	   views	   the	   challenges	   surrounding	   proteomics	   data	   as	   an	   opportunity	   to	  
innovate	   and	   drive	   the	   development	   of	   new	   software	   and	   techniques.	   With	   past	  
success	   and	  access	   to	   state	  of	   the	   art	   equipment,	   the	   Lamond	   Laboratory	  makes	   an	  
ideal	  test	  bed	  for	  developing	  new	  software	  that	  can	  be	  challenged	  by	  leading	  scientific	  
protocols	   and	   researchers	   recruited	   with	   varying	   expertise,	   ranging	   from	   traditional	  
biologists,	  chemists,	  mass	  spectrometrists	  to	  pathologists.	  	  
Through	   the	  development	  of	  new	   software	   the	   Lamond	   Laboratory	   aims	   to	  discover	  
patterns	  and	  trends,	  which	  were	  not	  previously	  visible.	  This	  chapter	  describes	  an	  effort	  
to	  tackle	  these	  issues,	  with	  the	  goal	  of	  making	  advances	  in	  the	  overall	  management	  of	  
the	   datasets	   produced	   by	   experimentalists,	   through	   the	   development	   of	   web-­‐based	  
visualisation	   tools	   that	   have	   access	   to	   a	   rich	   amount	   of	   data	   from	   past	   years	   of	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experimentation.	   These	   tools	   are	   aimed	   at	   providing	   insightful	   analysis	   through	  
interactions	   with	   individual	   datasets,	   as	   well	   as	   allowing	   for	   comparisons	   of	   data	  
produced	   by	   different	   researchers,	   using	   both	   similar	   and	   different	   experimental	  
methods	  and	  thereby	  helping	  to	  promote	  new	  collaborations	  and	  cross-­‐fertilisation	  of	  
projects.	  
This	   project	   has	   resulted	   in	   the	   creation	   of	   software,	   PepTracker	  
(http://peptracker.com),	  which	  allows	  robust	  data	  management	  and	  analysis	  capable	  
of	   dealing	   with	   high	   throughput	   quantitative	   data	   from	   MS	   experiments	   and	   the	  
corresponding	   metadata.	   PepTracker	   provides	   a	   suite	   of	   visualisation	   and	   analysis	  
tools	  to	  facilitate	  complex	  data	  mining	  tasks,	  including	  the	  objective	  normalisation	  and	  
comparison	  of	  data	  from	  separate	  experiments.	  	  
	  
Figure	  13:	  PepTracker	  workflow.	  
The	  PepTracker	  software	  consists	  of	  three	  main	  components:	  MsTrack	  -­‐	  an	  integrated	  
Laboratory	   Information	  Management	   System	   (LIMS),	   DataVault	   –	   sophisticated	   data	  
storage,	   visualisation	   and	   exploration	   for	   quantitative	   proteomics	   data	   and	  
ProteinLibrary	  –	  a	  protein	  search	  and	  management	  view	  that	  allows	  for	  querying	  of	  all	  
datasets	   and	   creation	   of	   specialised	   protein	   groups.	   Chapter	   4	   describes	   the	  
PepTracker	  software,	  focusing	  first	  on	  its	  three	  main	  components	  (sections	  4.2-­‐4.4),	  its	  
implementation	   (sections	   4.5	   and	   4.6)	   and	   finally	   on	   how	   data	   security	   and	   quality	  
control	  are	  ensured	  (section	  4.7).	  	  
4.2 MsTrack – Laboratory Information Management System 
The	   PepTracker	   system	   has	   been	   implemented	   to	   incorporate	   a	   Laboratory	  
Information	  Management	  System	  (LIMS).	  This	  LIMS	  provides	  recording	  and	  tracking	  of	  
samples,	   automated	   sample	   submission	   and	   intelligent	   data	   management.	   This	  
functionality	  ensures	  comprehensive	  linkage	  between	  the	  various	  metadata,	  raw	  files	  
and	  processed	  data	  (see	  Figure	  14).	  Thus,	  researchers	  can	  retrace	  their	  steps	  and	  re-­‐
analyse	  samples	  from	  any	  stage	  in	  the	  processing	  pipeline.	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Figure	  14:	  MsTrack	  workflow.	  
The	   LIMS	   part	   of	   the	   system	   records	   extensive	   metadata	   associated	   with	   the	  
experimental	   procedure	   used	   to	   create	   samples,	   as	  well	   as	   data	   regarding	   the	  mass	  
spectrometry	   process	   itself.	   The	   metadata	   collection	   was	   meticulously	   planned	   to	  
ensure	  that	  it	  was	  comprehensive	  enough	  to	  allow	  in	  depth	  analysis	  of	  data	  at	  a	  later	  
stage.	  In	  order	  to	  ensure	  data	  analysis	  can	  be	  carried	  out	  effectively	  it	  is	  imperative	  to	  
know	  the	  samples	   from	  which	  the	  data	  were	  generated.	  For	  example,	  when	  carrying	  
out	   data	   mining	   that	   involves	   collating	   historical	   data	   to	   analyse	   trends	   in	  
immunoprecipitation	   experiments	   (see	   Chapter	   5:	  Multidimensional	   Analysis	   with	   IP	  
Experiments),	   it	   is	   important	   to	   be	   able	   to	   identify	   a	   suitable	   subset	   of	   mass	  
spectrometry	  data	  that	  represents	   immunoprecipitation	  experiments,	  which	  can	  only	  
be	   done	   effectively	   through	   filtering	   well	   formed	   metadata.	   Hence,	   in	   addition	   to	  
simply	  collecting	  metadata,	  particular	  time	  was	  focused	  on	  ensuring	  it	  is	  collected	  in	  a	  
structured	  manner,	  for	  example	  using	  drop	  down	  lists	  where	  possible.	   
The	  metadata	  collection	  is	  carried	  out	  via	  a	  wizard	  interface	  that	  sections	  the	  data	  to	  
be	  collected	  into	  logical	  steps	  that	  are	  more	  comprehensive	  for	  a	  researcher	  wishing	  to	  
enter	   data.	   The	   steps	   in	   the	   wizard	   are	   customised	   dynamically	   based	   on	   the	   data	  
entered	  by	  a	  researcher.	  For	  example,	   if	  a	  user	  specifies	  that	  they	  have	  carried	  out	  a	  
SILAC	  experiment,	   an	  additional	   SILAC	   step	   is	   added	   into	   the	  wizard	   (see	   Figure	  15).	  
Additional	   methods,	   such	   as	   the	   requirement	   to	   enter	   data	   using	   drop	   down	   lists,	  
ensure	  researchers	  are	  consistent	  with	  data	  entry,	  avoiding	  mistakes	  such	  as	  spelling	  
errors,	   grammatical	   differences,	   variances	   in	   expression	   and	   enforcing	   the	   use	   of	   a	  
standard	  nomenclature.	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Figure	  15:	  MS	  submission	  wizard	  interface.	  
Furthermore,	   to	   ensure	   consistency	   of	   data	   entry,	   the	   LIMS	   system	   incorporates	   a	  
reagents	   database.	   This	   part	   of	   the	   LIMS	   system	   manages	   data	   on	   antibodies,	  
plasmids,	  cell	  lines,	  siRNAs	  and	  chemicals	  within	  the	  laboratory.	  When	  creating	  a	  new	  
experiment,	   researchers	   can	   choose	   items	   from	   the	   reagents	   database	   rather	   than	  
entering	   free	   text.	   Furthermore,	  metadata	   entry	  was	   customised	   so	   that	   PepTracker	  
can	   be	   comprehensive	   with	   regards	   to	   the	   information	   stored	   about	   experiments.	  
Hence,	  the	  data	  requested	  varies	  dependent	  upon	  the	  type	  of	  experiment	  carried	  out.	  
For	   example	   immunoprecipitation	   experiments	   require	   information	   to	   be	   entered	  
about	  buffers,	  beads	  and	   the	  protein	  pulled	  down.	  Also	  metadata	   collection	  may	  be	  
customised	   if	   a	   protocol	   is	   specialised,	   such	   as	   SILAC,	   which	   requires	   input	   of	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information	   about	   labelling	   used	   and	   description	   of	   each	   label	   condition.	   A	   full	  
specification	  of	  the	  metadata	  collected	  is	  available	  in	  Appendix	  B.	  
Users,	   wishing	   to	   add,	   update	   or	   remove	   entries,	   can	   amend	   all	   lookup	   lists	   in	  
PepTracker.	  However,	  the	  developer	  reviews	  any	  changes	  to	  these	  lookup	  tables	  on	  a	  
monthly	  basis.	  This	  strategy	  was	  chosen	  as	  it	  was	  realised	  that	  proteomics	  experiments	  
are	   constantly	   evolving	   and	   improving,	   which	   means	   researchers	   will	   need	   new	  
options	   in	   the	   lookup	   tables.	   By	   allowing	   user	   additions	   dynamically,	   the	   software	  
encourages	   users	   to	   be	   thorough	   in	   their	   data	   entry	   rather	   than	   entering	   incorrect	  
data	  or	  omitting	  data	  because	  their	  ideal	  selection	  item	  is	  not	  in	  the	  list.	  
The	  metadata	  collected	  regarding	  sample	  preparation	  is	  used	  by	  PepTracker	  to	  create	  
an	   electronic	   sample	   submission	   form	   for	   the	   Fingerprint	   Proteomics	   Facility	   at	   the	  
University	   of	   Dundee	   (http://proteomics.lifesci.dundee.ac.uk/).	   The	   electronic	  
submission	  is	  sent	  to	  the	  MS	  facility	  upon	  researcher	  request,	  leaving	  the	  researcher	  to	  
submit	  their	  physical	  samples,	  which	  must	  be	  labelled	  as	  per	  PepTracker	  convention.	  In	  
consultation	   with	   the	   in-­‐house	   Fingerprint	   Proteomics	   Facility,	   the	   workflow	   is	  
implemented	  to	  ensure	  all	  details	  of	  MS	  experiments	  conducted	  in	  the	  laboratory	  must	  
be	  entered	   into	  PepTracker	  before	  MS	  analysis	   is	   possible.	   Importantly,	   this	   ensures	  
that	  every	  MS	  experiment	  performed	  is	  always	  contained	  in	  the	  PepTracker	  database.	  
PepTracker	   can	   also	  manage	   and	   integrate	   “legacy	   data”,	   entered	   either	   from	   older	  
experiments	  from	  the	  laboratory,	  or	  from	  other	  researchers	  who	  do	  not	  have	  access	  to	  
the	  LIMS	  component.	  
After	  MS	  submission,	  the	  MsTrack	  component	  monitors	  the	  status	  of	  the	  submission.	  
It	  does	  so	  by	  initially	  logging	  the	  researcher,	  date	  and	  time	  of	  an	  electronic	  MS	  facility	  
submission	  and	  using	  this	  information	  to	  keep	  the	  researcher	  updated	  with	  regards	  to	  
the	  progress	  of	  the	  submission.	  To	  determine	  when	  samples	  are	  being	  run,	  PepTracker	  
continuously	   polls	   the	   proteomics	   server	   to	   identify	   the	   presence	   of	   raw	   files	  
associated	  to	  the	  samples.	  It	   identifies	  relevant	  files	  using	  the	  unique	  name	  allocated	  
to	  each	  sample	  submitted	  to	  the	  MS	  facility.	  When	  PepTracker	   is	  able	  to	   identify	  the	  
presence	   of	   the	   first	   of	   these	   files,	   it	   logs	   the	   date	   and	   time,	   indicating	   the	   starting	  
point	  of	  the	  MS	  analysis	  of	  the	  samples.	  Once	  all	  submitted	  samples	  have	  been	  linked	  
with	   a	   raw	   data	   file	   on	   the	   proteomics	   server,	   PepTracker	   once	   again	   updates	   the	  
status	  of	   the	  submission	  by	   logging	   the	  data	  and	   time	  when	   the	  MS	  submission	  was	  
94	  
identified	   as	   being	   complete.	   At	   this	   stage	   PepTracker	   sends	   an	   automated	   email	  
informing	   the	   researcher	   that	   the	   raw	  data	   files	  are	  available	   for	   further	  processing.	  
Depending	  on	  where	  the	  raw	  files	  are	  located	  on	  the	  proteomics	  server,	  PepTracker	  is	  
able	   to	   determine	  which	   instrument	  was	   used	   to	   run	   the	   samples.	  Moving	   forward,	  
PepTracker	  maintains	   a	   link,	   providing	  online	   access	   to	   the	   resulting	   raw	   files	   in	   the	  
future	  for	  re-­‐analysis	  if	  this	  were	  deemed	  necessary,	  for	  example	  if	  updated	  software	  
becomes	  available.	  
Once	   the	   raw	   data	   files	   are	   available,	   researchers	   can	   download	   these	   files	   from	  
PepTracker	   through	   a	   one-­‐step	   click.	   After	   carrying	   out	   the	   standard	   quantitative	  
analysis	  using	  3rd	  party	  software:	  Mascot	  and	  MaxQuant,	  researchers	  can	  upload	  their	  
MaxQuant	  data	  to	  PepTracker	  for	  further	  data	  analysis	  and	  visualisation.	  This	  includes	  
user-­‐selected	  options	  to	  automate	  downstream	  analysis	  and	  visualisation	  procedures,	  
dependent	   upon	   the	   type	   of	   experiment	   being	   performed.	   For	   example,	   pull-­‐down	  
analyses	  of	  protein-­‐protein	  interactions	  can	  be	  selected	  for	  automated	  data	  plots	  and	  
identification	  of	  contaminants	  and	  normalisation	  of	  data	  points	  with	  reference	  to	  the	  
Protein	   Frequency	   Library	   (see	   Chapter	   5:	   Multidimensional	   Analysis	   with	   IP	  
Experiments). 
Currently,	  the	  LIMS	  part	  of	  the	  system	  does	  not	  automate	  the	  data	  processing	  stage.	  
Due	   to	   the	   evolution	   in	   software	   this	   is	   a	   task	   that	   could	   not	   be	   easily	   automated.	  
However,	  as	  the	  software	  matures	  and	  becomes	  more	  stable	  this	  is	  a	  possibility	  for	  the	  
future	   development	   of	   PepTracker.	   Although	   not	   essential,	   this	   will	   streamline	   the	  
workflow	   and	   result	   in	   a	   fully	   automated	   system	   for	   the	   researcher,	   going	   from	  
submitting	  samples	  to	  the	  MS	  facility	  through	  to	  receiving	  output	  files	  from	  MaxQuant,	  
with	  quantified	  peptide	  identifications	  entered	  and	  managed	  within	  PepTracker.	  	  
4.2.1 Tag Cloud 
A	  tag	  cloud	  was	  implemented	  in	  PepTracker,	  using	  the	  keywords	  that	  are	  specified	  for	  
MS	   submissions	   by	   researchers.	   The	   size	   of	   the	   keywords	   on	   the	   tag	   cloud	   is	  
determined	   by	   the	   frequency	   of	   their	   use	   in	  MS	   submissions.	   This	   provides	   a	   quick	  
visual	  as	  to	  the	  types	  of	  experiments	  being	  carried	  out	  in	  the	  laboratory	  and	  any	  ‘hot’	  
topics	  (see	  Figure	  16).	  Current	  users	  of	  PepTracker	  thus	  often	  employ	  gel	  filtration	  and	  
fractionation	   in	   the	   preparation	   of	   their	   samples,	   work	   with	   worm	   and	   U2OS	   cells,	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most	  often	  run	  their	  samples	  on	  the	  VELOS	  mass	  spectrometer	  and	  within	  the	  Lamond	  
laboratory	  there	  is	  a	  particular	  interest	  in	  the	  proteins	  SMN	  and	  MRFAP1.	  
When	   entering	   keywords,	   users	   can	   choose	   to	   either	   select	   three	   words	   from	   an	  
existing	  list,	  populated	  from	  all	  keywords	  entered	  into	  PepTracker,	  or	  users	  can	  enter	  
new	   words.	   This	   type	   of	   keyword	   selection	   shows	   problems	   as	   users	   often	   simply	  
select	  three	  keywords	  from	  the	  existing	  list	  for	  ease,	  rather	  than	  entering	  new	  words.	  
It	  is	  realised	  that	  this	  will	  develop	  over	  time	  as	  an	  improved	  vocabulary	  of	  keywords	  is	  
built	  up.	  In	  addition,	  PepTracker	  has	  been	  updated	  to	  allow	  researchers	  the	  option	  of	  
selecting	  as	  many	  keywords	  as	  they	  want	  rather	  than	  restricting	  to	  only	  three	  words.	  
	  
Figure	  16:	  Tag	  cloud	  generated	  from	  MS	  submission	  keywords.	  
	  
4.3 DataVault – Storage, Visualisation & Exploration of Quantitative 
Proteomics Data 
The	  DataVault	  provides	  researchers	  with	  the	  means	  to	  upload	  quantitated	  data,	  which	  
is	   parsed	   and	   stored	   in	   a	   data	   warehouse.	   These	   data	   are	   then	   presented	   to	  
researchers	  via	  an	  interactive	  interface	  that	  allows	  exploration	  and	  discovery	  tasks	  to	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be	   carried	   out.	   The	   DataVault	   has	   been	   created	   with	   a	   desktop	   appearance	   and	  
interaction.	   The	   focus	   of	   the	   interface	   is	   to	   maximise	   interactivity	   with	   data	   and	  
provide	  easy	  access	  to	  features	  that	  aid	  data	  exploration.	  	  
The	  overall	  DataVault	   interface	   is	   split	   into	  various	  panes	   that	   separate	   functionality	  
into	  logical	  sections.	  The	  two	  main	  views	  on	  the	  DataVault	  are	  the	  browser	  view	  and	  
data	   view.	   The	   browser	   view	   provides	   the	   ability	   to	   upload	   and	   store	   MaxQuant	  
datasets	   and	   implements	   an	   organised	   view,	   browsing	   functionality	   and	   selection	   of	  
multiple	  datasets.	  The	  data	  view	  focuses	  on	  the	  visualisation	  and	  exploration	  of	  one	  or	  
more	  datasets.	  These	  views	  are	  further	  enhanced	  by	  menu	  bars	  that	  provide	  additional	  
features	   such	   as	   Full	   Screen	   mode	   to	   allow	   maximisation	   of	   screen	   usage	   for	   the	  
exploration	  of	  data	  (see	  Figure	  21).	  
4.3.1 Data Storage 
Once	   raw	  data	  have	  been	  processed	  using	  MaxQuant	   to	   generate	  quantitative	  data,	  
researchers	   can	   choose	   to	   upload	   their	   resultant	   dataset	   to	   PepTracker	   for	  
downstream	  analysis,	  visualisation	  and	  exploration.	  	  
Considerable	   effort	   has	   been	   devoted	   to	   optimise	   uploads	   of	   MS	   data	   so	   that	  
PepTracker	   can	  handle	   the	  varying	   sizes	  of	  datasets	   in	  an	  efficient	  manner.	  Datasets	  
can	  vary	   from	  a	   few	  hundred	  megabytes	   to	  a	   few	  gigabytes.	  PepTracker	  handles	   the	  
upload	  of	  these	  datasets	  by	  providing	  a	  form	  for	  researchers	  to	  specify	  files	  from	  their	  
MaxQuant	  output	  plus	  a	  description	  of	   the	  dataset.	  The	  output	   files	   from	  MaxQuant	  
used	  in	  the	  upload	  are	  listed	  in	  Table	  4.	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File	  Name	   Description	  
parameters.txt	   Logs	  the	  parameters	  used	  in	  the	  MaxQuant	  search.	  
experimentalDesign.txt	   Documents	   the	   fractions,	   experiments	   and	   raw	   files	   that	  
are	  represented	  in	  the	  dataset.	  	  
evidence.txt	   Combines	   the	   information	   obtained	   about	   the	   identified	  
peptides	   in	   a	   mass	   spectrometer	   run,	   logging	   a	   row	   for	  
each	  occurrence	  of	  a	  peptide.	  
modificationSpecificPeptides.txt	   Contains	   aggregated	   information	   on	   the	   identified	  
peptides	  in	  the	  processed	  raw	  files,	   logging	  only	  one	  row	  
for	  each	  modified	  version	  of	  a	  peptide.	  
peptides.txt	   Contains	   aggregated	   information	   on	   the	   identified	  
peptides	  in	  the	  processed	  raw	  files,	   logging	  only	  one	  row	  
for	  each	  peptide.	  
proteinGroups.txt	   Contains	   information	   on	   the	   identified	   proteins	   in	   the	  
processed	  raw	  files.	  Each	  single	  row	  contains	  the	  group	  of	  
proteins	   that	   could	   be	   reconstructed	   from	   a	   set	   of	  
peptides.	  
Table	  4:	  MaxQuant	  Output	  Files.	  
The	   experimental	   design	   file	   is	   important	   as	   it	   is	   used	   to	   link	   back	   to	   the	   original	  
metadata	  used	   in	   the	  submission	  of	   the	  MS	  experiment.	  PepTracker	  creates	   this	   link	  
through	  matching	  raw	  file	  names	  from	  experimental	  design	  file	  to	  sample	  names	  that	  
were	  originally	  logged	  in	  the	  PepTracker	  database	  at	  the	  time	  of	  MS	  Submission.	  The	  
remainder	   of	   the	   files,	   required	   in	   the	   MaxQuant	   data	   upload,	   contain	   the	   major	  
quantitative	   information	   that	  was	   generated	  by	   the	  mass	   spectrometer	   and	  used	  by	  
researchers	  to	  generate	  hypotheses	  and	  draw	  conclusions	  from	  data.	  
During	   the	   dataset	   upload,	   PepTracker	   uploads	   the	   MaxQuant	   data	   files	   to	   a	  
temporary	   folder	   on	   the	   PepTracker	   server	   and	   then	   processes	   the	   files	   as	   a	  
background	  task	  using	  the	  PepTracker	  scheduler	  (see	  4.6.4	  PepTracker	  Task	  Scheduler,	  
Figure	  17).	  This	  scheduler	  has	  been	  created	  to	  manage	  tasks	  on	  the	  PepTracker	  server	  
in	  the	  background	  so	  that	  researchers	  on	  the	  front-­‐end	  are	  not	  restricted	  to	  keeping	  a	  
web	  page	  open	  for	  an	  extended	  period	  while	  the	  data	  upload	  and	  processing	  occurs.	  
Instead	   researchers	   can	   navigate	   away	   from	   the	   upload	   dataset	   page	   and	   the	  
scheduler	   automatically	   notifies	   them	   by	   email	   once	   their	   task	   is	   completed.	   This	  
scheduler	   also	   aids	   in	   distributing	   the	   processing	   required	   if	   multiple	   researchers	  
attempt	  to	  upload	  datasets	  at	  the	  same	  time.	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Figure	  17:	  PepTracker	  scheduler	  for	  handling	  data	  uploads.	  
4.3.2 Browser View for Dataset Management 
One	  of	   the	   important	  needs	  highlighted	  by	   researchers	  was	   the	  easy	  navigation	  and	  
management	   of	   datasets	   generated	   from	   MaxQuant.	   Hence,	   PepTracker	   has	   been	  
implemented	   to	   provide	   a	   variety	   of	   views	   to	   browse	   the	   datasets	   available	   in	   the	  
PepTracker	   database.	   These	   views	   include	   a	   list	   view	   or	   customised	   icon	   view	   (see	  
Figure	  18).	  The	  icon	  view	  allows	  for	  quick	  recognition	  of	  different	  types	  of	  experiments	  
and	  datasets.	  	  




Figure	  18:	  DataVault	  browser	  views.	  
The	   browser	   view	   also	   provides	   smart	   folders	   that	   allow	   easy	   access	   to	   the	   most	  
recently	   uploaded	   datasets.	   Furthermore,	   researchers	   can	   set	   up	   their	   own	   smart	  
folders	  containing	  a	  set	  of	  specified	  datasets	  of	  their	  choosing.	  A	  search	  feature	  is	  also	  
available,	  which	  filters	  datasets	  dynamically	  based	  on	  keywords	  entered	  into	  a	  search	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box.	   In	  addition,	  researchers	  can	  filter	  the	  datasets	  viewable	  via	  drop	  down	  lists	  that	  
allow	  specification	  of	  researchers,	  keywords	  and	  experiment	  name	  etc.	  	  
4.3.3 Data View for Data Visualisation and Exploration 
In	   order	   to	   provide	   additional	   benefit	   of	   having	   datasets	   stored	   in	   PepTracker,	  
researchers	  felt	  it	  would	  be	  invaluable	  to	  have	  methods	  of	  viewing	  their	  data	  in	  novel	  
ways.	   This	   involved	  providing	   advanced	   interactivity	  with	  datasets,	   functionality	   that	  
mostly	  is	  currently	  unavailable	  with	  other	  proteomics	  software.	  	  
A	   set	   of	   tools	   has	   been	   created	   within	   PepTracker	   for	   the	   convenient	   visualisation,	  
statistical	  analysis	  and	  comparison	  of	  datasets.	  Advanced	  tools	  are	  currently	  available	  
for	   second-­‐generation	  proteomics	  experiments,	   including	  protein	  pull-­‐down	  analyses	  
(see	  Chapter	  5:	  Multidimensional	  Analysis	  with	  IP	  Experiments),	  spatial	  proteomics	  and	  
pulse	   labelling/turnover	   studies	   (see	   Chapter	   6:	   Spatial	   Localisation	   &	   Turnover	  
Analyses).	   
Interface	  Evolution	  
Initially	   the	   PepTracker	   visualisation	   functionality	   was	   implemented	   using	   Google’s	  
Visualisation	  API	  (see	  Figure	  19).	  This	  API	  provides	  a	  series	  of	  charts	  and	  gadgets	  that	  
can	   be	   incorporated	   into	   web	   pages.	   The	   charts	   used	   HTML5/SVG	   technology	   to	  
provide	  cross-­‐platform	  interactive	  visualisation	  of	  data.	  The	  data	  source	  was	  supplied	  
to	  the	  charts	  using	  JavaScript	  code.	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Figure	  19:	  Early	  PepTracker	  interfaces	  created	  using	  Google	  Visualisation	  API.	  
This	  solution	  was	  effective	  as	   it	  provided	  researchers	  with	  the	  ability	  to	  navigate	  and	  
explore	   their	   data	   using	   simple	   mouse	   manoeuvres.	   However,	   drawbacks	   to	   this	  
technology	   included	   the	   considerable	   development	   time	   required	   to	   integrate	   the	  
charts	   into	   a	   wider	   solution	   and	   the	   limitations	   in	   customisation	   of	   the	   charts.	  
Researchers	   also	   highlighted	   the	   restricted	   interactivity	   with	   the	   data.	   Furthermore,	  
researchers	  wanted	  a	  solution	  that	  provided	  flexibility	  with	  the	  data	  fields	  used	  on	  the	  
visualisations	  and	  advanced	  features	  such	  as	  slider-­‐based	  filtering	  of	  chart	  data.	  Hence,	  
new	   solutions	   were	   explored	   and	   the	   final	   outcome	   was	   the	   use	   of	   Adobe	   Flex	  
technology	   to	   create	   an	   integrated	   web	   and	   desktop	   based	   viewer	   that	   provided	   a	  
more	  immersive	  experience	  for	  the	  researchers.	  
102	  
Visualisation	  Interface	  	  
The	  data	  view	  on	  the	  DataVault	  provides	  a	  variety	  of	  chart	  and	  graph	  types	  to	  explore	  
data	  (see	  Figure	  20).	  These	  include:	  
• Bar	  Chart	  
• Column	  Chart	  
• Bubble	  Chart	  
• Area	  Chart	  
• Line	  Chart	  
• Plot	  Chart	  
• Network	  Map	  	  
The	  charts	  and	  graphs	  have	   the	  ability	   to	  detect	  and	  plot	  various	  experiment	  groups	  
within	   a	   dataset	   as	   separate	   series	   on	   a	   chart	   or	   graph	   of	   choice.	   Furthermore,	  
researchers	  can	  select	  multiple	  datasets	  and	  plot	  one	  dataset	  variable	  against	  a	  second	  
dataset	  variable	  on	  the	  same	  graph	  or	  chart.	  
	  
Figure	  20:	  DataVault	  graphs	  and	  charts.	  
PepTracker	   provides	   a	   range	   of	   interactive	   features	   with	   the	   chart	   visualisations	  
including:	  	  
• Customisable	  x,	  y	  and	  z-­‐axis	  to	  plot	  user	  selected	  variables.	  
• Scrollable	  and	  zoom-­‐able	  axes.	  
• Option	  to	  show/hide	  series.	  
• Mouse	  and	  slider	  enabled	  range	  selection	  that	  can	  be	  used	  to	  zoom	  into	  a	  chart	  
or	  to	  create	  a	  custom	  protein	  group.	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• On	   click	   context	  menus	   that	   provide	   various	  options	   including	   easy	   access	   to	  
protein	  information	  pages.	  
• Customisable	  colours	  for	  single	  data	  points	  or	  series.	  
• Drag	  and	  drop,	  dynamic	  overlay	  of	  protein	  groups	  on	  a	  dataset.	  
• Mouse	  hover	  tooltips	  that	  can	  be	  used	  to	  identify	  proteins.	  
• Filter	  options,	  including	  contaminants,	  reverse	  proteins,	  PFL	  frequencies	  etc.	  
• Customisable	  chart	  colours,	  fonts	  and	  line	  thicknesses.	  
• Output	  to	  JPG	  and	  PNG	  formats.	  	  
These	  interactive	  features	  allow	  intuitive	  navigation	  of	  datasets	  and	  provide	  the	  ability	  
to	   understand	   data	   more	   quickly.	   Through	   interacting	   with	   the	   data	   at	   the	   protein	  
level,	  researchers	  can	  drill-­‐down	  to	  discover	  interesting	  clusters	  or	  individual	  proteins	  
for	   further	   exploration.	   From	   the	   researcher	   experience	  of	   interacting	  with	   the	  data	  
(see	  Figure	  21),	  it	  is	  intended	  that	  a	  better	  feel	  for	  the	  data	  can	  be	  obtained	  and	  hence,	  
time	   and	   effort	   can	   be	   focused	   on	   hypotheses	   that	   are	   grounded	   in	   experimental	  
evidence.	  
	  
Figure	  21:	  Interactive	  DataVault	  interface.	  
The	  visualisation	   interface	  also	  provides	   the	  ability	   to	   create	  dynamic	  network	  maps	  
(see	  Figure	  22).	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Figure	  22:	  PepTracker	  protein	  network	  map.	  
The	  aim	  of	  these	  maps	  is	  to	  allow	  researchers	  to	  visually	  detect	  which	  proteins	  might	  
be	  of	  interest	  to	  them.	  In	  order	  to	  make	  this	  task	  easier	  and	  quicker	  the	  network	  map	  
is	  customisable	  so	  users	  can	  control	  various	  parameters	  such	  as:	  
• Line	  Thickness/Alpha/Colour	  
• Node	  Alpha/Colour	  
• Text	  Size	  
• Distance	  from	  Root	  Node	  
• Node	  Spacing/Visibility	  
• Number	  of	  Nodes	  Visible	  
Each	  of	  the	  parameters	  mentioned	  above	  can	  be	  allocated	  a	  variable	  from	  the	  dataset,	  
such	  as	  ratio,	  intensity	  or	  peptide	  count,	  in	  order	  that	  they	  each	  visually	  represent	  an	  
aspect	  of	  the	  dataset	  (see	  Figure	  23).	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Figure	  23:	  PepTracker	  customised	  protein	  network	  map.	  
4.4 ProteinLibrary – Protein Search and Specialised Protein Group 
Management 
The	   ProteinLibrary	   section	   within	   PepTracker	   provides	   a	   simple	   search	   interface	   to	  
allow	   researchers	   to	   look	   for	   a	   specific	   protein	   in	   the	   PepTracker	   database.	   It	   also	  
provides	  functionality	  to	  create	  specialised	  protein	  groups.	  
4.4.1 Protein Search 
The	  protein	   search	  within	   the	  ProteinLibrary	  provides	   researchers	  with	   the	  ability	   to	  
search	  for	  a	  protein	  using	  UniProtKB	  identifier,	  gene	  name	  or	  protein	  description.	  Once	  
searched,	   the	   ProteinLibrary	   interface	   is	   able	   to	   provide	   a	   quick	   overview	   of	   the	  
datasets	  that	  were	  found	  to	  contain	  the	  protein	  of	   interest.	  From	  these	  results,	   links	  
are	  provided	  to	  access	  further	  information	  regarding	  the	  protein	  identification	  within	  a	  
specific	  dataset.	  
One	  of	  the	  visualisations	  provided	  by	  PepTracker	  is	  the	  Protein	  Peptide	  Alignment	  Map	  
(see	  Figure	  24).	  This	  diagram	  is	  able	  to	  quickly	  convey	  the	  reliability	  of	  identification	  by	  
indicating	  the	  sequence	  coverage	  of	  peptide	   identifications.	  The	  map	  consists	  of	   two	  
parts,	   a	   linear	   block	   representation	   (grey	   bar	   representing	   a	   protein	   with	  
superimposed	  shades	  of	  red	  blocks	  representing	  peptides	  in	  the	  correct	  position)	  and	  a	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sequence	  representation	  (amino	  acid	  sequence	  of	  the	  protein,	  with	  peptide	  sequences	  
highlighted	  in	  shades	  of	  red).	  On	  both	  representations	  of	  a	  protein,	  all	  peptides	  within	  
the	  sequence	  that	  have	  been	  identified	  and	  quantified	  by	  MS	  are	  highlighted	  in	  colour,	  
which	   quickly	   conveys	   the	   peptide	   distribution	   and	   sequence	   coverage,	   and	   colour	  
coded	   to	   illustrate	   conveniently	   the	   variation	   in	   SILAC	   ratios	   for	   each	   peptide	  
quantified.	  	  
	  
Figure	  24:	  Protein	  peptide	  alignment	  map.	  
Finally,	   some	  reporting	  views	  have	  also	  been	   implemented.	  These	  are	  created	   in	   the	  
form	  of	  information	  sheets.	  Each	  information	  sheet	  relates	  to	  a	  record	  that	  was	  stored	  
in	   the	   MaxQuant	   results	   data	   output.	   These	   information	   sheets	   are	   linked	   so	   that	  
researchers	  can	  navigate	  between	  data	  from	  the	  four	  separate	  MaxQuant	  entities,	  i.e.	  
evidence,	  modified	  peptide,	  peptide	  and	  protein	  group.	  The	  protein	  group	  information	  




Figure	  25:	  Protein	  group	  information	  sheet.	  
4.4.2 Protein Group Definition and Enrichment Analysis 
Another	   feature	   of	   the	   ProteinLibrary	   is	   the	   ability	   to	   manage	   protein	   groupings.	  
During	   the	   analysis	   of	   mass	   spectrometry	   data,	   one	   approach	   employed	   involves	  
grouping	  proteins	  based	  on	  a	  variety	  of	  parameters,	  such	  as	  their	  function,	  behaviour	  
etc.	   This	   strategy	   allows	   researchers	   to	   deal	   with	   the	   complexity	   of	   the	   data	   and	  
provide	  guidance	  as	  to	  which	  proteins	  should	  be	  further	  investigated.	  By	  keeping	  track	  
of	   groups	  of	  proteins	   that	  are	  of	   interest,	   researchers	   can	  monitor	   their	  behavioural	  
properties	  between	  experiments.	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In	  order	  to	  aid	   in	  the	  analysis	  of	  datasets,	  PepTracker	  provides	  functionality	  to	  setup	  
protein	  groups	  that	  can	  be	  overlapped	  with	  datasets.	  Currently	  there	  is	  the	  option	  to	  
create	  three	  different	  types	  of	  protein	  groups:	  
• Sub-­‐selection	  of	  a	  dataset.	  
• Researcher-­‐defined	  group	  (defined	  by	  UniProtKB	  Identifier).	  
• Globally	  defined	  group	  (defined	  by	  UniProtKB	  Identifier	  or	  Gene	  Ontology).	  
These	   groups	   can	   be	   used	   in	   conjunction	   with	   the	   visualisations	   to	   show	   the	  
intersection	  of	  the	  group	  with	  the	  current	  dataset.	  Furthermore,	  especially	  in	  the	  case	  
of	  gene	  ontology	  defined	  groups,	  researchers	  can	  view	  the	  enrichment	  of	  a	  particular	  
group	  in	  each	  dataset,	  for	  example	  the	  enrichment	  of	  nuclear	  proteins	  (defined	  by	  the	  
‘nuclear’	  gene	  ontology	  term).	  This	  enrichment	  is	  calculated	  based	  on	  intensity	  values	  
produced	  by	  MaxQuant,	  which	  provides	  a	  more	  accurate	  enrichment	   value	   than	   the	  
traditional	  approach	  of	   simply	  counting	   the	  number	  of	  proteins	   found	   in	   the	  dataset	  
that	  overlap	  a	  particular	  set	  of	  known	  proteins.	  
4.5 PepTracker Desktop Client 
The	   DataVault	   component	   of	   PepTracker	   has	   been	   further	   extended	   to	   run	   as	   a	  
desktop	  application	  with	  web	  connectivity.	  The	  Adobe	  Flex	  code	  base	  that	  makes	  up	  
the	   DataVault	   is	   used	   and	   extended	  within	   Adobe	   AIR	   (Adobe	   Integrated	   Runtime),	  
which	   provides	   a	   cross-­‐platform	   runtime	   environment	   for	   building	   rich	   interactive	  
applications	  that	  can	  be	  deployed	  as	  desktop	  applications.	  	  
As	  a	  desktop	  client,	  the	  DataVault	  can	  be	  downloaded	  and	  installed	  by	  a	  researcher	  on	  
their	   machine	   and	   then	   used	   for	   visualisation	   and	   exploration	   of	   datasets.	   This	  
method,	  compared	  to	  a	  web	  browser,	  is	  more	  robust	  and	  powerful	  as	  the	  application	  
can	  make	  use	  of	   the	   full	   resources	   available	  on	   a	  user’s	  machine	   as	   opposed	   to	   the	  
restricted	   access	   provided	   by	   a	   web	   browser.	   The	   desktop	   client	   can	   be	   further	  
enhanced	  in	  the	  future	  to	  implement	  a	  local	  database	  that	  can	  provide	  offline	  access	  
to	  datasets.	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4.6 Technical Implementation 
4.6.1 System Architecture 
	  
Figure	  26:	  PepTracker	  system	  architecture	  overview.	  
4.6.2 Database Development 
PepTracker	  contains	  two	  different	  types	  of	  databases,	  relational	  and	  multi-­‐dimensional	  
(described	  in	  5.4.2	  Multidimensional	  Database).	  
The	  relational	  database	  was	  originally	  set	  up	  using	  a	  MySQL	  database	  engine	  (version	  
5.0.77).	  MySQL	  is	  a	  multithreaded,	  multi-­‐user	  SQL	  database	  management	  system	  that	  
is	  fast	  and	  robust	  with	  a	  good	  feature	  set.	  The	  administration	  and	  security	  setup	  of	  a	  
MySQL	  database	  are	  effective	  and	  not	  over	   complicated	   to	   implement.	   Even	   though	  
MySQL	  is	  a	  very	  popular,	  open	  source	  web	  database,	  reliable	  and	  easy	  to	  use,	  it	  cannot	  
match	  up	  to	  the	  performance	  and	  the	  variety	  of	  advanced	  tools	  and	  functions	  that	  are	  
available	  in	  a	  larger	  database	  engine,	  such	  as	  Oracle.	  Oracle	  is	  much	  more	  versatile	  and	  
can	  run	  and	  handle	  more	  transactions	  compared	  with	  MySQL.	  As	  a	  project	  grows,	  both	  
in	  terms	  of	  functionality	  and/or	  users,	  Oracle	  provides	  additional	  features	  such	  as	  SQL	  
transactions,	   stored	   procedures	   and	   data	   transformation	   services,	   which	   become	  
important	  to	  ensure	  good	  performance	  of	  an	  end	  application.	  	  
During	   the	   development	   of	   PepTracker,	   the	   functionality	   and	   demands	   from	   users	  
resulted	  in	  the	  decision	  to	  move	  from	  the	  original	  MySQL	  database	  engine	  to	  an	  Oracle	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instance	   (Oracle	   Database	   10g	   Enterprise	   Edition	   Release	   10.2.0.5.0).	   This	   Oracle	  
database	  engine	   is	  able	   to	  handle	   the	  data	  capacity	  growth	  and	  ensure	  performance	  
for	   end	   users.	   However,	   due	   to	   the	   expense	   associated	  with	   an	  Oracle	   license,	   it	   is	  
understood	  that	  not	  all	  institutes	  will	  readily	  have	  access	  to	  an	  Oracle	  license	  and	  so	  it	  
was	   decided	   that	   an	   open	   source,	   alternative	   backend	   database	   option	   should	   be	  
maintained.	   The	   database	   engine	   chosen	   for	   this	   task	   is	   PostgreSQL	   as	   it	   is	   easy	   to	  
maintain,	  yet	  provides	  some	  of	  the	  advanced	  functionality	  available	  in	  Oracle.	  	  
The	   relational	   database	   holds	   all	   datasets	   uploaded	   to	   PepTracker	   and	   also	   stores	  
extensive	  metadata	  describing	   the	  conditions	  under	  which	  experiments	  were	  carried	  
out	   and	   parameters	   associated	   with	   the	   experiments,	   such	   as	   cell	   type,	   organism,	  
extract,	  type	  of	  beads,	  machine,	  date,	  user,	  antibody	  and	  treatment	  etc.	  Furthermore,	  
local	  copies	  of	  the	  frequently	  accessed	  components	  of	  the	  publicly	  available	  UniProtKB	  
database	   (Apweiler	   et	   al.,	   2010)	   are	   included	   in	   the	   relational	   PepTracker	   database.	  
These	  UniProtKB	  tables	  are	  periodically	  updated	  (every	  4	  weeks)	  to	  coincide	  with	  the	  
UniProtKB	  releases.	  	  
The	  main	   PepTracker	   application	   communicates	   with	   the	   relational	   databases	   using	  
SQL.	   However,	   various	   databases	   will	   use	   their	   own	   SQL	   dialect,	   hence	   tying	   the	  
application	   to	  a	   specific	  database	  engine.	  Projects,	   such	  as	  SQL	  Alchemy,	  attempt	   to	  
remove	  this	  dependency	  by	  providing	  a	  SQL	  toolkit	  and	  object	  relational	  mapper	  that	  
is	   non-­‐database	   specific	   for	   high	   performance	   database	   access.	   This	   provides	   an	  
abstracted	  layer	  above	  the	  database,	  that	  the	  application	  can	  use	  rather	  than	  directly	  
interfacing	   with	   the	   database.	   This	   software	   toolkit	   was	   adopted	   in	   PepTracker	   to	  
make	  database	  selection	  and	  communication	  more	  maintainable	  and	  extendible.	  The	  
major	   benefit	   of	   using	   SQLAlchemy	   to	   communicate	   with	   the	   relational	   PepTracker	  
database	  is	  that	  the	  backend	  database	  engine	  can	  be	  changed	  without	  having	  to	  alter	  
the	  server	  side	  code	  that	  communicates	  with	  the	  database.	  This	  was	  particularly	  useful	  
when	   the	   decision	   was	   made	   to	   move	   the	   PepTracker	   database	   from	   the	   MySQL	  
engine	  to	  an	  Oracle	  database.	  
The	  relational	  database	  is	  normalised	  to	  third	  normal	  form,	  as	  defined	  by	  Codd	  in	  1971	  
(Codd	   et	   al.,	   1971),	   to	   eliminate	   data	   redundancy	   and	   inconsistencies	   within	   and	  
between	   tables	   and	   to	   make	   the	   database	   more	   maintainable.	   This	   normalisation	  
results	  in	  relational	  databases	  modelling	  reality	  by	  breaking	  the	  data	  into	  one	  or	  more	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sets,	   each	   of	   which	   represent	   a	   class	   of	   real-­‐world	   entity,	   for	   example	   protein,	  
experiment,	  user	  etc.	  This	  method	  creates	  a	  data	  store	  that	  is	  optimal	  for	  storage	  and	  
transaction	   based	   operations.	   However,	   more	   complex	   relationships	   and	   larger	  
volumes	  of	  data	  can	   lead	  to	  slower	  analytical	  performance,	  especially	  as	  the	  analysis	  
becomes	   more	   complex,	   hence	   additional	   tables	   are	   implemented	   that	   contain	   an	  
aggregated	  copy	  of	  denormalised	  data	  to	  act	  as	  a	  cache	  for	  fast	  access.	  
4.6.3 Server-Side Setup 
The	   main	   PepTracker	   server	   is	   a	   HTTP	   (HyperText	   Transfer	   Protocol)	   server	   that	   is	  
implemented	   on	   a	   Virtual	   Machine	   running	   Linux	   (CentOS	   Release	   5.3).	   This	   HTTP	  
server	   is	   able	   to	   communicate	   with	   web	   browser	   clients	   by	   understanding	   HTTP	  
requests	  that	  are	  sent	  to	  it	  and	  forming	  valid	  HTTP	  responses	  that	  the	  client	  machine	  
can	  display	  as	  HTML	   (HyperText	  Markup	  Language)	  pages	  on	  a	  web	  browser.	  Hence,	  
the	  server	  has	  to	  store	  all	  code	  that	  is	  served	  to	  researchers	  when	  requests	  are	  made	  
through	  a	  browser.	  	  
Any	  software	  that	   is	  put	   into	  production	  needs	  to	  be	  fixed,	  maintained	  and	  updated.	  
Each	  of	  these	  aspects	  requires	  either	  the	  modification	  or	  addition	  of	  source	  code.	  It	  is	  
therefore	   of	   the	   utmost	   importance	   that	   key	   software	   systems	   (such	   as	   a	   data	  
management	   and	   analysis	   systems)	   are	   written	   in	   clear,	   understandable	   and	  
documented	   code.	   The	   choice	   of	   programming	   language	   was	   Python	   as	   it	   was	  
understood	  that	  all	  code	  would	  need	  to	  be	  carried	  through	  for	  many	  years,	  potentially	  
having	   to	   deal	   with	   changes	   in	   programmer	   staff	   over	   that	   time	   period.	   Python	  
benefits	   from	   being	   a	   very	   robust,	   object-­‐oriented	   language	   with	   highly	   desirable	  
cross-­‐platform	  capabilities.	  This	  means	  that	  the	  compiled	  code	  itself	  can	  be	  distributed	  
and	   run	  on	  diverse	  platforms	  and	  architectures	  without	  any	  problems	  and	  with	  only	  
minor	   (if	   any)	   differences.	   Finally,	   the	   popularity	   of	   Python	   and	   the	   elegance	   of	   its	  
object-­‐oriented	  design	  have	  made	   it	  a	  favourite	  for	  programmers,	  especially	  those	   in	  
the	  bioinformatics	  field.	  
The	   majority	   of	   the	   PepTracker	   server-­‐side	   code	   base	   is	   written	   in	   Python	   (version	  
2.6.1)	  using	  the	  Django	  framework	  (version	  1.1.1).	  Django	  provides	  a	  high-­‐level	  Python	  
Web	   framework	   for	   rapid	   development	   and	   structured,	   clean,	   pragmatic	   design	   of	  
code.	   The	   Django	   code	   is	   structured	   using	   the	  Model-­‐View-­‐Controller	   (MVC)	   design	  
pattern	  so	  that	  the	  database,	  business	  and	  client	  logic	  are	  separated.	  Django	  has	  an	  in-­‐
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built	   object	   relational	  mapper	   that	   allows	   definition	   of	   data	  models	   and	   provides	   a	  
dynamic	  database	  access	  API.	  Django’s	  template	  system	  provides	  a	  powerful	  template	  
language	   that	   is	   extensible	   to	   separate	   the	   application	   interface	   design	   from	   the	  
Python	  code.	  
As	  well	  as	  making	  use	  of	  the	  in-­‐built	  Django	  database	  access	  API,	  raw	  SQL	  statements	  
had	  to	  be	  constructed	  for	  more	  complex	  queries.	  In	  order	  to	  ensure	  the	  code	  remained	  
extensible	   and	   not	   tied	   down	   to	   one	   database	   engine,	   SQLAlchemy	  
(http://www.sqlalchemy.org/)	  was	  employed	  (see	  4.6.2	  Database	  Development).	  	  
4.6.4 PepTracker Task Scheduler 
A	   scheduler	   was	   implemented	   on	   the	   PepTracker	   server	   to	   run	   tasks	   in	   the	  
background.	  Highly	  demanding	  tasks	  (CPU	  and	  memory	  intensive)	  require	  considerable	  
server	  resource	  and	  time	  to	  be	  processed.	  Hence,	  having	  these	  tasks	  running	  in	  parallel	  
and	  competing	  for	  resources	  is	  not	  ideal.	  Instead	  it	  is	  more	  logical	  to	  run	  these	  tasks	  in	  
a	  queue	  as	  background	  tasks	  on	  the	  PepTracker	  server.	  In	  order	  to	  manage	  such	  tasks,	  
including	  data	  upload	  and	  dataset	  caching,	  a	  scheduler	  was	  implemented	  to	  manage	  a	  
queue	  of	  tasks,	  execute	  these	  tasks	  and	  inform	  the	  researcher	  once	  these	  tasks	  were	  
complete.	  This	  scheduler	   is	  built	  as	  a	  Django	  application,	  which	  the	  main	  PepTracker	  
application	  communicates	  with.	  The	  scheduler	  supports	  two	  types	  of	  tasks:	  
• Naïve	   tasks:	   These	   are	   ordinary	   functions,	  which	   are	  wrapped	   by	   a	   very	   thin	  
execution	  interface,	  which	  in	  turn	  is	  called	  directly	  by	  the	  scheduler.	  Whatever	  
is	   ordinarily	   returned	   by	   the	   function	   is	   cast	   to	   a	   string	   and	   returned	   to	   the	  
user.	  If	  the	  function	  raises	  an	  exception,	  the	  exception	  message	  is	  returned	  to	  
the	   researcher,	   and	   a	   full	   traceback	   is	   made	   available	   to	   the	   system	  
administrator.	  
• Jobs:	   These	   are	   functions,	   which	   are	   developed	   specifically	   for	   use	   with	   the	  
scheduler,	   as	   they	   adhere	   to	   a	   number	   of	   conventions	   and	  must	   implement	  
certain	   behaviours.	   However,	   they	   provide	   a	   wider	   range	   of	   functionality	  
compared	  to	  naïve	  tasks	  alone,	  including	  the	  ability	  to	  manually	  abort	  the	  task,	  
a	  prioritisation	  scheme	  for	  allocating	  more	  resources	  to	  important	  tasks,	  more	  
robust	  detection	  of	  failed	  tasks,	  and	  the	  ability	  to	  return	  progress	  report	  strings	  
to	  the	  user	  while	  the	  task	  is	  running.	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4.6.5 Proteomics Server 
The	  raw	  data	  produced	  by	  the	  mass	  spectrometer	  is	  stored	  by	  the	  mass	  spectrometry	  
facility	  on	  a	  server	  (known	  as	  the	  Proteomics	  Server).	  In	  order	  to	  create	  a	  link	  between	  
datasets	  and	   the	  original	   raw	   files,	   the	  PepTracker	   server	  has	  an	  active	   link	  with	   the	  
Proteomics	   Server.	   The	   PepTracker	   server	   polls	   the	   Proteomics	   Server	   for	   new	   raw	  
data	   files	   associated	   with	   samples	   that	   have	   been	   submitted	   via	   the	   PepTracker	  
application.	  When	   found,	   the	   PepTracker	   database	   is	   updated	   to	   log	   the	   location	   of	  
original	   raw	   files,	   hence	  maintaining	   an	   active	   link	   between	   experimental	  metadata	  
and	  raw	  data.	  
4.6.6 LDAP Authentication 
In	  order	  to	  be	  more	  accommodating	  to	  researchers,	  the	  logging	  process	  to	  PepTracker	  
is	   linked	  with	   the	  University	  of	  Dundee	  Lightweight	  Directory	  Access	  Protocol	   (LDAP)	  
server.	   This	  means	   researchers	   can	  use	   the	   same	  username	  and	  password	   to	   access	  
PepTracker	   as	   they	   do	   for	   other	   University	   IT	   facilities.	   PepTracker	   requests	   login	  
credentials	  and	  sends	  the	  username	  and	  password	  to	  the	  LDAP	  server,	  which	  confirms	  
whether	   the	   details	   have	   been	   entered	   correctly.	   Based	   on	   the	   response	   from	   the	  
LDAP	  server,	  PepTracker	  can	  then	  provide	  secure	  access	  to	  the	  application	  and	  data.	  
To	   accommodate	   non-­‐university	   researchers,	   PepTracker	   also	   has	   in-­‐built	  
authentication	  features.	  
4.6.7 Graphical User Interfaces 
All	  GUIs	  in	  PepTracker	  have	  been	  designed	  to	  be	  user	  friendly	  and	  provide	  a	  good	  user	  
experience	   of	   the	   PepTracker	   application.	   The	   web	   interfaces	   in	   PepTracker	   are	  
implemented	  using	  HyperText	  Markup	  Language	  (HTML)	  for	  the	  general	  structure,	  Ajax	  
(Asynchronous	   Javascript	   And	   XML)	   for	   dynamic	   data	   loading	   using	   the	   REST	  
(REpresentational	   State	   Transfer)	   approach,	   Javascript	   to	   provide	   advanced	  
functionality	  and	  Cascading	  Styling	  Sheets	  (CSS)	  for	  styling.	  
A	  number	  of	  Javascript	  libraries	  were	  used,	  including	  JQuery	  (version	  1.3.2),	  JQueryUI	  
(version	  1.7.2),	  Mootools	   (version	  1.2.1)	  and	  YUI	   (version	  2.7.0),	   to	  add	  and	  enhance	  
the	   functionality	   available	   through	   the	   PepTracker	   interfaces.	   Features,	   such	   as	   live	  
searching	   implemented	   using	   Mootools,	   enhance	   user	   experience.	   Furthermore,	  
libraries	   such	   as	   the	  Google	   Chart	   API	   and	  Google	   Visualisation	   API	  were	   utilised	   to	  
enhance	  interfaces	  through	  display	  of	  data	  in	  charts	  and	  graphs.	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The	   interfaces	   are	   made	   more	   dynamic	   using	   AJAX,	   which	   allows	   the	   PepTracker	  
interfaces	   to	   generate	   and	   send	   requests	   to	   the	   PepTracker	   Server	   using	   HTTP.	   The	  
PepTracker	  server	  processes	  the	  requests	  and	  returns	  a	  response,	  which	  can	  be	  used	  
by	   the	   clients	   interface	   to	   update	   its	   display	   without	   having	   to	   refresh	   the	   full	  
interface.	   The	   PepTracker	   web	   interfaces	   can	   be	   accessed	   through	   a	   web	   browser,	  
such	  as	  Firefox,	  Safari	  or	  IE.	  	  
To	   complement	   the	  HTML	  pages	   served	   through	  Django,	   the	   PepTracker	   application	  
also	  includes	  components	  programmed	  in	  Adobe	  Flex	  (SDK	  3.4).	  Flex	  is	  an	  open	  source	  
Software	   Development	   Kit	   (SDK),	   released	   by	   Adobe,	   for	   the	   development	   and	  
deployment	  of	  cross-­‐platform,	  rich	  interactive	  applications	  that	  deploy	  across	  all	  major	  
browsers,	  operating	  systems	  and	  desktops	  via	  the	  Adobe	  Flash	  Player	  and	  Adobe	  AIR	  
runtimes.	  In	  order	  to	  build	  Flex	  components	  the	  Adobe	  Flash	  Builder	  (formally	  known	  
as	  the	  Adobe	  Flex	  Builder)	  was	  used.	  All	  code	  in	  Adobe	  Flex	  is	  written	  using	  MXML,	  an	  
XML-­‐based	   markup	   language,	   for	   building	   Graphical	   User	   Interfaces	   (GUIs)	   and	  
Actionscript	  for	   interactivity.	  This	  code	  is	  built	  around	  the	  Cairngorm	  framework	  (see	  
Appendix	   A.	   Cairngorm	   Framework),	   an	   open-­‐source	   MVC-­‐based	   framework	   for	  
application	   architecture.	   Many	   of	   the	   in-­‐built	   Adobe	   Flex	   display	   components	  
(Accordions,	   Menus,	   Data	   Grids,	   Titled	   Windows,	   and	   Buttons)	   data	   types,	   effects	  
(Zoom,	   Blur,	   and	   Dissolve),	   and	   charts	   were	   used	   and/or	   extended	   to	   generate	   the	  
PepTracker	  interfaces.	  	  
The	  Adobe	  Flex	  code	  base	  is	  used	  and	  extended	  within	  Adobe	  AIR	  (Adobe	  Integrated	  
Runtime).	  Adobe	  Air	  provides	  a	  cross-­‐platform	  runtime	  environment	  for	  building	  rich	  
interactive	   applications	   that	   can	   be	   deployed	   as	   desktop	   applications.	   This	   provides	  
huge	  benefit	  for	  a	  developer,	  as	  code	  for	  a	  web	  client	  and	  desktop	  client	  only	  needs	  to	  
be	  written	  once,	  with	  minor	  adjustments	  the	  same	  code	  can	  be	  deployed	  on	  both	  web	  
and	  desktop	  platforms.	  Adobe	  Air	  was	  used	  to	  create	  and	  deploy	  a	  PepTracker	  desktop	  
client	  that	  is	  downloadable	  through	  the	  PepTracker	  Server.	  
4.6.8 Protein Identification Strategies 
There	  are	  two	  main	  approaches	  to	  protein	  identification	  using	  mass	  spectrometry,	  the	  
first	  approach	  analyses	  intact	  proteins	  (top-­‐down,	  protein-­‐centric)	  whereas	  the	  second	  
approach	   involves	   digesting	   proteins	   into	   peptides	   and	   attempting	   to	   identify	   these	  
peptides	   (bottom-­‐up,	   peptide-­‐centric).	   With	   a	   peptide-­‐centric	   approach,	   more	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complex	   computation	   is	   needed	   to	   reassemble	   the	   identified	   peptides	   to	   the	  
corresponding	  proteins.	  	  
A	  protein-­‐centric	  approach	  often	  makes	   it	  easier	   to	  map	  between	   identified	  proteins	  
and	   a	   search	   database,	   as	   the	   analysis	   algorithms	   are	   working	   with	   a	   full	   protein	  
identified	   via	   MS.	   Furthermore,	   this	   approach	   negates	   the	   need	   for	   the	   time-­‐
consuming	  protein	  digestions	   required	  with	  a	  peptide-­‐centric	   approach.	  However,	   in	  
order	   to	   identify	   these	   large	   proteins,	   highly	   sensitive	   MS	   equipment	   is	   needed.	  
Average	   mass	   spectrometers	   find	   it	   difficult	   to	   handle	   large	   proteins	   (>50kDa),	  
particularly	   due	   to	   the	   challenges	   faced	   in	   chromatographically	   separating	   proteins.	  
Often	  the	  resultant	  mass	  spectra	   for	  a	  protein	  will	   show	  numerous	  peaks	  due	  to	  the	  
stochastic	   changing	   nature	   of	   separation	   and	   will	   be	   further	   complicated	   due	   to	  
multiply	   charged	   proteins.	   Furthermore,	   many	   proteins	   can	   be	   lost	   in	   the	   initial	  
experimental	   protein	   separation	   phase.	   These	   challenges	   limit	   the	   protein-­‐centric	  
approach	  to	  the	  analyses	  of	  isolated	  proteins	  or	  simple	  protein	  mixtures	  at	  best.	  
However	   a	   protein-­‐centric	   approach	   does	   have	   advantages	   when	   attempting	   to	  
identify	  PTMs.	  Having	   the	  ability	   to	   identify	  and	  measure	  a	  whole	  protein	  allows	   for	  
data	   analysis	   algorithms	   to	  determine	  which	  modifications	  may	  occur	   in	   conjunction	  
with	  one	  another,	  whereas	  in	  a	  peptide-­‐centric	  approach,	  modifications	  identified	  on	  
separate	  peptides	  from	  the	  same	  protein	  may	  come	  from	  different	  pools	  of	  the	  same	  
protein.	  
Biologists	  analysing	  proteomes	  often	  favour	  the	  mature,	  bottom-­‐up	  approach,	  due	  to	  
its	   ability	   to	   handle	   larger	   proteins	   and	  more	   complex	   samples.	   This	   is	   the	   strategy	  
used	  by	  the	  Lamond	  Laboratory.	  With	  a	  peptide-­‐centric	  approach,	  biologists	  must	  first	  
digest	   their	   sample	   proteins	   to	   peptides	   using	   an	   enzyme.	   The	   peptides	   are	   then	  
passed	   through	   the	   mass	   spectrometer	   to	   produce	   mass	   spectra	   (MS)	   and	   can	   be	  
further	   fragmented	   within	   the	   mass	   spectrometer	   (MS/MS).	   The	   data	   analysis	  
algorithms	   used	   to	   determine	   the	   proteins	   in	   the	   constituent	   sample	   are	   complex.	  
Measurements	   from	   the	  mass	   spectrometer,	  which	   actually	  measures	   ions,	  must	   be	  
mapped	  to	  theoretical	  peptide	  masses,	  calculated	  from	  a	  proteomics	  database,	  before	  
finally	  being	  reconstructed	  to	  proteins.	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An	  additional	  complexity	  that	  must	  be	  considered	  is	  the	  relationship	  between	  proteins	  
and	   peptides.	   In	   fact,	   a	   peptide	   can	   belong	   to	   multiple	   proteins	   due	   to	   sequence	  
homology.	   This	   sharing	   of	   peptides	   makes	   it	   increasingly	   difficult	   for	   a	   search	   and	  
matching	   algorithm	   to	   determine	   exactly	   which	   protein	   was	   detected.	   Hence,	  
software,	   such	   as	   MaxQuant,	   will	   report	   protein	   groups	   rather	   than	   single	   protein	  
identifications	  to	  deal	  with	  this	  ambiguity.	  	  
With	  a	  peptide-­‐centric	  approach,	  only	  a	   fraction	  of	   the	   total	  peptide	  population	  of	  a	  
protein	  will	  be	  identified,	  therefore,	  information	  about	  a	  protein	  sequence	  is	  lost.	  This	  
loss	   of	   information	   combined	  with	   the	  many-­‐to-­‐many	   relationship	  between	  proteins	  
and	  peptides	   is	  particularly	  problematic	  when	  attempting	  to	  detect	  protein	   isoforms,	  
which	  may	  differ	   by	   only	   a	   short	   string	   of	   amino	   acids.	   These	   amino	   acids	  might	   be	  
captured	  in	  one	  peptide,	  which	  requires	  the	  mass	  spectrometer	  to	  identify	  this	  single	  
peptide	   to	   accurately	   determine	  which	   protein	   isoform	  was	   detected.	   However,	   the	  
stochastic	  nature	  of	  MS	  makes	  it	  very	  difficult	  to	  identify	  a	  specific	  single	  peptide.	  
When	   using	   the	   peptide-­‐centric	   approach,	   data	   analysis	   algorithms	   must	   take	   into	  
account	  the	  number	  of	  peptides	  identified	  and	  the	  sequence	  coverage	  of	  a	  protein	  to	  
accurately	  convey	   the	  confidence	   in	  protein	   identifications.	  This	   raises	  challenges	   for	  
the	   identification	   of	   low	   abundance	   proteins	   for	  which	   there	  will	   be	   fewer	   peptides	  
available	  for	  detection	  in	  mass	  spectra	  that	   is	  dominated	  by	  high	  abundance	  species,	  
hence	  reducing	  the	  likelihood	  of	  detection.	  	  
Furthermore,	  it	  is	  also	  challenging	  to	  identify	  PTMs	  using	  the	  peptide-­‐centric	  approach,	  
as	   it	   relies	   on	   the	   detection	   of	   peptides	   with	   the	   modification	   to	   enable	   accurate	  
inferences.	   To	   aid	   with	   PTM	   detection,	   biologists	   will	   often	   turn	   to	   experimental	  
protocols	   that	  enable	  them	  to	  enrich	  their	  sample	   for	  certain	  types	  of	  PTM.	  Another	  
possible	   technique	   that	   could	   be	   employed	   to	   detect	   PTMs	   from	  mass	   spectra	   is	   a	  
spectrum-­‐centric	  approach,	  whereby	  the	   ion	   fragmentation	  spectra	  could	  be	  used	  to	  
build	   a	   spectral	   library.	   This	   spectral	   library	  would	   capture	   previously	   identified	   and	  
validated	   spectra,	   which	   in	   turn	   could	   be	   used	   by	   a	   search	   and	  match	   algorithm	   to	  
identify	  the	  same	  peptide	  modifications	  in	  new	  spectra.	  By	  creating	  spectral	  libraries,	  it	  
would	  be	  possible	  to	  benefit	   from	  previously	   found	  and	  annotated	  spectra.	  This	  may	  
also	  help	  in	  situations	  where	  there	  are	  overlapping	  spectra	  of	  two	  separate	  peptides.	  A	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data	   analysis	   algorithm	   could	   distinguish	   between	   these	   peptides	   by	   matching	  
multiple,	  validated	  spectra	  to	  the	  results.	  	  
PepTracker	  takes	  data	  generated	  in	  the	  Lamond	  Laboratory	  using	  the	  peptide-­‐centric	  
approach	   and	   aims	   to	   provide	   visualisations,	   such	   as	   the	   Protein-­‐Peptide	   Alignment	  
Map	   (see	   Figure	   24)	   to	   aid	   in	   the	   analysis	   and	   evaluation	   of	   protein	   identifications.	  
Furthermore,	   during	   this	   thesis,	   additional	   tools	   and	   techniques	   were	   developed	   to	  
help	   combat	   some	   of	   the	   challenges	   with	   a	   peptide	   centric	   approach,	   such	   as	   the	  
detection	   of	   novel	   isoforms.	   Chapter	   7:	   Protein	   Isoform,	   Localisation	   and	   Turnover	  
Analysis,	  describes	  strategies	  that	  deal	  with	  missing	  protein	  sequence	  data	  by	  making	  
use	  of	  protein	  properties	  to	  determine	  novel	  isoforms	  or	  pools	  of	  proteins.	  
4.6.9 Protein Definitions 
A	  commonly	  understood	  problem	  in	  proteomics	  is	  related	  to	  the	  definition	  of	  proteins.	  
In	   the	   proteomics	   field	   there	   are	   a	   number	   of	  major	   databases	   that	   define	   proteins	  
using	   their	  own	   specific	  methods,	   for	   example	   some	  databases	  may	  allocate	  protein	  
isoforms	  each	  with	  their	  own	  identifier	  whereas	  other	  databases	  may	  chose	  to	  group	  
these	  isoforms	  together.	  This	  results	  in	  each	  database	  using	  a	  customised	  convention	  
for	  assigning	  protein	  identifiers.	  Furthermore,	  the	  identifiers	  used	  can	  be	  unstable	  and	  
change	   between	   database	   versions,	   being	   created,	   deleted,	   updated	   or	   merged.	  
Translating	  between	  these	  identifiers	  remains	  a	  major	  challenge.	  
When	  choosing	  the	   identifier	  mechanism	  to	  be	  used	   for	   the	  software	  created	  during	  
this	   project,	   a	   number	   of	   issues	   were	   considered,	   including	   the	   popularity	   of	   the	  
database,	   the	   longevity	   of	   the	   database	   and	   its	   developers	   and	   the	   most	   relevant	  
database	   to	   the	   area	   of	   quantitative	   proteomics	   addressed	   during	   this	   work.	   It	   was	  
important	  to	  choose	  a	  single	  identifier	  to	  be	  used	  to	  map	  proteins	  within	  datasets,	  as	  
this	  enables	  the	  comparison	  and	  cross	  analysis	  of	  datasets.	  Furthermore,	  it	  was	  vital	  to	  
choose	  a	  database	  that	   is	  robust	  and	  has	  a	  significant	  development	  effort	  supporting	  
it,	  both	  in	  terms	  of	  funding	  and	  developers.	  
For	   the	   software	   within	   this	   project	   the	   UniProt	   Knowledgebase	   Identifier	   was	  
selected.	   This	   decision	   was	   made	   due	   to	   UniProtKB	   positioning	   amongst	   the	   other	  
database	  vendors,	  relevance	  and	  usefulness.	  UniProtKB	  is	  a	  collaboration	  between	  the	  
European	  Bioinformatics	  Institute	  (EBI),	  the	  Swiss	  Institute	  of	  Bioinformatics	  (SIB)	  and	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the	  Protein	  Information	  Resource	  (PIR).	  UniProtKB	  combines	  both	  automated	  protein	  
identification	  with	  manually	  curated	  protein	  specifications.	   It	  holds	  these	  data	   in	  two	  
subsections,	  UniProtKB/Swiss-­‐Prot,	  containing	  data	  from	  manual	  analysis	  of	  literature	  
and	   reviewed	   computational	   analysis,	   and	   UniProtKB/TrEMBL,	   containing	  
computationally	  annotated	  entries	  that	  are	  reviewed	  in	  due	  course	  and	  transferred	  to	  
UniProtKB/Swiss-­‐Prot.	   In	   addition,	   UniProtKB	   collects	   a	   range	   of	   data	   from	   various	  
sources,	   including	  biological	  ontologies,	  classifications,	  cross-­‐references	  and	  evidence	  
of	   annotation.	   This	   information	   supplements	   the	   basic	   protein	   information,	   such	   as	  
protein	  sequence,	  name	  and	  description,	  to	  provide	  researchers	  with	  rich	  annotation	  
that	  can	  aid	  with	  functional	  analysis	  of	  proteins.	  UniProtKb	  releases	  four	  weekly	  builds	  
that	   are	   well	   annotated	   with	   version	   information	   for	   each	   entry	   in	   the	   database.	  
Furthermore,	  UniProtKB	  appears	   to	  have	  a	  dominant	  position	  due	   to	   its	   takeover	  of	  
the	  International	  Protein	  Index	  database	  (last	  release	  27th	  September	  2011),	  another	  
popular	   protein	   cross-­‐reference	   database	   curated	   by	   the	   European	   Bioinformatics	  
Institute	  (EBI).	  
4.7 Data Security & Quality Control 
The	   system	   has	   been	   designed	   securely,	   with	   restricted	   researcher	   access.	   All	  
University	   of	   Dundee	   (UoD)	   researchers	   have	   the	   option	   of	   Lightweight	   Directory	  
Access	  Protocol	  (LDAP)	  access,	  which	  negates	  the	  use	  of	  an	  additional	  username	  and	  
password.	   Instead	   researchers	   login	   with	   their	   UoD	   credentials,	   which	   are	  
authenticated	   against	   a	   UoD	   LDAP	   Server	   by	   PepTracker.	   Having	   multiple	   login	  
credentials	   is	   inconvenient	   for	   researchers	   and	   often	   results	   in	   researchers	   writing	  
down	   passwords	   or	   sharing	   them.	   Furthermore,	   the	   UoD	   policy	   actively	   encourages	  
researchers	  to	  routinely	  update	  their	  password,	  hence	  increasing	  security.	  	  
However,	   some	   users,	   such	   as	   external	   collaborators,	   are	   not	   directly	   affiliated	  with	  
the	  UoD,	  hence	  do	  not	  have	  UoD	  access	  credentials.	  In	  order	  to	  accommodate	  external	  
researchers,	  PepTracker	  implements	  its	  own	  authentication	  that	  allows	  researchers	  to	  
create	  a	  customised	  PepTracker	  username	  and	  password	  for	  use	  with	  the	  system.	  
Access	   is	   restricted	   due	   to	   privacy	   concerns	   for	   data.	   Within	   PepTracker	   each	  
researcher	  belongs	   to	   single	  or	  multiple	   groups.	   Each	  group	   typically	   represents	  one	  
laboratory.	   PepTracker	   researchers	  have	  access	   to	   all	  metadata	   and	  quantitative	  MS	  
data	   uploaded	   to	   the	   PepTracker	   database	   by	   researchers	   within	   their	   group.	   In	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addition	  to	  this	  read	  access,	  researchers	  are	  provided	  with	  editing	  privileges	  to	  the	  MS	  
submissions	  and	   linked	  data	   that	   they	   themselves	  have	  generated	  or	  been	  allocated	  
permission	  to	  edit	  by	  the	  owner	  of	  the	  data.	  Due	  to	  this	  open	  data	  access	  policy,	  direct	  
access	   to	   PepTracker	   is	   controlled	   via	   usernames	   and	   passwords.	   Data	   that	  may	   be	  
useful	  to	  external	  researchers	  is	  shared	  through	  externally	  available	  PepTracker	  tools,	  
such	  as	  the	  PFL	  and	  Turnover	  Viewers.	  These	  external	  tools	  require	  registration,	  which	  
is	  free	  of	  charge,	  but	  is	  essential	  as	  it	  allows	  monitoring	  of	  demand	  for	  these	  tools.	  
Furthermore,	  an	  important	  aspect	  of	  controlling	  access	  to	  PepTracker	  revolves	  around	  
data	  quality	  issues.	  The	  usefulness	  of	  PepTracker	  tools	  relies	  on	  data	  being	  generated	  
in	   a	   known	   style,	  well	   and	   consistently	   annotated	   and	   of	   high	   quality	   and	   adequate	  
stringency.	   Due	   to	   the	   variance	   in	   protocols	   and	   instruments,	   the	   quality	   of	   data	  
generated	   can	   vary.	   One	   of	   the	   future	   goals	   of	   PepTracker	   will	   be	   automated	  
evaluation	   of	   data	   quality	   at	   the	   point	   of	   data	   upload.	   This	   could	   be	   accomplished	  
through	  using	  existing	  PepTracker	  datasets	  as	  a	  baseline	  to	  generate	  an	  overall	  profile	  
of	  what	   is	   expected	   in	   different	   types	   of	   dataset.	   These	   profiles	   could	   be	   compared	  
with	   new	   datasets	   to	   highlight	   inconsistencies	   and/or	   unexpected	   inputs	   that	   could	  
suggest	  data	  quality	  issues.	  This	  would	  open	  up	  the	  possibility	  of	  external	  researchers	  
being	  able	  to	  contribute	  data	  that	  could	  add	  to	  the	  usefulness	  of	  PepTracker	  tools.	  
4.8 Discussion 
The	   PepTracker	   data	   environment	   (http://peptracker.com)	   is	   a	   scalable,	   fast	   and	  
secure,	   large	  repository	   for	  proteomics	  data,	  accessible	  via	   the	  web.	  This	  proteomics	  
repository	  has	  huge	  potential	  and	   is	  already	  growing	  rapidly	  based	  on	  current	  usage.	  
The	   PepTracker	   software	   has	   three	   main	   components,	   MsTrack,	   DataVault	   and	  
ProteinLibrary.	   These	   components	   work	   together	   to	   provide	   an	   integrated	   data	  
environment	  for	  mass	  spectrometry	  data	  management	  and	  analysis.	  
The	   MsTrack	   component	   implements	   a	   LIMS	   that	   tracks	   all	   data	   produced	   and	  
analysed	  in	  the	  laboratory.	  Data	  entry	  is	  standardised	  and	  where	  possible	  drop	  down	  
menus	  are	  used	  for	  entering	  metadata	  associated	  with	  each	  experiment,	  ensuring	  that	  
all	   experiments	   are	   annotated	   consistently	   and	   in	   detail.	   New	   development	   efforts	  
have	   also	   been	   allocated	   to	   creating	   an	   online	   laboratory	   book,	   LabTracker	   (see	  
Appendix	   E).	   This	   software	   aims	   to	   provide	   computerised	   data	   collection	   at	   the	   lab	  
bench	  via	  an	  iPad,	  as	  well	  as	  providing	  researchers	  with	  easy-­‐access	  to	  sets	  of	  common	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tools,	  such	  as	  molecular	  calculators,	  molecule	  viewers,	  reagent	  database	  searches	  etc.	  
In	   the	   future	   LabTracker	   be	   further	   integrated	   with	   PepTracker	   so	   that	   each	   MS	  
submission	  is	  also	  annotated	  with	  a	  protocol	  from	  a	  users	  online	  laboratory	  book.	  
Having	   thorough	  metadata	   recording	   is	   vital	   for	   current	   and	   future	  data	   analytics.	  A	  
huge	  range	  of	  biological	  questions	  can	  be	  answered	  by	  taking	  measurements	  made	  on	  
the	  levels	  and	  properties	  of	  every	  protein	  in	  every	  cell	  type	  and	  under	  a	  wide	  range	  of	  
experimental	  conditions,	  thanks	  to	  the	  detailed	  annotation	  with	  associated	  metadata.	  
Through	   accurate	   tagging	   and	   aggregation	   of	   complex	   quantitative	   biological	   data	  
there	   has	   been	   development	   of	   pioneering	   new	   approaches	   that	   allow	  
multidimensional	   analysis	   to	   be	   carried	   out,	   suitable	   for	   benefitting	   both	   basic	   and	  
applied	   biomedical	   projects.	   The	   Lamond	   Laboratory	   is	   already	   generating	   vast	  
amounts	  of	  data,	  which	  can	  be	  used	  along	  with	  the	  metadata	  recorded	  as	  a	  test	  bed	  
for	  mining.	  
After	   logging	   samples	   into	   the	   LIMS	   and	   submitting	   them	   to	   the	  mass	   spectrometry	  
facility,	  researchers	  can	  continue	  with	  other	  work-­‐related	  activities	  while	  the	  workflow	  
automatically	   deals	   with	   logging	   the	   data	   files	   from	   the	   mass	   spectrometer	   and	  
generating	  a	  notification	  email	  when	  all	  samples	  have	  been	  run.	  
Currently	  researchers	  download	  files	  and	  run	  them	  through	  third	  party	  software,	  e.g.	  
MaxQuant.	  However,	  it	  is	  envisioned	  that	  this	  step	  could	  be	  automated	  in	  the	  future,	  
so	   that	   the	   PepTracker	   system	   initiates	   the	   MaxQuant	   analysis	   (or	   equivalent	  
functionality),	  before	  automatically	   loading	  the	  results	   into	  the	  data	  repository.	  Once	  
the	   quantitative	   results	   have	   been	   uploaded	   to	   the	   PepTracker	   system,	   researchers	  
can	  use	  the	  DataVault	  component	  of	  PepTracker	   to	  view	  automated	  visualisations	  of	  
their	   data,	   such	   as	   charts	   and	   network	  maps,	   and	   to	   interact	   with	   their	   data.	   Data	  
interaction	  has	  been	  considered	  as	  being	  of	  high	   importance	  as	   researchers	  working	  
on	   proteomics	   data	   must	   find	   a	   way	   of	   combating	   the	   complexity	   of	   the	   data.	   By	  
focusing	   on	   interaction,	   PepTracker	   provides	   researchers	   with	   the	   ability	   to	   explore	  
their	  results	  and	  drill	  down	  into	  their	  data	  and	  hence	  convert	  the	  many	  data	  points	  to	  
meaningful	   biological	   insight.	   In	   feedback	   sessions,	   researchers	   have	   commented	  
positively	  on	  the	  usefulness	  of	  interaction-­‐focused	  visualisation,	  which	  allows	  them	  to	  
make	  sense	  of	  their	  data	  much	  more	  rapidly	  compared	  with	  previous	  attempts	  using	  
other	  software.	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Finally	   the	   ProteinLibrary	   component	   maximises	   on	   the	   benefit	   of	   having	   datasets	  
stored	   in	   a	   meaningful	   structure	   by	   providing	   researchers	   with	   the	   ability	   to	   query	  
datasets.	   The	   output	   search	   results	   of	   the	   querying	   are	   presented	   with	   the	   aid	   of	  
additional	   visualisations,	   such	   as	   protein	   peptide	   alignment	  maps,	  which	   deliver	   the	  
information	   to	   be	   conveyed	   in	   an	   easy	   human	   understandable	   form	   that	   is	   more	  
appealing	   than	   traditional	   text	   or	   table	   methods.	   Furthermore,	   the	   ProteinLibrary	  
allows	   researchers	   to	   store	   protein	   groups	   of	   interest.	   These	   protein	   groups	   can	   be	  
generated	  in	  a	  number	  of	  ways	  and	  used	  in	  the	  analysis	  of	  MS	  datasets.	  
The	  Lamond	  Laboratory	  experience	  of	  data	  analysis	   is	  that	  analysis	  and	  management	  
of	  MS	  data	  (rather	  than	  experimental	  design	  or	  data	  generation)	  has	  been	  rate	  limiting	  
for	   all	   proteomics	   work.	   Therefore,	   the	   creation	   of	   PepTracker	   has	   already	   been	  
transformational	  for	  enhancing	  proteomics	  projects	  and	  is	  integral	  to	  the	  future	  of	  MS	  
experiments.	  	  
Whilst	   creating	   PepTracker,	   the	   challenges	   with	   existing	   software	   were	   considered	  
carefully	   (see	   1.1.4	   Challenges	   in	   the	   Proteomics	   Field).	   In	   order	   to	   ensure	   that	  
PepTracker	   meets	   user	   requirements	   and	   is	   taken	   up	   and	   utilised	   by	   researchers	   a	  
user-­‐centred	  approach	  was	   taken	  whereby	   there	  was	   close	   communication	  between	  
software	  developer	  and	  biologists.	  This	  is	  seen	  as	  an	  essential	  part	  of	  the	  creation	  and	  
future	  development	  of	  PepTracker.	  Having	  computer	  scientists	  working	  directly	  within	  
the	   Lamond	   Laboratory	   and	   in	   daily	   contact	   with	   the	   molecular	   and	   cell	   biologists,	  
performing	   the	  MS	   studies,	   results	   in	   immediate	   feedback	   and	   suggestions	   for	   new	  
features	   and	   improvements.	   Thus,	   the	   project	   has	   been	   led	   by	   the	   biology	   and	   the	  
needs	   of	   the	   researchers	   and	   a	  major	   emphasis	  was	   placed	   on	   the	   ease	   of	   use	   and	  
intuitive	  design	  of	  researcher	  interfaces.	  
Furthermore,	   to	   support	   the	   software,	   especially	   new	  users,	   a	   number	   of	   video	   and	  
written	   tutorials	   have	   been	   implemented.	   In	   addition,	   a	   mailing	   list	   was	   created	   to	  
which	   researchers	   can	   report	   errors,	   ask	   questions	   and	   provide	   feedback.	   The	  
PepTracker	  developer	  aimed	  to	  respond	  to	  user	  requests/queries	  as	  soon	  as	  possible.	  
Furthermore,	  over	  the	  three-­‐year	  development	  of	  the	  PepTracker	  software	  there	  were	  
an	  additional	  seven	  developers,	  both	  at	  undergraduate	  and	  graduate	   levels,	   involved	  
in	   the	   development.	   This	   ensured	   PepTracker	   was	   created	   in	   an	   extensible	  manner	  
where	   multiple	   developers	   can	   contribute	   to	   the	   software.	   Furthermore,	   having	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several	   developers	   contribute	   promotes	   security	   for	   the	   software	   beyond	   this	   PhD	  
project,	  as	  the	  software	   is	  not	  reliant	  on	  only	  one	  developer.	  This	  ensures	  continuity	  
for	  the	  project	  and	  continued	  support	  for	  users,	  which	  are	  both	  attributes	  of	  successful	  
software	   developments	   by	   research	   laboratories.	   Beyond	   this	   work,	   the	   continued	  
success	  of	  PepTracker	  is	  reliant	  upon	  sustaining	  a	  team	  of	  developers	  who	  are	  able	  to	  
maintain	  and	  support	  the	  software.	  	  
In	   addition,	   to	   ensure	   that	   users	   can	   access	   the	   PepTracker	   software	   without	   high	  
licensing	  fees	  it	  was	  decided	  to	  make	  the	  PepTracker	  software	  freeware	  and	  ensure	  its	  
implementation	  is	  based	  on	  open	  source	  technologies,	  such	  as	  Apache	  CentOS	  Server,	  
Python	  server-­‐side	  code	  and	  PostgreSQL	  database	  engine.	   	  This	  means	  users	  have	  no	  
additional	  cost	  in	  implementing	  the	  PepTracker	  solution.	  In	  the	  future,	  the	  PepTracker	  
codebase	  could	  also	  be	  released	  as	  open	  source,	  which	  would	  further	  encourage	  the	  
community	  to	  actively	  contribute	  to	  the	  development	  of	  the	  PepTracker	  suite.	  
PepTracker	   addresses	   the	   main	   issues	   found	   with	   other	   software	   targeted	   at	   the	  
downstream	   analysis	   of	   quantitative	   proteomics	   data	   (see	   Table	   3:	   Comparison	   of	  
Major	  Mass	  Spectrometry	  Data	  Analysis	  Software.).	  There	  is	  an	  evident	  gap	  in	  software	  
designed	   for	   mass	   spectrometry	   analysis,	   whereby	   no	   available	   current	   software	  
provides	   central	   data	   warehousing	   functionality.	   However,	   this	   functionality	   is	   built	  
into	   PepTracker,	   and	   is	   viewed	   as	   providing	   a	   key	   advantage	   for	   data	   analysis	  
possibilities.	   Furthermore,	   the	   software	   reviewed	   lack	   in	   functionality	   to	   capture,	  
organise	  and	  store	  metadata	  in	  a	  systematic	  manner.	  Only	  a	  select	  few	  programs	  had	  a	  
built	   in	  LIMS	  system	  that	  can	  systematically	   record	  metadata	  and	   link	   this	  additional	  
metadata	   to	   the	   resultant	   data	   files.	   Within	   PepTracker	   the	   LIMS	   functionality	   is	  
integrated	   with	   automated	   mass	   spectrometry	   submissions,	   which	   guarantees	  
metadata	   recording,	   and	   much	   attention	   has	   been	   placed	   in	   ensuring	   metadata	  
capture	   is	  carried	  out	  efficiently	  as	  possible.	  Furthermore,	  PepTracker	   is	  able	   to	  deal	  
with	  both	  label-­‐free	  and	  labelled	  experiments,	  which	  is	  vital	  functionality	  missing	  from	  
other	  software.	  	  	  
The	  PepTracker	  environment	  is	  already	  in	  daily	  use	  and	  in	  active	  development	  within	  
the	   Lamond	   Laboratory.	   More	   recently,	   users	   from	   other	   laboratories	   within	   the	  
College	  of	  Life	  Sciences	  have	  been	  given	  access	   to	   the	  core	  PepTracker	   functionality.	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This	   allows	   for	   evaluation	   with	   researchers	   working	   in	   external	   laboratories	   with	  
modified	  protocols	  and	  experimental	  setups.	  	  
Moving	   forward	  with	   the	  project	   it	   is	   intended	   that	   the	  PepTracker	   resource	  will	   be	  
expanded	  in	  terms	  of	  its	  development	  and	  support	  a	  larger	  group	  of	  researchers.	  Plans	  
include	  widening	  access	   to	   the	  other	   groups	   in	   the	  Wellcome	  Trust	  Centre	   for	  Gene	  
Regulation	  and	  Expression,	  as	  well	  as	  other	  researchers	  in	  the	  College	  of	  Life	  Sciences	  
at	  the	  University	  of	  Dundee.	  It	  is	  envisioned	  that	  this	  could	  take	  place	  by	  maintaining	  a	  
single	   data	   warehouse	   within	   the	   College	   of	   Life	   Sciences	   but	   sharding	   the	   web	  
application	   across	   a	   number	  of	   servers	   to	  deal	  with	   the	  higher	  demand	  of	   users.	   To	  
support	  external	  collaborators	  it	  is	  intended	  that	  the	  server	  will	  be	  packaged	  up	  into	  a	  
downloadable	   installation.	   External	   users	  would	   be	   provided	  with	   a	   database	   server	  
setup	  for	  the	  main	  data	  warehouse	  and	  a	  web	  server	  setup	  for	  the	  PepTracker	  tools.	  A	  
number	  of	  configuration	  interfaces	  will	  be	  created	  to	  help	  users	  with	  external	  setups	  
get	  started	  and	  populate	  the	  basic	  lookup	  tables.	  Initially	  a	  few	  test	  groups,	  external	  to	  
the	  University	  of	  Dundee,	  will	  be	  selected	  to	  allow	  evaluation	  and	  trouble-­‐shooting	  of	  
practical	  issues	  involved	  in	  distributing	  the	  software	  and	  making	  it	  widely	  accessible.	  
The	  collection	  of	  uploaded	  datasets	  in	  PepTracker	  provides	  an	  ideal	  target	  population	  
that	   is	   large	  enough	   to	  be	  used	  as	  a	  baseline	   for	   identifying	  patterns	  and	   trends.	  As	  
described	   in	   1.4.1	   Super-­‐Experiment	   Data	   Analysis,	   a	   	   ‘super-­‐experiment’	   can	   be	  
understood	  as	  analysis	  involving	  multiple	  independent	  datasets	  in	  which	  each	  dataset	  
provides	  value	  to	  the	  analysis	  of	  every	  other	  dataset	  in	  the	  collection.	  An	  example	  of	  
what	  a	  ‘super-­‐experiment’	  can	  yield	  is	  demonstrated	  by	  the	  Protein	  Frequency	  Library	  
(PFL),	  which	  is	  described	  in	  Chapter	  5:	  Multidimensional	  Analysis	  with	  IP	  Experiments.	  
The	  PFL	  study	  demonstrates	  the	  huge	  added	  value	  of	  integrating	  and	  utilising	  all	  data	  
collected	  in	  every	  pull-­‐down	  experiment.	  	  
It	   is	   expected	   that	   the	   set	  of	   tools	   for	   super-­‐experiment	  analysis	  will	   continue	   to	  be	  
expanded	  and	   interfaces	  will	  be	   refined	  and	  updated	   to	  make	   it	  easier	  and	   faster	   to	  
analyse	   and	   compare	   datasets.	   For	   example,	   new	   tools	   will	   be	   added	   for	   the	  
visualisation	  and	  analysis	  of	  PTMs	  and	   to	   combine	  analysis	  of	  PTM	  data	  with	  Spatial	  
Proteomics	  approaches.	  Tools	  will	  be	  provided	  for	  researchers	  to	  create	  and	  annotate	  
libraries	  of	  datasets,	  based	  either	  on	  data	  outputs	   from	  experiments,	  or	   from	  online	  
resources,	  e.g.	  according	  to	  GO	  annotation	  terms,	  and	  to	  use	  these	  datasets	  flexibly	  for	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comparative	  analyses	  and	  statistical	  comparisons.	  It	  is	  also	  hypothesised	  that	  this	  will	  
spark	   collaboration	   where	   datasets	   from	   other	   researchers	   could	   be	   imported	   into	  
PepTracker	  to	  enhance	  the	  analyses.	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Chapter 5: Multidimensional Analysis with IP Experiments 
5.1 Summary 
The	   reliable	   identification	   of	   protein	   interaction	   partners	   and	   how	   such	   interactions	  
change	  in	  response	  to	  physiological	  or	  pathological	  perturbations	  is	  a	  key	  goal	  in	  most	  
areas	   of	   cell	   biology.	   In	   order	   to	   identify	   protein-­‐protein	   interactions	   pull-­‐down	  
experiments	   are	   carried	   out,	   whereby	   proteins,	   and	   their	   interacting	   partners,	   are	  
isolated	  from	  experimental	  samples	  and	  then	  run	  through	  the	  mass	  spectrometer.	  This	  
method	   allows	   biologists	   to	   identify	   the	   proteins	   that	   are	   interacting	  with	   a	   specific	  
protein	  of	  choice	  under	  certain	  experimental	  conditions.	  	  
Typically,	  for	  a	  pull-­‐down	  experiment,	  the	  mass	  spectrometer	  can	  identify	  500	  or	  more	  
proteins.	  All	  of	  these	  do	  not	  constitute	  genuine	  interaction	  partners	  and	  most	  of	  these	  
will	  be	  contaminants	   that	  are	   introduced	  either	   from	  the	  environment	  or	  during	   the	  
experimental	   procedure.	   In	   order	   to	   distinguish	   the	   real	   interaction	   partners	   from	  
these	  contaminants	  a	  number	  of	  methods	  can	  be	  employed,	   including	   increasing	  the	  
stringency	  of	  the	  experimental	  procedure	  or	  repeating	  experiments	  multiple	  times	  to	  
have	  many	  controls.	  However,	  these	  methods	  risk	  biologists	   losing	  low	  abundance	  or	  
low	  affinity	  real	  interaction	  proteins	  and	  repeating	  experiments	  is	  very	  costly	  and	  time	  
intensive.	   An	   alternative,	   more	   beneficial	   approach	   involves	   identifying	   all	   proteins	  
(both	  interaction	  partners	  and	  contaminants)	  and	  then	  finding	  a	  method	  of	  annotating	  
them	  accordingly.	  This	  requires	  an	  accurate	  and	  reliable	  mechanism	  of	  distinguishing	  
between	  the	  two	  categories	  of	  proteins.	  This	  method	  can	  be	  based	  on	  how	  a	  biologist	  
would	   carry	   out	   this	   task	   manually	   using	   their	   experience	   to	   make	   informed	  
judgements.	  	  
The	  aim	  of	  this	  work	  was	  to	  capture	  this	  process	  in	  an	  automated	  system	  that	  makes	  
use	  of	  previous	  experimental	  experience	  through	  the	  datasets	  generated.	  Due	  to	  the	  
complexity	  of	  the	  cell	  biology	  system	  and	  the	  human	  aspect	  of	  doing	  this	  task	  reliably,	  
it	  would	  be	  better	  for	  such	  a	  system	  to	  annotate	  proteins	  with	  a	  likelihood	  of	  being	  a	  
real	   interaction	   partner	   rather	   than	   simply	   categorise	   as	   contaminants	   and	   non-­‐
contaminants.	   Using	   these	   predictions,	   the	   likely	   contaminants	   can	   be	   used	   to	   re-­‐
normalise	  a	  dataset	  that	  may	  have	  been	  affected	  by	  experimental	  abnormalities.	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The	  resultant	  tool	  was	  the	  Protein	  Frequency	  Library	  (PFL)	  (Boulon	  et	  al.,	  2010a).	  The	  
PFL	   collates	   a	   large	   amount	   of	   experimental	   data	   and	   generates	   automated	  
annotations	  for	  proteins	  based	  on	  their	  frequency	  of	  detection	  in	  experiments.	  These	  
annotations	   can	   be	   further	   improved	   by	   the	   PFL	   through	   creating	   a	   customised	   PFL	  
that	   generates	   annotations	   using	   only	   experiments	   that	   meet	   certain	   experimental	  
conditions.	   In	   order	   to	   achieve	   this	   technically,	  methods	   from	   the	  world	   of	   BI	  were	  
employed.	  BI	  allows	  for	  fast	  train-­‐of-­‐thought	  analysis	  through	  rapid	  responses,	  making	  
it	  an	  ideal	  tool	  for	  enabling	  biologists	  to	  carry	  out	  this	  type	  of	  complex	  analysis.	  BI	  has	  
rarely	   been	   used	   in	   the	   field	   of	   proteomics,	   however	   this	   case	   study	   validated	   the	  
usefulness	  of	  the	  analytical	  benefits	  provided	  by	  BI	  techniques.	  
To	  enable	  biologists	  to	  carry	  out	  fast	  and	  effective	  analysis,	  the	  PFL	  functionality	  was	  
integrated	   into	   PepTracker.	   Within	   PepTracker,	   researchers	   can	   filter	   a	   selected	  
dataset	  using	  customised	  PFL	   frequencies	  and	  also	  normalise	  an	  entire	  dataset	  using	  
the	   likely	   contaminants	   identified	   by	   the	   PFL	   frequencies.	   Furthermore,	   to	   enable	  
external	  researchers	  to	  benefit	  from	  the	  PFL	  in	  the	  analysis	  of	  their	  own	  data,	  a	  custom	  
interface	  was	  built.	  This	  interface	  was	  partly	  developed	  by	  an	  undergraduate	  honours	  
project	   student	   whom	   I	   supervised.	   The	   interface	   provides	   an	   intuitive	   method	   for	  
researchers	  around	  the	  globe	  to	  access	  protein	  annotations,	  coming	  from	  an	  extensive	  
data	  repository	  of	  high	  quality	  and	  high	  consistency	  data.	  
Chapter	  5	  describes	  the	  development	  of	  an	  analysis	  methodology	  for	  IP	  experiments,	  
focusing	   first	   on	   the	   purpose	   of	   IP	   experiments	   and	   established	   analysis	   techniques	  
(section	  5.2),	  following	  with	  a	  description	  of	  the	  PFL	  (section	  5.3),	   its	  implementation	  
(sections	  5.4)	  and	  finally	  a	  discussion	  on	  the	  use	  of	  the	  PFL	  (section	  5.5).	  	  	  
5.2 Background 
Pull-­‐down	  experiments	  are	  used	  to	  identify	  proteins	  that	  interact	  with	  one	  another.	  To	  
create	  a	  sample	  in	  a	  pull-­‐down	  experiment,	  a	  protein	  is	  isolated	  from	  a	  mixture	  along	  
with	   its	   interacting	   proteins.	   In	   order	   to	   isolate	   these	   proteins	   from	   the	  mixture,	   an	  
affinity	  matrix	  or	  ‘bead’	  is	  used.	  Protein	  identification	  of	  the	  sample	  yields	  the	  protein	  
of	   interest	  along	  with	   the	   interacting	  proteins.	  The	  high	  sensitivity	  of	  MS	   technology	  
has	   increased	   the	   total	  number	  of	  proteins	   identified	   in	  each	  pull-­‐down	  experiment.	  
However,	   the	   majority	   of	   these	   proteins	   usually	   represent	   contaminants,	   including	  
proteins	  that	  bind	  non-­‐specifically	  to	  the	  affinity	  matrix.	  Thus,	  despite	  many	  technical	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improvements	   made	   in	   recent	   years,	   the	   unambiguous	   discrimination	   between	  
genuine	   protein	   interaction	   partners,	   either	   stable	   or	   transient,	   and	   contaminants,	  
remains	  one	  of	  the	  major	  challenges	  in	  the	  field.	  
Most	   researchers	   have	   sought	   to	   identify	   specific	   protein	   interactors	   by	   reducing	   or	  
eliminating	   the	   background	   of	   non-­‐specific	   proteins,	   either	   through	   biochemical	   or	  
data	  analysis	  strategies.	  For	  example,	  at	  the	  experimental	   level,	  the	  buffer	  stringency	  
can	  be	  increased	  to	  reduce	  binding	  of	  low	  affinity	  contaminants,	  and	  a	  2-­‐step	  tandem	  
affinity	  purification	  method	  can	  be	  used	  rather	  than	  a	  one	  step	  procedure	  (Babu	  et	  al.,	  
2009,	  Rigaut	  et	  al.,	  1999).	  However,	  this	  can	  decrease	  the	  yield	  of	  proteins	  recovered	  
and	   risks	   losing	   low	   abundance	   and/or	   lower	   affinity	   specific	   protein	   interaction	  
partners.	  Alternatively,	  on	  the	  data	  analysis	  level,	  several	  approaches	  have	  been	  used	  
to	   identify	   and	   thereby	   discard	   the	   putative	   contaminants	   that	   are	   recovered	   after	  
purification.	   For	   example,	   bioinformatics	   can	   be	   employed	   to	   measure	   “confidence	  
scores”,	  by	  comparing	  the	  results	  of	  interaction	  studies	  with	  either	  predicted	  protein-­‐
protein	  interaction	  data,	  or	  with	  previous	  results	  described	  in	  literature	  (Blow,	  2009),	  
or	   by	   integrating	   different	   properties	   of	   the	   interaction	   network	   generated	   by	   the	  
analysis,	  e.g.	  interaction	  bidirectionality	  etc.	  (Cloutier	  et	  al.,	  2009,	  Ewing	  et	  al.,	  2007).	  
The	   combination	  of	  quantitative	  MS	  and	  differential	   labelling	  of	  proteins	  with	  heavy	  
isotopes,	   especially	   SILAC	   (Ong	   et	   al.,	   2002,	  Ong	   and	  Mann,	   2006),	   can	   also	   help	   to	  
distinguish	   between	   specific	   and	   non-­‐specific	   binding	   proteins	   in	   a	   co-­‐
immunoprecipitation	   (co-­‐IP)	  experiment.	  This	   is	  achieved	  through	  the	   inclusion	  of	  an	  
internal	   negative	   control,	   which	   allows	   for	   direct	   comparison	   between	   the	   relative	  
levels	  of	  each	  protein	  present	  in	  the	  control	  and	  experimental	  samples	  (see	  Figure	  27).	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Figure	  27:	  Overview	  of	  triple	  SILAC-­‐based	  analysis	  of	  protein	  interaction	  partners.	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(A)	  Metabolic	  labelling	  of	  cells	  in	  culture	  using	  the	  triple	  SILAC	  approach	  can	  be	  used	  to	  
detect	  specific	  protein	  interaction	  partners	  and	  dynamic	  changes	  in	  protein	  interactions	  
under	  different	  biological	  conditions.	  Examples	  include	  comparing	  control	  conditions	  
with;	  (i)	  treatment	  with	  chemical	  inhibitors/stress	  etc.	  (ii)	  effect	  of	  mutations	  in	  the	  bait	  
protein	  or	  (iii)	  isoform-­‐specific	  interactions.	  “Light”	  media	  refers	  to	  normal	  
environmental	  isotopes	  of	  carbon,	  nitrogen	  and	  hydrogen,	  i.e.	  “unlabeled”	  12C,	  14N	  and	  
1H,	  while	  “medium”	  and	  “heavy”	  media	  refer	  to	  cells	  grown	  in	  medium	  containing	  
heavy	  isotope-­‐labeled	  arginine	  (R)	  and	  lysine	  (K)	  as	  follows;	  medium	  -­‐	  13C6-­‐arginine	  (R6),	  
4,4,5,5-­‐D4-­‐lysine	  (K4),	  heavy	  -­‐	  13C615N4-­‐arginine	  (R10),	  13C615N2-­‐	  lysine	  (K8).	  (B)	  Diagram	  
illustrating	  SILAC	  principle	  of	  differential	  labeling	  and	  how	  specific	  interacting	  proteins	  
have	  higher	  ratios	  of	  heavy	  isotope-­‐	  labeled	  peptides	  as	  compared	  with	  non-­‐specific	  
contaminants.	  (C)	  Overview	  showing	  workflow	  in	  a	  representative	  triple	  SILAC	  analysis	  
of	  protein	  interactions	  and	  their	  response	  to	  inhibitor	  treatment	  for	  either	  GFP-­‐tagged	  
or	  endogenous	  cell	  proteins.	  (D)	  Example	  of	  MS	  spectra	  for	  representative	  peptides	  
illustrating	  either	  a	  specific	  protein	  interaction	  partner	  (top),	  an	  internal	  contaminant	  
binding	  non-­‐specifically	  to	  the	  beads	  (middle)	  and	  an	  external	  environmental	  
contaminant,	  e.g.	  keratins	  (bottom).	  
SILAC	   thus	   objectively	   identifies	   proteins	   that	   can	   bind	   non-­‐specifically,	   e.g.	   to	   the	  
affinity	  matrix	  and/or	  the	  fusion	  tag,	  and	  by	  comparison	  highlights	  proteins	  that	  bind	  
specifically	   to	   the	   bait	   protein	   (reviewed	   in	   (Ranish	   et	   al.,	   2007,	   Vermeulen	   et	   al.,	  
2008)).	  The	  Lamond	  Laboratory	  and	  others	  have	  used	  this	  isotope-­‐based,	  quantitative	  
MS	   approach	   to	   characterise	   both	   tagged	   and	   endogenous	   protein	   complexes	   in	  
mammalian	  cells	  (Blagoev	  et	  al.,	  2003,	  Selbach	  and	  Mann,	  2006,	  Trinkle-­‐Mulcahy	  et	  al.,	  
2006,	   Trinkle-­‐Mulcahy	   et	   al.,	   2008a).	   Related	   differential	   isotope-­‐based	   labelling	  
strategies,	  combined	  with	  MS,	  have	  also	  been	  used	  to	  analyse	  specific	  binding	  proteins	  
(Brand	  et	  al.,	  2004,	  Tackett	  et	  al.,	  2005).	  
However,	   relying	   upon	   isotope	   labelling	   ratios	   alone	   does	   not	   entirely	   solve	   the	  
contaminant	  problem.	  Indeed,	  it	  is	  often	  impossible	  to	  establish	  a	  threshold	  ratio	  level	  
in	   these	   experiments	   that	   eliminates	   all	   of	   the	   contaminating	   proteins	   without	  
discarding,	  en	  passant,	  genuine	  interaction	  partners	  of	  lower	  abundance	  and/or	  lower	  
binding	   affinity.	   This	   issue	   was	   previously	   addressed	   by	   systematically	   identifying	  
proteins	   that	   frequently	   occur	   in	   pull-­‐down	   experiments.	   These	   proteins	   were	  
documented	   in	   a	   “bead	   proteome”,	   which	   provided	   a	   filter	   to	   help	   discriminate	  
between	   specific	   interaction	   partners	   and	   the	   inevitable	   non-­‐specific	   background	  
(Trinkle-­‐Mulcahy	   et	   al.,	   2008a).	   The	   bead	   proteome	   has	   proved	   a	   useful	   tool	   for	  
understanding	  contaminant	  behaviour	  and	  how	  it	  can	  be	  modelled.	   It	  has	  been	  used	  
extensively	   in	  the	  analysis	  of	  many	  pull-­‐down	  experiments	  to	  guide	  the	   identification	  
of	  specific	  interaction	  partners.	  However,	  a	  number	  of	  limitations	  have	  been	  identified	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of	  the	  static	  list	  of	  proteins	  included	  in	  this	  bead	  proteome.	  It	  has	  increasingly	  become	  
apparent	  that	  this	  list	  can	  never	  be	  definitive	  due	  to	  the	  constant	  changing	  nature	  of	  
protein	  discoveries.	   The	  original	  bead	  proteome	  paper	   focused	  on	  protein	   clustering	  
and	  frequency,	  as	  the	  method	  used	  to	  determine	  the	  proteins	  belonging	  to	  the	  bead	  
proteome,	   however,	   this	   is	   an	   unreliable,	   stand-­‐alone	   method	   of	   determining	  
contaminants.	  The	  original	  paper	  identified	  these	  limitations:	  
“The	  bead	  proteome	  filters	  thus	  provide	  a	  useful	  and	  objective	  resource	  that	  
can	  be	  consulted	  by	  cell	  biologists	  to	  help	  avoid	  expending	  time	  and	  effort	  on	  
the	  analysis	  of	  proteins	  that	  may	  prove	  to	  be	  simple	  contaminants.	  In	  the	  
future,	  accumulating	  information	  from	  many	  laboratories	  on	  the	  range	  of	  
nonspecific	  protein	  interactions	  observed	  using	  different	  cell	  types,	  
extracts,	  tags,	  and	  affinity	  matrices	  will	  provide	  an	  invaluable	  resource	  and	  
we	  propose	  this	  should	  be	  established	  as	  a	  freely	  accessible	  online	  
database.”	  (Trinkle-­‐Mulcahy	  et	  al.,	  2008a).	  
Clusters	   of	   contaminants	   are	   not	   always	   well	   defined	   in	   datasets,	   nor	   are	   all	   the	  
proteins	  found	  within	  the	  clusters,	  guaranteed	  to	  be	  contaminants.	  Furthermore,	  it	  is	  
impossible	  to	  generate	  an	  absolute	  list	  that	  can	  apply	  to	  all	  pull-­‐down	  experiments,	  as	  
the	   contaminant	   proteins	   differ	   based	   on	   experimental	   conditions.	   Variations	   in	  
experimental	  design,	  such	  as	  cell	  type,	  cell	  extract,	  organism,	  beads	  and	  sensitivity	  of	  
the	   mass	   spectrometry	   machine,	   have	   all	   been	   shown	   to	   have	   an	   impact	   on	   the	  
contaminants	   found	   in	   pull-­‐down	   experiments.	   Rather	   than	   a	   static	   list	   of	  
contaminants,	   a	   more	   objective	   approach	   would	   involve	   a	   dynamic	   list	   of	  
contaminants	  that	  can	  be	  customised	  for	  individual	  experiments.	  
This	  chapter	  presents	  a	  methodology	  for	  the	  reliable	   identification	  of	  specific	  protein	  
interaction	   partners	   that	   overcomes	   limitations	   with	   the	   previous	   bead	   proteome	  
approach.	   This	   methodology	   draws	   on	   data	   analysis	   strategies	   from	   the	   field	   of	  
Business	  Intelligence	  (BI)	  and	  applies	  them	  to	  integrate	  complex	  datasets	  arising	  from	  
MS	  pull-­‐down	  experiments.	  This	  methodology	  is	  used	  to	  generate	  a	  Protein	  Frequency	  
Library	   (PFL)	   that	   can	   be	   customized	   to	   the	   conditions	   of	   specific	   experiments	   and	  
continually	  updated.	  The	  PFL	  can	  be	  used	  as	  a	  specificity	  filter	  to	  discriminate	  specific	  
protein	   interactions	   and	   as	   a	   tool	   to	   normalise	   datasets	   and	   hence	   facilitate	  
comparison	  of	  separate	  experiments.	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5.3 Results 
The	  analysis	  of	  pull-­‐down	  data	  theoretically	  allows	  for	   (i)	   the	  discrimination	  between	  
contaminants	   and	   genuine	   interaction	   partners,	   and	   (ii)	   the	   characterisation	   of	  
changes	  in	  protein	  complexes	  under	  specific	  biological	  conditions.	  
5.3.1 Discriminating Specific from Non-Specific Interaction Partners  
	  
Figure	  28:	  Visualisation	  of	  contaminant	  profiles	  and	  threshold	  levels.	  	  
A	  representative	  example	  of	  a	  triple	  SILAC	  co-­‐IP	  experiment,	  using	  GFP-­‐Pol2C	  as	  bait	  in	  
cells	  either	  with,	  or	  without,	  α-­‐amanitin	  treatment	  (Boulon	  et	  al.,	  2010b),	  was	  used	  to	  
generate	  the	  graphs	  shown.	  (A)	  Graphs	  showing	  median	  SILAC	  ratios	  for	  every	  protein	  
group	  identified	  and	  quantified	  by	  MaxQuant	  (604	  distinct	  protein	  groups),	  with	  each	  
protein	  group	  plotted	  on	  the	  X-­‐axis	  and	  the	  median	  SILAC	  value	  for	  that	  protein	  group	  
plotted	  on	  the	  Y-­‐axis.	  Two	  arbitrarily	  chosen	  thresholds	  are	  illustrated	  (black	  horizontal	  
lines	  in	  left	  and	  right	  panels).	  (B)	  Representative	  ratio	  distribution	  plots.	  Data	  are	  
plotted	  as	  a	  histogram	  with	  log2	  SILAC	  ratios	  on	  the	  X-­‐axis	  and	  number	  of	  proteins	  for	  a	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given	  ratio	  on	  the	  Y-­‐axis.	  Non-­‐specific	  contaminants	  reproducibly	  cluster	  in	  a	  Gaussian	  
(normal)	  distribution	  centered	  ~zero	  (left	  panel),	  although	  the	  exact	  mean	  can	  deviate	  
from	  zero	  due	  to	  experimental	  variability,	  as	  seen	  for	  GFP-­‐	  Pol2C	  dataset	  (right	  panel).	  
(C)	  Data	  from	  the	  GFP-­‐Pol2C	  dataset	  plotted	  with	  log2	  (M/L)	  SILAC	  ratio	  on	  the	  X-­‐axis	  
and	  log2	  (H/M)	  SILAC	  ratio	  on	  the	  Y-­‐axis,	  with	  each	  point	  corresponding	  to	  the	  ratio	  
value	  for	  a	  specific	  protein	  group.	  The	  bait	  protein	  is	  shown	  in	  red.	  Putative	  
experimental	  contaminants	  cluster	  around	  the	  origin.	  
Figure	   28	   shows	   an	   example	  of	   data	   analysis	   from	  a	   representative	   SILAC	  pull-­‐down	  
experiment	  in	  which	  a	  tagged	  complex	  (Pol2C)	  was	  affinity	  purified	  from	  U2OS	  cells.	  In	  
this	  case,	  after	  in-­‐gel	  digestion,	  the	  MS	  analysis	  identified	  and	  quantitated	  over	  4,000	  
peptides	   that	   were	   assigned	   by	  MaxQuant	   to	   604	   human	   protein	   groups.	   For	   each	  
protein	   group	   (X-­‐axis),	   a	   median	   M/L	   SILAC	   ratio	   was	   calculated	   from	   all	   of	   the	  
individual	   peptide	   values	   determined	   and	   shown	   plotted	   on	   the	   Y-­‐axis	   (see	   Figure	  
28A).	  This	  shows	  that	  a	  minor	  group	  of	  proteins	  have	  a	  high	  SILAC	  M/L	  ratio	  (>2),	  while	  
approximately	  80%	  of	  the	  proteins	  (i.e.	  over	  480	  out	  of	  a	  total	  of	  604	  protein	  groups)	  
have	  a	  SILAC	   ratio	  <1.4.	  As	  described	  above,	   the	   former	  are	   strong	  candidates	   to	  be	  
specific	  interaction	  partners	  (see	  Figure	  28A,	  green	  columns),	  while	  the	  latter	  are	  more	  
likely	   to	   be	   non-­‐specific	   interaction	   partners.	   However,	   experience	   has	   shown	   that	  
some	   bona	   fide	   specific	   interaction	   partners	   can	   have	   SILAC	   ratios	   lower	   than	  
abundant	  contaminants	  (e.g.	   in	  the	  range	  ~0.6-­‐1.4).	  Thus,	  when	  setting	  the	  threshold	  
to	  an	  arbitrary	  value	  it	  is	  important	  to	  understand	  that	  if	  the	  selected	  threshold	  is	  high,	  
although	   most	   or	   all	   contaminants	   will	   be	   eliminated,	   low	   abundance	   and/or	   low	  
affinity	  genuine	   interaction	  partners	  will	  be	   lost.	  Conversely,	   if	   the	  threshold	  value	   is	  
chosen	   to	   be	   low,	  with	   the	   aim	  of	   identifying	   all	   low	   abundance	   and/or	   low	   affinity	  
partners,	   a	   larger	   number	   of	   contaminants	  will	   remain	   (see	   Figure	   28A,	   comparison	  
between	  left	  and	  right	  panels).	  It	  is	  therefore	  not	  possible	  to	  use	  a	  specific	  ratio	  value	  
as	   a	   threshold	   that	   consistently	   and	   unambiguously	   separates	   the	   specific	   from	   the	  
non-­‐specific	  interaction	  partners.	  
Another	   way	   of	   visualizing	   the	   same	   SILAC	   pull-­‐down	   data	   is	   to	   plot	   the	   ratio	  
distribution	  as	  a	  histogram.	  Thus,	  for	  either	  M/L,	  H/L	  or	  H/M	  SILAC	  ratios,	  the	  number	  
of	  proteins	  with	  each	  ratio	  value	  is	  plotted	  on	  the	  Y-­‐axis,	  against	  log2	  SILAC	  ratio	  values	  
on	   the	   X-­‐axis	   (see	   Figure	   28B).	   Here,	   non-­‐specific,	   experimental	   contaminants	  
reproducibly	   cluster	   in	   a	   Gaussian	   (normal)	   distribution	   centred	   at	   the	   log2	   ratio	   ~0	  
(which	  corresponds	  to	  a	  SILAC	  ratio	  ~1)	  (see	  Figure	  28B	  left	  panel).	  Theoretically,	  the	  
133	  
normal	  distribution	   should	  be	  centred	  on	  a	   log2	  value	  of	  exactly	   zero	  but	   in	  practice	  
this	  varies	  between	  individual	  experiments	  and	  the	  actual	  mean	  can	  be	  either	  higher	  
or	   lower,	   even	   for	   the	   separate	  M/L,	   H/L	   and	   H/M	   ratios	  measured	  within	   a	   single	  
triple	  SILAC	  experiment	  (see	  Figure	  28B,	  right	  panel).	   In	  contrast,	  putative	  interaction	  
partners	  are	  expected	  to	  show	  log2	  ratio	  values	  greater	  than	  the	  mean	  of	  the	  Gaussian	  
curve,	  while	  environmental	  (external)	  contaminants	  always	  have	  values	  lower	  than	  the	  
central	  mean	  value	   (see	  Figure	  28B,	   left	  panel).	  The	  Gaussian	  curve	  can	  be	  useful	   to	  
help	  refine	  the	  analysis	  of	  predicted	  specific	  interacting	  proteins,	  using	  a	  mathematical	  
description	  of	   the	  protein	  distribution.	  However,	   there	   is	  still	  no	  single	  ratio	  value	  to	  
reliably	  distinguish	  specific	  from	  non-­‐	  specific	  proteins.	  
Figure	  28C	  shows	  a	  third	  way	  of	  visualising	  the	  data,	  i.e.	  by	  plotting	  log2(H/M)	  (Y-­‐axis)	  
versus	  log2(M/L)	  (X-­‐axis)	  SILAC	  ratio	  values	  for	  all	  proteins	  identified	  in	  the	  triple	  SILAC	  
co-­‐IP	  experiment	  using	  GFP-­‐Pol2C	  as	  bait.	  This	  visualisation	  provides	  an	   indication	  of	  
both	  the	  specificity	  of	  the	  interaction	  (M/L	  ratio),	  and	  the	  changes	  occurring	  between	  
the	  two	  conditions	  tested	  (H/M	  ratio).	  From	  this	  graph	  it	  is	  evident	  that	  most	  proteins	  
have	  SILAC	  ratio	  values	  that	  cluster	  around	  the	  origin	  (see	  Figure	  28C,	  circled	  proteins).	  
As	   these	   proteins	   have	   log2(M/L)	   and	   log2(H/M)	   ratios	   of	   approximately	   zero,	   they	  
have	   a	   high	   probability	   of	   being	   contaminants.	   Due	   to	   small	   variations	   in	   each	  
experiment,	  e.g.	  volume	  differences	  when	  mixing	  extracts,	  the	  contaminants	  typically	  
cluster	   around	   values	   that	   can	   however	   deviate	   from	   zero	   (see	   Figure	   28,	   B,	   right	  
panel,	  and	  C).	  In	  contrast,	  putative	  specific	  interaction	  partners	  are	  present	  in	  the	  right	  
side	  of	  the	  graph.	  But	  as	  described	  above,	  and	  regardless	  of	  how	  the	  SILAC	  pull-­‐down	  
data	   are	   visualised,	   the	   problem	   remains	   that	   a	   significant	   overlap	   invariably	   exists	  
between	   the	   SILAC	   ratio	   values	   of	   specific	   interaction	   partners	   and	   contaminating	  
background	   proteins.	   Thus,	   although	   the	   SILAC	   approach	   is	   a	   powerful	   approach	   to	  
identify	  stable	  interaction	  partners,	  it	  is	  observed	  that	  relying	  upon	  SILAC	  ratios	  alone	  
is	   often	   not	   enough	   to	   reliably	   identify	   bona	   fide	   interaction	   partners	   of	   lower	  
abundance	  and/or	  lower	  binding	  affinity.	  To	  address	  this	  problem,	  additional	  objective	  
criterion	  was	  sought	  to	  add	  to	  the	  analysis.	  Thus	  a	  strategy	  was	  developed	  based	  upon	  
systematically	  annotating	  each	  protein	  in	  the	  proteome	  with	  its	  frequency	  of	  detection	  
in	   a	   database	   of	   independent	   co-­‐IP	   experiments,	   creating	   what	   is	   termed	   a	   Protein	  
Frequency	   Library	   (PFL).	   Hence,	   the	   PFL	   provides	   a	   probability	   estimate	   for	   each	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protein	  to	  be	  a	  contaminant,	  which	  is	   independent	  of	  the	  information	  given	  by	  SILAC	  
ratios	  and,	  therefore,	  can	  be	  applied	  to	  analyse	  both	  SILAC	  and	  label-­‐free	  data.	  
5.3.2 Sun Model and the Protein Frequency Library 
In	   order	   to	   quantify	   the	   analytical	   requirements	   that	   typify	   quantitative	   SILAC	   pull-­‐
down	  experiments,	  a	  logical	  model	  was	  constructed.	  This	  takes	  form	  as	  a	  “Sun	  Model”	  
(see	   Figure	   37),	   which	   shows	   the	   “measures”	   (e.g.	   SILAC	   ratio	   values,	   number	   of	  
peptides	  identified	  etc.)	   in	  the	  centre	  of	  the	  diagram	  and	  the	  “dimensions”	  (e.g.	  type	  
of	   affinity	   matrix,	   type	   of	   extract,	   date,	   user	   etc.)	   radiating	   from	   the	   centre.	   The	  
hierarchies	   that	  can	  exist	  within	  each	  dimension	   (e.g.	  date	  can	   include,	  year,	  month,	  
day	   etc.)	   are	   symbolised	   by	   the	   levels	   marked	   along	   a	   dimension	   line.	   This	   logical	  
model	  was	   then	  converted	   to	  an	  OLAP	  cube	   implementation.	  The	  PFL	  was	  extracted	  
using	  the	  logical	  model	  combined	  with	  the	  OLAP	  cube,	  focusing	  on	  the	  measure	  called	  
“Identified”.	  	  
The	   “Identified”	   measure	   signifies	   whether	   a	   given	   protein	   was	   identified	   and	  
quantified	  in	  a	  particular	  co-­‐IP	  experiment	  that	  is	  currently	  in	  the	  data	  repository.	  The	  
data	  repository	  used	  in	  the	  initial	  tests	  contained	  38	  SILAC	  co-­‐IP	  experiments,	  but	  it	  is	  
important	  to	  note	  that	  the	  PFL	  can	  also	  be	  generated	  using	  data	  from	  non-­‐SILAC,	  label-­‐
free	  experiments.	  Proteins	   in	  the	   initial	  PFL	  were	   identified	  via	   IPI	  accession	  number,	  
which	  provides	   a	   comprehensive	  description	   that	   is	   consistent	  with	   the	  output	   from	  
MaxQuant.	  It	  was	  noted	  that,	  due	  to	  the	  continuously	  updating	  IPI	  identifiers,	  proteins	  
were	  mapped	   to	   the	  most	   current	   identifier	   and,	   thus,	   multiple	   occurrences	   of	   the	  
same	   protein	   accession	   number,	   in	   a	   single	   experiment,	   were	   only	   allocated	   the	  
weighting	   of	   a	   single	   identification	   and	   quantification	   in	   the	   frequency	   value	   of	   any	  
generated	  protein	   library	  annotation.	  Using	   the	  “Identified”	  measure,	   the	  number	  of	  
times	   each	   protein	   appeared	   in	   all	   38	   experiments	   in	   the	   database	   was	   calculated,	  
giving	   rise	   to	  a	  deduced	   ‘frequency	  of	  detection’	   for	  each	  of	   the	  10,623	   IPI	  numbers	  
described	  by	  the	  datasets.	  This	  value	  was	  used	  in	  the	  generation	  of	  the	  initial	  PFL.	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Figure	  29:	  Protein	  Frequency	  Library	  construction	  and	  validation.	  	  
(A)	  The	  sun	  diagram	  was	  used	  in	  conjunction	  with	  an	  OLAP	  cube	  to	  analyse	  the	  
frequency	  of	  protein	  detection	  in	  a	  database	  containing	  data	  from	  38	  separate	  SILAC	  
co-­‐IP	  experiments.	  Graph	  illustrates	  the	  frequency	  of	  detection	  (Y-­‐axis)	  for	  10,623	  
separate	  IPI	  numbers	  (X-­‐axis).	  This	  defines	  a	  Protein	  Frequency	  Library	  (PFL).	  (B)	  
Comparison	  of	  data	  from	  the	  current	  PFL	  and	  a	  previously	  determined	  list	  of	  “bead	  
proteome”	  contaminants	  (Trinkle-­‐Mulcahy	  et	  al.,	  2008b).	  (C)	  Correlation	  between	  the	  
“bead	  proteome”	  coverage	  (Trinkle-­‐Mulcahy	  et	  al.,	  2008b)	  and	  the	  PFL,	  with	  PFL	  
proteins	  ranked	  from	  highest	  to	  lowest	  detection	  frequency	  (left	  to	  right).	  (D)	  
Comparison,	  for	  each	  10%	  PFL	  segment,	  measuring	  the	  number	  of	  “bead	  proteome”	  
proteins	  (Trinkle-­‐Mulcahy	  et	  al.,	  2008b)	  found	  in	  that	  segment	  versus	  the	  total	  number	  
of	  proteins	  found	  in	  that	  segment.	  
The	   PFL	   graph	   presented	   in	   Figure	   29A	   shows	   a	   visualisation	   of	   the	   frequency	   of	  
detection	  plotted	  against	  all	  proteins	  that	  were	  identified	  and	  quantified	  in	  any	  of	  the	  
38	  experiments.	   In	   this	   graph,	  each	  protein	   is	   shown	   sorted	   from	   the	  highest	   to	   the	  
lowest	  percentage.	  Hence,	  the	  proteins	  appearing	  nearest	  the	  origin	  of	  the	  graph	  have	  
the	  highest	  probability	  of	  being	  contaminants.	  	  
The	   PFL	   was	   compared	   with	   the	   previously	   characterised	   “bead	   proteome”,	   which	  
contains	   3,400	   separate	   human	   IPI	   numbers	   that	   were	   frequently	   found	   in	   27	  
independent	   SILAC	  pull-­‐down	  experiments	   (Trinkle-­‐Mulcahy	   et	   al.,	   2008b).	   The	  bead	  
proteome	   includes	  many	   abundant	   factors,	   such	   as	   histones,	   cytoskeleton	   and	   heat	  
shock	   proteins,	   and	  was	   thus	   extrapolated	   to	   include	  most	  members	   of	   these	   large	  
protein	   families.	  Although	   they	  all	   potentially	   can	  behave	  as	   common	  contaminants,	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not	  all	  are	  either	  expressed,	  or	  detected,	   in	  every	  cell	  type	  or	  pull	  down	  experiment.	  
An	  overlap	  of	  64%	  was	  observed	  between	   the	  static	  bead	  proteome	  and	   the	  PFL,	  as	  
shown	  in	  the	  Venn	  diagram	  (see	  Figure	  29B).	  The	  36%	  of	  bead	  proteome	  proteins	  that	  
were	  not	  present	  in	  the	  PFL	  were	  mostly	  additional	  members	  of	  large	  protein	  families	  
that	  did	  not	  appear	  in	  this	  set	  of	  38	  pull-­‐down	  experiments.	  	  
Further	  comparison	  shows	  that	  most	  of	  the	  common	  proteins	  listed	  in	  both	  the	  bead	  
proteome	  and	  PFL	  appear	  in	  the	  top	  2,000	  out	  of	  10,623	  IPI	  numbers	  of	  the	  PFL,	  when	  
proteins	   are	   ranked	   from	   highest	   to	   lowest	   detection	   frequency.	   In	   contrast,	   only	   a	  
small	  fraction	  of	  the	  bead	  proteome	  proteins	  are	  found	  in	  the	  bottom	  (low	  frequency)	  
end	  of	  the	  PFL	  (see	  Figure	  29C).	  This	  shows	  that	  most	  contaminants	   identified	   in	  the	  
bead	  proteome	  are	  associated	  with	  a	  high	  frequency	  in	  the	  PFL.	   In	  addition,	  for	  each	  
sequential	  PFL	  “10%”	  segment,	  i.e.	  all	  proteins	  associated	  with	  a	  PFL	  frequency	  range	  
between	   90-­‐100%,	   80-­‐90%	   etc.,	   the	   number	   of	   bead	   proteome	   proteins	   versus	   the	  
total	   number	   of	   proteins	   found	   in	   that	   segment	   were	   compared.	   This	   shows	   that	  
almost	  all	  proteins	  with	  a	  high	  frequency	  of	  detection	  in	  the	  PFL	  (>60%)	  are	  also	  listed	  
in	   the	  bead	  proteome,	  while	  most	  proteins	  with	  a	   low	   frequency	  of	  detection	   in	   the	  
PFL	   (<20%)	   are	   not	   (see	   Figure	   29D).	   These	   data	   underline	   the	   positive	   correlation	  
between	  the	  PFL	  and	  the	  bead	  proteome	  and	  validate	  the	  utility	  of	  the	  PFL	  approach	  
for	  predicting	  contaminant	  proteins.	  A	  major	  advantage	  of	  the	  PFL,	  as	  compared	  with	  
the	  previous	  “static”	  bead	  proteome,	  is	  that	  it	  provides	  an	  annotation	  of	  proteins	  that	  
is	   both	   customisable	   to	   reflect	   the	   details	   of	   individual	   experiments	   and	   updatable.	  
Hence	  it	  will	  increase	  in	  accuracy	  as	  new	  data	  are	  added	  to	  the	  data	  repository.	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5.3.3 Filtering of Protein Frequency Library using Experimental 
Parameters 
	  
Figure	  30:	  Filtering	  of	  PFL	  using	  experimental	  parameters	  (“dimensions”).	  	  
(A)	  Using	  a	  web-­‐based	  interface,	  any	  individual	  dimensions	  within	  the	  data	  model	  
(corresponding	  to	  experimental	  parameters	  recorded	  in	  the	  database)	  can	  be	  used	  in	  
conjunction	  with	  the	  OLAP	  cube	  to	  create	  a	  customised	  PFL.	  This	  is	  illustrated	  here	  for	  
the	  dimensions;	  (B)	  Cell	  extract	  (cytoplasmic	  and	  nuclear)	  and	  (C)	  Affinity	  matrix	  
(sepharose	  beads)	  used	  for	  pull-­‐down	  experiments.	  
The	   use	   of	   the	   OLAP	   cube,	   and	   its	   range	   of	   measures	   and	   dimensions,	   provides	   a	  
dynamic	  list	  of	  contaminants	  that	  can	  be	  customised	  for	  individual	  experiments.	  Figure	  
30A	   shows	   an	   example	   of	   an	   interface	   in	   PepTracker	   that	   can	   be	   used	   to	   flexibly	  
specify	   the	   parameters	   (in	   principle,	   drawing	   on	   all	   of	   the	   dimensions	   that	   were	  
incorporated	  into	  the	  cube)	  on	  which	  the	  library	  can	  be	  filtered	  so	  that	  an	  analysis	   is	  
customised	  to	  the	  detailed	  conditions	  used	  for	  a	  specific	  pull-­‐down	  experiment.	  Here,	  
the	   PFL	   has	   been	   filtered	   using	   the	   dimensions	   “cell	   extract”	   (see	   Figure	   30B)	   and	  
“bead	  type”	  (i.e.	  type	  of	  affinity	  matrix)	  (see	  Figure	  30C).	  Thus,	  among	  all	  38	  SILAC	  pull-­‐
down	   experiments	   in	   the	   data	   repository,	   only	   the	   ones	   that	   were	   performed	   with	  
either	  a	  specific	  type	  of	  extract	  (e.g.	  cytoplasmic	  or	  nuclear	  extract)	  (see	  Figure	  30B),	  
or	  with	  a	  specific	  type	  of	  bead	  (e.g.	  sepharose	  beads)	  (see	  Figure	  30C),	  were	  used	  to	  
generate	  a	  customised	  PFL.	  This	  customisation	  feature	  of	   the	  PFL	  avoids	  the	  need	  to	  
have	   a	   large	   set	   of	   control	   experiments	   that	   exhaustively	   cover	   every	   possible	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experimental	  parameter	  analysed,	  by	   combining	   the	  different	  parameters	  associated	  
with	   each	   experiment	   in	   the	   data	   repository	   and	   thus	   increasing	   the	   value	   of	   each	  
individual	  dataset.	  The	  PFL	  is	  thus	  applicable	  also	  for	  the	  analysis	  of	  low	  throughput	  co-­‐
IP	   experiments,	  when	   high-­‐throughput	   bioinformatics	   analysis	   techniques,	   aiming	   to	  
discard	  contaminants,	  cannot	  be	  applied.	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5.3.4 Application of PFL to Analysis of Multi-Protein Complexes 
	  
Figure	  31:	  Application	  of	  PFL	  in	  the	  identification	  of	  specific	  protein	  interactors.	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(A)	  Cross-­‐reference	  between	  the	  customized	  “sepharose”	  PFL	  data	  (as	  in	  Figure	  30C),	  
and	  the	  GFP-­‐Pol2C	  dataset.	  Continuous	  colour	  coding	  from	  red	  (highest)	  to	  green	  
(lowest)	  is	  used	  to	  depict	  frequency	  of	  protein	  detection	  (left	  panel).	  On	  the	  right	  panel,	  
the	  same	  colour	  coding	  is	  applied	  to	  the	  log2(H/M)	  against	  log2(M/L)	  SILAC	  ratio	  plot	  of	  
GFP-­‐Pol2C	  dataset	  (plot	  as	  shown	  in	  Figure	  28C).	  (B)	  Comparison	  of	  arbitrary	  threshold	  
values	  (80%,	  60%,	  40%	  and	  20%	  detection	  frequency	  in	  PFL),	  to	  visualise	  the	  most	  
frequently	  detected	  proteins	  in	  the	  PFL	  (highlighted	  in	  red)	  on	  the	  log2	  plot	  of	  SILAC	  
ratios	  for	  the	  same	  pull-­‐down	  experiment	  shown	  in	  (A).	  Lower	  threshold	  values	  result	  in	  
highlighting	  of	  larger	  number	  of	  proteins.	  (C)	  The	  graph	  shows	  the	  PFL	  frequency	  (Y-­‐
axis),	  plotted	  against	  the	  SILAC	  M/L	  ratio	  (X-­‐axis)	  for	  each	  protein	  group	  in	  the	  Pol2C	  
dataset.	  A	  red	  line	  is	  drawn	  indicating	  the	  minimum	  suitable	  PFL	  threshold	  that	  
includes	  all	  protein	  groups	  with	  a	  high	  M/L	  ratio	  in	  the	  likely	  set	  of	  putative	  interaction	  
partners.	  
The	   PFL	   was	   applied	   to	   analyse	   the	   SILAC	   data	   from	   the	   GFP-­‐Pol2C	   pull-­‐down	  
experiment	  (see	  Figure	  31A).	  As	  this	  was	  performed	  with	  sepharose	  beads,	  the	  PFL	  was	  
filtered	  to	  generate	  a	  sepharose	  PFL,	  as	   in	  Figure	  30C.	  A	  subset	  of	  the	  sepharose	  PFL	  
library	  is	  shown,	  where	  only	  proteins	  that	  are	  identified	  in	  the	  GFP-­‐Pol2C	  dataset	  are	  
displayed,	   i.e.	   a	   cross-­‐reference	   between	   the	   Pol2C	   dataset	   and	   the	   sepharose	   PFL,	  
which	   gives	   a	   total	   of	   2,973	   IPI	   numbers.	   A	   continuous	   colour	   coding	   (from	   red	   to	  
green)	   was	   applied	   to	   the	   graph,	   representing	   proteins	   with	   highest	   detection	  
frequency	   (red)	   to	   the	   proteins	  with	   lowest	   detection	   frequency	   (green)	   (see	   Figure	  
31A,	  left	  panel).	  The	  same	  high	  (red)	  to	  low	  (green)	  colour	  coding	  was	  then	  applied	  to	  
the	   log2(H/M)	  against	   log2(M/L)	  ratio	  plot	  (see	  Figure	  31A,	  right	  panel).	  Proteins	  with	  
high	   frequency	   of	   detection	   (red)	   cluster	   around	   the	   origin,	  while	   the	   proteins	  with	  
lower	  frequency	  of	  detection	  (green)	  spread	  further	  across	  the	  graph.	  This	   illustrates	  
the	   strong	   positive	   correlation	   between	   proteins	   that	   show	   a	   high	   frequency	   of	  
detection	  and	  proteins	  that	  cluster	  around	  the	  origin	  in	  this	  IP	  experiment,	  which	  is	  the	  
expected	  behaviour	  of	  contaminant	  proteins.	  	  
Next,	  the	  sepharose	  PFL	  was	  used	  to	  isolate	  within	  the	  GFP-­‐Pol2C	  dataset	  a	  group	  of	  
proteins	   predicted	   to	   include	   predominantly	   contaminants.	   This	   was	   done	   by	   (i)	  
establishing	  a	  threshold	  value	  for	  protein	  detection	  frequency	  and,	  (ii)	  highlighting	  all	  
proteins	   in	   the	   dataset	   that	   show	   a	   frequency	   of	   detection	   above	   that	   threshold.	   A	  
threshold	  value	  of	  100%	  corresponds	  to	  only	  those	  proteins	  detected	  in	  every	  dataset	  
in	  the	  library.	  A	  threshold	  value	  of	  zero	  instead	  would	  include	  every	  protein	  identified	  
in	   any	  dataset.	   Therefore	   four	   intermediate	   frequency	   thresholds	  were	   investigated,	  
corresponding	  to	  80%,	  60%,	  40%	  and	  20%	  frequency	  of	  detection.	  Each	  was	  applied	  to	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log2(H/M)	   versus	   log2(M/L)	   ratio	   plots	   of	   the	   GFP-­‐Pol2C	   dataset	   and	   compared	   (see	  
Figure	   31B).	   As	   the	   threshold	   value	   for	   the	   frequency	   of	   detection	   decreases,	   the	  
number	  of	  proteins	  included	  in	  the	  subset	  of	  putative	  contaminants	  (highlighted	  in	  red	  
on	  the	  graphs),	  increases.	  The	  majority	  of	  these	  proteins	  cluster	  either	  at	  the	  origin,	  or	  
on	   the	   left	   quadrants	   of	   the	   graph,	   exactly	   as	   expected	   if	   they	   are	   indeed	  
contaminants.	  External	  contaminants,	  such	  as	  keratins,	  are	  always	  present	   in	  the	   left	  
hand	   quadrants.	   At	   lower	   threshold	   values,	   the	   probability	   that	   some	   specific	  
interacting	   proteins	   are	   also	   highlighted	   is	   increased.	   By	   plotting	   the	   PFL	   frequency	  
value	  against	  the	  M/L	  SILAC	  ratio	  for	  every	  protein	   in	  the	  dataset	  (see	  Figure	  31C),	  a	  
threshold	   value	   of	   40%	   was	   chosen,	   because	   it	   retains	   the	   main	   stable	   interaction	  
partners	  of	  the	  bait	  and	  selects	  a	  suitable	  subset	  of	  clustered	  contaminants	  for	  further	  
normalisation	  of	  the	  GFP-­‐Pol2C	  dataset,	  as	  described	  below.	  The	  choice	  of	  an	  optimal	  
frequency	  threshold	  may	  vary	  for	  different	  experiments.	  However,	  the	  threshold	  value	  
used	  is	  expected	  to	  become	  lower	  as	  the	  number	  of	  experiments	  used	  to	  generate	  the	  
PFL	  increases.	  Although	  it	  is	  currently	  not	  possible	  to	  calculate	  accurately	  the	  minimal	  
number	   of	   independent	   experiments	   required	   to	   provide	   a	   reliable	   PFL,	   based	  upon	  
current	   experience	   it	   was	   estimated	   that	   at	   least	   10-­‐15	   independent	   pull-­‐down	  
experiments	  using	  different	  baits	  constitute	  a	  basic	  requirement.	  
5.3.5 Use of PFL to Normalise Datasets  
Ideally,	   samples	   for	   SILAC	   analysis	   are	   prepared	   identically,	   with	   no	   variability	   in	  
experimental	  conditions	  and	  with	  precisely	  equal	  amounts	  of	   labelled	  samples	  mixed	  
before	   MS,	   which	   should	   lead	   to	   a	   normal	   distribution	   of	   SILAC	   ratios	   centred	   on	  
exactly	   zero.	   However,	   in	   practice	   slight	   variations	   in	   experimental	   conditions,	   e.g.	  
pipetting	  accuracy	  etc.,	   are	  unavoidable,	   resulting	   in	  minor	   variations	   in	   SILAC	   ratios	  
and	  hence	  in	  a	  ratio	  distribution	  whose	  mean	  deviates	  from	  zero	  (see	  Figure	  28,	  B	  and	  
C).	  While	  this	  generally	  does	  not	  compromise	  the	  interpretation	  of	  data	  within	  a	  given	  
experiment,	  it	  can	  complicate	  the	  accurate	  comparison	  of	  separate	  datasets,	  i.e.	  either	  
biological	   replicates	   or	   independent	   experiments.	   Accurate	   comparison	   of	   separate	  
experiments	  thus	  requires	  that	  datasets	  are	  normalised	  objectively	  to	  compensate	  for	  
intrinsic	  variations	  in	  SILAC	  ratios.	  	  
The	  MaxQuant	  software	  provides	  a	  method	  of	  data	  normalisation	  that	  is	  based	  on	  the	  
whole	   dataset	   in	   a	   specific	   experiment	   being	   analysed	   and	   this	   assumes	   that	   most	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proteins	   should	   not	   change	   between	   conditions.	   	   However,	   in	   a	   SILAC	   pull-­‐down	  
experiment	  it	  is	  expected	  that	  specific	  interacting	  proteins	  should	  change	  between	  the	  
three	  conditions:	  L,	  M	  and	  H.	  Thus,	  the	  PFL	  is	  used	  to	  normalise	  datasets	  by	  isolating	  a	  
group	   of	   proteins	   that	   can	   confidently	   be	   predicted	   as	   mostly	   contaminants	   and,	  
hence,	  whose	  log	  SILAC	  ratios	  should	  be	  exactly	  zero.	  	  
	  
Figure	  32:	  Normalisation	  of	  datasets	  using	  the	  PFL.	  	  
(A)	  Graphs	  show	  log2	  SILAC	  ratio	  plots	  of	  total	  proteins	  identified	  from	  co-­‐IP	  using	  GFP-­‐
Pol2C	  as	  bait	  (i)	  before	  normalisation	  or	  threshold	  analysis	  (ii)	  after	  application	  of	  a	  
40%	  “sepharose”	  PFL	  threshold	  filter,	  with	  the	  plot	  now	  showing	  only	  putative	  
contaminants	  (light	  green),	  i.e.	  proteins	  with	  PFL	  values	  over	  40%	  (iii)	  total	  dataset	  re-­‐
plotted	  after	  normalisation	  to	  set	  median	  SILAC	  log2	  ratio	  value	  of	  predicted	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contaminants	  to	  zero.	  Predicted	  contaminants	  are	  shaded	  in	  light	  green	  and	  other	  
proteins	  shown	  in	  dark	  green.	  The	  effect	  of	  this	  normalisation	  procedure	  on	  the	  
Gaussian	  ratio	  distribution	  curves	  for	  the	  three	  separate	  M/L,	  H/L	  and	  H/M	  values	  
recorded	  in	  the	  triple	  SILAC	  analysis	  is	  shown	  in	  parallel	  on	  the	  right	  for	  panels	  (i)-­‐	  (iii)	  
in	  the	  form	  of	  SILAC	  ratio	  distribution	  histograms	  (as	  in	  Figure	  28B).	  (B)	  Repeat	  of	  the	  
normalisation	  procedure	  shown	  above	  using	  data	  from	  a	  separate	  triple	  SILAC	  co-­‐IP	  
experiment	  using	  antibodies	  to	  an	  endogenous	  protein	  (Pol2A)	  rather	  than	  a	  GFP-­‐
tagged	  bait.	  
The	   normalisation	   process	   is	   illustrated	   for	   the	   GFP-­‐Pol2C	   dataset	   (see	   Figure	   32A).	  
Using	   the	   sepharose	   PFL	  with	   a	   threshold	   value	   set	   to	   40%	   frequency,	   the	   resulting	  
proteins	  with	  frequency	  above	  40%	  were	  isolated	  within	  the	  dataset	  (see	  Figure	  32A,	  
middle	   graph),	   and	   their	   median	   value	   of	   SILAC	   ratios	   calculated	   for	   all	   three	  
conditions	  (i.e.,	  M/L,	  H/L	  and	  H/M).	  MaxQuant	  non-­‐normalised	  SILAC	  ratios	  were	  used	  
and	  the	  SILAC	  ratios	  of	  external	  contaminants,	  e.g.	  keratins,	  were	  excluded	   from	  the	  
normalisation	   process.	   SILAC	   ratio	   values	   for	   all	   proteins	   in	   the	   dataset,	   including	  
putative	   contaminants	   and	   specific	   interactors,	   were	   then	   divided	   by	   the	  
corresponding	   median	   value.	   This	   normalises	   the	   median	   log	   ratio	   value	   for	   the	  
predicted	  contaminant	  group	  to	  exactly	  zero	  (see	  Figure	  32A,	  right	  panels).	  The	  cluster	  
of	  contaminants	  is	  thereby	  centred	  on	  the	  origin	  of	  the	  graph	  (see	  Figure	  32A,	  bottom	  
graph).	  This	  normalisation	  process	  does	  not	  alter	  the	  positions	  of	  proteins	  relative	  to	  
each	  other	  within	  this	  experiment,	  but	  rather	  globally	  affects	  the	  ratio	  values	  of	  all	  the	  
proteins	  in	  the	  dataset.	  The	  same	  normalisation	  process	  can	  be	  applied	  to	  any	  dataset,	  
including	  co-­‐IP	  analysis	  of	  an	  endogenous	  protein,	  as	  shown	  for	  the	  dataset	  from	  SILAC	  
affinity-­‐purification	   of	   endogenous	   RNA	   polymerase	   II	   subunit	   A	   (Pol2A)	   (see	   Figure	  
32B).	  	  
5.3.6 Comparative Analysis of Normalised Datasets  
Next	  the	  data	  analysis	  workflow	  described	  above	  was	  used	  to	  analyse	  normalised	  GFP-­‐
Pol2C	  pull-­‐down	  and	  endogenous	  Pol2A	  co-­‐IP	  triple	  SILAC	  experiments.	  A	  customised	  
sepharose	  PFL	  combined	  with	  a	   frequency	  threshold	  of	  40%	  was	  used	  (i)	   to	  highlight	  
putative	  non-­‐specific	  contaminants	  and	  (ii)	  to	  normalise	  the	  datasets.	  Figure	  33	  shows	  
the	  GFP-­‐Pol2C	  and	  endogenous	  Pol2A	  datasets	  plotted	  as	  log2(H/M)	  against	  log2(M/L)	  
ratios	  after	  normalisation	  (see	  Figure	  33	  A	  and	  B,	  respectively).	  Each	  point	  represents	  
the	  normalised	  median	   SILAC	   ratio	   value	   for	   all	   quantified	  peptides	   assigned	   to	   that	  
protein.	  Bait	  proteins	  are	  shown	  in	  red.	  Core	  subunits	  of	  RNA	  polymerase	  II	  are	  shown	  
in	   blue.	   The	   predicted	   contaminant-­‐enriched	   group,	   i.e.	   proteins	   that	   show	   a	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frequency	  of	  detection	  above	  40%	  in	  the	  Sepharose	  PFL,	  are	  shaded	  in	  light	  green,	  and	  
all	  other	  proteins	  shown	  in	  dark	  green.	  	  
	  
Figure	  33:	  Analysis	  of	  protein	  interaction	  dynamics	  using	  normalised	  datasets.	  
Graphs	  A	  and	  B	  are	  log2	  SILAC	  M/L	  versus	  H/M	  ratios	  comparing	  normalised	  datasets	  
from	  triple	  SILAC	  experiments	  analysing	  proteins	  specifically	  interacting	  with	  either	  (A)	  
GFP-­‐RNA	  polymerase	  II	  subunit	  C	  (Pol2C)	  or	  (B)	  endogenous	  RNA	  polymerase	  II	  subunit	  
A	  (Pol2A).	  Each	  point	  represents	  the	  normalised	  median	  SILAC	  ratio	  value	  for	  all	  
quantified	  peptides	  assigned	  to	  that	  protein.	  Bait	  proteins	  are	  shown	  in	  red.	  Core	  
subunits	  of	  RNA	  polymerase	  II	  are	  shown	  in	  blue.	  A	  threshold	  PFL	  value	  of	  40%	  was	  
used	  and	  all	  proteins	  with	  a	  40%	  or	  greater	  frequency	  value	  are	  shown	  in	  light	  green.	  
Dotted	  red	  line	  shows	  an	  alternative	  X-­‐axis	  defined	  by	  the	  behaviour	  of	  the	  bait	  protein.	  
Proteins	  within	  red	  ovals	  are	  RNA	  polymerase	  II	  subunits	  whose	  specific	  interaction	  
with	  the	  bait	  shows	  a	  decrease	  of	  2-­‐fold	  or	  more.	  (C)	  Identification	  of	  specific	  protein	  
interaction	  partners	  with	  low	  M/L	  SILAC	  ratios	  using	  PFL	  frequencies.	  The	  graph	  shows	  
each	  protein	  group	  identified	  in	  the	  Pol2C	  dataset	  plotted	  on	  the	  X-­‐axis	  and	  the	  
normalised	  median	  SILAC	  value	  for	  that	  protein	  group	  plotted	  on	  the	  Y-­‐axis	  (similar	  to	  
Figure	  28A).	  It	  has	  been	  colour	  coded	  to	  highlight	  all	  protein	  groups	  with	  a	  PFL	  value	  
below	  40%	  in	  dark	  green	  while	  protein	  groups	  showing	  a	  frequency	  value	  above	  40%	  
are	  shown	  in	  light	  green.	  Proteins	  belonging	  to	  the	  R2TP/prefoldin-­‐like	  complex	  are	  
highlighted	  in	  purple.	  (D)	  Same	  graph	  as	  Fig.	  8A	  with	  the	  proteins	  of	  the	  
R2TP/prefoldin-­‐like	  complex	  highlighted	  in	  purple.	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POLR2K	   IPI00023975.1	   3	   53.4	   3	   56.2	   0.51	   3.4	  



















81	   62.1	   272	   21.5	   0.35	   16.6	  





116	   61.4	   215	   22.2	   -­‐0.97	   36.1	  




8	   58	   12	   29.9	   -­‐1.15	   31.5	  
POLR2G	   IPI00218895.6	   11	   74.4	   14	   11.2	   -­‐1.32	   35.7	  
POLR2I	   IPI00006113.1	   7	   78.4	   9	   20.1	   -­‐1.33	   42.1	  
POLR2E	   IPI00291093.3	   10	   58.1	   23	   27.6	   -­‐1.34	   34.8	  
Table	  5:	  Comparison	  of	  Peptide	  Data	  Quality	  for	  RNA	  Polymerase	  II	  Subunits.	  
All	  known	  RNA	  polymerase	  II	  subunits	  (Pol2A–Pol2L)	  except	  Pol2F	  were	  identified	  and	  
quantified	  in	  the	  SILAC	  co-­‐IP	  using	  GFP-­‐Pol2C	  as	  bait.	  They	  all	  show	  high	  sequence	  
coverage	  and	  a	  large	  number	  of	  peptides	  identified	  and	  quantified,	  underlining	  the	  
quality	  of	  the	  data.	  The	  bait	  protein,	  GFP-­‐Pol2C,	  is	  bold.	  Log2(H/M)	  ratios	  of	  all	  subunits	  
are	  normalized	  in	  the	  table	  so	  that	  log2(H/M)	  of	  Pol2C	  is	  0.	  Subunits	  are	  listed	  above	  
the	  bait	  protein	  when	  their	  interaction	  with	  the	  bait	  was	  increased	  upon	  α-­‐amanitin	  
treatment	  (log2(H/M)	  versus	  2C	  >	  0),	  whereas	  subunits	  are	  listed	  below	  when	  their	  
interaction	  with	  the	  bait	  protein	  was	  decreased	  upon	  α-­‐amanitin	  treatment	  (log2(H/M)	  
versus	  2C	  <	  0).	  Interactions	  are	  considered	  significantly	  affected	  when	  log2(H/M)	  versus	  
2C	  >	  1	  or	  log2(H/M)	  versus	  2C	  <	  −1	  (equivalent	  to	  a	  change	  in	  value	  of	  2-­‐fold	  or	  
greater).	  
GFP-­‐Pol2C	  interaction	  partners	  were	  analysed	  in	  U2OS	  cells	  either	  with,	  or	  without,	  α-­‐
amanitin	   treatment	   (see	   Figure	   33A),	   while	   endogenous	   Pol2A	   interaction	   partners	  
were	   analysed	   in	   U2OS	   cells	   either	   with,	   or	   without,	   combined	   α-­‐amanitin	   and	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leptomycin	  B	  (LMB)	  treatment.	  In	  the	  Pol2C	  co-­‐IP	  experiment,	  eleven	  out	  of	  the	  twelve	  
known	  RNA	  polymerase	   II	   subunits	   (Pol2A-­‐Pol2L),	   except	   Pol2F,	  were	  detected,	  with	  
high	  sequence	  coverage	  and	  a	  large	  number	  of	  peptides	  identified	  and	  quantified	  (see	  
Table	  5	  for	  GFP-­‐Pol2C	  dataset),	  underlining	  the	  quality	  of	  the	  data.	  	  
If	   the	   pull-­‐down	   efficiency	   is	   the	   same	   between	   the	   two	   conditions	   tested	   (+/-­‐	   α-­‐
amanitin),	   the	   log2(H/M)	   ratio	   should	  be	   zero	   for	   the	  bait	   protein.	   In	   practice	   this	   is	  
often	   not	   the	   case,	   due	   for	   example	   to	   variations	   in	   expression	   levels,	   accessibility	  
and/or	  fractionation	  efficiency	  induced	  by	  the	  treatment.	  Hence,	  the	  bait	  protein	  has	  
been	  used	  as	  a	  reference	  point	  to	  draw	  a	  second	  X-­‐axis	  such	  that	  proteins	  falling	  above	  
the	   new	   X-­‐axis	   line	   indicate	   increased	   interaction	   with	   the	   bait	   and	   proteins	   falling	  
below	   indicate	  decreased	   interaction	  as	  a	   result	  of	   the	   treatment.	  Here,	   interactions	  
were	   considered	   as	   significantly	   affected	   when	   a	   two-­‐fold	   or	   greater	   change	   was	  
observed	   upon	   treatment	   (see	   Table	   5).	   The	   GFP-­‐Pol2C	   dataset	   shows	   partial	  
disassembly	  of	  the	  RNA	  polymerase	  II	  complex	  after	  α-­‐amanitin	  treatment	  (see	  Figure	  
33A),	  because	  GFP-­‐Pol2C	  interaction	  with	  many	  RNA	  polymerase	  II	  subunits,	  including	  
2A,	   2D,	   2E,	   2G,	   2H	   and	   2I,	   is	   significantly	   decreased	   after	   α-­‐amanitin	   treatment	  
(proteins	  within	  the	  red	  oval,	  Figure	  33A).	  However,	  some	  subunits	  remain	  associated,	  
and	   new	   protein	   interaction	   partners	   were	   also	   identified,	   suggesting	   that	  
intermediate	   sub-­‐complexes	   are	   formed	   upon	   α-­‐amanitin	   treatment.	   The	   same	  
approach	  was	   applied	   to	   analyse	   the	   Pol2A	   dataset,	   showing	   that	   Pol2A	   interaction	  
with	  all	  RNA	  polymerase	   II	  subunits,	  except	  Pol2H,	   is	  decreased	  after	  treatment	  with	  
both	   α-­‐amanitin	   and	   LMB	   (see	   Figure	   33B,	   proteins	   within	   the	   red	   oval).	   A	   more	  
detailed	   analysis	   and	   discussion	   of	   these	   data	   characterising	   the	   formation	   of	   sub-­‐
complexes	  during	  RNA	  polymerase	   II	  assembly	   is	  presented	  elsewhere	  (Boulon	  et	  al.,	  
2010b).	  
Importantly,	   while	   high	   SILAC	  M/L	   ratios	   unambiguously	   identify	   specific	   interaction	  
partners,	  the	  application	  of	  the	  PFL	  to	  the	  dataset	  can	  help	  identify	  additional	  specific	  
interaction	   partners	   otherwise	  missed	   because	   their	   lower	   SILAC	   ratios	   overlap	  with	  
non-­‐specific	  contaminants.	  This	  overlap	  is	  particularly	  visible	  for	  proteins	  with	  a	  SILAC	  
M/L	   ratio	   <3	   (see	   Figure	   33C,	   dark	   and	   light	   green	   columns).	   By	   highlighting	   all	  
predicted	   contaminants	   (frequency	   of	   detection	   >	   40%),	   the	   PFL	   approach	   helps	   to	  
focus	   on	   the	   remaining	   putative	   specific	   interaction	   partners.	   For	   example,	   many	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proteins	  of	  the	  R2TP/prefoldin-­‐like	  complex,	  i.e.	  UXT,	  RUVBL1/2,	  PFDN2/6	  and	  PDRG1,	  
are	  not	  identified	  in	  the	  Pol2C	  dataset	  with	  high	  SILAC	  M/L	  ratios	  but	  show	  a	  frequency	  
value	  below	  40%	   (see	  Table	  6	  and	  Figure	  33D,	  purple	  data	  points).	   Interestingly,	   the	  
R2TP/prefoldin-­‐like	   complex	   has	   been	   connected	   to	   the	   RNA	   polymerase	   II	   complex	  
(11,	  36).	  This	   shows	   that	   these	  proteins	  are	   indeed	  bona	   fide	   interaction	  partners	  of	  
Pol2C	  that	  would	  have	  been	  overlooked	  in	  the	  analysis	  without	  the	  PFL.	  	  
Gene	  






KRT19	   IPI00479145.2	   5.03	   100	  
UXT	   IPI00170862.1;IPI00002646.1;IPI0055308
0.1	  





3.43	   52	  
RUVBL2	   IPI00009104.7;IPI00909925.1	   2.70	   26	  
TUBB8	   IPI00292496.1	   2.01	   77	  
PDRG1	   IPI00027887.4	   1.81	   16	  
HIST2H2AB	   IPI00216730.3;IPI00829588.1	   1.77	   81	  








1.62	   97	  
RUVBL1	   IPI00021187.4;IPI00788942.1;IPI0090250
1.1;IPI00796459.1	  
1.61	   29	  
FLNC	   IPI00178352.5;IPI00413958.4;IPI0045502
1.3	  
1.44	   77	  
PFDN6	   IPI00005657.1	   1.28	   13	  
Table	  6:	  Embedding	  of	  Putative	  Specific	  Interaction	  Partners	  within	  Contaminants.	  
A	  selection	  of	  protein	  groups	  from	  the	  Pol2C	  dataset	  with	  low	  SILAC	  M/L	  ratios	  (<5)	  are	  
listed	  with	  their	  PFL	  frequencies	  and	  ranked	  by	  M/L	  ratio	  from	  highest	  to	  lowest.	  
Protein	  groups	  with	  a	  PFL	  value	  below	  the	  threshold	  (40%),	  and	  belonging	  to	  the	  
R2TP/prefoldin-­‐like	  complex,	  are	  shaded	  in	  grey.	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In	   summary,	   the	   PFL	   approach	   combined	  with	   triple	   SILAC	   experiments	   is	   shown	   to	  
provide	   an	   effective	   and	   flexible	  workflow	   for	   the	   detection	   and	   analysis	   of	   specific	  
interactions	  within	  multi-­‐protein	  complexes.	  
5.3.7 PFL Viewer  
To	   enable	   researchers	   from	   external	   laboratories	   to	   benefit	   from	   the	   PFL	   concept	   a	  
web-­‐based	  interface	  was	  created	  providing	  access	  to	  the	  PFL	  generated	  by	  the	  Lamond	  
Laboratory.	   This	   interface	   is	   particularly	   important	   for	   researchers	  who	   do	   not	   have	  
the	   resources	   or	   technical	   expertise	   to	   generate	   their	   own	   PFL.	   Furthermore,	  
researchers	   who	   have	   limited	   experience	   in	   carrying	   out	   pull-­‐down	   experiments	   or	  
limited	  access	   to	  other	   researchers	  experiments	  may	  not	  have	   the	  ability	   to	  compile	  
enough	  datasets	  to	  generate	  a	  reliable	  PFL	  to	  distinguish	  between	  genuine	  interaction	  
partners	   and	   contaminants.	   The	   Lamond	   Laboratory	   benefits	   from	   having	   data	  
generated	  by	  multiple	  researchers	  over	  time	  using	  a	  variety	  of	  parameters.	  Hence,	  the	  
PFL	  generated	  by	  the	  Lamond	  Laboratory	  can	  be	  useful	  in	  a	  variety	  of	  experiments	  and	  
is	  continuously	  being	  improved.	  Allowing	  external	  researchers	  access	  to	  the	  PFL	  via	  a	  
web	  interface	  would	  be	  providing	  the	  research	  community	  with	  a	  useful	  resource.	  	  
The	   PFL	   interface	   was	   created	   in	   conjunction	   with	   an	   honours	   project	   student.	   The	  
honours	  project	  student,	  Laurence	  Hole	  (School	  of	  Computing,	  University	  of	  Dundee),	  
was	   supervised	  over	  a	  9-­‐month	  period	  and	  carried	  out	  work	   that	   contributed	   to	   the	  
development	  of	  a	  GUI	  for	  the	  PFL.	  The	  use	  case	  for	  this	  tool	  was:	  
Researcher:	   Navigates	  to	  the	  website:	  http://proteinfrequencylibrary.com.	  
System:	  	   Displays	   a	   form	   allowing	   a	   researcher	   to	   customise	   the	   PFL	   and/or	  
search	  for	  a	  specific	  protein(s).	  	  
Researcher:	   Enters	  a	  set	  of	  filtering	  criteria	  and/or	  proteins.	  
System:	   Displays	   the	   PFL	   in	   graph	   form	   to	   the	   researcher	   with	   the	   selected	  
protein(s)	  highlighted.	  
Researcher:	   Can	  choose	  to	  download	  the	  PFL	  as	  an	  excel	  spreadsheet.	  
The	  above	  use	  case	  has	  been	  fully	  implemented	  in	  the	  PFL	  Viewer	  tool.	  The	  PFL	  tool	  is	  
built	  on	  top	  of	  the	  multidimensional	  OLAP	  cube.	  Laurence’s	  work	  centred	  on	  creating	  a	  
library	   in	   Python,	   which	   allowed	   the	   execution	   of	   arbitrary	   Multi	   Dimensional	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Expression	   (MDX)	  queries	  against	   the	  OLAP	  cube.	  This	  was	  accomplished	  by	  creating	  
an	   abstraction	   layer	   that	   used	   XMLA	   to	   transfer	   data	   to	   and	   from	   any	   pre-­‐defined	  
cube.	  Laurence	  then	  focused	  on	  creating	  a	  basic	  interface	  structure	  to	  display	  the	  data	  
retrieved	   from	   the	   PFL	   database.	   This	  was	   implemented	   as	   a	  web	   based	   prototype.	  
Final	   work	   involved	   converting	   this	   prototype	   to	   a	   fully	   functional	   tool	  
(http://proteinfrequencylibrary.com)	  (see	  Figure	  34).	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Figure	  34:	  The	  PFL	  Viewer	  tool.	  
The	  PFL	  functionality	  has	  also	  been	  incorporated	  into	  the	  main	  PepTracker	  application.	  
For	  each	  dataset,	  a	  researcher	  can	  choose	  to	  apply	  the	  PFL	  to	  filter	  proteins	  from	  the	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display.	  This	  has	  been	  implemented	  via	  a	  form	  that	  has	  a	  slider,	  specifying	  a	  selected	  
frequency,	  and	  drop	  down	  boxes,	  allowing	  customization	  of	  the	  PFL	  (see	  Figure	  35).	  
	  
Figure	  35:	  PFL	  filter	  form	  within	  the	  PepTracker	  application.	  
In	   addition,	   after	   having	   selected	   to	   filter	   a	   set	   of	   proteins	   based	   on	   their	   PFL	  
frequency	   annotation,	   a	   researcher	   can	   choose	   to	   normalise	   their	   dataset	   based	   on	  
these	  predicted	  contaminant	  proteins.	  As	  mentioned	  in	  5.3.5	  Use	  of	  PFL	  to	  Normalise	  
Datasets,	  accurate	  comparison	  of	  separate	  datasets	  can	  be	  skewed	  by	  slight	  variations	  
in	  experimental	  conditions.	  Hence	  a	  method	  of	  normalisation	  has	  been	  proposed	  that	  
is	   based	   on	   a	   predicted	   set	   of	   contaminants.	   The	   PFL	   functionality	   in	   PepTracker	  
automates	  this	  normalisation	  process	  (see	  Figure	  36).	  
	  
Figure	  36:	  Built-­‐in	  normalisation	  functionality.	  	  
Original	  dataset	  without	  normalisation	  is	  shown	  on	  the	  left.	  The	  normalised	  dataset	  is	  
shown	  on	  the	  right.	  
5.4 Technical Implementation 
5.4.1 Business Intelligence Application 
Due	  to	  the	  complexity	  of	   the	  analysis	  and	  the	   large	  volumes	  of	  data	   involved,	  a	  new	  
approach	  was	  required.	  The	  alternative	  approach	  adopted	  made	  use	  of	  BI	  principles,	  
which	   include	   methods	   of	   leveraging	   data	   to	   provide	   an	   informed	   platform	   for	  
decision-­‐making	   (see	   1.4.2	   Applying	   Business	   Intelligence	   for	   Super-­‐Experiment	  
Analysis).	  	  
The	   core	   concept	   of	   BI	   revolves	   around	   understanding	   and	   modelling	   data	   in	   an	  
appropriate	   format	   that	   makes	   analysis	   easier	   and	   more	   intuitive	   for	   end-­‐users.	   BI	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technology	   is	   designed	   for	   rapid	   interactive	   response	  and	  works	  particularly	  well	   for	  
train-­‐of-­‐thought	  analysis,	  whereby	  response	  times	  from	  queries	  are	  rapid	  enough	  (one	  
to	  two	  seconds)	  to	  allow	  a	  user	  to	  follow	  a	  sequence	  of	  ideas	  where	  each	  answer	  can	  
prompt	   another	   question.	   	   The	   advantages	   of	   rapid	   response	   times	   on	   productivity	  
have	  been	  well	  understood	  for	  many	  years	  (Lambert,	  1984).	  
When	  designing	   the	  multidimensional	   structure,	   the	  user	  model,	  which	   is	  defined	  by	  
the	   users’	   understanding	   and	   perception	   of	   the	   data,	   was	   translated	   into	   a	   logical	  
model.	   This	   logical	  model	   is	   presented	   in	   the	   form	   of	   a	   sun	   diagram	   illustrating	   the	  
relationship	  between	  Measures	   and	  Dimensions	   captured	   in	   an	  MS	  experiment.	   The	  
measures	   are	   numerical	   values	   from	   the	   experimental	   data	   that	   are	   of	   interest	   to	  
researchers,	   e.g.	   ratio,	   intensity	   etc.	   The	   dimensions	   define	   the	   various	   groupings	  
(often	  hierarchical)	  by	  which	  users	  can	  aggregate	   the	  measures,	  e.g.	   treatment,	  date	  
and	  cell	  cycle.	  The	  logical	  model	  was	  then	  represented	  as	  a	  Sun	  Model	  (see	  Figure	  37),	  
which	  shows	  the	  measures	  in	  the	  centre	  of	  the	  diagram	  and	  dimensions	  radiating	  from	  
the	  centre.	  	  
	  
Figure	  37:	  Sun	  diagram	  and	  logical	  model	  of	  SILAC	  data.	  	  
A	  logical	  model	  is	  presented	  in	  the	  form	  of	  a	  sun	  diagram	  illustrating	  the	  relationship	  
between	  Measures	  and	  Dimensions	  captured	  in	  a	  SILAC	  experiment.	  The	  measures	  are	  
typically	  numerical	  values	  from	  the	  experimental	  data,	  e.g.	  “number	  of	  peptides”.	  The	  
dimensions	  define	  the	  various	  groupings	  (often	  hierarchical)	  by	  which	  users	  can	  
aggregate	  the	  measures,	  e.g.	  cell	  type,	  date,	  cell	  extract,	  etc.	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The	  hierarchies	  in	  a	  dimension	  are	  symbolised	  by	  the	  levels	  marked	  along	  a	  dimension	  
line.	   For	   example	   the	   date	   dimension	   is	   hierarchical	   and	   has	   year,	   month	   and	   day	  
levels.	   Dimensions,	   such	   as	   “bead	   type”	   and	   “cell	   extract”,	   can	   be	   used	   as	   filters	   to	  
obtain	  customised	  PFLs.	  
The	   data	   for	   the	   analysis	   came	   from	   three	   sources	   -­‐	   the	   relational	   database	   within	  
PepTracker	  (see	  4.6.2	  Database	  Development),	  and	  local	  versions	  of	  the	  IPI	  database,	  
later	   updated	   to	   UniProtKB,	   and	   Gene	   Ontology	   (GO)	   (www.geneontology.org)	  
databases.	   In	   order	   to	   ensure	   high	   data	   quality	   and	   consistency	   of	   format,	   the	   data	  
were	   extracted	   from	   these	   systems,	   transformed	   appropriately	   and	   loaded	   into	   a	  
central	   repository	   (Data	   Warehouse).	   During	   this	   process,	   appropriate	   tables	   were	  
created	  to	  store	  the	  data.	  The	  measures	  were	   incorporated	  into	  a	  Fact	  table	  and	  the	  
dimensions	  each	  became	  a	  Dimension	  table.	  The	  Fact	  table	  maintained	  a	  link	  to	  all	  of	  
the	   related	  Dimension	   tables,	   creating	  a	   Star	   Schema	  whereby	   the	  Dimension	   tables	  
relate	  to	  a	  central	  Fact	  table	  producing	  a	  star	  shape.	  This	  Extract,	  Transform	  and	  Load	  
(ETL)	   process	   is	   characteristic	   of	   most	   BI	   systems,	   as	   is	   the	   creation	   of	   a	   Data	  
Warehouse.	  The	  data	  in	  the	  Data	  Warehouse	  are	  not	  updated,	  but	  rather	  appended	  to	  
when	   new	   datasets	   become	   available.	   This	   method	   created	   a	   Data	   Warehouse	  
containing	   historical	   experimental	   data	   that	   are	   subject-­‐orientated,	   non-­‐volatile	   and	  
well	   integrated,	  existing	   separately	   from	  the	  operational	  environment	  of	   the	  original	  
data.	  	  
In	  terms	  of	  the	  pull-­‐down	  datasets,	  there	  were	  a	  number	  of	  decisions	  that	  had	  to	  be	  
considered	   carefully	   to	   agree	   how	   best	   to	   transform	   the	   data	   into	   an	   accurate	  
representation	   of	   the	   user	   model.	   This	   involved	   making	   the	   determination	   that	  
proteins	  should	  only	  be	  included	  if	  they	  were	  both	  identified	  and	  quantified	  in	  a	  SILAC	  
experiment.	   In	   addition,	   it	   was	   decided	   that	   proteins	   should	   be	   identified	   via	  
UniProtKB	  identifiers,	  as	  this	  is	  the	  identifier	  type	  common	  to	  all	  datasets	  searched	  in	  
the	   MaxQuant	   suite	   (3rd	   party	   analysis	   software)	   to	   make	   protein	   identifications.	  
Furthermore,	  due	   to	   the	   continuously	  updating	  UniProtKB	   identifiers,	   it	  was	  decided	  
that	   proteins	   should	   be	   mapped	   to	   the	   most	   current	   identifier.	   Thus,	   multiple	  
occurrences	  of	  the	  same	  protein	  accession	  number,	  in	  a	  single	  experiment,	  should	  only	  
be	  allocated	  the	  weighting	  of	  a	  single	  identification	  and	  quantification	  in	  the	  frequency	  
value	  of	  any	  generated	  protein	  library	  annotation.	  In	  addition,	  it	  was	  determined	  that	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datasets	  should	  be	  split	   into	  separate	  experiment	  sets	  for	  analysis,	  where	  applicable,	  
i.e.	  single	  datasets	  produced	  from	  MaxQuant	  analysis	  of	  multiple	  experiments	  should	  
be	  broken	  down	  into	  the	  constituent	  experiments	  for	  inclusion	  in	  the	  cube.	  
5.4.2 Multidimensional Database 
The	  next	  step	  involved	  converting	  the	  logical	  model,	  designed	  for	  the	  PFL,	  to	  a	  physical	  
model,	   using	   the	   SQL	   Server	   Analysis	   Services	   (SSAS)	   component	   of	   Microsoft	   SQL	  
Server	  2008	  R2.	  This	  physical	  model,	  a	  multidimensional	  database,	   is	  often	  known	  as	  
an	   OnLine	   Analytical	   Processing	   (OLAP)	   cube.	   The	   OLAP	   cube	   is	   a	   multidimensional	  
data	   model	   that	   alleviates	   problems	   inherent	   in	   a	   relational	   database	   by	   making	   it	  
easier	   to	  select,	  navigate	  and	  explore	  data.	   It	   is	  also	  able	   to	  provide	   increased	  query	  
performance	   in	   comparison	   to	   a	   relational	   database,	   due	   to	   the	   structure,	   which	  
supports	  pre-­‐aggregation	  of	  data.	  Almost	  all	  query	  result	  times	  benefit	  from	  this	  type	  
of	  pre-­‐computation.	  	  
The	  PFL	  multi-­‐dimensional	  database	  is	  implemented	  in	  Microsoft	  SQL	  Server	  2008	  R2.	  
The	   SQL	   Server	   Integration	   Services	   (SSIS)	   component	   of	   SQL	   Server	   was	   used	   to	  
connect	   and	   pull	   in	   data	   from	   the	   relational	   database	   into	   SQL	   Server	   tables.	   These	  
tables	  were	   then	  used	   to	  generate	   the	  OLAP	   cube	  on	   the	  SQL	  Server	  using	  Business	  
Intelligence	   Development	   Studio	   (BIDS).	   The	   main	   PepTracker	   server	   communicates	  
with	  the	  multi-­‐dimensional	  OLAP	  cube	  using	  MDX	  wrapped	  in	  XMLA	  (XML	  for	  Analysis)	  
requests.	   XMLA	   is	   an	   industry	   standard,	   XML	   based	   Simple	   Object	   Access	   Protocol	  
(SOAP)	  method	  of	  accessing	  data	  in	  analytical	  systems.	  An	  OLAP	  cube	  manages	  data	  in	  
a	   cube	   like	   structure	   in	  which	   the	   edges	   of	   the	   cube	   represent	   dimensions	   and	   the	  
measures	   are	   contained	  within	   the	   cube.	  Data	   are	   then	   extracted	   from	   the	   cube	   by	  
traversing	  the	  edges.	  Using	  the	  hierarchies	  within	  the	  dimensions,	  users	  can	  both	  drill-­‐
down	   and	   drill-­‐up	   to	   the	   required	   level	   of	   detail	   and	   make	   use	   of	   “slice	   and	   dice”	  
operations	   to	   change	   the	   set	   of	   dimensions	   being	   viewed.	   Although	   an	   OLAP	   cube	  
suggests	  modelling	   of	   only	   three	   dimensions,	   in	   reality	   data	   of	   n-­‐dimensions	   can	   be	  
modelled	  by	  OLAP	  in	  a	  hypercube	  structure.	  
When	   generating	   the	   OLAP	   cube,	   the	   data	   source,	   fact	   tables,	   dimension	   tables,	  
relationships	  between	  fact	  and	  dimension	  tables	  and	  hierarchies	  had	  to	  be	  specified.	  
Using	  this	  information,	  the	  cube	  was	  then	  processed,	  with	  all	  of	  the	  data	  aggregated	  at	  
defined	   levels	  within	   the	  multidimensional	   structure.	  With	   the	  use	  of	   the	  OLAP	  cube	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and	  its	  modelling	  of	  a	  range	  of	  measures	  and	  dimensions,	  it	  was	  possible	  to	  perform	  a	  
variety	   of	   query	   and	   analysis	   tasks.	   In	   order	   to	   extract	   data	   from	   the	   OLAP	   cube	   a	  
powerful	   analytical	   query	   language	   (MDX)	   is	   available	   which	   allows	   very	   complex	  
analytical	   queries	   to	   be	   expressed	   with	   ease	  
(www.microsoft.com/msj/0899/mdx/mdx.aspx).	   Initially,	   the	   PowerPivot	   component	  
of	   Excel	   2010	   (www.office.microsoft.com/excel/)	   was	   used	   to	   connect	   to	   the	   OLAP	  
cube	   and	   extract	   the	   required	   data.	   Following	   this	   a	   dedicated	   web	   interface	   was	  
created.	  
5.5 Discussion 
The	   analysis	   of	   immunoprecipitation	   experiments	   is	   a	   challenging	   task	   that	   requires	  
much	  thought	  and	  consideration	  (ten	  Have	  et	  al.,	  2011).	  This	  chapter	  has	   introduced	  
the	  use	  of	  data	  analysis	  technology	  adapted	  from	  the	  field	  of	  business	  intelligence	  (BI)	  
to	   improve	   the	   reliability	   of	   discriminating	   specific	   from	   non-­‐specific	   protein	  
interaction	  partners	  (Boulon	  et	  al.,	  2010a).	  While	  this	  approach	  is	  broadly	  applicable	  to	  
a	   wide	   range	   of	   protein	   interaction	   analyses,	   this	   study	   focused	   on	   describing	   an	  
enhanced	   methodology	   for	   the	   analysis	   of	   triple	   SILAC	   immuno-­‐affinity	   purification	  
experiments.	  This	   identifies	  genuine	  protein	  interaction	  partners	  more	  efficiently	  and	  
also	  aids	  the	  characterization	  of	  changes	  in	  protein	  complexes	  that	  can	  arise	  either	  as	  a	  
result	  of	  varied	  biological	  conditions,	  or	  in	  response	  to	  specific	  perturbations.	  To	  date,	  
there	  are	  still	  relatively	  few	  studies	  that	  have	  explored	  the	  dynamics	  of	  protein-­‐protein	  
interactions	   using	   quantitative	   proteomics-­‐based	   approaches	   (Blagoev	   et	   al.,	   2003,	  
Foster	   et	   al.,	   2006).	   A	   major	   aim	   of	   the	   methodology	   described	   in	   this	   study	   is	   to	  
facilitate	   such	   analyses.	   In	   contrast	   with	   other	   common	   approaches,	   this	   workflow	  
discourages	   the	   premature	   removal	   of	   putative	   contaminant	   proteins,	   either	  
experimentally,	  or	  in	  silico.	  Instead,	  a	  comprehensive	  and	  inclusive	  approach	  has	  been	  
adopted	  that	  takes	  advantage	  of	  the	  high	  sensitivity	  of	  protein	  detection	  now	  possible	  
using	   MS-­‐based	   identification	   of	   proteins	   from	   model	   organisms.	   An	   interactive	  
analysis	   is	   used	   that	   integrates	   several	   objective	   criteria	   to	   annotate,	   rather	   than	  
discard,	  all	  proteins	  in	  every	  dataset.	  This	  is	  of	  particular	  importance	  for	  the	  detection	  
and	  characterisation	  of	  low	  affinity	  and/or	  low	  abundance	  specific	  protein	  interaction	  
partners	   that	   would	   otherwise	   remain	   undetected	   amongst	   the	   large	   excess	   of	  
background	  contaminants	  and	  non-­‐specific	  interactors.	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An	   important	   issue	   in	   all	  MS-­‐based	   protein	   identification	   studies	   is	   the	   reliability	   of	  
protein	   identification	   and	   quantification.	  While	   analyses	   of	   biological	   responses	   are	  
mostly	  concerned	  with	  comparing	  the	  differential	  behaviour	  of	  individual	  proteins,	  the	  
MS	  analysis	  and	  SILAC	  procedures	  directly	  measure	  peptides.	  It	  must	  be	  remembered	  
that	   the	   quality	   of	   data	   can	   differ	   considerably	   between	   separate	   proteins	   in	   the	  
dataset,	  which	  can	  vary	  in	  the	  number	  of	  peptides	  identified	  and	  quantified,	  the	  total	  
sequence	  coverage	  as	  well	  as	  the	  accuracy	  and	  similarity	  in	  the	  SILAC	  ratios	  measured	  
for	  separate	  peptides	  assigned	  to	  the	  same	  protein.	  Consideration	  of	  these	  parameters	  
can	  assist	  with	  drawing	  reliable	  conclusions	  and	  they	  can	  be	  incorporated	  also	  into	  the	  
visualisations	  of	   the	  experiments	   to	  provide	   further	  depth	   to	   the	   analysis	   of	   the	  MS	  
data.	  
A	   key	   feature	   of	   the	   approach	   described	   is	   the	   generation	   of	   a	   Protein	   Frequency	  
Library	  (PFL)	  that	  provides	  a	  dynamic	  list	  of	  all	  proteins	  identified	  in	  co-­‐IP	  experiments	  
and	   annotation	   of	   their	   frequency	   of	   detection.	   As	   opposed	   to	   the	   static	   “bead	  
proteome”,	   the	   PFL	   benefits	   from	   continuously	   being	   updated	   with	   every	   new	  
experiment	   that	   is	   performed.	   Thus,	   addition	   of	   new	   datasets	   will	   improve	   both	   its	  
reliability	  and	   its	  coverage.	  The	   initial	  PFL	  described	   in	  this	  chapter	  contained	  10,623	  
IPI	  numbers,	  which	  corresponds	  to	  ~12%	  of	  the	  IPI	  human	  proteome.	  However,	  this	  is	  
and	   can	   be	   expanded	   in	   the	   future	   to	   cover	   the	   entire	   human	   proteome,	   as	   more	  
datasets	   from	   additional	   co-­‐IP	   experiments	   are	   added,	   incorporating	   different	  
conditions	  and	  other	  cell	  types.	  In	  contrast	  with	  the	  previous	  notion	  of	  characterising	  a	  
set	   of	   putative	   contaminants	   to	   eliminate	   them	   from	   the	   dataset,	   the	   PFL	   approach	  
does	   not	   stigmatise	   any	   protein	   as	   a	   contaminant.	   This	  more	   accurately	   reflects	   the	  
fact	  that	  a	  given	  protein	  can	  interact	  specifically	  with	  certain	  baits	  and	  non-­‐specifically	  
with	  others.	   Instead,	  the	  PFL	  provides	  an	  objective	  annotation	  for	  all	  proteins,	  which	  
predicts	  their	  probability	  of	  being	  a	  contaminant	  under	  a	  defined	  set	  of	  experimental	  
conditions.	   Applying	   this	   annotation	   to	   co-­‐IP	   datasets	   facilitates	   discrimination	  
between	  proteins	  with	  high	   versus	   low	  probabilities	  of	  being	  either	   specific,	   or	  non-­‐
specific,	   interaction	   partners.	   This	   is	   further	   enhanced	   by	   the	   use	   of	   powerful	  
visualisation	   tools,	   including	   the	   use	   of	   colour	   coding	   to	   focus	   attention	  on	   selected	  
sets	  of	  proteins	   identified	   for	   further	  analysis.	  Furthermore,	   it	  provides	   the	  ability	   to	  
flexibly	  adjust	  threshold	  values,	  as	  determined	  by	  the	  user,	  to	  create	  optimal	  settings	  
for	  each	  individual	  experiment.	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Another	   advantage	  of	   the	  PFL	   approach	   is	   that	   it	   can	  be	   filtered	   for	   the	  parameters	  
from	  the	  dataset	  under	  analysis,	  e.g.	  cell	  extract,	  type	  of	  affinity	  matrix	  etc.,	  to	  create	  a	  
customised	   PFL	   that	   more	   accurately	   predicts	   contaminants	   relevant	   to	   each	   new	  
experiment.	   The	   spectrum	   of	   parameters	   available	   for	   customisation	   of	   the	   PFL	  
includes	   all	   of	   the	   dimensions	   and	   metadata	   recorded	   in	   the	   data	   repository.	  
PepTracker	   is	  designed	  to	  incorporate	  a	   laboratory	  management	  tool	  to	  facilitate	  the	  
detailed	  and	  consistent	  recording	  of	  metadata	  from	  each	  experiment	  that	  can	  be	  used	  
directly	   to	   generate	   customised	   PFLs	   (see	   4.2	   MsTrack	   –	   Laboratory	   Information	  
Management	  System).	  While	  the	  spectrum	  of	  dimensions	  and	  experimental	  conditions	  
incorporated	  in	  PepTracker	  is	  currently	  focussed	  on	  human	  cells,	  this	  can	  in	  future	  be	  
expanded	  to	  include	  a	  wider	  range	  of	  data,	  such	  as	  other	  model	  organisms,	  and	  new	  
dimensions,	   such	   as	   detailed	   genotypes	   of	   the	   cells	   or	   organisms	   being	   analysed.	   In	  
addition,	  the	  PFL	   is	  applicable	  also	  to	  other	  types	  of	  MS	  analyses	  not	   involving	  SILAC	  
data.	   For	   example,	   it	   can	   enhance	   the	   analysis	   of	   label-­‐free	   experiments	   by	   adding	  
additional	  objective	  criteria	  to	  identify	  putative	  non-­‐specific	  contaminants.	  	  
The	   generation	   of	   the	   PFL	   involved	   adapting	   advanced	   techniques	   from	   the	   BI	   field	  
that	   deal	   well	   with	   the	   efficient	   analysis	   of	   large	   datasets.	   The	   core	   concept	   of	   BI	  
revolves	   around	   understanding	   and	   modelling	   data	   in	   an	   appropriate	   format	   that	  
makes	  analysis	  easier	  and	  more	   intuitive	   for	  end-­‐users.	  BI	   technology	   is	  designed	  for	  
rapid	   interactive	   response	   and	   works	   particularly	   well	   for	   train-­‐of-­‐thought	   analysis,	  
whereby	  response	  times	  from	  queries	  are	  rapid	  enough	  (one	  to	  two	  seconds)	  to	  allow	  
a	  user	  to	  follow	  a	  sequence	  of	  ideas	  where	  each	  answer	  can	  prompt	  another	  question.	  
The	  advantages	  of	  rapid	  response	  times	  on	  productivity	  have	  been	  well	  understood	  for	  
many	   years	   (Lambert,	   1984).	   Based	   on	   current	   knowledge,	   this	   is	   the	   first	   direct	  
application	  of	  such	  BI	  technology	  in	  cell	  biology	  or	  proteomics	  research.	  BI	  techniques	  
facilitate	  the	  analysis	  of	  complex	  data	  and	  are	  essentially	  discipline	  agnostic.	  They	  have	  
recently	   been	   successfully	   applied,	   for	   example,	   to	   analyse	   historical	   science	   data,	  
which	  has	  enhanced	  understanding	  of	  how	  Darwin	  developed	  the	  theory	  of	  Evolution	  
by	   natural	   selection	   (Kohn	   et	   al.,	   2005).	   It	   is	   hypothesised	   that	  wider	   application	   of	  
these	  techniques	  will	  be	  of	  great	  utility,	  not	  only	  for	  proteomics	  research,	  but	  also	  for	  
other	   research	  areas	   involving	   the	  collection	  and	  mining	  of	   very	   large	  datasets,	   as	   is	  
now	  common	  in	  biomedical	  science.	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The	  workflow	   highlights	   the	   need	   for	   automation	   that	   can	   deal	   with	   the	   integrated	  
analysis	   of	   many	   large	   datasets	   that	   are	   inherently	   multidimensional.	   The	   PFL	  
approach	   can	  be	   applied	   to	   objectively	   normalise	   data	   and	   facilitate	   comparisons	   of	  
information	   from	   separate	   experiments.	   The	   PepTracker	   environment	   is	   capable	   of	  
storing	  many	   consistently	   annotated	   datasets	   and	   thus	   presents	   the	   opportunity	   to	  
integrate	   these	   datasets,	   along	  with	   associated	  metadata,	   to	   perform	  what	   is	   being	  
termed	   as	   a	   “super-­‐experiment”.	   The	   PFL	   represents	   an	   example	   of	   a	   super-­‐
experiment	   that	   incorporates	  data	   from	  a	   large	  number	  of	   separate	   immuno-­‐affinity	  
purification	   experiments.	   By	   using	   this	   approach	   to	   encompass	   other	   types	   of	  
quantitative	   proteomics	   experiments	   it	   is	   aimed	   to	   expand	   the	   super-­‐experiment	  
concept.	  For	  example,	  other	  types	  of	  SILAC	  and	  MS	  analyses	  provide	  information	  about	  
the	  dynamics	  of	  distinct	  protein	  properties,	  such	  as	  sub-­‐cellular	   localisation,	  turnover	  
and	  post-­‐translational	  modifications	  (Boisvert	  et	  al.,	  2010).	  Future	  work	  will	  therefore	  
develop	  the	  use	  of	  BI	  technology	  within	  the	  PepTracker	  environment	  to	  normalise	  and	  
mine	  these	  combined	  datasets.	  	  
5.6 Distribution of Effort 
Lamond	  Laboratory	  biologists,	  primarily	  Severine	  Boulon,	  carried	  out	  the	  experimental	  
bench	  work	  during	  this	  study.	  The	  analysis	  described	  in	  this	  chapter	  was	  a	  joint	  effort	  
between	   Yasmeen	   Ahmad	   and	   Severine	   Boulon.	   Yasmeen	   Ahmad	   carried	   out	   all	  
technical	   implementation	   with	   regards	   to	   the	   BI	   implementation	   and	   supervised	   a	  
honours	   project	   placement	   student,	   Laurence	   Hole,	   who	   provided	   assistance	   in	  
creating	  the	  PFL	  Viewer.	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Chapter 6: Spatial Localisation & Turnover Analyses 
6.1 Summary 
Measuring	   the	   properties	   of	   endogenous	   cell	   proteins,	   such	   as	   expression	   level,	  
subcellular	  localisation	  and	  turnover	  rates,	  on	  a	  whole	  proteome	  level	  remains	  a	  major	  
challenge	   in	   the	   post-­‐genome	   era.	   Quantitative	   methods	   for	   measuring	   mRNA	  
expression	  do	  not	  reliably	  predict	  corresponding	  protein	  levels	  and	  provide	  little	  or	  no	  
information	  on	  other	  protein	  properties.	  Within	   the	   Lamond	   Laboratory	   a	   combined	  
pulse-­‐labelling,	  spatial	  proteomics	  and	  data	  analysis	  strategy	  was	  used	  to	  characterize	  
the	   expression,	   localisation,	   synthesis,	   degradation	   and	   turnover	   rates	   of	  
endogenously	   expressed,	   untagged	   human	   proteins	   in	   different	   subcellular	  
compartments.	  	  
Recent	   advances	   in	   mass	   spectrometry	   based	   proteomics	   have	   revolutionized	   the	  
study	  of	  protein	  dynamics.	  Mass	  spectrometry	  combined	  with	  pulsed	  incorporation	  of	  
stable	  isotopes	  of	  arginine	  and	  lysine	  has	  been	  used	  to	  perform	  quantitative	  analyses	  
of	   the	   rates	   at	   which	   newly	   synthesized,	   endogenous	   proteins	   appear.	   The	   Lamond	  
Laboratory	  have	  developed	  a	  method	  using	  a	  pulse-­‐labelling	   strategy	  combined	  with	  
SILAC	  mass	  spectrometry	  to	  characterize	  the	  turnover	  rates	  and	  half-­‐lives	  of	  proteins	  
in	   different	   cellular	   compartments.	   HeLa	   cells	   were	   grown	   in	   two	   different	   SILAC	  
media,	  containing	  arginine	  and	  lysine,	  either	  with	  the	  normal	  ‘light’	  isotopes	  of	  carbon,	  
hydrogen	   and	   nitrogen	   (i.e.	   12C14N)	   (light),	   or	   L-­‐arginine-­‐13C614N4	   and	   L-­‐lysine-­‐2H4	  
(medium).	   The	  medium	   is	   then	   changed	   for	   the	   cells	   growing	   in	   the	   SILAC	  medium	  
from	   “medium”	   to	   “heavy”,	   with	   L-­‐arginine-­‐	   13C6-­‐15N4	   and	   L-­‐lysine-­‐13C6-­‐15N2,	   while	  
leaving	  the	  cells	  growing	  in	  the	  “light”	  medium	  as	  a	  control.	  Cells	  were	  then	  incubated	  
for	   0.5,	   4,	   7,	   11,	   27	   and	   48	   hours	   before	   being	   fractionated	   into	   cytoplasm,	  
nucleoplasm	  and	  nucleoli	   fractions.	  Proteins	   from	  each	   fraction	  and	   time	  point	  were	  
trypsin	  digested	  and	  analysed	  by	  LC-­‐MS/MS	  using	  an	  LTQ	  OrbiTrap.	  The	  resulting	  ratios	  
between	   light,	   medium	   and	   heavy	   isotopic	   forms	   for	   each	   peptide	   identified	   were	  
quantified	  using	  MaxQuant.	  
Using	   this	   quantitative	   mass	   spectrometry	   and	   SILAC	   approach,	   a	   total	   of	   80,098	  
peptides	   from	   8,041	   HeLa	   proteins	   were	   quantified,	   and	   their	   spatial	   distribution	  
between	   the	   cytoplasm,	   nucleus	   and	   nucleolus	   determined	   and	   visualised	   using	  
specialised	   software	   tools	   developed	   in	   PepTracker.	   Using	   information	   from	   ion	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intensities	  and	  rates	  of	  change	  in	  isotope	  ratios,	  protein	  abundance	  levels	  and	  protein	  
synthesis,	  degradation	  and	   turnover	   rates	  were	  calculated	   for	   the	  whole	  cell	  and	   for	  
the	  respective	  cytoplasmic,	  nuclear	  and	  nucleolar	  compartments.	  	  
The	  results	  showed	  that	  expression	  levels	  of	  endogenous	  HeLa	  proteins	  varied	  by	  up	  to	  
seven	   orders	   of	   magnitude.	   The	   average	   turnover	   rate	   for	   HeLa	   proteins	   was	  
approximately	  20	  hours.	  Turnover	  rate	  did	  not	  correlate	  with	  either	  molecular	  weight	  
or	   net	   charge,	   but	   did	   correlate	   with	   abundance,	   with	   highly	   abundant	   proteins	  
showing	  longer	  than	  average	  half-­‐lives.	  Fast	  turnover	  proteins	  had	  an	  overall	  a	  higher	  
frequency	  of	  PEST	  motifs	  than	  slow	  turnover	  proteins	  but	  no	  general	  correlation	  was	  
observed	  between	  amino	  or	  carboxy	  terminal	  amino	  acid	  identities	  and	  turnover	  rates.	  
A	   subset	  of	  proteins	  were	   identified	   that	  exist	   in	  pools	  with	  different	   turnover	   rates	  
depending	   on	   their	   subcellular	   localisation.	   This	   strongly	   correlated	  with	   subunits	   of	  
large,	   multi-­‐protein	   complexes,	   suggesting	   a	   general	   mechanism	   whereby	   their	  
assembly	  is	  controlled	  in	  a	  different	  subcellular	  location	  to	  their	  main	  site	  of	  function.	  
A	  database	  viewer	  has	  been	  setup	  to	  provide	  access	  to	  the	  data	  generated	  during	  this	  
study	  through	  a	  web-­‐based	  interface	  (http://peptracker.com/turnover/).	  
Chapter	  6	  describes	  the	  analysis	  of	  spatial	  localisation	  and	  turnover	  rates	  of	  the	  HeLa	  
proteome,	  focusing	  first	  on	  the	  reasons	  for	  protein	  degradation	  and	  turnover,	  how	  to	  
experimentally	  measure	  protein	  properties	  	  (section	  6.2),	  following	  with	  a	  description	  
of	   the	   outcomes	   of	   the	   analysis	   of	   the	  MS	   data	   generated	   and	   the	   turnover	   viewer	  
(section	   6.3),	   implementation	   of	   the	   turnover	   viewer	   (section	   6.4)	   and	   finally	   a	  
discussion	  on	  the	  importance	  of	  protein	  properties	  in	  data	  analysis	  (section	  6.5).	  	  	  
6.2 Background 
Cells	  can	  regulate	  proteins	  via	  phosphorylation	  and	  other	  reversible	  modifications,	  and	  
through	   altering	   protein	   level	   by	   changing	   the	   rate	   of	   synthesis	   and/or	   degradation	  
(Ohsumi,	  2006).	  DNA	  microarrays	  are	  used	  extensively	  for	  analysis	  of	  gene	  expression	  
at	   the	   RNA	   level.	   Although	   abundant	   mRNAs	   usually	   result	   in	   high	   protein	   levels	  
(Lundberg	   et	   al.,	   2010),	   the	   general	   correlation	   between	   mRNA	   levels	   and	   protein	  
abundance	   is	   often	   poor	   (Gygi	   et	   al.,	   1999b).	   The	   regulatory	   complexity	   of	   mRNA	  
translation	   and	   protein	   stability	   emphasises	   the	   need	   for	   direct	   measurements	   of	  
protein	  levels.	  Mass	  spectrometry-­‐based	  proteomics	  has	  emerged	  as	  the	  technology	  of	  
choice	   for	   studying	  proteins	  directly,	   allowing	  not	  only	   identification	  of	  proteins	   and	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post-­‐translational	   modifications,	   but	   also	   quantitative	   comparisons	   of	   how	   relative	  
protein	  levels	  change	  in	  cells	  under	  different	  conditions	  (Walther	  and	  Mann,	  2010b).	  
There	   are	   two	   main	   pathways	   for	   intracellular	   protein	   degradation,	   i.e.	   the	  
proteasome	   and	   autophagy-­‐lysosomal	   systems.	   The	   ubiquitin-­‐proteasome	   pathway	  
identifies	  proteins	  for	  degradation	  by	  attachment	  of	  poly-­‐ubiquitin	  tags,	  which	  targets	  
the	  modified	  proteins	  for	  degradation	  by	  the	  proteasome	  (Clague	  and	  Urbe,	  2010).	  In	  
the	   autophagy-­‐lysosomal	   system	   proteins	   destined	   for	   degradation	   are	   captured	  
within	  membrane	  bound	  organelles	   (phagosomes)	   for	  bulk	  digestion	  (Ohsumi,	  2006).	  
Cell	  growth	  requires	  a	  net	  increase	  in	  total	  protein	  and	  thus	  higher	  levels	  of	  translation	  
than	  degradation.	  Maintaining	  protein	   levels	  at	  steady	  state	  also	   involves	  continuous	  
protein	   synthesis,	  balanced	  with	  degradation.	  Protein	   turnover	   rates	   can	   range	   from	  
under	  ten	  minutes	  to	  over	  a	  hundred	  hours	  (Ohsumi,	  2006).	  
Some	   biological	   processes	   involve	   constant	   cycles	   of	   protein	   production	   and	   rapid	  
degradation.	  For	  example,	  despite	  continuous	  synthesis	  of	  the	  tumour	  suppressor	  p53,	  
its	   constant	   rapid	   degradation	   results	   in	   low	   steady	   state	   levels	   under	   normal	   cell	  
growth	  conditions	  (Lane	  and	  Levine,	  2010).	  Upon	  oncogene	  activation,	  degradation	  of	  
p53	   is	   prevented	   through	   sequestration	   of	   the	   E3	   ligase	   mdm2,	   causing	   a	   rapid	  
increase	   in	   p53	   levels	   independent	   of	   transcriptional	   activation.	   Control	   of	   protein	  
degradation	   thus	   provides	   a	   flexible	   mechanism	   for	   the	   rapid	   activation	   of	   gene	  
expression	  in	  mammalian	  cells.	  	  
The	   turnover	   rates	   of	   specific	   proteins	   can	   vary	   between	   different	   subcellular	  
compartments.	  Using	  a	  combination	  of	  pulsed	  SILAC	  and	   fluorescence	  microscopy,	   it	  
was	  shown	  that	  HeLa	  cells	  constantly	  import	  and	  degrade	  high	  levels	  of	  free	  ribosomal	  
proteins	   in	   the	   nucleus.	   Ribosomal	   protein	   stability	   is	   dramatically	   increased	   upon	  
assembly	  into	  ribosome	  subunits	  and	  export	  to	  the	  cytoplasm	  (Lam	  et	  al.,	  2007).	  This	  
constant	   degradation	   of	   free	   ribosomal	   proteins	   in	   the	   nucleus	   may	   allow	   cells	   to	  
rapidly	   upregulate	   the	   rate	   of	   ribosome	   subunit	   production	   when	   cell	   growth	   rate	  
increases	   while	   preventing	   the	   accumulation	   of	   a	   large	   pool	   of	   unbound	   ribosomal	  
proteins.	   Importantly,	   this	  analysis	  of	   ribosomal	  protein	   turnover	   shows	   that	  protein	  
half-­‐life	   values	  based	  only	  on	   analyses	  of	  whole	   cell	   extracts	   provide	   average	   values	  
that	  can	  mask	  the	  existence	  of	  pools	  of	  protein	  with	  different	  properties.	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Early	   studies	   of	   protein	   turnover	   relied	   on	   detecting	   incorporation	   of	   radiolabeled	  
amino	   acids	   into	   newly	   translated	   proteins	   and	   either	   analysed	   bulk	   cellular	   protein	  
turnover,	  or	  else	  turnover	  of	  individual	  proteins	  (Garlick	  and	  Millward,	  1972).	  Typically,	  
proteins	   were	   labelled	   with	   [35S]	   methionine	   and	   pulse-­‐chase	   experiments	   used	   to	  
determine	   their	   rate	  of	  degradation	  after	  blocking	  protein	   synthesis,	  using	   inhibitors	  
such	  as	  cycloheximide.	  The	  use	  of	  protein	  synthesis	  inhibitors	  raises	  concerns	  whether	  
the	   normal	   degradation	   processes,	   or	   other	   aspects	   of	   cellular	   activity,	  may	   also	   be	  
disrupted.	   Mass	   spectrometry-­‐based	   proteomics	   now	   allows	   determination	   of	   the	  
turnover	  rates	  of	  large	  numbers	  of	  proteins	  in	  single	  experiments	  using	  pulse	  labelling	  
with	  amino	  acids	  incorporating	  stable	  isotopes	  (Pratt	  et	  al.,	  2002,	  Doherty	  et	  al.,	  2005,	  
Milner	  et	  al.,	  2006,	  Schwanhausser	  et	  al.,	  2009).	  	  
SILAC	   (see	  1.1.3	  Stable	   Isotope	  Labelling	  using	  Amino	  Acids	   in	  Cell	  Culture)	  has	  been	  
successful	   for	   quantitative	   analysis	   of	   cell	   and	   organelle	   proteomes	   and	   for	  
comparative	   studies	   of	   protein	   modifications,	   and	   interactions	   (Walther	   and	  Mann,	  
2010b).	   SILAC	   has	   been	   used	   in	   combination	   with	   cell	   fractionation	   to	   generate	  
‘isotope-­‐encoded’	   subcellular	   compartments	   allowing	   subcellular	   protein	   localisation	  
to	  be	  evaluated	  on	  a	  system-­‐wide	  level	  (Boisvert	  et	  al.,	  2010).	  This	  spatial	  proteomics	  
approach	   provides	   a	   high-­‐throughput	   assay	   for	   the	   unbiased	   analysis	   of	   changes	   in	  
subcellular	   protein	   localisation	   arising	   in	   response	   to	   perturbations	   such	   as	   DNA	  
damage	   and	   for	   comparing	   protein	   localisation	   and	   responses	   in	   cell	   lines	   with	  
different	  genotypes	  (Boisvert	  et	  al.,	  2010).	  
Here	   an	   enhanced	   pulse	   SILAC	   approach	   is	   combined	   with	   spatial	   proteomics	   to	  
perform	  a	   system-­‐wide	  analysis	   of	   protein	   turnover	   in	   cultured	  human	   cells.	   Protein	  
abundance	   and	   the	   rates	   of	   protein	   synthesis,	   degradation	   and	   turnover	   have	   been	  
measured	   in	   parallel	   for	   whole	   cells	   and	   for	   separate	   cytoplasmic,	   nuclear	   and	  
nucleolar	   compartments,	   providing	   a	   cell-­‐based	   functional	   annotation	   of	   the	   human	  
proteome.	  
6.2.1 Experimental Design 
The	   experiment	   was	   designed	   and	   carried	   out	   by	   researchers	   in	   the	   Lamond	  
Laboratory.	  HeLa	  cells	  were	  grown	  in	  parallel	  in	  media	  containing	  arginine	  and	  lysine,	  
either	  with	   the	  normal	   ‘light’	   isotopes	  of	   carbon,	  hydrogen	  and	  nitrogen	   (i.e.	   12C14N)	  
(light	  –	  ‘L’),	  or	  else	  with	  L-­‐arginine-­‐13C614N4	  and	  L-­‐lysine-­‐2H4	  (medium	  –	  ‘M’)	  for	  at	  least	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5	  cell	  divisions,	   resulting	   in	  >99%	   incorporation	  of	   the	  M	  amino	  acids	   in	  cell	  proteins	  
(see	  Figure	  38A).	  The	  culture	  media	  of	  the	  cells	  growing	  with	  the	  M	  amino	  acids	  is	  then	  
replaced	  with	  media	  containing	  L-­‐arginine-­‐	  13C6-­‐15N4	  and	  L-­‐lysine-­‐13C6-­‐15N2	  (heavy	  –‘H’).	  
Thus,	  H	  amino	  acids	  are	  pulsed	   into	  cells	  with	  M-­‐labelled	  proteins	   for	  varying	   times,	  
from	  30	  minutes	   to	  48	  hours.	   For	  each	  peptide	  at	   each	   time	  point	   the	   fraction	  of	  H	  
amino	  acids	  incorporated,	  replacing	  the	  pre-­‐existing	  M	  amino	  acids,	  is	  determined	  by	  
MS.	  	  
	  
Figure	  38:	  Pulse	  SILAC	  method.	  
A)	  HeLa	  cells	  are	  cultured	  in	  different	  SILAC	  media	  containing	  either	  “light”	  (L),	  or	  
“medium”	  (M)	  arginines	  and	  lysines	  until	  full	  incorporation	  of	  the	  amino	  acids.	  The	  
medium	  of	  the	  cells	  growing	  with	  the	  “medium”	  amino	  acids	  is	  then	  changed	  for	  a	  
“heavy”	  (H)	  medium.	  Cells	  are	  then	  harvested	  at	  different	  times,	  along	  with	  the	  
equivalent	  cells	  growing	  in	  the	  “light”	  medium.	  Equal	  amounts	  of	  cells	  are	  then	  
combined	  and	  separate	  cytoplasmic,	  nuclear	  and	  nucleolar	  fractions	  were	  isolated	  
from	  each	  time	  point.	  The	  resulting	  ratios	  M/L	  isotopes	  over	  time	  measures	  the	  rate	  of	  
protein	  degradation	  B),	  increase	  in	  the	  ratio	  of	  H/L	  measures	  new	  protein	  synthesis	  C)	  
and	  the	  change	  in	  the	  H/M	  ratio	  measures	  the	  rate	  of	  net	  protein	  turnover	  D).	  
Cells	  were	  harvested	  at	  0.5,	  4,	  7,	  11,	  27	  and	  48	  hour	  time	  points	  following	  the	  H	  amino	  
acid-­‐pulse.	  A	  key	   feature	  of	   this	  pulse-­‐labelling	  strategy	   involves,	  at	  each	   time	  point,	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mixing	  the	  pulsed	  cell	  sample	  with	  an	  equal	  number	  of	  HeLa	  cells	  grown	  in	  normal	  (i.e.	  
light	   –	   ‘L’)	   culture	   media.	   This	   provides	   an	   internal	   control,	   allows	   separate	  
measurement	   of	   protein	   synthesis,	   degradation	   and	   turnover	   rates	   and	   facilitates	  
normalisation	  of	  the	  isotope	  incorporation	  data,	  thereby	  improving	  the	  accuracy	  of	  the	  
measurements.	  Moreover,	  this	  light	  sample	  enables	  the	  use	  of	  peptide	  ion	  intensity	  to	  
estimate	   protein	   abundance,	   both	   in	   the	   whole	   cell,	   and	   in	   each	   subcellular	  
compartment.	   The	   decreasing	   ratio	   of	  M/L	   isotopes	   over	   time	  measures	   the	   rate	   of	  
protein	   degradation	   (see	   Figure	   38B),	   while	   the	   increasing	   ratio	   of	   H/L	   measures	  
protein	  translation	  (see	  Figure	  38C)	  and	  the	  change	  in	  the	  H/M	  ratio	  measures	  the	  rate	  
of	  net	  protein	  turnover	  (see	  Figure	  38D).	  The	  turnover	  time	  for	  each	  protein	  was	  also	  
determined	  separately	  by	  analysis	  of	   the	  crossover	  between	  the	  respective	  synthesis	  
and	  degradation	  curves	  and	  these	  values	  compared	  with	  the	  turnover	  values	  obtained	  
by	  measuring	  rates	  of	  change	  in	  H/M	  ratio.	  
The	  mixture	  of	  50%	  L	  cells	  with	  50%	  H/M	  cells	  was	  fractionated	  to	  generate	  separate	  
cytoplasmic,	   nuclear	   and	   nucleolar	   fractions	   for	   each	   time	   point	   (see	   Figure	   38A).	  
External	   protein	   contaminants,	   such	   as	   keratins,	   will	   only	   appear	   in	   the	   L	   samples	  
because	   the	   heavy	   isotopes	   used	   occur	   at	   very	   low	   levels	   in	   the	   environment.	   All	  
resulting	  samples	  were	  solubilised	  with	   loading	  buffer,	  proteins	  separated	  using	  SDS-­‐
PAGE	  and	  the	  resulting	  gels	  cut	  into	  16	  equal	  pieces,	  trypsin	  digested	  and	  analysed	  by	  
LC-­‐MS/MS.	  Every	  sample	  was	  analysed	  twice	  by	  mass	  spectrometry	  and	  the	  resulting	  
ratios	   between	   light,	   medium	   and	   heavy	   isotopic	   forms	   for	   each	   peptide	   identified	  
were	  quantified	  using	  MaxQuant	  (Cox	  and	  Mann,	  2008).	  	  
6.3 Results 
6.3.1 Protein Identification, Abundance and Subcellular Localisation 
Time-­‐resolved	  protein	  abundances	   (hereafter	  protein	  profiles)	  were	  measured	  based	  
on	   the	   constituent	   peptide	   signal	   intensities	   of	   the	   light	   sample	   at	   each	   time	   point	  
(Carrillo	  et	  al.,	  2010).	  This	  initial	  data	  processing	  was	  carried	  out	  using	  the	  Chromoprot	  
software	  package.	  
This	   analysis	   has	   identified	   and	   quantitated	   80,098	   peptides,	   mapped	   onto	   8,041	  
endogenous	  HeLa	  cell	  proteins,	  yielding	  an	  average	  of	  ~10	  peptides	  per	  protein.	  The	  
abundance	   of	   each	   protein	   was	   estimated	   based	   on	   the	   averaged	   peptide	   ion	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intensities	   from	   the	   control,	   light	   sample	   at	   each	   time	   point	   (Carrillo	   et	   al.,	   2010).	  
Peptide	  intensity	  profiles	  were	  normalised	  from	  the	  top	  three	  peptides,	  based	  on	  their	  
mean	  profile	  intensity.	  
	  
Figure	  39:	  Protein	  identification,	  abundance	  and	  subcellular	  localisation.	  
Peptide	  intensity	  profiles	  normalized	  from	  the	  top	  three	  peptides	  based	  on	  their	  mean	  
profile	  intensity	  were	  used	  to	  measure	  protein	  abundance.	  A)	  A	  distribution	  plot	  with	  
the	  protein	  count	  on	  the	  y-­‐axis	  and	  bins	  of	  0.1	  of	  the	  log10	  intensity	  values	  on	  the	  x-­‐axis.	  
The	  inset	  shows	  the	  distribution	  from	  the	  lowest	  intensity	  to	  the	  highest	  intensity	  
protein	  with	  the	  intensity	  on	  the	  y-­‐axis	  and	  the	  protein	  number	  on	  the	  x-­‐axis.	  B)	  A	  gene	  
ontology	  annotation	  analysis	  of	  the	  5%	  most	  abundant	  proteins	  identified	  using	  
functional	  clustering	  of	  biological	  processes	  and	  molecular	  functions	  (GO_BP	  and	  
GO_MF).	  C)	  A	  gene	  ontology	  annotation	  analysis	  of	  the	  5%	  lowest	  abundant	  proteins	  
identified	  using	  functional	  clustering	  of	  biological	  processes	  and	  molecular	  functions.	  D)	  
A	  hierarchical	  clustering	  was	  performed	  using	  the	  log10	  value	  for	  intensity	  for	  the	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cytoplasm,	  the	  nucleus	  and	  the	  nucleolus	  and	  represented	  as	  a	  heat	  map.	  In	  each	  case	  
high	  values	  are	  shown	  in	  red	  and	  low	  ratios	  in	  black.	  
The	   protein	   abundance	   data	   span	   a	   dynamic	   range	   intensity	   of	   ~1x107	   following	   a	  
normal	  distribution	  with	  a	  mean	   intensity	  of	  ~7,000	  (see	  Figure	  39A).	  This	  shows	  the	  
very	   large	   variation	   in	   copy	   number	   of	   endogenous	   human	  proteins	   expressed	   from	  
different	   genes.	   Known	   abundant	   proteins,	   including	   nucleophosmin,	   histones,	  
ribosomal	  proteins,	  actin,	  tubulin,	  GAPDH	  and	  heat	  shock	  proteins,	  were	  amongst	  the	  
top	  1%	  highest	  intensity	  proteins.	  Histones	  are	  predominantly	  stably	  incorporated	  into	  
nucleosomes	  with	  on	  average	  ~150	  million	  nucleosomes	  per	  human	  cell.	  Therefore,	  as	  
histones	   showed	   ion	   intensities	   	   ~1,000,000,	   it	   is	   estimated	   that	   proteins	   with	   the	  
lowest	  intensity	  values	  have	  a	  copy	  number	  ~50-­‐150	  molecules	  per	  cell	  while	  the	  bulk	  
of	   HeLa	   proteins	   are	   expressed	   at	   ~1,000-­‐10,000	   copies	   per	   cell	   (see	   Figure	   39A).	  
However,	   as	   these	   estimates	   are	   derived	   from	   averaging	   values	   over	   the	   cell	  
population,	  there	  could	  be	  significant	  variation	  in	  the	  levels	  of	  proteins	  present	  at	  the	  
single	  cell	  level.	  
Gene	  ontology	  annotation	  analysis	  of	  the	  5%	  most	  abundant	  proteins	  identified	  factors	  
involved	   in	   nucleotide	   binding,	   intracellular	   transport,	   RNA	   processing	   and	  
macromolecular	   complex	   subunit	   organization	   (see	   Figure	   39B).	   Analysis	   of	   the	   5%	  
lowest	   abundance	   proteins	   revealed	   functions	   related	   to	   nucleotide	   binding,	   GTP	  
binding,	  RNA	  binding	  and	  cell	  cycle	  regulation	  (see	  Figure	  39C).	  While	  both	  the	  highest	  
and	   lowest	   abundance	   protein	   groups	   had	   “nucleotide	   binding”	   as	   the	   largest	   class,	  
the	   types	   of	   nucleotide	   binding	   proteins	   were	   different	   in	   each	   case.	   Thus,	   many	  
transcription	   factors	  were	   included	   amongst	   the	   very	   low	   abundance	   proteins	  while	  
histones	   and	   hnRNPs	   were	   prominent	   amongst	   the	   high	   abundance	   proteins.	   Over	  
40%	  of	  the	  lowest	  abundance	  proteins	  are	  either	  uncharacterized	  open	  reading	  frames	  
(ORFs),	   or	   else	   proteins	   named	   only	   based	   on	   their	   molecular	   weight,	   or	   on	   a	  
recognizable	  domain.	   In	  contrast,	   less	   than	  1%	  of	   the	  most	  highly	  abundant	  proteins	  
are	  uncharacterized	  ORFs	  or	  of	  unknown	  function.	  Overall,	  these	  results	  show	  that	  the	  
intensity	   values	   measured	   reflect	   the	   relative	   abundance	   of	   the	   over	   8,000	   HeLa	  
proteins	  identified.	  
The	   ‘light’	   peptide	   ion	   intensities	   measured	   in	   the	   fractionated	   subcellular	  
compartments	   allow	   separate	   estimation	   of	   protein	   abundance	   in	   the	   cytoplasm,	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nucleus	  and	  nucleolus,	  providing	  a	  quantitative	  map	  of	  protein	  localisation	  within	  the	  
cell.	   The	   absence	   of	   ion	   intensity	   values	   in	   a	   specific	   compartment	   is	   interpreted	   as	  
meaning	  that	  the	  protein	  was	  present	  in	  very	  low	  abundance	  in	  this	  location	  and	  thus	  
assigns	   it	   an	   intensity	   value	   of	   0.	   A	   hierarchical	   clustering	   was	   performed	   and	  
visualised	  as	  a	  heat	  map,	  using	  log10	  intensity	  value	  for	  each	  compartment	  (see	  Figure	  
39D).	  For	  more	  than	  half	  of	  the	  proteins,	  intensity	  values	  were	  detected	  in	  more	  than	  
one	   compartment.	   Relatively	   few	  proteins	   show	  equal	   distributions	   between	   two	  or	  
three	  compartments	   (see	  Figure	  39D).	  This	  suggests	   that,	  at	  steady	  state,	  most	  HeLa	  
proteins	   are	   predominantly	   partitioned	   into	   specific	   subcellular	   locations.	   However,	  
this	   does	   not	   exclude	   that	   proteins	   can	   shuttle	   between	   their	   major	   site	   of	  
accumulation	  and	  other	  compartments.	  
6.3.2 Determination of Protein Turnover 
Two	  methods	  have	  been	  used	  to	  evaluate	  the	  time	  point	  at	  which	  50%	  turnover	  has	  
occurred	   for	   each	   protein.	   The	   first	  method,	   relying	   on	   changes	   in	   the	  H/M	   isotope	  
ratio,	  directly	  measures	  when	  50%	  of	  the	  intensity	  signal	  for	  a	  peptide	  is	  M	  and	  50%	  H,	  
isotope.	  The	  corresponding	  protein	  turnover	  is	  the	  mean	  time	  for	  50%	  incorporation	  of	  
H	  amino	  acids	  for	  all	  peptides	  identified	  from	  that	  protein.	  The	  second	  method	  relies	  
upon	   measuring	   the	   separate	   curves	   of	   synthesis	   and	   degradation	   rates	   for	   each	  
protein,	  based	  on	  rates	  of	  change	  in	  H/L	  and	  M/L	  isotope	  ratios,	  and	  then	  identifying	  
the	  point	  at	  which	  these	  curves	  cross,	  which	  corresponds	  to	  the	  time	  it	  takes	  for	  50%	  
of	  the	  protein	  to	  turn	  over.	  	  
An	  interesting	  observation	  from	  the	  crossover	  method	  is	  a	  measured	  offset	  value	  (B’)	  
of	  ~20%.	  This	  B’	  value	  reflects	  the	  fraction	  of	  M	  amino	  acids	  remaining	  in	  proteins	  once	  
a	   steady	   state	   level	   of	   H	   amino	   acid	   incorporation	   is	   established.	   If	   H	   amino	   acid	  
incorporation	   completely	   replaced	   the	   pre-­‐existing	  M	   amino	   acids	   then	   the	   B’	   value	  
should	   be	   zero.	   The	   fact	   that	   it	   remains	   at	   ~20%	   suggests	   recycling	   of	   M	   isotope-­‐
containing	  amino	  acids	   into	  proteins.	  Most	   likely	  this	  results	  from	  degradation	  of	  the	  
pre-­‐existing	  pool	  of	  exclusively	  M	  isotope-­‐labelled	  proteins	  within	  cells	  at	  the	  start	  of	  
the	   pulse.	   Indeed,	   previous	   work	   has	   reported	   amino	   acid	   recycling	   from	   degraded	  
proteins	  (Davies	  and	  Humphrey,	  1978).	  To	  test	  whether	  the	  amino	  acid	  pool	  settles	  at	  
approximately	  80%	  H	  amino	  acids,	  the	  mass	  isotopomer	  distribution	  of	  peptides	  with	  
missed	   trypsin	   cleavage	   was	   analysed	   to	   determine	   the	   level	   of	   peptides	   that	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contained	  both	  M	  +	  H	  amino	  acids.	  This	  showed	  that	  ~10-­‐20%	  of	  peptides	  with	  missed	  
cleavages	  consistently	  had	  both	  M	  and	  H	  amino	  acids	  in	  the	  same	  peptide,	  consistent	  
with	   a	   precursor	   pool	   of	   ~80-­‐90%	  H	   amino	   acids.	  Moreover,	   it	   was	   found	   for	   these	  
same	  missed	   cleavage	   peptides	   that	   there	  was	   virtually	   no	   combined	  M	   +	   H	   amino	  
acids	   in	   the	   same	   peptide	   in	   an	   experiment	  where	   the	   SILAC	  medium	  was	   changed	  
every	   hour	   over	   the	   time	   course.	   It	   was	   infered	   that	   without	   more	   than	   one	  
replacement	   of	   the	   cell	   growth	   medium	   during	   the	   course	   of	   the	   experiment,	   the	  
internal	   amino	   acid	   pool	   is	   likely	   not	   fully	   replaced	   with	   the	   externally	   supplied	   H	  
amino	  acids.	  
A	   simple	  mathematical	  model	   of	   protein	   synthesis	   and	   degradation	   developed	   here	  
demonstrates	   that	   recycling	   of	   degraded	   proteins	   can	   lead	   to	   a	   non-­‐zero	   offset	   in	  
degradation	   curves.	   To	   test	   this	   hypothesis,	   the	   offset	   value	   B	   was	   analysed	   to	  
determine	  whether	   it	  would	  decrease	   towards	   zero	   if	   during	   the	   time	   course	  of	   the	  
pulse	   the	   external	   media	   containing	   H	   amino	   acids	   was	   repeatedly	   replaced.	   This	  
showed	  that	  replacing	  the	  media	  containing	  the	  H	  amino	  acids	  several	  times	  during	  the	  
time	   course	   of	   the	   pulse	   resulted	   in	   the	   offset	   B	   reducing	   to	   ~	   0,	   as	   expected	   for	  
complete	   replacement	   of	   M	   with	   H	   amino	   acids.	   It	   can	   be	   concluded	   that	   the	  
intracellular	   pool	   of	  M	  amino	   acids	   either	   is	   not	   fully	   depleted	  when	   the	  medium	   is	  
initially	   replaced,	   or	   else	   is	   replenished	   through	   recycling	   of	   amino	   acids	   from	  
degradation	  of	  pre-­‐existing	  M-­‐labelled	  proteins,	  or	  both.	  
Another	   parameter	   that	  was	   determined	  was	   the	   respective	   protein	   half-­‐life	   values,	  
which	  represents	  here	  the	  time	  taken	  for	  50%	  of	  the	  pool	  of	  each	  pre-­‐existing	  protein	  
species	  to	  be	  degraded.	  It	  was	  noted	  that	  this	  study	  does	  not	  provide	  half-­‐life	  values	  at	  
the	  single	  molecule	  level	  but	  rather	  reflects	  average	  values	  for	  populations	  of	  protein	  
molecules.	  The	  half-­‐live	  values	  should	  reflect	  rates	  of	  protein	  degradation.	  To	  take	  into	  
account	  the	  inevitable	  dilution	  effect	  on	  pools	  of	  pre-­‐existing	  M-­‐labelled	  proteins	  as	  a	  
result	  of	  cell	  growth	  and	  new	  protein	  synthesis,	  rather	  than	  degradation,	  the	  half-­‐lives	  
were	  calculated	  using	  a	  formula	  that	  incorporates	  the	  growth	  rate	  measured	  here	  for	  
HeLa	  cells	  growing	   in	  SILAC	  medium.	  A	  comparison	  of	   the	   separate	  protein	   turnover	  
and	  half-­‐life	  values	  determined	   in	   this	   study	  showed	  that	   they	  are	  closely	  correlated	  
(Pearson	   Correlation	   Coefficient	   0.54).	   As	   the	   50%	   turnover	   values	   more	   directly	  
reflect	   both	   protein	   synthesis	   and	   degradation	   rates,	   and	   can	   be	   measured	   more	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accurately,	  the	  subsequent	  analyses	  has	  been	  focused	  specifically	  on	  a	  comparison	  of	  
turnover	  values	  with	  other	  protein	  properties.	  
6.3.3 Distribution of Protein Turnover 
	  
Figure	  40:	  Distribution	  of	  protein	  turnover.	  
Proteins	  were	  sorted	  on	  the	  x	  axis	  from	  fastest	  to	  slowest	  turnover	  and	  represented	  as	  
a	  scatter	  plot	  with	  the	  50%	  protein	  turnover	  value	  on	  the	  y	  axis.	  Approximately	  60%	  
(blue	  lines)	  of	  the	  HeLa	  proteins	  show	  a	  50%	  turnover	  rate	  within	  5	  hours	  of	  the	  
average	  of	  ~	  20	  hours	  (red	  lines).	  Functional	  annotation	  clustering	  of	  gene	  ontology	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terms	  for	  the	  10%	  proteins	  with	  the	  fastest	  (bottom)	  and	  slowest	  (top)	  turnover	  rates	  
are	  shown	  as	  pie	  charts,	  using	  the	  number	  of	  proteins	  as	  weight	  for	  each	  annotation.	  
Proteins	  are	  sorted	  on	  the	  x-­‐axis	  from	  fastest	  to	  slowest	  turnover	  rate,	  represented	  as	  
a	   scatter	  plot	  with	   the	  protein	   turnover	  on	   the	  y-­‐axis	   (see	  Figure	  40).	  Approximately	  
60%	   of	   HeLa	   proteins	   have	   turnover	   values	   clustered	  within	   5	   hours	   of	   the	   average	  
turnover	  rate	  of	  ~	  20	  hours	  (see	  Figure	  40,	  blue	  lines).	  This	  is	  close	  to	  the	  cell	  doubling	  
time	  under	  the	  growth	  conditions	  used,	  consistent	  with	  approximate	  doubling	  of	  the	  
protein	  content	  as	  the	  cell	  divides	  (see	  Figure	  40),	  red	  line).	  It	  takes	  ~24	  hours	  for	  50%	  
turnover	   of	   the	   total	   HeLa	   proteome,	   however,	   a	   subset	   of	   abundant	   proteins,	  
including	  ribosomal	  proteins,	  cytoskeletal	  proteins	  and	  histones,	  have	  half-­‐lives	  longer	  
than	  the	  mean	  of	  ~20	  hours.	  
Functional	   annotation	   clustering	   of	   gene	   ontology	   terms	   for	   the	   fastest	   and	   slowest	  
turnover	   rates	   showed	   specific	   enrichments	   of	   proteins	   with	   similar	   functions	   or	  
characteristics	  (Dennis	  et	  al.,	  2003,	  Huang	  da	  et	  al.,	  2009)	  (see	  Figure	  40).	  The	  slowest	  
turnover	  proteins	  have	  a	  wide	  range	  of	  functions.	  However,	  most	  are	  either	  present	  in	  
large,	   abundant	   and	   stable	   protein	   complexes,	   such	   as	   ribosome	   and	   spliceosome	  
subunits,	  RNA	  polymerase	   II,	   the	  nuclear	  pore,	   the	  exosome	  and	  the	  proteasome,	  or	  
else	   are	  mitochondrial	   (see	   Figure	   40,	   top).	   In	   contrast,	  many	   proteins	  with	   a	   faster	  
than	   average	   turnover	   are	   involved	   in	   either	   mitosis,	   or	   other	   aspects	   of	   cell	   cycle	  
regulation	   (see	   Figure	   40,	   bottom).	   This	   includes	   protein	   components	   of	   the	  
centromere,	   proteins	   with	   microtubule	   motor	   activity,	   proteins	   involved	   in	  
cytoskeleton	   reorganization	   and	   proteins	   involved	   in	   chromatin	   assembly	   and	  
condensation.	   It	   is	   noted	   that	   this	   study	   analysed	   unsynchronised	   HeLa	   cells	   where	  
only	  a	  minor	  fraction	  of	  the	  cells	  at	  any	  time	  point	  would	  be	  in	  mitosis.	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6.3.4 Protein Turnover in Different Subcellular Compartments 
	  
Figure	  41:	  Protein	  turnover	  in	  subcellular	  compartments.	  
The	  turnover	  data	  for	  subcellular	  compartments	  are	  plotted	  against	  each	  other	  to	  
compare	  the	  50%	  turnover	  values	  for	  each	  protein	  in	  the	  cytoplasm	  versus	  the	  nucleus	  
(A),	  the	  cytoplasm	  versus	  the	  nucleolus	  (B)	  and	  the	  nucleus	  versus	  the	  nucleolus	  (C).	  
The	   spatial	   proteomics	   approach	   (Boisvert	   et	   al.,	   2010,	   Boisvert	   and	   Lamond,	   2010)	  
was	  combined	  with	  pulsed	  SILAC	  to	  measure	  the	  turnover	  of	  proteins	  in	  the	  separate	  
cytoplasmic,	  nucleoplasmic	  and	  nucleolar	   fractions.	  The	  turnover	  data	   for	  subcellular	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compartments	   are	   plotted	   against	   each	   other	   for	   comparison	   (see	   Figure	   41).	   This	  
shows	   that	   most	   proteins	   have	   a	   similar	   turnover	   rate	   in	   each	   compartment,	  
particularly	   comparing	   nucleus	   and	   cytoplasm	   (see	   Figure	   41	   A	   versus	   B	   and	   C).	  
Performing	   correlation	   analyses	   between	   the	   different	   compartment	   shows	   that	   the	  
Pearson	   correlation	   coefficient	   between	   the	   cytoplasm	   and	   the	   nucleus	   is	   0.67,	  
compared	   to	   0.42	   between	   the	   cytoplasm	   and	   the	   nucleolus	   and	   0.50	   between	   the	  
nucleus	  and	  the	  nucleolus.	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Figure	  42:	  Distribution	  of	  protein	  turnover	  in	  subcellular	  compartments.	  
A	  distribution	  plot	  with	  the	  protein	  count	  on	  the	  y-­‐axis	  and	  bins	  of	  1	  hour	  50%	  turnover	  
values	  on	  the	  x-­‐axis	  for	  the	  whole	  cell	  (B),	  the	  cytoplasmic	  (C),	  nuclear	  (D)	  and	  nucleolar	  
(E)	  proteins,	  as	  well	  as	  an	  overlay	  of	  all	  four	  (A).	  
The	  turnover	  data	  for	  subcellular	  compartments	  are	  shown	  sorted	  on	  the	  x-­‐axis	  in	  the	  
same	  order	   in	  each	  case,	  reflecting	  highest	  to	  slowest	  turnover	  rate	  when	  the	  whole	  
cell	  protein	  turnover	  measurements	  are	  compared	  (see	  Figure	  42A).	  Again,	  this	  shows	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that	   most	   proteins	   have	   a	   similar	   turnover	   rate	   in	   each	   compartment,	   particularly	  
comparing	  nucleus	  and	  cytoplasm	  (see	  Figure	  42C	  versus	  E),	  likely	  reflecting	  the	  large	  
amount	   of	   nucleo-­‐cytoplasmic	   shuttling.	   However,	   a	   subset	   of	   proteins	   show	  
differences	  in	  turnover	  rate	  between	  the	  subcellular	  compartments	  (see	  Figure	  42A).	  	  
Protein	   turnover	   follows	  an	  apparent	  bimodal	  distribution,	  with	   a	  major	  peak	   in	   the	  
number	  of	  proteins	  with	  a	  50%	  turnover	  value	  of	  ~20	  hours,	  and	  a	  minor	  peak	  of	  ~10	  
hours	  (see	  Figure	  42C,	  D	  &	  E).	  The	  similar	  distribution	  of	  protein	  turnover	  rates	  for	  the	  
cytoplasm	  and	  the	  nucleoplasm	  (see	  Figure	  42,	  C	  &	  D),	  contrasts	  with	   the	  nucleolus,	  
where	   there	   appears	   to	   be	   a	   third	   peak	  with	   a	   faster	   50%	   turnover	   rate	   (<6	  hours),	  
while	   the	   major	   peak	   is	   centred	   ~22-­‐23	   hours,	   slower	   than	   the	   whole	   cell	   mean	  
turnover	  value	  of	  ~20	  hours	  (see	  Figure	  42A).	  The	  nucleolar	  proteins	  with	  the	  fastest	  




Figure	  43:	  Subcellular	  clustering	  analysis	  of	  protein	  turnover.	  
A)	  A	  hierarchical	  clustering	  using	  the	  50%	  turnover	  values	  for	  proteins	  in	  the	  cytoplasm,	  
the	  nucleus	  and	  the	  nucleolus	  is	  shown	  represented	  as	  a	  heat	  map.	  Fast	  turnover	  
values	  are	  represented	  in	  red	  and	  slow	  turnover	  in	  black.	  B)	  A	  table	  showing	  the	  50%	  
turnover	  of	  the	  Sm	  proteins,	  i.e.,	  subunits	  of	  the	  small	  nuclear	  ribonucleoprotein	  
(snRNP)	  spliceosome	  and	  the	  Importin	  transport	  receptor	  proteins	  in	  the	  three	  
subcellular	  compartments.	  C)	  Graphical	  representation	  of	  the	  50%	  turnover	  value	  of	  
each	  protein	  in	  the	  cytoplasm	  (blue),	  the	  nucleus	  (red)	  or	  the	  average	  for	  the	  whole	  cell	  
(green),	  with	  the	  turnover	  on	  the	  y-­‐axis.	  
A	   clustering	   analysis	   grouped	   proteins	   with	   similar	   turnover	   rates	   in	   either	   the	  
cytoplasm,	   nucleoplasm	   or	   nucleoli,	   represented	   as	   a	   heat	   map	   with	   the	   protein	  
clusters	  on	  the	  y	  axis	  and	  the	  subcellular	  compartments	  on	  the	  x-­‐axis	  (see	  Figure	  43A).	  
Most	  proteins	  showed	  similar	  turnover	  rates	  in	  each	  compartment.	  Ribosomal	  proteins	  
provide	   a	   clear	   example	   of	   a	   protein	   cluster	   with	   differing	   turnover	   rates	   between	  
compartments,	  i.e.	  fast	  turnover	  in	  the	  nucleolus	  (~6	  hours),	  but	  slow	  turnover	  in	  the	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cytoplasm	   (~30	   hours),	   (see	   Figure	   43A,	   bottom	   cluster).	   Other	   examples	   were	  
identified	   where	   multiple	   subunits	   of	   the	   same	   multi-­‐protein	   complex	   also	   show	   a	  
differential	   turnover	   rate	   in	   one	   of	   the	   subcellular	   compartments.	   For	   example,	   Sm	  
proteins,	   (components	   of	   the	   small	   nuclear	   ribonucleoprotein	   (snRNP)	   spliceosome	  
subunits),	  showed	  faster	  turnover	  rates	  of	  ~18	  hours	   in	  the	  cytoplasm,	  where	  snRNP	  
proteins	   are	   assembled	   on	   snRNAs,	   compared	   with	   an	   average	   of	   ~35	   hours	   in	   the	  
nucleus,	   where	   the	   snRNPs	   function	   to	   splice	   pre-­‐mRNAs	   (see	   Figure	   43B	   and	   C).	  
Interestingly,	  the	  Sm	  C	  subunit,	  which	  is	  not	  part	  of	  the	  same	  Sm	  complex	  as	  the	  other	  
Sm	  subunits,	  did	  not	  show	  this	  difference	  in	  protein	  turnover	  between	  compartments.	  
Other	   complexes	  with	   differences	   in	   subunit	   turnover	   rates	   between	   compartments	  
include	   the	   26S	   proteasome,	   nuclear	   pore,	   T-­‐complex	   and	   RNA	   polymerase	   II.	   A	  
common	   feature	   is	   that	   protein	   subunits	   have	   a	   faster	   turnover	   rate	   in	   the	  
compartment	  where	  the	  complex	  assembles	  and	  are	  more	  stable	  in	  the	  compartment	  
where	  the	  fully	  assembled	  complex	  functions.	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6.3.5 Protein Characteristics Related to Turnover Rate 
	  
Figure	  44:	  Protein	  characteristics	  related	  to	  turnover	  rate.	  
A)	  Protein	  abundance	  was	  estimated	  from	  the	  averaged	  sum	  of	  ion	  intensities	  
measured	  for	  every	  peptide	  in	  a	  protein	  and	  plotted	  on	  the	  y-­‐axis	  versus	  the	  turnover	  
on	  the	  x-­‐axis.	  B)	  A	  distribution	  plot	  with	  the	  average	  log	  base	  10	  intensity	  on	  the	  y-­‐axis	  
and	  bins	  of	  100	  proteins	  on	  the	  x-­‐axis,	  where	  proteins	  are	  sorted	  from	  the	  fastest	  
turnover	  to	  the	  slowest	  turnover	  for	  the	  whole	  cell.	  C)	  The	  log	  base	  10	  of	  molecular	  
weight	  (in	  Daltons)	  was	  plotted	  versus	  the	  protein	  turnover	  in	  the	  whole	  cell.	  D)	  A	  
distribution	  plot	  of	  the	  average	  molecular	  weight	  in	  Daltons	  on	  the	  y-­‐axis	  and	  turnover	  
(shown	  in	  5	  hour	  bins)	  on	  the	  x-­‐axis.	  E)	  A	  comparison	  of	  the	  protein	  turnover	  on	  the	  x-­‐
axis	  with	  isoelectric	  point	  on	  the	  y-­‐axis.	  F)	  A	  distribution	  plot	  of	  the	  number	  of	  proteins	  
in	  each	  bin	  of	  isoelectric	  points.	  
A	  range	  of	  protein	  properties	  and	  characteristics,	  including	  abundance,	  size,	  pI	  values,	  
sequence	   motifs	   and	   amino	   acid	   composition	   were	   analysed	   for	   correlations	   with	  
turnover	   rates.	   A	   positive	   correlation	   was	   detected	   between	   protein	   abundance,	   as	  




















































B).	  This	  correlation	  was	  also	  recently	  observed	  in	  a	  study	  of	  protein	  turnover	  in	  mouse	  
cells	  (Schwanhausser	  et	  al.,	  2011).	  While	  there	  is	  variation,	  higher	  abundance	  proteins	  
generally	  had	  slower	  than	  average	  turnover	  rates	  (see	  Figure	  44B).	  The	  corollary	  is	  that	  
the	  time	  to	  turn	  over	  half	  of	  the	  total	  protein	  content	  of	  a	  HeLa	  cell	  is	  ~	  15-­‐20%	  longer	  
than	  the	  mean	  turnover	  value	  of	  all	  proteins	  measured.	  
In	  contrast	  with	  the	  positive	  correlation	  with	  abundance,	  there	  is	  minimal	  correlation	  
between	   turnover	   rate	   and	   protein	   size	   (see	   Figure	   44C	   and	   D).	   Comparison	   of	  
predicted	   molecular	   weights	   deduced	   from	   amino	   acid	   sequences	   with	   measured	  
protein	   turnover	   rates	   showed	   a	   Pearson	   correlation	   coefficient	   of	   -­‐0.09	   (see	   Figure	  
44B).	  It	  has	  been	  proposed	  that	  acidic	  proteins	  are	  degraded	  more	  rapidly	  than	  basic	  
proteins	  (Dice	  and	  Goldberg,	  1975).	  A	  comparison	  of	  the	  rate	  of	  protein	  turnover	  with	  
isoelectric	  point	  however	  showed	  no	  correlation	  (see	  Figure	  44E,	  Pearson	  correlation	  
0.009).	   It	   is	   concluded	   that	   the	   bulk	   charge	   property	   of	   proteins	   is	   not	   a	   significant	  
determinant	   of	   their	   stability.	   However,	   the	   analysis	   showed	   that	   nucleolar	   proteins	  
have	   an	   inverse	   correlation	   between	   pI	   and	   protein	   turnover,	   with	   a	   Pearson	  
correlation	  of	  -­‐0.23.	  Thus,	  basic	  nucleolar	  proteins	  have	  a	  faster	  than	  average	  turnover	  
(see	  Figure	  42E,	  purple),	  likely	  due	  to	  the	  large	  number	  of	  basic	  ribosomal	  proteins	  in	  
the	  nucleolus,	  which	  have	  a	  very	  fast	  turnover.	  	  
The	  presence	  of	  protein	  segments	  rich	  in	  proline,	  glutamic	  acid,	  serine	  and	  threonine,	  
(PEST	   sequences)	   are	   reported	   to	   affect	   degradation	   levels	   (Rogers	   et	   al.,	   1986).	  
Therefore,	  the	  proteins	  whose	  turnover	  was	  measured	  for	  the	  presence	  and	  frequency	  
of	   PEST	   motifs	   were	   analysed	   using	   the	   PEST-­‐find	   tool	  
(http://emboss.sourceforge.net/).	   Parameters	   used	   include	   a	  minimal	   distance	   of	   10	  
positively	   charged	   amino	   acids	   and	   a	   threshold	   of	   5,	   to	   differentiate	   between	  weak	  
and	  strong	  potential	  PEST	  motifs.	  All	  PEST	  motifs	  assessed	  as	  ‘poor’	  and	  ‘invalid’	  were	  
removed	   from	   the	   analysis.	  While	   no	   simple	   correlation	  was	   observed	   between	   the	  
presence	  of	  PEST	  sequences	  per	  se,	  and	  short	  half-­‐lives,	  the	  average	  number	  of	  PEST	  
regions	  found	   in	  proteins	  with	  a	  shorter	  than	  average	  turnover	  was	  ~1,	  as	  compared	  
with	  a	  PEST	   frequency	  of	  ~0.5	   for	  proteins	  with	  a	   longer	   than	  average	  turnover.	   It	   is	  
concluded	   that	   there	   is	   a	  positive	   relationship	  between	   the	  presence	  of	  PEST	  motifs	  
and	   protein	   turnover	   rates	   in	   HeLa	   cells	   but	   PEST	   motifs	   alone	   are	   not	   solely	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responsible	  for	  rapid	  protein	  turnover.	  The	  data	  suggest	  that	  PEST	  motifs	  are	  only	  one	  
of	  multiple	  factors	  that	  can	  affect	  protein	  half-­‐lives.	  
	  
Figure	  45:	  PEST	  sequence	  analysis.	  
	  A	   and	   B	   show	   all	   proteins	   binned	   in	   2	   hour	   segments,	   based	   on	   their	   respective	  
turnover	  values	  (X	  axis).	  Axis	  Y	  in	  A	  shows	  the	  average	  number	  of	  PEST	  regions	  for	  the	  
proteins	   in	  each	  bin	  and	  B	  shows	  how	  many	  proteins	  are	   in	  each	  bin.	  As	  expected,	  B	  
shows	  a	  larger	  number	  of	  proteins	  in	  the	  bins	  near	  the	  average	  turnover	  found	  for	  the	  
human	   proteome	   in	   this	   study	   (i.e.	   ~20	   hours).	   However,	   as	   A	   suggests,	   there	   is	   no	  
simple	   correlation	   between	   the	   turnover	   rate	   of	   a	   protein	   and	   the	   number	   of	   PEST	  
regions	  found	  in	  the	  protein	  sequence.	  
6.3.6 Protein Turnover and the N-terminal Amino Acid Rule 
A	   previously	   characterised	   determinant	   of	   protein	   stability	   is	   the	   N-­‐terminal	   amino	  
acid	   of	   the	  mature	   protein,	   where	   the	   N-­‐terminal	   amino	   acid	   is	   classified	   as	   either	  
stabilizing,	  or	  destabilizing	  (Varshavsky,	  1992).	  While	  for	  most	  proteins,	  methionine	  is	  
the	  first	  amino	  acid	  encoded	  and	  translated,	  methionine	  aminopeptidase	  is	  thought	  to	  










































C	   or	   P	   (Hu	   et	   al.,	   2006).	   Some	   mature	   proteins	   can	   also	   be	   generated	   by	   post-­‐
translational	  cleavage,	  resulting	   in	  different	  amino	  acids	  occurring	  at	  the	  N-­‐terminus.	  
The	   empirical	   measurements	   of	   protein	   turnover	   rates	   reported	   were	   used	   to	   test	  
whether	   the	   identity	   of	   the	   N-­‐	   or	   C-­‐terminal	   amino	   acid	   could	   affect	   endogenous	  
protein	   stability	   in	   HeLa	   cells.	   The	   turnover	   rates	   were	   averaged	   for	   all	   proteins	  
measured	  with	  each	  amino	  acid	  at	  either	  the	  first	  ten	  N-­‐terminal	  positions	  (i.e.	  +1	  to	  
+10),	   or	   the	   last	   ten	   positions	   from	   the	   C-­‐terminus.	   No	   significant	   differences	   were	  
observed	  between	  mean	  protein	  turnover	  rates	  according	  to	  the	  amino	  acid	  identity	  at	  
either	   the	   first	   or	   last	   ten	   N-­‐terminal,	   or	   C-­‐terminal	   positions,	   respectively.	   This	  
comparison	  was	  also	  made	  specifically	   for	  the	  10%	  fastest	  and	  10%	  slowest	  turnover	  
proteins	  and	  also	  saw	  no	  correlation	  with	  amino	  acid	  identity	  at	  N-­‐	  or	  C-­‐	  termini.	  It	  is	  
concluded	  that	  protein	  stability	  for	  full-­‐length,	  endogenous	  proteins	  in	  HeLa	  cells	  is	  not	  
determined	  primarily	  by	  either	  N-­‐terminal	  or	  C-­‐terminal	  rules	  based	  upon	  amino	  acid	  
identity.	  	  
6.3.7 Amino Acid Frequency Distribution 
The	   matrix	   of	   frequencies	   for	   each	   amino	   acid	   occurring	   at	   either	   the	   first	   ten	   N-­‐
terminal	  positions	  or	   last	   ten	  C-­‐terminal	  positions	   in	  each	  protein	   identified	  was	  also	  
determined	   and	   compared	  with	   the	   corresponding	   in	   silico	   prediction	   of	   amino	   acid	  
frequencies	   for	   each	   ORF	   in	   the	   human	   genome.	   The	   resulting	   Pearson	   correlation	  
coefficient	  of	  0.99	  shows	   that	   the	  sample	  of	  6,402	  proteins	   for	  which	   turnover	   rates	  
were	   measured	   have	   a	   near	   identical	   distribution	   of	   N-­‐	   and	   C-­‐terminal	   amino	   acid	  
frequencies	  to	  the	  total	  translated	  human	  proteome.	  It	  is	  concluded	  that	  the	  subset	  of	  




6.3.8 Turnover Viewer 
	  
Figure	  46:	  PepTracker	  spatial	  and	  turnover	  viewer.	  
A	  database	  viewer	  has	  been	  setup	  to	  provide	  access	  to	  the	  data	  generated	  during	  this	  
study	  through	  a	  web-­‐based	  interface	  (http://peptracker.com/turnover/).	  The	  
application	  includes	  a	  search	  facility	  (A)	  that	  allows	  users	  to	  search	  for	  a	  protein(s)	  of	  
interest	  using	  protein	  name,	  description,	  gene	  as	  well	  as	  IPI	  or	  Uniprot	  identifiers.	  A	  
user	  can	  also	  select	  a	  protein	  using	  the	  interactive	  chart	  component	  that	  is	  provided	  on	  
the	  home	  page	  (B).	  A	  more	  detailed	  page	  describing	  specific	  proteins	  (C)	  which	  
documents	  previous	  subcellular	  localisation	  data	  from	  human	  HCT116	  cells,	  calculated	  
using	  spatial	  proteomics,	  as	  well	  as	  the	  localisation	  data	  resulting	  from	  averaging	  the	  
intensity	  of	  the	  peptides	  identified	  in	  each	  subcellular	  compartment	  in	  this	  study.	  The	  
viewer	  displays	  the	  peptides	  identified	  over	  the	  protein	  sequence,	  with	  different	  
shading	  of	  red	  for	  each	  peptide	  reflecting	  differences	  in	  turnover	  rates.	  The	  different	  
curve	  fits	  are	  displayed	  showing	  the	  degradation	  and	  synthesis	  rates	  for	  each	  protein,	  
and	  showing	  the	  turnover	  rate	  of	  each	  protein	  in	  each	  subcellular	  compartment.	  The	  
protein	  turnover	  for	  the	  selected	  protein	  is	  shown	  overlaid	  in	  red	  on	  the	  scatter	  plots	  
showing	  all	  of	  the	  proteins	  in	  the	  different	  subcellular	  compartments	  in	  blue.	  	  
A	   database	   viewer	   has	   been	   implemented	   within	   the	   PepTracker	   software	  
environment	   to	   provide	   convenient	   access	   to	   these	   data	   through	   a	   web-­‐based	  
interface	   (see	   Figure	   46)	   (http://www.peptracker.com/turnover/).	   The	   application	  
includes	  a	  search	  facility	   that	  allows	  users	   to	  search	  for	  a	  protein(s)	  of	   interest	  using	  
protein	  name,	  description,	  gene	  as	  well	  as	  IPI	  or	  UniProt	  identifiers.	  The	  search	  result	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page	  (see	  Figure	  46C)	  documents	  also	  spatial	  proteomics	  localisation	  data	  from	  human	  
HCT116	   cells	   (Boisvert	   et	   al.,	   2010),	   as	   well	   as	   the	   localisation	   data	   resulting	   from	  
averaging	   the	   intensity	   values	   of	   the	   peptides	   identified	   in	   each	   subcellular	  
compartment	   in	   this	   study.	   The	   viewer	  displays	   all	   peptides	   identified	   for	   a	   selected	  
protein	   sequence,	   with	   different	   shading	   for	   each	   peptide	   reflecting	   differences	   in	  
turnover	   rates.	  The	  curve	   fits	  are	  displayed	  showing	  degradation	  and	  synthesis	   rates	  
for	   each	   protein,	   and	   showing	   the	   turnover	   rate	   of	   each	   protein	   in	   each	   subcellular	  
compartment.	   Protein	   turnover	   for	   a	   selected	   protein	   is	   shown	   overlaid	   in	   red	   on	  
scatter	  plots	  showing	  all	  proteins	   in	  the	  respective	  subcellular	  compartments	   in	  blue,	  
providing	  a	  rapid	  overview	  of	  turnover	  rates	  between	  subcellular	  compartments.	  
6.4 Technical Implementation 
The	   PepTracker	   turnover	   and	   spatial	   viewer	   consists	   of	   a	   web-­‐based,	   multi-­‐tier	  
architecture,	  where	  the	  data	  storage,	  server-­‐side	  logic	  and	  user	  interface	  are	  separate	  
components.	   The	   data	   storage	   is	   implemented	   as	   a	   fully	   relational	   Oracle	   database	  
(Oracle	   Database	   10g	   Enterprise	   Edition	   Release	   10.2.0.5.0).	   This	   database	   holds	  
turnover	  details,	  both	  at	  the	  protein	  and	  peptide	  level.	  
The	   server-­‐side	   logic	   and	   client	   interface	   reside	   on	   an	   Apache	   web	   server	   (Version	  
2.2.3	  -­‐	  CentOS	  Linux	  Distribution).	  The	  server-­‐side	  logic	  is	  built	  as	  an	  extension	  to	  the	  
main	  PepTracker	  software.	  It	   is	   implemented	  using	  Python	  (Version	  2.6.4),	  structured	  
using	   the	   Django	   framework	   (Version	   1.2.1,	   http://www.djangoproject.com/).	   The	  
Django	   framework	   enforces	   code	   to	   follow	   the	  model	   view	   controller	   (MVC)	   design	  
pattern,	  thus	  the	  functionality	  within	  the	  application	  is	  separated	  from	  the	  overall	  look	  
and	   feel	   of	   the	   application,	   ensuring	   a	   more	   customisable	   solution.	   The	   server-­‐side	  
logic	  makes	  use	  of	  complex	  Structured	  Query	  Language	  (SQL)	  in	  order	  to	  communicate	  
with	  the	  database	  and	  extract	  the	  relevant	  data	  required	  by	  the	  user	  interface.	  It	  does	  
so	  using	   SQLAlchemy	   (http://www.sqlalchemy.org/),	   a	  Python	  SQL	   toolkit	   and	  object	  
relational	  mapper.	  The	  Django	  framework	  provides	  the	  ability	  to	  setup	  html	  templates	  
that	  form	  the	  user	  interface.	  These	  templates	  are	  customised	  on	  the	  fly	  using	  the	  data	  
passed	   to	   them	   from	   the	   server-­‐side	   logic.	   The	   templates	   are	   coded	   in	   HyperText	  
Markup	   Languages	   (HTML),	   with	   Javascript	   additions	   to	   enhance	   functionality.	  
Specifically,	   the	   viewer	   makes	   use	   of	   the	   JQuery	   library	   (http://jquery.com/)	   and	  
Google	   Visualisation	   API	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(http://code.google.com/apis/visualization/interactive_charts.html)	   to	   provide	  
additional	  elements,	   such	  as	   interactive	  charts.	  The	   interface	  also	   includes	  an	  Adobe	  
Flex	  component	  that	  provides	  an	   interactive	  chart	  and	  cell	  map	  for	  users	  to	  navigate	  
through	  the	  data.	  To	  further	  enhance	  the	  user	  experience	  the	  user	  interface	  performs	  
dynamic	   requests	   to	   the	   server	   using	   REST	   (Representational	   State	   Transfer).	   These	  
requests	  prevent	  HTML	  pages	  from	  having	  to	  be	  completely	  redrawn	  and	  instead	  only	  
the	  relevant	  sections	  of	  a	  page	  are	  updated.	  	  
6.5 Discussion 
A	   combined	   pulse-­‐labelling,	   spatial	   proteomics	   and	   data	   analysis	   strategy	   was	  
developed	   to	   characterize	   the	   expression,	   localisation,	   synthesis,	   degradation	   and	  
turnover	   rates	   of	   endogenously	   expressed,	   untagged	   human	   proteins	   in	   different	  
subcellular	   compartments.	   Using	   SILAC	   and	   mass	   spectrometry,	   a	   total	   of	   80,098	  
peptides	   from	   an	   estimated	   8,041	   HeLa	   proteins	   were	   quantified,	   and	   their	   spatial	  
distribution	  between	  the	  cytoplasm,	  nucleus	  and	  nucleolus	  determined	  and	  visualised	  
using	  PepTracker.	  Using	  information	  from	  ion	  intensities	  and	  rates	  of	  change	  in	  isotope	  
ratios,	  protein	  abundance	  levels	  and	  protein	  synthesis,	  degradation	  and	  turnover	  rates	  
were	   calculated	   for	   the	   whole	   cell	   and	   for	   the	   respective	   cytoplasmic,	   nuclear	   and	  
nucleolar	   compartments.	   Based	   on	   the	   large	   number	   of	   proteins	   quantified	   and	   the	  
close	   correlation	   between	   the	   N-­‐	   and	   C-­‐terminal	   amino	   acid	   frequencies	   of	   the	  
experimentally	   identified	   proteins	   and	   the	   in	   silico	   predicted	   frequencies	   based	   on	  
translation	   of	   human	   genome	   ORFs,	   it	   is	   argued	   that	   the	   dataset	   reported	   here	   is	  
highly	  representative	  of	  the	  properties	  of	  the	  human	  proteome.	  	  
This	  study	  provides	  the	  first	  systematic,	  system	  wide	  quantitative	  analysis	  of	  proteome	  
localisation	  and	  turnover	  that	  has	  evaluated	  the	  properties	  of	  endogenous	  proteins	  in	  
different	   subcellular	   compartments.	   The	   approach	   described,	   together	   with	   the	  
software	   tools	   for	   data	   visualisation	   and	   analysis,	   provides	   a	   basis	   for	   further	  
systematic	   proteome-­‐wide	   characterization	   of	   protein	   localisation	   and	   turnover	   that	  
can	   be	   compared	   between	   different	   cell	   types,	   cell	   cycle	   stages,	   physiological	  
conditions	  and	  genetic	  backgrounds.	  	  
Many	   large-­‐scale,	   functional	   genomics	   studies	   characterise	   global	   gene	   expression	  
levels,	   either	   in	   different	   cell	   types	   and/or	   under	   a	   range	   of	   growth	   conditions,	   by	  
measuring	   differences	   in	   mRNA	   expression	   levels.	   This	   either	   involves	   microarray	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technology,	   or,	   more	   recently,	   high-­‐throughput	   RNA	   sequencing.	   However,	  
quantitative	  mRNA	  expression	  data	  alone	  are	  not	  sufficient	  to	  reliably	  document	  gene	  
expression	  at	  the	  proteome	  level.	  Previous	  large-­‐scale	  analyses	  correlating	  mRNA	  and	  
protein	   expression	   have	   found	   that	   similar	   mRNA	   expression	   levels	   can	   be	  
accompanied	   by	   a	   wide	   range	   (up	   to	   20-­‐fold	   difference)	   in	   the	   corresponding	  
abundance	   levels	   of	   the	   proteins	   encoded	   by	   these	   mRNAs	   (Gygi	   et	   al.,	   1999b).	   In	  
agreement,	  only	  weak	  correlations	  are	  observed	  (Pearson	  correlation	  coefficients	  ~0.2)	  
comparing	   the	   estimates	   of	   HeLa	   protein	   expression	   levels	   from	   this	   study	   with	  
publicly	   available	   HeLa	  mRNA	   expression	   data	   (ArrayExpress,	   EBI).	   This	   overall	   poor	  
correlation	   between	   cognate	   mRNA	   and	   protein	   expression	   levels	   likely	   reflects	  
differences	  both	   in	   rates	  of	  mRNA	   translation	  and	   in	  protein	   turnover,	   but	  may	  also	  
result,	  at	  least	  in	  part,	  from	  noisy	  microarray	  measurements	  and/or	  variability	  of	  HeLa	  
cell	  batches.	  It	  is	  important	  to	  note	  that	  many	  proteins	  can	  differ	  substantially	  in	  their	  
in	  vivo	  half-­‐lives,	  regardless	  of	  how	  fast	  they	  are	  synthesised	  (Greenbaum	  et	  al.,	  2003).	  
This	   underlines	   the	   importance	   of	   making	   direct	   measurements	   of	   endogenous	   cell	  
proteins,	   including	  the	  high-­‐throughput	  analysis	  of	  protein	  turnover,	  to	  fully	  evaluate	  
gene	   expression	   responses	   and	   accurately	   determine	   factors	   and	   mechanisms	  
regulating	  intracellular	  protein	  abundance.	  
Together	  with	  Lamond	  Laboratory	  collaborators,	  previously	  a	  heavy–light	  amino	  acid	  
pulse	  SILAC	  protocol	  was	  used	  to	  measure	  protein	  turnover	   in	  HeLa	  cell	  nucleoli	  and	  
this	  study	  also	  compared	  the	  MS	  data	  with	  parallel	  studies	  on	  turnover	  of	  GFP-­‐tagged	  
nucleolar	  proteins	  using	  fluorescence	  microscopy	  (Lam	  et	  al.,	  2007).	  A	  similar	  heavy	  –	  
light	  pulse	  SILAC	  approach	  was	   recently	  used	   to	   study	   turnover	  of	  human	  A549	   lung	  
carcinoma	   cell	   proteins	   (Doherty	   et	   al.,	   2009)	   and	   also	   to	   study	  mouse	  NIH3T3	   cells	  
(Schwanhausser	  et	  al.,	  2011).	  In	  my	  thesis	  work,	  the	  pulse	  SILAC	  technique	  is	  extended	  
by	  analysing	  a	  combination	  of	  heavy	  –	  medium	  pulsed	  cells	  and	  an	  equal	  amount	  of	  
control,	  light	  cells	  at	  each	  time	  point.	  This	  offers	  advantages	  in	  terms	  of	  improved	  data	  
analysis	  and	  statistical	  evaluation	  procedures.	  	  
Overall,	  the	  pulse	  SILAC	  approach	  is	  useful	  for	  determining	  protein	  turnover	  because	  it	  
allows	  measurement	   of	   endogenous	   proteins	   expressed	   at	   physiological	   levels	  while	  
avoiding	   the	   need	   to	   treat	   cells	   with	   translation	   inhibitors.	   Techniques	   based	   on	  
translation	   inhibition	  complicate	   the	   interpretation	  of	  protein	   turnover	  values	  as	   the	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effect	   of	   the	   inhibitors	   on	   cell	   physiology,	  which	   can	   in	   turn	   affect	   protein	   stability,	  
must	  be	  taken	  into	  account	  (Belle	  et	  al.,	  2006).	  The	  pulse	  SILAC	  method,	  as	  previously	  
demonstrated,	   can	   also	   be	   used	   to	   compare	   the	   turnover	   rates	   of	   tagged	   and	  
endogenous	  forms	  of	  the	  same	  protein	  in	  stable	  cell	  lines,	  which	  is	  often	  important	  to	  
validate	   independently	   the	   conclusions	   to	   be	   drawn	   from	   microscopy	   studies	   in	  
mammalian	  cells	  using	  GFP-­‐fusion	  proteins	  (Lam	  et	  al.,	  2007).	  
Several	   lines	  of	  evidence	  argue	  that	  the	  MS-­‐based	  proteomics	  approach	  used	  here	   is	  
robust	   and	   reproducible.	   First,	   a	   strong	   positive	   correlation	   (Pearson	   correlation	  
coefficient	   ~0.73)	   was	   observed	   between	   the	   present	   data	   and	   the	   smaller	   dataset	  
from	   previous	   pulse	   SILAC	   analysis	   of	   HeLa	   nucleolar	   protein	   turnover	   (Lam	   et	   al.,	  
2007),	  despite	  the	   lower	  number	  of	  peptides	   identified	  for	  each	  protein	   in	  that	  case.	  
This	   demonstrates	   that,	   at	   least	   when	   comparing	   the	   same	   cell	   line,	   biological	  
replicates	   produce	   similar	   results.	   Second,	   it	   has	   been	   confirmed	   that	   values	   from	  
technical	   replicates	   are	   reproducible	   by	   evaluating	   data	   obtained	   from	   separate	  MS	  
analysis	   and	   quantitation	   of	   the	   same	   protein	   samples	   using	   different	   mass	  
spectrometers.	  Thirdly,	  it	  is	  noted	  that	  there	  was	  a	  strong	  positive	  correlation	  between	  
the	   localisation	   and	   turnover	   values	   obtained	   for	  most	   shared	   subunits	   of	   common	  
multi-­‐protein	  complexes,	  consistent	  with	  proteins	  in	  the	  same	  complex	  having	  similar	  
biological	  properties.	  Most	  peptides	  in	  the	  same	  protein	  also	  produced	  similar	  values.	  	  
This	  approach	  differs	   in	  several	  aspects	  from	  most	  previous	  studies	  on	  global	  protein	  
turnover	   (Belle	  et	  al.,	  2006,	  Yen	  et	  al.,	  2008,	  Doherty	  et	  al.,	  2009,	  Eden	  et	  al.,	  2011,	  
Schwanhausser	  et	  al.,	  2011).	  First,	  it	  was	  decided	  to	  simultaneously	  determine	  not	  only	  
net	   protein	   turnover,	   but	   also	   both	   protein	   degradation	   and	   synthesis	   rates.	   This	  
provides	   additional	   information	   on	   the	   protein	   properties	   and	   allows	   calculation	   of	  
turnover	  using	  two	  separate	  methods	  and	  statistical	  evaluation	  of	  the	  accuracy	  of	  the	  
turnover	  values	  for	  each	  protein.	  Second,	  protein	  turnover	  was	  characterised	  not	  only	  
for	   the	   global	   protein	   population	   in	   whole	   cells,	   but	   also	   for	   proteins	   in	   separate	  
subcellular	  fractions.	  This	  spatial	  information	  recognises	  that	  separate	  pools	  of	  protein	  
with	  distinct	  properties	  can	  exist	  in	  different	  subcellular	  locations.	  Inevitably,	  analysis	  
of	  whole	   cell	   extracts	  measure	   ensemble,	   average	   values	   for	   the	   protein	   population	  
and	  will	  not	   identify	  cases	  where	  the	  same	  protein	  can	  be	  present	   in	  more	  than	  one	  
complex	  with	  different	  turnover	  rates,	  as	  revealed	  in	  this	  study.	  Third,	  measurements	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are	  made	  on	  endogenous,	  untagged	  cell	  proteins	  and	  not	  based	  upon	  analysis	  of	  over-­‐
expressed,	   tagged	   fusion	   constructs.	   Either	   transient,	   or	   stable,	   overexpression	   of	  
tagged	  fusion	  proteins	  may	  affect	  their	  turnover	  properties,	  both	  through	  changing	  the	  
protein	   structure	   and	   by	   altering	   their	   abundance	   and	   stoichiometry	   relative	   to	  
interaction	  partners.	  	  
A	   comparison	   of	   the	   protein	   turnover	   values	   reported	   here	   with	   the	   corresponding	  
turnover	   or	   half-­‐life	   values	   reported	   for	   the	   same	   proteins	   in	   previous	   large-­‐scale	  
studies	   showed	   major	   differences.	   Thus,	   there	   appeared	   to	   be	   a	   near	   random	  
correlation	  with	  the	  values	  reported	  in	  two	  of	  these	  studies	  (Doherty	  et	  al.,	  2009,	  Eden	  
et	   al.,	   2011),	   and	   only	   a	   partial	   positive	   correlation	   (Pearson	   correlation	   coefficient	  
~0.2)	   with	   the	   data	   of	   Yen	   et	   al.	   (Yen	   et	   al.,	   2008).	   However,	   it	   is	   noted	   that	   cross	  
comparison	   of	   the	   datasets	   from	   each	   of	   these	   previous	   studies	   also	   shows	  mostly	  
random	   correlations	   between	   them.	   However,	   we	   found	   a	   stronger	   correlation	  
(Pearson	   correlation	   coefficient	   of	   0.34)	   between	   our	   data	   and	   a	   recent	   study	   also	  
using	   a	   pulse-­‐SILAC	   method	   to	   analyse	   protein	   turnover	   in	   mouse	   NIH	   3T3	   cells	  
(Schwanhausser	  et	  al.,	  2011).	  	  
The	  lack	  of	  correlation	  between	  the	  previous	  high-­‐throughput	  studies	  and	  this	  present	  
data	  is	  not	  simply	  explained	  by	  variation	  in	  the	  quality	  of	  the	  data	  in	  this	  study.	  Even	  
focusing	  on	  the	  subset	  of	  proteins	  in	  this	  study	  with	  the	  highest	  quality	  measurements	  
did	  not	   significantly	   improve	   the	  degree	  of	   correlation	  with	   the	  previously	  published	  
analyses.	  Thus,	  considering	  only	  the	  ~25%	  of	  proteins	  for	  which	  this	  study	  quantitated	  
at	   least	   20	   separate	   peptides	   with	   optimal	   chi2	   curve	   fitting	   did	   not	   increase	   the	  
positive	   correlation	   with	   the	   other	   datasets.	   It	   is	   concluded	   that	   our	   study	   has	  
generated	   a	   dataset	   for	   endogenous	   human	   proteins	   that	   is	   distinct	   from	   previous	  
studies	  and,	  considering	  the	  overall	  stringent	  data	  evaluation	  employed,	  argue	  that	  the	  
lack	   of	   agreement	   in	   protein	   turnover	   values	   between	   this	   data	   and	   previous	   large-­‐
scale	  studies	  is	  not	  primarily	  reflecting	  data	  quality	  issues	  in	  measurements	  described	  
here.	  	  
This	   surprising	   situation	  where	  apparently	  each	   separate	  high-­‐throughput	  analysis	  of	  
protein	   turnover	  produces	  different	   results	  could	  have	  multiple	  explanations.	  Two	  of	  
the	  previous	  studies	  specifically	  analysed	  the	  turnover	  of	  over-­‐expressed,	  GFP-­‐tagged	  
fusion	  proteins	  (Yen	  et	  al.,	  2008,	  Eden	  et	  al.,	  2011).	  It	  is	  anticipated	  that	  the	  resulting	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fusion	  protein	  turnover	  values	  may	  differ	  from	  the	  rates	  of	  turnover	  reported	  here	  for	  
the	   corresponding	   endogenous	   proteins	   expressed	   at	   physiological	   levels.	   It	   is	   also	  
important	   to	   note,	   however,	   that	   there	   is	   no	   expectation	   that	   different	   cell	   lines	  
growing	   under	   different	   culture	   conditions	   should	   show	   identical	   protein	   turnover	  
values,	   as	   observed	   from	   the	   differences	   in	   turnover	  measured	   between	   A549	   cells	  
(Doherty	  et	  al.,	  2009),	  NIH	  3T3	  cells	  (Schwanhausser	  et	  al.,	  2011)	  and	  HeLa	  cells	  (this	  
study).	   It	   will	   be	   interesting,	   therefore,	   to	   carefully	   evaluate	   differences	   in	   protein	  
turnover	   rates	   between	   cell	   lines	   and	   growth	   conditions	   using	   the	   same	   stringent	  
methodologies	   for	   all	   measurements.	   Indeed,	   while	   most	   homologous	   proteins	  
showed	   a	   similar	   trend	   when	   comparing	   turnover	   values	   from	   our	   study	   to	   those	  
found	  in	  NIH	  3T3	  cells	  (Schwanhausser	  et	  al.,	  2011),	  it	  is	  interesting	  to	  note	  that	  a	  few	  
proteins	  showed	  a	  dramatic	  difference	  in	  protein	  turnover	  between	  the	  two	  cell	  lines,	  
indicating	   that	   specific	   protein	   degradation	   might	   be	   either	   cell	   type	   specific,	   or	  
species-­‐specific,	  or	  both.	  
An	  interesting	  general	  feature	  from	  this	  study	  is	  the	  observation	  that	  protein	  subunits	  
from	  multi-­‐protein	  complexes	  show	  faster	  turnover	  as	  free	  proteins,	  prior	  to	  complex	  
assembly.	  This	  is	  exemplified	  by	  the	  ribosomal	  proteins,	  which	  have	  a	  50%	  turnover	  of	  
~6	  hours	  in	  the	  nucleus,	  where	  the	  protein	  pool	  includes	  free,	  unassembled	  ribosomal	  
proteins	   (Lam	   et	   al.,	   2007).	   In	   contrast,	   ribosomal	   proteins	   are	   very	   stable	   in	   the	  
cytoplasm,	  with	  turnover	  of	  over	  30	  hours,	  where	  they	  accumulate	  only	  after	  assembly	  
into	   a	   ribosome	   subunit.	   An	   important	   corollary	   is	   that	   a	   large	   increase	   in	   the	  
expression	  of	  a	  specific	  protein,	  as	  often	  occurs	  upon	  either	  transient	  or	  stable	  over-­‐
expression	  of	  tagged	  proteins,	  may	  change	  drastically	  its	  turnover	  in	  comparison	  with	  
the	   endogenous	   counterpart.	   The	  measured	   turnover	   of	   interaction	   partners	   of	   the	  
over-­‐expressed	   factor	  and	  of	  other	  proteins	  may	  also	  be	  altered.	   It	   is	  proposed	   that	  
this	  could	  account	   for	  much	  of	   the	  difference	  between	  the	   turnover	  values	   reported	  
here	  for	  endogenous	  proteins	  expressed	  at	  physiological	  levels	  and	  the	  faster	  turnover	  
rates	   measured	   using	   fluorescent	   protein-­‐tagged	   proteins.	   For	   example,	   Yen	   et	   al.,	  
reported	  that	  the	  turnover	  rates	  of	  over	  8,000	  GFP-­‐tagged	  human	  proteins	  showed	  a	  
bimodal	  pattern,	  where	  the	  average	  turnover	  values	  were	  measured	  as	  30	  min	  and	  2	  
hours,	   respectively	   (Yen	   et	   al.,	   2008).	   This	   study	   also	   found	   that	   protein	   turnover	  
followed	  a	  bimodal	  distribution,	  but	  with	  slower	  turnover	  values	  of	  ~20	  hours,	  close	  to	  
the	  HeLa	  cell	  division	  rate,	  and	  a	  minor	  peak	  with	  a	  turnover	  value	  of	  ~10	  hours.	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The	   data	   indicate	   that	   the	   bulk	   of	   HeLa	   cell	   proteins	  may	   be	   turned	   over	   passively	  
during	  normal	  cell	  growth	  and	  are	  consistent	  with	   the	  mean	   turnover	   rate	   reflecting	  
approximate	  doubling	  of	  the	  amount	  of	  proteins	  as	  the	  cell	  divides	  and	  hence	  doubles	  
its	   protein	   content.	   However,	   a	   subset	   of	   proteins	   show	   faster	   turnover,	   suggesting	  
they	   may	   be	   directly	   targeted	   for	   degradation.	   The	   similar	   distribution	   of	   protein	  
turnover	  rates	  seen	  for	  the	  cytoplasm	  and	  the	  nucleoplasm	  likely	  reflects	  the	  high	  level	  
of	  protein	  shuttling	  between	  these	  compartments.	  This	  contrasts	  with	   the	  nucleolus,	  
where	  a	  distinct	  group	  of	  proteins	  show	  fast	  turnover	  (<6	  hours),	  mostly	  corresponding	  
to	  ribosomal	  proteins.	  Interestingly,	  recent	  studies	  point	  to	  a	  role	  for	  the	  accumulation	  
of	  specific	  free	  ribosomal	  proteins	  in	  the	  nucleus	  in	  signalling	  mechanisms	  involved	  in	  
stress	   responses	   and	   growth	   control	   (Sundqvist	   et	   al.,	   2009),	   suggesting	   that	   the	  
control	  of	  ribosomal	  protein	  stability	  in	  the	  nucleus	  is	  involved	  in	  biological	  regulation.	  	  
Proteins	  with	  the	  slowest	  turnover	  have	  a	  wide	  range	  of	  functions,	  but	  are	  commonly	  
present	  either	  in	  large,	  abundant	  and	  stable	  protein	  complexes,	  such	  as	  ribosome	  and	  
spliceosome	   subunits,	   RNA	   polymerases,	   the	   nuclear	   pore,	   the	   exosome	   and	   the	  
proteasome,	   or	   else	   are	   found	   inside	  mitochondria.	   Interestingly,	   with	   almost	   all	   of	  
these	   slow	   turnover	  proteins,	   it	   is	   noted	   that	   the	   turnover	   rate	  of	   each	   subunit	  was	  
significantly	   slower	   in	   one	   subcellular	   compartment,	   correlating	   with	   the	   location	  
where	   they	   exert	   their	   function.	   These	   observations	   suggest	   a	   general	   assembly	  
strategy	   whereby	   cells	   produce	   an	   excess	   of	   subunits	   in	   order	   to	   favour	   complex	  
formation,	   but	   carry	   out	   this	   assembly	   in	   a	   compartment	   separate	   to	   the	   eventual	  
main	   site	   of	   function.	   This	   avoids	   the	   need	   to	   tightly	   co-­‐regulate	   transcription,	  
processing,	   transport	   and	   translation	   of	   the	   mRNAs	   encoding	   different	   protein	  
subunits	   in	   eukaryotes	   where	   genes	   are	   not	   organised	   in	   operons	   and	   not	   co-­‐
transcribed	   and	   translated.	   Any	   excess	   protein	   subunits	   produced	   will	   simply	   be	  
degraded	   in	  the	  assembly	  compartment.	  This	  model	  explains	  the	  differential	  stability	  
of	  ribosomal	  proteins	  between	  the	  nucleus,	  where	  they	  are	  assembled	  with	  RNA,	  and	  
the	   cytoplasm	   where	   they	   function	   to	   translate	   mRNA	   and	   conversely,	   the	   higher	  
stability	  of	  snRNP	  proteins	  in	  the	  nucleus,	  where	  they	  function	  in	  pre-­‐mRNA	  splicing,	  as	  
opposed	  to	  in	  the	  cytoplasm,	  where	  they	  assemble	  on	  snRNAs.	  	  
The	   empirical	   measurements	   of	   turnover	   values	   allows	   an	   objective	   evaluation	   of	  
protein	   features	   that	   influence	   stability	   for	   endogenous	   cell	   proteins	   and	   a	   parallel	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analysis	  of	  how	  this	  may	  vary	  between	  subcellular	  compartments.	  Thus,	  it	  is	  observed	  
a	   general	   correlation	   that	   highly	   abundant	   proteins	   are	   more	   stable	   than	   average,	  
consistent	   with	   the	   enduring	   roles	   of	   abundant	   structural	   proteins	   and	   major	  
complexes	   involved	   in	   gene	   expression.	   In	   contrast,	   the	   net	   charge	   and	   molecular	  
weight	   of	   proteins	   shows	   little	   or	   no	   correlation	   with	   turnover	   rate.	   Somewhat	  
surprisingly,	  given	  the	  previous	  literature	  describing	  an	  ‘N-­‐end	  rule’,	  whereby	  protein	  
degradation	   mechanisms	   favour	   more	   rapid	   degradation	   of	   protein	   and	   peptide	  
fragments	  with	  specific	  amino	  acids	  at	  the	  amino	  terminus,	  no	  evidence	  was	  found	  for	  
either	  an	  N-­‐end	  or	  C-­‐end	  rule	  for	  endogenous	  HeLa	  proteins.	  Thus,	  the	  mean	  turnover	  
rates	  for	  HeLa	  proteins	  is	  remarkably	  similar	  regardless	  of	  which	  amino	  acid	  is	  present	  
at	   either	   the	   first	   ten,	   or	   last	   ten,	   positions	   in	   the	   polypeptide	   chain.	   This	   contrasts	  
with	   budding	   yeast,	  where	   a	   dramatic	   difference	   in	   stability	   is	   reported	   for	   proteins	  
with	   either	   Arg,	   Lys,	   Asp,	   Phe	   or	   Leu	   at	   their	   N-­‐terminus,	   which	   show	   rapid	  
degradation,	  as	  opposed	  to	  proteins	  having	  Met,	  Gly,	  Ala,	  Ser,	  Thr	  or	  Val	  at	  their	  amino	  
terminus,	  which	  have	  half-­‐lives	  significantly	  longer	  than	  the	  division	  rate	  of	  yeast	  cells	  
(Varshavsky,	  1992).	  Nonetheless,	  currently	  it	  can	  not	  be	  excluded	  that	  a	  more	  complex	  
sequence	   motif	   pattern	   at	   the	   terminus	   of	   human	   proteins	   might	   correlate	   with	  
degradation	   efficiency	   and	   it	   is	   also	   possible	   that	   the	   degradation	   rate	   of	   cleaved	  
protein	   fragments,	   rather	   than	   full	   length	  proteins,	  may	  be	  affected	   in	  HeLa	   cells	  by	  
the	  identity	  of	  specific	  amino-­‐terminal	  amino	  acids	  or	  motifs.	  
A	   positive	   correlation	   is	   observed	   between	   the	   prevalence	   of	   PEST	   sequence	  motifs	  
and	   rapid	   protein	   turnover,	   consistent	   with	   prior	   evidence	   that	   PEST	   motifs	  
destabilized	   proteins	   in	   vivo	   (Rechsteiner	   and	   Rogers,	   1996).	   However,	   the	  
considerable	   variability	   in	   the	   turnover	   rates	   of	   specific	   proteins	   containing	   PEST	  
motifs	   pointed	   to	   a	   complex	   relationship	   between	   sequence	   motifs	   and	   protein	  
stability.	   It	   is	   likely	   that	   multiple	   structural	   and	   sequence	   elements,	   as	   well	   as	  
abundance,	  localisation	  and	  the	  presence	  of	  interaction	  partners,	  can	  all	  affect	  the	  net	  
stability	  of	  individual	  proteins.	  It	  is	  thus	  difficult	  to	  accurately	  predict	  protein	  stability	  
based	   on	   primary	   sequence	   information	   and	   this	   demonstrates	   the	   importance	   of	  
determining	  protein	   turnover	  empirically	  under	  different	   cell	   growth	   conditions.	   It	   is	  
anticipated	  that	  at	   least	  some	  patterns	  of	  post-­‐translational	  modification	  will	  also	  be	  
found	   to	   correlate	   with	   protein	   properties	   such	   as	   turnover	   rate,	   subcellular	  
localisation	   and	   abundance.	   Future	   work	   will	   address	   this	   issue	   and	   mining	   of	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relational	   databases	   of	   protein	   properties	   and	   PTM	   patterns	  may	   predict	   functional	  
relationships	  that	  can	  be	  evaluated	  further	  experimentally.	  	  
It	  is	  envisaged	  in	  future	  that	  this	  general	  approach	  for	  characterising	  protein	  turnover	  
rates	   and	   associated	   protein	   properties	   such	   as	   subcellular	   localisation,	   abundance,	  
interaction	  partners	  and	  PTM	  patterns	  can	  be	  extended	  in	  several	  ways.	  It	   is	  possible	  
to	  expand	  the	  subcellular	  fractionation	  strategy	  for	  example	  and	  thereby	  obtain	  higher	  
resolution	   spatial	   information	   regarding	   the	   subcellular	  distribution	  of	   the	  proteome	  
and	   how	   this	   correlates	   with	   protein	   structure,	   isoforms	   and	   PTM	   patterns.	   This	  
present	   study	   has	   not	   distinguished	   effects	   on	   the	   proteome	   of	   cells	   growing	   at	  
different	  stages	  of	  the	  cell	  cycle.	  However,	  specific	  examples	  are	  already	  known	  where	  
either	   protein	   stability	   or	   subcellular	   localisation	   can	   alter	   as	   cells	   progress	   through	  
interphase	   and	   mitosis.	   Work	   is	   in	   progress	   therefore	   to	   carry	   out	   systematic,	  
proteome	   wide	   analyses	   of	   how	   protein	   properties,	   including	   turnover	   rates	   and	  
subcellular	  localisation	  patterns,	  vary	  as	  a	  function	  of	  cell	  cycle	  progression,	  providing	  
a	   detailed	   quantitative	   annotation	   of	   the	   human	   proteome	   in	   both	   time	   and	   space.	  
None	  of	  the	  protein	  properties	  discussed	  above	  represent	  ‘absolute’	  values,	  and	  it	  is	  to	  
be	  expected	  that	  rates	  of	  protein	  turnover,	   localisation	  patterns,	   interaction	  partners	  
and	  PTMs	  will	   vary	   considerably	  between	  different	   cell	   lines,	  under	  different	  growth	  
conditions	   and	   in	   response	   to	   drugs	   or	   other	   external	   stimuli.	   Specific	   mutations,	  
which	  may	  be	  associated	  with	  either	  oncogenic	  transformation	  or	  genetic	  disease,	  can	  
also	  alter	   these	  protein	  properties.	   The	  development	  and	   integration	  of	  many	   large-­‐
scale,	   quantitative	   proteomic	   datasets	   of	   the	   sort	   described	   here	   thus	   offers	   a	  
promising	   future	   direction	   for	   expanding	   the	   functional	   annotation	   of	   the	   human	  
genome,	   and	   the	   genomes	   of	   other	  model	   organisms,	   and	   for	   the	   discovery	   of	   new	  
biological	  regulatory	  mechanisms.	  
6.6 Distribution of Effort 
Lamond	   Laboratory	   biologists,	   primarily	   Francois-­‐Michel	   Boisvert,	   carried	   out	   the	  
experimental	  bench	  work	  during	  this	  study.	  The	  analysis	  described	  in	  this	  chapter	  was	  
a	   joint	   effort	   between	   Yasmeen	   Ahmad	   and	   Francois	   Michel	   Boisvert.	   Software,	  
created	   by	   Marek	   Gierlinkski,	   was	   used	   to	   aid	   with	   the	   data	   analysis,	   i.e.	   to	   build	  
smoothed	   synthesis,	   degradation,	   turnover	   and	   intensity	   profile	   curves	   for	   each	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protein	   identified	   by	   MS.	   Yasmeen	   Ahmad	   carried	   out	   all	   of	   the	   technical	  
implementation	  with	  regards	  to	  the	  Turnover	  &	  Spatial	  Viewer.	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Chapter 7: Protein Isoform, Localisation and Turnover 
Analysis 
7.1 Summary  
In	   higher	   eukaryotes,	   many	   genes	   encode	   two	   or	   more	   protein	   isoforms	   and	   the	  
properties	   and	   biological	   roles	   of	   these	   separate	   isoforms	   are	   often	   poorly	  
characterised.	   This	   chapter	   describes	   a	   number	  of	   systematic	   approaches	  developed	  
for	  the	  detection	  of	  protein	  isoforms	  with	  differential	  biological	  properties	  (Ahmad	  et	  
al.,	  2011).	  	  
Previously,	  information	  from	  ion	  intensities	  and	  rates	  of	  change	  in	  SILAC	  isotope	  ratios	  
allowed	   calculation	   of	   protein	   abundance	   levels,	   turnover	   rates	   and	   subcellular	  
distribution	  between	   cytoplasmic,	   nuclear	   and	  nucleolar	   compartments	   for	   the	  HeLa	  
cell	   proteome	   (see	   Chapter	   6:	   Spatial	   Localisation	   &	   Turnover	   Analyses).	   Protein	  
isoforms	  were	  detected	  using	  three	  data	  analysis	  strategies:	  candidate	  approach,	  rule	  
of	  thirds	  approach	  and	  three	  in	  a	  row	  approach.	  These	  strategies	  evaluate	  differences	  
between	   SILAC	   isotope	   ratios	   for	   specific	   groups	   of	   peptides	   within	   the	   total	   set	   of	  
peptides	  assigned	  to	  a	  protein.	  For	  known	  isoforms,	  the	  candidate	  approach	  compares	  
SILAC	  isotope	  ratios	  for	  peptides	  predicted	  to	  be	  isoform-­‐specific,	  with	  ratio	  values	  for	  
peptides	  shared	  by	  all	   the	   isoforms.	  The	  rule	  of	   thirds	  approach	  compares	   the	  mean	  
isotope	  ratio	  values	  for	  all	  peptides	   in	  each	  of	  three	  equal	  segments	  along	  the	   linear	  
length	  of	   the	  protein,	   assessing	  differences	  between	   segment	   values.	   The	   three	   in	   a	  
row	  approach	   compares	   the	  mean	   isotope	   ratio	   values	   for	   each	   sequential	   group	  of	  
three	   adjacent	   peptides,	   assessing	   differences	   with	   the	  mean	   value	   for	   all	   peptides	  
assigned	  to	  the	  protein.	  	  
Protein	   isoforms	  were	   also	   detected	   and	   their	   properties	   evaluated	   by	   fractionating	  
cell	   extracts	   on	   1-­‐D	   SDS	   PAGE	   prior	   to	   trypsin	   digestion	   and	   MS	   analysis	   and	  
independently	   evaluating	   isotope	   ratio	   values	   for	   the	   same	   peptides	   isolated	   from	  
different	   gel	   slices.	   This	   strategy	   allowed	   detection	   of	   isoforms	   that	   migrate	   across	  
multiple	   gel	   slices.	   Furthermore,	   the	   effect	   of	   protein	   phosphorylation	   on	   turnover	  
rates	  was	  analysed	   individually	   for	  cytoplasmic,	  nuclear	  and	  nucleolar	  compartments	  
by	   comparing	   the	   mean	   turnover	   values	   calculated	   for	   all	   peptides	   assigned	   to	   a	  
protein,	   either	   including,	   or	   excluding,	   values	   for	   cognate	   phosphopeptides.	   This	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showed	   that	   phosphorylation	   affected	   turnover	   of	   nucleolar	   proteins	   to	   a	   greater	  
extent	   than	   for	   proteins	   localised	   to	   the	   nucleus	   or	   cytoplasm.	   Collectively,	   these	  
experimental	   and	   analytical	   approaches	   provide	   a	   framework	   for	   expanding	   the	  
functional	  annotation	  of	  the	  genome.	  
Chapter	   7	   describes	   the	   analysis	   protein	   properties	   to	   identify	   protein	   isoforms,	  
focusing	   first	   on	   the	   occurrence	   of	   protein	   isoforms	   (section	   7.2),	   following	   with	   a	  
description	  of	   the	  bioinformatics	   analysis	   tools	   used	   (section	  7.3),	   description	  of	   the	  
novel	  approaches	  employed	  (sections	  7.4)	  and	  finally	  a	  discussion	  on	  the	   importance	  
of	  protein	  properties	  in	  data	  analysis	  (section	  7.5).	  	  	  
7.2 Background  
Biological	  regulatory	  mechanisms	  and	  cellular	  responses	  are	  predominantly	  mediated	  
by	   proteins	   and	   multi-­‐protein	   complexes.	   The	   structures	   and	   properties	   of	   these	  
proteins	   are	   crucial	   for	   their	   function	   and	   can	   vary	   greatly.	   For	   example,	   protein	  
expression	  levels	   in	  mammalian	  cells	  vary	  over	  a	   large	  dynamic	  range	  of	  106	  or	  more	  
(Corthals	   et	   al.,	   2000),	   while	   subcellular	   localisation	   patterns,	   post-­‐translational	  
modifications,	   rates	   of	   synthesis	   and	   degradation	   and	   interactions	   with	   partner	  
proteins	   are	   also	   variable	   properties	   (Hinkson	   and	   Elias,	   2011).	   Furthermore,	   all	   of	  
these	  properties	  not	  only	  vary	  between	  proteins,	  they	  are	  also	  dynamic	  and	  can	  vary	  
for	   the	   same	  protein	   at	   different	   times,	   depending	  on	  parameters	   such	   as	   cell	   cycle	  
progression,	  growth	  rate	  and	  signalling	  events.	  Proteomes	  are	  thus	  inherently	  complex	  
and	   their	   properties	   in	   constant	   flux.	   This	   presents	   a	  major	   challenge	   for	   proteomic	  
studies,	  which	   ideally	  should	  not	  only	   identify	  which	  proteins	  that	  are	  expressed	   in	  a	  
cell	  or	  organelle,	  but	  also	  characterise	  their	  properties	  and	  quantify	  how	  these	  change	  
in	  response	  to	  different	  perturbations	  and	  cell	  cycle	  stages	  etc.	  (Yates	  et	  al.,	  2005).	  
In	  higher	  eukaryotes,	  proteomic	  studies	  are	  complicated	  further	  by	  the	  fact	  that	  many	  
genes	   encode	   two	   or	   more	   separate	   protein	   isoforms	   (Jungblut	   et	   al.,	   2008).	  
Alternative	   splicing	   of	   pre-­‐mRNA	   transcripts	   is	   commonplace	   and	   this	   can	   generate	  
multiple	  mRNAs	  from	  the	  same	  gene	  and	  hence	  multiple	  different	  proteins	  (Matlin	  et	  
al.,	   2005).	   Such	   isoforms	   can	   vary	   in	   length,	   share	   common	   exons,	   include	   variable	  
exons	  and	  even	  have	  very	  different	  amino	  acid	  sequences	  because	  splicing	  events	  can	  
alter	  the	  translational	  reading	  frame	  of	  the	  differentially	  spliced	  mRNAs.	  Isoforms	  can	  
also	   arise	   from	   differential	   post-­‐translational	   processing	   and	   modification	   of	   a	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polypeptide	   encoded	   by	   a	   single	   mRNA.	   In	   other	   cases	   gene	   duplication	   results	   in	  
expression	  of	  closely	   related	  protein	  paralogs	   that	   share	  extensive	  sequence	   identity	  
and	  are	  hard	   to	  distinguish.	  Even	  minor	   structural	  differences	  between	   isoforms	  can	  
alter	   their	  biological	  properties	  and	  result	   in	  distinct	  pools	  of	   related	  proteins	  whose	  
subcellular	  location,	  function	  and	  interactions	  vary.	  
The	   expression	   levels,	   structures,	   properties	   and	   biological	   roles	   of	   separate	   protein	  
isoforms	   are	   still	   poorly	   characterised	   and	   commonly	   ignored	   in	   many	   large-­‐scale	  
proteomic	   analyses	   (Jungblut	   et	   al.,	   2008).	   However,	   since	   protein	   isoforms	   usually	  
share	   common	   sequences,	   even	   if	   one	   or	   more	   exons	   are	   isoform-­‐specific,	   it	   is	  
important	   to	   the	   biological	   interpretation	   of	   proteomics	   experiments	   to	   decide	  
whether	  all	  peptides	  mapped	  to	  a	  specific	  gene	  are	  encoded	  in	  a	  single	  polypeptide.	  If	  
instead	   the	   peptides	   derive	   from	   two	   or	   more	   isoforms,	   these	   may	   have	   distinct	  
biochemical	   properties,	   such	   as	   subcellular	   localisation	   and/or	   turnover	   rate.	   In	   this	  
case	   the	   averaged	   value	   from	   all	   of	   the	   peptides	   may	   give	   a	   misleading	   picture	  
regarding	   the	   property	   of	   the	   protein	   under	   study.	   For	   example,	   when	   studying	  
subcellular	   localisation,	  the	  averaged	  value	  for	  all	  peptides	  from	  a	  gene	  may	   indicate	  
that	   the	  protein	   is	  present	   in	  both	   the	  cytoplasm	  and	   the	  nucleus,	  when	   in	   fact	  one	  
isoform	  is	  predominantly	  cytoplasmic	  and	  the	  other	  predominantly	  nuclear	  (see	  Figure	  
47).	   This	   is	   likely	   to	  be	  of	   general	   importance	   for	   annotating	   the	   genome	  because	   a	  
recent	  comparative	  study	  of	  subcellular	  protein	   localization	   in	  three	  human	  cell	   lines	  
detected	   ~40%	   of	   the	   4,000	   genes	   analysed	   localising	   to	   multiple	   subcellular	  
compartments	  (Fagerberg	  et	  al.,	  2011).	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Figure	  47:	  Alternative	  splicing	  leading	  to	  protein	  isoforms.	  	  
A)	  A	  single	  gene	  can	  encode	  multiple	  proteins	  due	  to	  alternative	  splicing.	  After	  
transcription	  of	  a	  gene,	  exons	  of	  the	  resultant	  RNA	  can	  be	  reconnected	  in	  multiple	  ways	  
during	  RNA	  splicing,	  resulting	  in	  the	  translation	  of	  protein	  isoforms.	  Shown	  are	  two	  
isoforms	  produced	  from	  the	  same	  gene,	  with	  red	  and	  green	  areas	  signifying	  differences	  
between	  the	  isoforms	  due	  to	  alternative	  splicing.	  B)	  Protein	  isoforms	  represent	  several	  
different	  forms	  of	  a	  protein	  and	  have	  a	  largely	  shared	  sequence,	  however	  small	  
differences	  occur.	  Protein	  isoforms	  can	  be	  recognised	  and	  differentiated	  via	  these	  
differences,	  by	  locating	  isoform	  specific	  peptides,	  i.e.	  amino	  acid	  sequences	  that	  encode	  
the	  difference.	  During	  mass	  spectrometry	  analysis,	  proteins	  are	  digested	  using	  an	  
enzyme,	  often	  trypsin,	  which	  fragments	  a	  protein	  into	  peptides.	  A	  mass	  spectrometer	  
can	  then	  be	  used	  to	  analyse	  samples	  and	  hence	  identify	  protein	  peptides.	  The	  list	  of	  
identified	  peptides	  contains	  common	  peptides	  shared	  by	  all	  isoforms,	  but	  also	  specific	  
peptides	  (shown	  in	  red	  and	  green)	  that	  are	  unique	  to	  each	  isoform.	  C)	  Using	  these	  
identified	  peptides	  it	  is	  possible	  to	  extract	  abundance,	  localisation	  and	  turnover	  
information	  for	  a	  protein.	  Using	  commonly	  shared	  peptides	  provides	  average	  
abundance,	  localisation	  and	  turnover	  values	  for	  a	  protein,	  however,	  using	  isoform	  
specific	  peptides	  it	  is	  possible	  to	  calculate	  values	  per	  isoform.	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Mass	   spectrometry-­‐based	   proteomics	   has	   become	   the	   technology	   of	   choice	   for	   the	  
direct	   identification	   and	   characterisation	   of	   proteins	   (Walther	   and	  Mann,	   2010a).	   In	  
combination	  with	  quantitative	  approaches,	  such	  as	  SILAC	  (Stable	  Isotope	  Labelling	  with	  
Amino	   acids	   in	   Cell	   culture),	   mass	   spectrometry	   can	   not	   only	   identify	   proteins	   and	  
post-­‐translational	  modifications,	  but	  also	  measure	  how	  relative	  protein	   levels	  change	  
in	   cells	   under	   different	   conditions	   (Ong	   et	   al.,	   2003,	   Mann,	   2006).	   This	   provides	   a	  
flexible	  assay	  format	  for	  proteomic	  studies	  that	  evaluate	  differences	  between	  two	  or	  
more	  cell	  states,	  each	  defined	  by	  metabolic	  labelling	  of	  proteins	  with	  amino	  acids	  that	  
have	   different	   combinations	   of	   isotopes	   incorporated	   into	   selected	   amino	   acids.	  
Subsequent	   isolation	   of	   proteins	   and	   enzyme	   cleavage	   results	   in	   mixtures	   of	  
isotopically	   labelled	   peptides	  where	   the	   relative	   levels	   of	   each	   isotopic	   form	   can	   be	  
resolved	   and	   quantified	   by	  mass	   spectrometry.	   The	   peptide	   isotope	   ratios	   are	   then	  
mapped	  back	   to	   the	   genome	   sequences	   encoding	   the	   cognate	   proteins	   and	   used	   to	  
infer	  whether	   either	   the	   levels,	   or	   properties,	   of	   these	  proteins	  have	  been	   changed.	  
The	   SILAC	   strategy	   has	   been	   used	   for	   quantitative	   studies	   of	   cell	   and	   organelle	  
proteomes	   and	   for	   comparative	   studies	   of	   protein	   modifications,	   and	   interactions	  
(Walther	   and	   Mann,	   2010b)	   and	   to	   identify	   proteins	   isolated	   from	   mitotic	  
chromosomes	   (Ohta	   et	   al.,	   2010).	   It	   has	   also	   been	   used	   in	   combination	   with	   cell	  
fractionation	   to	   generate	   ‘isotope-­‐encoded’	   subcellular	   compartments	   allowing	  
subcellular	  protein	  localisation	  to	  be	  evaluated	  on	  a	  system-­‐wide	  level	  (Boisvert	  et	  al.,	  
2010).	  
Chapter	  6	  reports	  a	  global	  analysis	  of	  protein	  abundance,	  subcellular	   localisation	  and	  
turnover	   in	   HeLa	   cells	   using	   SILAC	   and	   mass	   spectrometry	   that	   characterised	   over	  
80,000	  peptides	  mapped	  to	  ~8,000	  human	  genes	  (Boisvert	  et	  al.,	  2011).	  In	  this	  chapter	  
this	   HeLa	   dataset	   was	   analysed	   using	   systematic	   approaches	   for	   the	   detection	   of	  
protein	   isoforms	  with	  differential	  biological	  properties.	  Methods	  were	  evaluated	  that	  
can	   identify	   human	   protein	   isoforms	   whose	   turnover	   and/or	   subcellular	   localisation	  
properties	  vary	  and	  analyse	  phosphorylated	  peptides	  that	  are	  correlated	  with	  altered	  
rates	   of	   protein	   turnover	   in	   the	   separate	   cytoplasmic,	   nuclear	   and	   nucleolar	  
compartments.	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7.3 Quantification and Bioinformatics Analysis 
The	   methods	   used	   for	   preparation	   of	   SILAC	   labelled	   HeLa	   proteins	   from	   nuclear,	  
nucleolar	   and	   cytoplasmic	   fractions,	   protein	   chromatography	   by	   SDS	   PAGE,	   trypsin	  
digestion	   and	   mass	   spectrometry	   was	   described	   previously	   (Boisvert	   et	   al.,	   2011).	  
Peptide	  identification,	  quantitation	  and	  phosphopeptide	  analysis	  was	  performed	  using	  
MaxQuant	  version	  1.1.1.14	  (Cox	  and	  Mann,	  2008,	  Cox	  et	  al.,	  2009).	  The	  derived	  peak	  
list	   was	   searched	   using	   Andromeda	   as	   the	   database	   search	   engine	   for	   peptide	  
identifications	   against	   the	   International	   Protein	   Index	   (IPI)	   human	   protein	   database	  
(version	   3.68)	   containing	   89,422	   proteins,	   to	   which	   175	   commonly	   observed	  
contaminants	   and	   all	   the	   reversed	   sequences	   had	   been	   added.	   The	   initial	   mass	  
tolerance	  was	  set	  to	  7	  p.p.m.	  and	  MS/MS	  mass	  tolerance	  was	  0.5	  Da.	  Enzyme	  was	  set	  
to	  trypsin/p	  with	  2	  missed	  cleavages.	  Carbamidomethylation	  of	  cysteine	  was	  searched	  
as	   a	   fixed	   modification,	   whereas	   N-­‐acetyl	   protein,	   oxidation	   of	   methionine	   and	  
phosphorylation	   of	   serine,	   threonine	   and	   tyrosine	   were	   searched	   as	   variable	  
modifications.	  Identification	  was	  set	  to	  a	  false	  discovery	  rate	  of	  1%.	  To	  achieve	  reliable	  
identifications,	   all	   proteins	  were	   accepted	   based	   on	   the	   criteria	   that	   the	   number	   of	  
forward	  hits	  in	  the	  database	  was	  at	  least	  100-­‐fold	  higher	  than	  the	  number	  of	  reverse	  
database	  hits,	  thus	  resulting	  in	  a	  false	  discovery	  rate	  (FDR)	  of	  less	  than	  1%.	  A	  minimum	  
of	  2	  peptides	  were	  quantified	  for	  each	  protein.	  Data	  analysis	  was	  performed	  using	  the	  
PepTracker	   software	   environment.	   Clustering	   analysis	   was	   performed	   using	   the	  
software	   Cluster	   with	   complete	   linkage	   clustering	   and	   visualised	   using	   Treeview	  
(http://rana.lbl.gov/EisenSoftware.htm)	  (Eisen	  et	  al.,	  1998).	  
7.4 Results  
7.4.1 Protein Isoform Analysis: Candidate Approach 
The	   data	   described	   in	   Chapter	   6,	   i.e.	   HeLa	   cell	   SILAC	   data	   describing	   global	   protein	  
abundance,	   localisation	  and	  turnover	   (Boisvert	  et	  al.,	  2011),	  has	  been	  analysed	  using	  
three	   approaches	   to	   detect	   protein	   isoforms	   that	   have	   differential	   properties	   (see	  
Figure	  47).	  First,	  a	  candidate	  approach	  was	  used.	  For	  genes	  encoding	  known	  isoforms,	  
average	  intensity	  values	  were	  compared	  for	  peptides	  shared	  between	  all	  isoforms	  with	  
candidate,	  isoform-­‐specific	  peptides	  (see	  Figure	  48).	  This	  is	  illustrated	  for	  the	  NudCD1	  
protein,	  which	  has	  three	  reported	  isoforms	  (Yan	  et	  al.,	  2004).	  Using	  average	  values	  for	  
all	   peptides	   detected	   that	   are	   common	   to	   the	   three	   isoforms	   (blue),	   there	   is	   similar	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average	   peptide	   intensity	   in	   the	   cytoplasm	   and	   nucleus,	   with	   little	   signal	   in	   the	  
nucleolus.	  However,	  while	  analysis	  of	  a	  peptide	  predicted	  to	  be	  specific	   to	   isoform	  3	  
showed	   intensity	   in	   both	   cytoplasmic	   and	   nuclear	   compartments	   (green,	   ~3:2	  
cytoplasmic:nuclear),	   a	   peptide	   predicted	   to	   be	   specific	   for	   isoform	   2	   (red),	   instead	  
showed	  exclusively	  cytoplasmic	  signal	  (see	  Figure	  2A).	  In	  the	  case	  of	  isoform	  1,	  it	  was	  
not	   possible	   to	   identify	   an	   isoform-­‐specific	   peptide	   that	   could	   be	   reliably	   detected.	  
However,	   as	   there	   is	   strong	   overall	   peptide	   signal	   in	   the	   nucleus	   that	   cannot	   be	  
accounted	  for	  by	  the	  intensities	  of	  either	  the	  isoform	  2,	  or	  isoform	  3-­‐specific	  peptides,	  
it	  can	  be	  inferred	  that	  isoform	  1	  is	  likely	  to	  be	  enriched	  in	  the	  nucleus.	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Figure	  48:	  NUDCD1	  Protein	  isoform	  identification	  and	  localisation.	  
This	  figure	  describes	  the	  identification	  of	  NudCD1,	  NudC	  domain-­‐containing	  protein	  1.	  
A)	  Chart	  showing	  intensity	  (Y	  axis)	  in	  different	  cellular	  compartments	  (X	  axis)	  for	  three	  
peptides.	  The	  blue	  series	  provides	  an	  average	  intensity	  of	  common	  peptides	  shared	  
between	  all	  three	  known	  isoforms	  of	  NudCD1,	  indicating	  that	  the	  NudCD1	  protein	  has	  
approximately	  similar	  average	  peptide	  intensity	  in	  the	  cytoplasm	  and	  nucleus,	  with	  
little	  signal	  in	  the	  nucleolus.	  The	  remaining	  series	  show	  the	  intensity	  of	  peptides	  not	  
commonly	  shared	  by	  all	  three	  isoforms,	  i.e.	  MLYLQGWSMPAVAEVK	  (isoform	  2	  peptide	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shown	  in	  red)	  and	  YNQDTALGKPR	  (isoform	  3	  peptide	  shown	  in	  green).	  The	  isoform	  3	  
specific	  peptide	  shows	  intensity	  in	  both	  cytoplasmic	  and	  nuclear	  compartments	  (~3:2	  
cytoplasmic:nuclear),	  and	  the	  isoform	  2	  peptide	  shows	  exclusively	  cytoplasmic	  signal.	  
B)	  HeLa	  cells	  expressing	  GFP	  fused	  at	  the	  N-­‐terminus	  to	  isoform-­‐specifc	  cDNAs	  were	  
used	  to	  establish	  stable	  HeLa	  cell	  lines	  where	  expression	  of	  the	  fusion	  protein	  is	  under	  
the	  control	  of	  a	  tetracycline-­‐regulated	  promoter.	  All	  three	  stable	  HeLa	  cell	  lines	  
produced	  proteins	  of	  the	  expected	  sizes	  when	  induced	  by	  addition	  of	  tetracycline	  and	  
analysed	  by	  protein	  blotting,	  detected	  using	  an	  anti-­‐GFP	  antibody.	  As	  can	  be	  seen	  by	  
the	  upper	  bands	  on	  the	  western	  blot	  (orange	  arrow),	  three	  protein	  isoforms	  are	  
recognised,	  migrating	  at	  the	  predicted	  molecular	  weights	  of	  NudCD1	  isoforms,	  i.e.	  
isoform	  1	  at	  66.76kDa	  (lane	  1),	  isoform	  2	  at	  63.50kDa	  (lane	  2)	  and	  isoform	  3	  at	  
56.61kDa	  (lane	  3).	  Fluorescence	  microscopy	  analysis	  of	  HeLa	  cells	  expressing	  the	  
respective	  GFP-­‐fusion	  proteins	  was	  performed	  to	  determine	  localisation	  patterns,	  using	  
both	  an	  antibody	  to	  GFP	  (panels	  D,	  G	  &	  J),	  and	  direct	  GFP	  fluorescence	  (panels	  E,	  H	  &	  
K).	  NudCD1	  Isoform	  1	  shows	  nuclear	  accumulation	  in	  panels	  D	  &	  E,	  NudCD1	  isoform	  2	  
shows	  predominantly	  cytoplasmic	  accumulation	  in	  panels	  G	  &	  H	  and	  both	  cytoplasmic	  
and	  nuclear	  accumulation	  is	  shown	  of	  NudCD1	  isoform	  3	  in	  panels	  J	  &	  K.	  	  
As	  no	  suitable	  isoform-­‐specific	  antibodies	  for	  NudCD1	  were	  available,	  the	  localisation	  
patterns	  of	  the	  three	  NudCD1	  isoforms	  were	  next	  compared	  by	   immunofluorescence	  
microscopy	  analysis	  of	  HeLa	  cells	  expressing	  GFP	  fused	  at	  the	  N-­‐terminus	  to	   isoform-­‐
specific	  cDNAs	  (see	  Figure	  2,	  B-­‐K).	  All	  three	  GFP-­‐NudCD1	  isoform	  fusions	  were	  used	  to	  
establish	   stable	   HeLa	   cell	   lines	   where	   expression	   of	   the	   fusion	   protein	   is	   under	   the	  
control	  of	  a	  tetracycline-­‐regulated	  promoter.	  All	  three	  stable	  HeLa	  cell	  lines	  produced	  
proteins	  of	  the	  expected	  sizes	  when	  induced	  by	  addition	  of	  tetracycline	  and	  analysed	  
by	   protein	   blotting,	   detected	   using	   an	   anti-­‐GFP	   antibody	   (see	   Figure	   48B).	  
Fluorescence	  microscopy	   analysis	   of	   HeLa	   cells	   expressing	   the	   respective	  GFP-­‐fusion	  
proteins	  was	  performed,	  using	  both	  an	  antibody	  to	  GFP	  (see	  Figure	  48,	  panels	  D,	  G	  &	  
J),	   and	   direct	   GFP	   fluorescence	   (see	   Figure	   48,	   panels	   E,	   H	  &	   K),	   to	   determine	   their	  
localisation	   patterns.	   In	   agreement	   with	   the	   spatial	   proteomics	   data,	   this	   showed	  
predominantly	   nuclear	   accumulation	   of	   NudCD1	   isoform	   1	   (panels	   D	   &	   E),	  
predominantly	   cytoplasmic	   accumulation	   of	   NudCD1	   isoform	   2	   (panels	   G	   &	   H)	   and	  
both	  cytoplasmic	  and	  nuclear	  accumulation	  of	  NudCD1	  isoform	  3	  (panels	  J	  &	  K).	  None	  
of	  the	  three	  GFP-­‐NudCD1	  isoform	  fusions	  accumulated	  in	  nucleoli.	  
These	  data	  analysing	  NudCD1	  isoforms	  illustrate	  the	  validity	  of	  the	  candidate	  approach	  
but	  also	  highlight	  its	  limitations.	  It	  relies	  upon	  prior	  annotation	  to	  predict	  the	  existence	  
of	  isoforms	  and	  the	  ability	  to	  detect	  unique	  peptides	  that	  are	  isoform-­‐specific.	  As	  seen	  
for	  isoform	  1,	  it	  is	  not	  always	  possible	  to	  detect	  isoform-­‐specific	  peptides.	  Even	  when	  
isoform-­‐specific	  peptides	  can	  be	  detected,	  as	  with	   isoforms	  2	  and	  3,	  they	  are	  usually	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few	   in	   number	   (often	   only	   one)	   and	   this	   reduces	   the	   accuracy	   of	   the	   overall	  
quantitation.	  Nonetheless,	  the	  NudCD1	  data	  show	  clearly	  that	  analysis	  of	  a	  key	  protein	  
property,	   such	   as	   subcellular	   localisation,	   can	   be	   misleading	   when	   values	   for	   all	  
peptides	   are	   averaged	  without	   taking	   into	   account	   the	  existence	  of	   distinct	   pools	   of	  
protein	  with	  differential	  localisation	  phenotypes.	  
7.4.2 Protein Isoform Analysis: Rule of Thirds Approach 
Next,	   two	  methods	  were	  used	  to	  systematically	  evaluate	  whether	  the	  mean	  value	  of	  
all	  peptides	  quantitated	  for	  a	  given	  protein	  included	  clusters	  of	  adjacent	  peptides	  with	  
significantly	  different	  mean	  values.	  First,	  a	  ‘rule	  of	  thirds’	  approach	  was	  used	  to	  search	  
the	   data	   for	   examples	  where	   the	  mean	   values	   of	   peptides	   from	   the	   amino	   terminal	  
(S1,	   blue),	   central	   (S2,	   red)	   or	   carboxy	   terminal	   (S3,	   green)	   segments	   of	   the	   protein	  
differed	   by	   at	   least	   one	   standard	   deviation	   from	   an	   adjacent	   segment.	   This	   was	  
evaluated	   for	   over	   6,000	   HeLa	   proteins,	   where	   at	   least	   two	   peptides	   had	   been	  
quantitated	  within	  each	  segment	  of	  the	  protein	  sequence.	  The	  mean	  turnover	  rate	  for	  
each	  segmented	  third	  of	  every	  protein	  was	  plotted	  on	  the	  y	  axis	  against	  total	  proteins,	  
ranked	  on	  the	  X	  axis	  by	  the	  mean	  turnover	  value	  derived	  from	  all	  peptides	  assigned	  to	  
that	   protein	   (see	   Figure	   49A).	   Examples	   where	   the	   turnover	   value	   of	   any	   one	   third	  
segment	  of	  a	  given	  protein	  differed	  by	  more	  than	  70%	  from	  the	  overall	  turnover	  value	  
for	   the	   same	  protein,	   i.e.	   the	  mean	  of	   all	   the	  peptides	   assigned	   to	   that	   protein,	   are	  
highlighted	  and	  colour	  coded	  in	  blue,	  red	  and	  green	  for	  segments	  S1-­‐S3,	  respectively	  




Figure	  49:	  Protein	  isoform	  identification	  from	  protein	  sequence	  segmentation.	  
A)	  Graph	  showing	  all	  proteins	  (X	  axis)	  ordered	  by	  average	  turnover	  of	  all	  identified	  
peptides	  against	  turnover	  in	  hours	  (Y	  axis).	  The	  grey	  series	  shows	  the	  average	  turnover	  
for	  each	  protein,	  calculated	  from	  all	  peptides	  identified	  for	  the	  protein.	  To	  identify	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potential	  isoforms,	  each	  protein	  was	  divided	  into	  three	  equal	  segments	  based	  on	  
sequence	  length.	  A	  turnover	  value	  was	  calculated	  for	  each	  segment	  of	  the	  protein,	  
using	  only	  peptides	  found	  in	  that	  segment.	  The	  blue,	  red	  and	  green	  series	  highlight	  
segments	  of	  proteins	  that	  have	  a	  variance	  greater	  or	  less	  than	  70%	  compared	  to	  the	  
average	  protein	  turnover.	  RPS27A,	  Ubiquitin-­‐40S	  ribosomal	  protein	  S27a,	  is	  a	  protein	  
that	  shows	  a	  variance	  in	  segment	  3	  of	  the	  protein	  sequence	  (highlighted	  using	  orange	  
triangle).	  B)	  The	  chart	  shows	  that	  the	  three	  equal	  segments	  of	  RPS27A	  (X	  axis),	  show	  an	  
average	  turnover	  (Y	  axis)	  of	  10.73	  hours	  (segment	  1),	  14.46	  hours	  (segment	  2)	  and	  
31.06	  hours	  (segment	  3).	  As	  can	  be	  seen	  from	  the	  linear	  representation	  of	  the	  protein,	  
the	  peptides	  for	  each	  segment	  (examples	  shown	  underneath)	  have	  a	  significantly	  
different	  turnover	  in	  the	  carboxy	  terminal	  segment	  3	  (CCLTYCFNKPEDK:	  26.49	  hours,	  
ECPSDECGAGVFMASHFDR:	  35.63	  hours)	  compared	  with	  segment	  1	  (EGIPPDQQR:	  10.92	  
hours,	  IQDKEGIPPDQQR:	  10.93	  hours,	  LIFAGK:	  12.02	  hours,	  MQIFVK:	  9.19	  hours,	  
TITLEVEPSDTIENVK:	  10.62	  hours,	  TITLEVEPSDTIENVKAK:	  10.00	  hours,	  QLEDGR:	  11.41	  
hours)	  and	  segment	  2	  (ESTLHLVLR:	  12.80	  hours,	  QLEDGRTLSDYNIQK:	  11.72	  hours,	  
QLEDGRTLSDYNIQKESTLHLVLR:	  15.20	  hours,	  TLSDYNIQK:	  10.05	  hours,	  
TLSDYNIQKESTLHLVLR:	  10.95	  hours,	  SYTTPK:	  26.07	  hours).	  In	  fact,	  the	  full	  length	  
RPS27A	  protein	  is	  expressed	  as	  a	  precursor	  that	  is	  subsequently	  processed	  to	  yield	  
ubiquitin,	  reflecting	  the	  third	  segment	  that	  shows	  a	  much	  slower	  turnover.	  C)	  Two	  
further	  proteins	  were	  tested,	  CTSD	  -­‐	  Cathepsin	  D	  –	  (shown	  in	  orange	  square	  in	  A)	  and	  
RPRD1A	  -­‐	  Regulation	  of	  nuclear	  pre-­‐mRNA	  domain-­‐containing	  protein	  1A	  (shown	  in	  
orange	  circle	  in	  A).	  A	  cycloheximide	  inhibition	  experiment	  was	  performed	  on	  HeLa	  cells	  
to	  block	  protein	  synthesis	  and	  thus	  measure	  the	  rate	  of	  protein	  degradation.	  Both	  CTSD	  
(lanes	  1-­‐6)	  and	  RPRD1A	  (lanes	  7-­‐12)	  were	  detected	  by	  immunoblotting	  using	  specific	  
antibodies.	  The	  western	  blot	  for	  CTSD	  shows	  a	  band	  at	  the	  predicted	  molecular	  weight	  
of	  44.55kDa	  (white	  arrow).	  However	  another	  band	  is	  also	  visible,	  slightly	  higher	  (black	  
arrow),	  which	  shows	  a	  faster	  turnover	  across	  the	  5	  timepoints	  (lanes	  2-­‐6).	  This	  
correlates	  with	  the	  average	  turnover	  of	  the	  whole	  protein	  (9.45	  hours),	  which	  is	  much	  
faster	  compared	  to	  peptides	  found	  in	  segment	  1	  from	  CTSD1	  (26.20	  hours).	  In	  relation	  
to	  the	  second	  protein	  tested,	  RPRD1A,	  the	  segmentation	  method	  of	  analysis	  showed	  
segment	  1	  (28.73	  hours)	  had	  a	  significantly	  different	  turnover	  compared	  with	  segments	  
2	  (7.63	  hours)	  and	  3	  (14.04	  hours),	  indicating	  potential	  isoforms	  with	  different	  
turnover.	  The	  western	  blot	  for	  RPRD1A	  shows	  two	  bands,	  which	  correlate	  with	  the	  
expected	  molecular	  weight	  of	  the	  known	  isoforms	  of	  RPRD1A	  (isoform	  1	  at	  35.72kDa,	  
isoform	  2	  at	  32.92kDa	  and	  31.63kDa).	  Furthermore,	  the	  upper	  band	  (black	  arrow,	  
isoform	  1)	  shows	  slower	  degradation	  over	  the	  timecourse	  (lanes	  8-­‐12)	  (consistent	  with	  
segment	  1)	  compared	  with	  the	  lower	  band	  (white	  arrow)	  (isoforms	  2	  and	  3,	  consistent	  
with	  segments	  2	  and	  3).	  
The	  validity	  of	  the	  rule	  of	  thirds	  approach	  was	  confirmed	  by	  its	  unbiased	  identification	  
of	  RPS27A	  as	  one	  of	  the	  proteins	  with	  a	  segment	  showing	  differential	  turnover	  to	  the	  
mean	   value	   for	   the	  whole	   protein	   (see	   Figure	   49B).	   In	   this	   case	   the	  mean	   turnover	  
value	  of	  peptides	  from	  the	  carboxy	  terminal	  segment	  (green,	  ~31	  hours),	  was	  ~three	  
fold	  higher	  than	  the	  mean	  turnover	  values	  for	  the	  peptides	  in	  either	  of	  the	  other	  two	  
segments	  (blue	  ~11	  hours	  &	  red	  ~14	  hours)	  and	  ~200%	  higher	  than	  the	  mean	  of	  all	  the	  
peptides	   in	   this	   protein	   (~15	   hours).	   Interestingly,	   the	   full	   length	   RPS27A	   protein	   is	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expressed	   as	   a	   precursor	   that	   is	   subsequently	   processed	   to	   yield	   ubiquitin,	   which	  
accounts	  for	  approximately	  70%	  of	  the	  sequence,	  and	  a	  carboxy	  terminal	  segment	  of	  
~30%	  that	  corresponds	  to	  the	  mature	  ribosomal	  small	  subunit	  protein	  S27A	  (Chan	  et	  
al.,	  1995).	  As	  ubiquitin	   is	   subsequently	  conjugated	  to	  proteins	  as	  a	  post-­‐translational	  
modification	   that	   can	   promote	   proteasome-­‐mediated	   degradation,	   while	   ribosomal	  
proteins	   are	   typically	   stable	   after	   incorporation	   into	   ribosome	   subunits,	   it	   is	   not	  
surprising	  that	  these	  two	  products	  of	  the	  original	  RPS27A	  polypeptide	  exhibit	  different	  
turnover	  values.	  
Two	  other	  examples	  were	  selected	  from	  the	  group	  of	  highlighted	  proteins	  for	  further	  
analysis,	   corresponding	   to	   Cathepsin	   D	   (CTSD)	   and	   Regulation	   of	   nuclear	   pre-­‐mRNA	  
domain-­‐containing	  protein	   1A	   (RPRD1A)	   (see	   Figure	   49C).	  A	   cycloheximide	   inhibition	  
experiment	  was	  performed	  on	  HeLa	  cells	  to	  block	  protein	  synthesis	  and	  thus	  measure	  
the	  rate	  of	  protein	  degradation.	  Both	  CTSD	  (lanes	  1-­‐6)	  and	  RPRD1A	  (lanes	  7-­‐12)	  were	  
detected	   by	   immunoblotting,	   using	   specific	   antibodies	   generated	   by	   the	   Human	  
Protein	  Atlas	  Project.	  In	  both	  cases	  the	  blotting	  experiments	  reveal	  two	  bands	  for	  each	  
protein	   that	   decay	   at	   different	   rates	   following	   cycloheximide	   treatment	   (see	   Figure	  
49C,	  arrows).	  These	  data	   support	   the	  prediction	   from	  the	   rule	  of	   thirds	  analysis	   that	  
the	  CTSD	  and	  RPRD1A	  proteins	   are	  expressed	  as	  distinct	  polypeptides	  with	  different	  
turnover	  values.	  
7.4.3 Protein Isoform Analysis: Three in a Row Approach 
A	  limitation	  with	  the	  rule	  of	  thirds	  approach	  is	  that	  not	  all	  isoforms	  will	  have	  structures	  
that	  are	  separable	  based	  on	  analysis	  of	  arbitrary	  equal	  third	  regions	  of	  the	  protein.	  The	  
available	  peptide	  coverage	  is	  also	  often	  not	  evenly	  distributed	  between	  each	  of	  these	  
three	   equal	   segments.	   To	   provide	   a	   more	   general	   approach	   for	   predicting	   isoform	  
expression,	  based	  on	  local	  clusters	  of	  peptide	  values,	  the	  project	  turned	  to	  a	  ‘three	  in	  a	  
row’	   method.	   Here,	   mean	   turnover	   values	   were	   calculated	   for	   each	   set	   of	   three	  
consecutive	   peptides	   within	   the	   total	   set	   of	   peptides	   assigned	   to	   a	   given	   protein,	  
moving	  along	  one	  peptide	  at	  a	  time	  from	  the	  amino	  to	  carboxyl	  terminus	  (see	  Figure	  
50A).	   The	   resulting	   mean	   turnover	   values	   for	   every	   group	   of	   three	   consecutive	  
peptides	  were	   then	   plotted	   on	   the	   y	   axis,	   against	   the	   corresponding	  mean	   turnover	  
value	  on	   the	  x	  axis	   calculated	  using	  all	  peptides	  mapped	   to	  each	  protein	   (see	  Figure	  
50B).	  In	  this	  plot	  each	  triple	  peptide	  mean	  value	  is	  shown	  either	  in	  light	  blue	  (default),	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or	   in	   dark	   blue	   if	   two	   conditions	   are	   met.	   Thus,	   dark	   blue	   indicates	   that	   both	   the	  
turnover	  value	   for	   that	  group	  of	   three	  consecutive	  peptides	  differs	  by	  20%	  or	  more,	  
(either	  higher	  or	   lower),	   than	   the	  mean	  value	  of	  all	  of	   the	  peptides	  assigned	   to	   that	  
protein	  and	  that	  all	   three	  peptides	   in	   the	  group	  have	  similar	  values,	   i.e.	  all	   three	  are	  
either	  higher,	  or	  lower,	  than	  the	  protein	  mean.	  	  
	  
Figure	  50:	  Protein	  isoform	  identification	  from	  consecutive	  peptide	  analysis.	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In	  order	  to	  identify	  potential	  protein	  isoforms,	  an	  unbiased	  approach	  was	  employed	  
whereby	  any	  region	  of	  a	  protein	  showing	  a	  very	  different	  turnover	  from	  the	  whole	  
protein	  was	  highlighted.	  A)	  In	  order	  to	  do	  this,	  groups	  of	  three	  consecutive	  peptides	  
were	  identified	  and	  the	  average	  turnover	  value	  of	  each	  group	  calculated.	  A	  linear	  
representation	  of	  a	  protein	  is	  shown,	  with	  highlighted	  regions	  indicating	  identified	  
peptides.	  	  Any	  group	  of	  three	  peptides	  where	  each	  peptide	  showed	  a	  20%	  variance	  in	  
turnover	  from	  the	  average	  protein	  turnover	  (calculated	  from	  all	  peptides)	  was	  labelled	  
as	  interesting	  (Group	  3).	  B)	  Graph	  showing	  average	  protein	  turnover	  from	  all	  peptides	  
(X	  axis)	  versus	  the	  average	  turnover	  of	  three	  consecutive	  peptides	  from	  the	  protein	  (Y-­‐
axis).	  The	  data	  points	  highlighted	  in	  blue	  indicate	  three	  consecutive	  peptides	  that	  all	  
have	  a	  turnover	  that	  varies	  by	  20%	  greater	  or	  less	  than	  the	  average	  protein	  turnover	  
calculated	  from	  all	  peptides,	  indicating	  potential	  isoforms.	  Highlighted	  in	  red,	  is	  protein	  
HBS1L,	  HBS1-­‐like	  protein,	  which	  was	  investigated	  further.	  C)	  A	  cycloheximide	  
experiment	  was	  carried	  out	  to	  independently	  measure	  the	  degradation	  rate	  of	  HBS1L.	  
An	  antibody	  specific	  for	  HBS1L	  detected	  two	  bands	  on	  an	  immunoblot,	  consistent	  with	  
expression	  of	  two	  isoforms	  (blue	  and	  red	  arrows).	  These	  bands	  correlate	  to	  the	  known	  
isoforms	  of	  HBS1L	  (isoform	  1	  at	  75.5kDa	  (blue	  arrow),	  isoforms	  2	  and	  3	  at	  70.13kDa	  
and	  70.63kDa	  (red	  arrow)).	  D)	  Quantitation	  of	  the	  two	  bands	  at	  multiple	  time	  points	  
from	  0.5-­‐24	  hours	  (lanes	  2-­‐6)	  following	  cycloheximide	  treatment	  is	  shown	  on	  the	  
graph.	  The	  percentage	  intensity	  is	  plotted	  on	  the	  Y	  axis,	  across	  the	  timecourse	  on	  the	  X	  
axis	  for	  the	  two	  bands	  found	  on	  the	  immunoblot.	  The	  graph	  shows	  that	  the	  two	  
putative	  isoforms	  of	  HBS1L	  differ	  in	  their	  degradation	  rates.	  
For	   the	   whole	   cell	   protein	   turnover	   dataset,	   analysis	   of	   178,509	   groups	   of	   three	  
consecutive	  peptides	   identified	  1,790	  groups	   (~1	  %)	   that	  met	   this	   criteria	  and	  hence	  
are	   shaded	  dark	  blue	   (Figure	  50B).	   To	   validate	   this	   approach,	  one	  of	   the	  highlighted	  
proteins	   was	   selected	   for	   which	   specific	   antibodies	   were	   available,	   i.e.	   HBS1L	   (red	  
diamond	   in	   Figure	   50B).	   A	   cycloheximide	   experiment	   was	   carried	   out	   to	   measure	  
independently	  the	  degradation	  rate	  of	  HBS1L	  (see	  Figure	  50	  C	  &	  D).	  An	  antibody	  from	  
the	   Human	   Protein	   Atlas	   Project	   specific	   for	   HBS1L	   detected	   two	   bands	   on	   an	  
immunoblot,	  consistent	  with	  expression	  of	  two	  isoforms	  (see	  Figure	  50C).	  Quantitation	  
of	   the	   two	  bands	  at	  multiple	   time	  points	   from	  0.5-­‐24	  hours	   following	   cycloheximide	  
treatment	   showed	   that	   the	   two	   putative	   isoforms	   of	   HBS1L	   differed	   in	   their	  
degradation	  rates	  (see	  Figure	  50D).	  It	  was	  concluded	  that	  the	  three	  in	  a	  row	  approach	  
can	  help	  to	  detect	  proteins	  expressed	  as	  isoforms	  with	  differential	  properties.	  
7.4.4 Isoform Analysis by Combined Protein Fractionation and Peptide MS 
Protein	   isoforms	   that	   differ	   in	   size	   can	   be	   separated	   by	   chromatography	   prior	   to	  
enzyme	   cleavage	   and	   MS	   identification	   of	   peptides.	   Therefore	   information	   derived	  
from	  fractionation	  of	  HeLa	  cell	  proteins	  by	  1-­‐D	  SDS	  PAGE	  has	  been	  incorporated	  into	  
the	  analysis	   (see	  Figure	  51).	  HeLa	  cell	  extracts	  were	  separated	  on	  a	  4-­‐12%	  SDS	  PAGE	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gel,	  which	  was	  then	  cut	  into	  16	  slices,	  numbered	  from	  the	  top	  (slice	  1,	  largest	  proteins)	  
to	  the	  bottom	  (slice	  16,	  smallest	  proteins)	  of	  the	  gel	  (see	  Figure	  51A).	  Proteins	  in	  each	  
gel	  slice	  were	  digested	  with	  trypsin	  and	  the	  resulting	  peptides	  eluted	  and	  analysed	  by	  
MS	  (Boisvert	  et	  al.,	  2011),	  with	  the	  resulting	  data	  plotted	  on	  a	  graph	  showing	  gel	  slice	  
on	  the	  y	  axis	  and	  log	  predicted	  molecular	  weight	  of	  each	  identified	  protein,	  based	  on	  
genome	   sequence	   annotation,	   on	   the	   x	   axis	   (see	   Figure	   51B).	   These	   empirical	   data	  
demonstrate	   that,	   as	   expected,	   the	   position	   of	   protein	   migration	   on	   SDS	   PAGE	   is	  
positively	  correlated	  with	  predicted	  molecular	  weight,	  (Pearson	  correlation	  coefficient	  
0.73).	  In	  this	  gel	  system,	  that	  correlation	  holds	  true	  at	  least	  within	  the	  size	  range	  from	  
~10k-­‐180kDa.	  Using	   the	  MS	   identification	   information	   the	  approximate	   size	   range	  of	  
proteins	  migrating	  in	  each	  gel	  slice	  can	  thus	  be	  estimated.	  Based	  upon	  a	  best	  linear	  fit	  
within	   the	   10k-­‐180kDa	   size	   range,	   the	  majority	   of	   proteins	   (~78%),	  migrate	   at	   their	  
predicted	   molecular	   weight	   +/-­‐40%	   (see	   Figure	   51B,	   blue	   dots).	   Nonetheless,	   a	  
substantial	   number	   of	   proteins	   identified	   by	   MS	   (>20%),	   migrate	   anomalously	   with	  
respect	   to	   predicted	   molecular	   weight	   (see	   Figure	   51B,	   red	   dots).	   Reasons	   for	  
apparently	   anomalous	  migration	   is	   likely	   to	   include	   the	   expression	   of	   novel	   protein	  
isoforms	   and	   processed	   polypeptides,	   as	   well	   as	   effects	   of	   post-­‐translational	  
modifications	  on	  migration	  behaviour.	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Figure	  51:	  Protein	  migration	  study	  on	  gel	  fractionation.	  
To	  identify	  potential	  isoforms,	  data	  collected	  on	  1-­‐D	  SDS	  PAGE	  gel	  fractions	  was	  
analysed.	  Proteins	  with	  isoforms	  are	  likely	  to	  have	  a	  difference	  in	  molecular	  weight	  and	  
hence	  may	  migrate	  on	  the	  gel	  at	  different	  heights,	  hence	  appearing	  on	  different	  gel	  
slices.	  A)	  A	  heat	  map	  of	  the	  16	  gel	  slices	  (horizontally)	  is	  shown	  with	  every	  protein	  
identified	  (vertically)	  ordered	  by	  the	  average	  gel	  slice	  the	  protein	  was	  found	  in.	  This	  
heat	  map	  shows	  that	  the	  proteins	  migrate	  across	  the	  16	  gel	  slices.	  B)	  Graph	  showing	  
predicted	  log	  protein	  molecular	  weight	  (X	  	  axis)	  against	  gel	  slice	  (Y	  axis),	  indicating	  that	  
proteins	  predictably	  migrated	  across	  the	  gel	  based	  on	  their	  molecular	  weights	  (Pearson	  
Correlation:	  0.73),	  i.e.	  lower	  molecular	  weight	  proteins	  at	  higher	  bands	  compared	  with	  
high	  molecular	  weight	  proteins	  at	  lower	  bands.	  The	  majority	  of	  proteins	  (~77%),	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migrate	  at	  their	  predicted	  molecular	  weight	  +/-­‐40%	  (blue	  dots),	  however	  	  substantial	  
number	  (>20%),	  migrate	  anomalously	  with	  respect	  to	  predicted	  molecular	  weight.	  
Graphs	  C,	  D	  and	  E	  highlight	  three	  examples	  of	  proteins,	  GCN1L1	  (Translational	  
activator	  GCN1),	  USP14	  (Ubiquitin	  carboxyl-­‐terminal	  hydrolase	  14)	  and	  CCDC58	  
(Coiled-­‐coil	  domain-­‐containing	  protein	  58)	  respectively,	  where	  the	  peptide	  count	  (Y	  
axis)	  is	  plotted	  against	  gel	  slice	  (X	  axis).	  These	  graphs	  show	  that	  the	  proteins	  migrate	  at	  
different	  gel	  slices	  consistent	  with	  their	  molecular	  weight.	  F)	  Graph	  showing	  peptide	  
count	  (Y	  axis)	  versus	  gel	  slice	  and	  molecular	  weight	  (X	  axis)	  for	  protein	  GLMN,	  
Glomulin.	  The	  gel	  fractionation	  data	  indicates	  that	  this	  protein	  migrates	  at	  two	  gel	  
slices,	  6	  and	  8,	  potentially	  indicating	  the	  presence	  of	  isoforms.	  GLMN,	  has	  in	  fact	  two	  
known	  isoforms,	  isoform	  1	  at	  68.21kDa	  and	  isoform	  2	  at	  48.17kDa.	  
Examination	   of	   the	   number	   of	   unique	   peptide	   identifications	   assigned	   to	   a	   given	  
protein	   in	   each	   gel	   slice	   reveals	   the	   migration	   profile	   of	   that	   protein	   in	   SDS	   PAGE	  
(Figure	  51,	  C-­‐E).	  For	   representative	   large	   (see	  Figure	  51C,	  GCN1L1,	  293kDa),	  medium	  
(see	  Figure	  51D,	  USP14,	  60kDa)	  and	  small	   (see	  Figure	  51E,	  CCDC58,	  17kDa)	  proteins,	  
the	   number	   of	   unique	   peptides	   identified	   shows	   a	   clear	   single	   peak	   across	   the	  
respective	  gel	  slices.	  The	  breadth	  of	  the	  unique	  peptide	  abundance	  peak	   is	  positively	  
correlated	   with	   protein	   abundance	   (see	   Figure	   52),	   such	   that	   the	   most	   abundant	  
proteins	   show	   broad	   horizontal	   lines	   in	   the	   heat	  map	   (see	   Figure	   51A).	   The	   unique	  
peptide	  count	  per	  gel	  slice	  also	  helps	  to	  identify	  distinct	  protein	  isoforms.	  As	  shown	  for	  
the	   protein	   Glomulin	   (GLMN),	   which	   has	   two	   known	   isoforms	   of	   48kDa	   and	   68kDa,	  
respectively.	  Two	  peaks	  of	  unique	  GLMN	  peptides	  are	  detected,	  centred	  on	  different	  
gel	   slices	   (see	   Figure	   51F).	   Thus,	   combined	   protein	   chromatography	   on	   SDS	   PAGE,	  
together	  with	  peptide	  MS	  analysis,	   can	  detect	   the	  presence	  of	   protein	   isoforms	  and	  
together	  with	  ion	  intensity	  values	  provides	  information	  concerning	  protein	  expression	  
levels.	   Importantly,	   this	   approach	   can	   aid	   detection	   of	   previously	   unknown	   isoforms	  
and/or	  processed	  and	  modified	  pools	  of	  proteins,	  which	  may	  have	  different	  biological	  




Figure	  52:	  Protein	  intensity	  relation	  to	  gel	  slice	  
A)	  Graphs	  show	  number	  of	  proteins	  (Y	  axis)	  identified	  in	  each	  gel	  slice	  (X	  axis)	  for	  three	  
proteins:	  NOP56	  (Nucleolar	  protein	  56),	  PARP1	  (Poly	  [ADP-­‐ribose]	  polymerase	  1)	  and	  
PROSC	  (Proline	  synthetase	  co-­‐transcribed	  bacterial	  homolog	  protein).	  The	  breadth	  of	  
the	  unique	  peptide	  abundance	  peak	  on	  each	  graph	  is	  positively	  correlated	  with	  the	  
abundance	  of	  each	  protein.	  B)	  Graph	  showing	  Log	  Intensity	  (Y	  axis)	  against	  all	  proteins	  
ordered	  by	  the	  number	  of	  gel	  slices	  the	  protein	  is	  found	  in	  (X	  axis).	  This	  graph	  shows	  
that	  the	  proteins	  that	  spread	  across	  gel	  slices	  have	  a	  higher	  intensity	  compared	  to	  
proteins	  primarily	  found	  in	  only	  one	  gel	  band.	  
Next,	   correlation	   analyses	   were	   performed	   to	   examine	   potential	   differences	   in	  
subcellular	   localisation	   and	   protein	   turnover	   properties	   for	   examples	   of	   protein	  
isoforms	  predicted	  from	  the	  combined	  SDS	  PAGE	  and	  peptide	  MS	  data	  (see	  Figure	  53).	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Figure	  53:	  Protein	  isoform	  identification	  from	  gel	  fractionation	  
To	  identify	  potential	  isoforms	  from	  gel	  fractionation	  data,	  the	  peptide	  count	  across	  gel	  
slices	  was	  analysed	  to	  identify	  proteins	  that	  seem	  to	  migrate	  at	  multiple	  gel	  slices.	  A)	  
Heat	  map	  showing	  the	  16	  gel	  slices	  and	  their	  corresponding	  molecular	  weights	  
(horizontally)	  for	  every	  protein	  identified	  (vertically)	  ordered	  by	  the	  average	  gel	  slice	  
the	  protein	  was	  found	  in.	  This	  heat	  map	  was	  filtered	  to	  show	  only	  those	  proteins	  that	  
seem	  to	  migrate	  at	  multiple	  gel	  slices.	  B)	  Two	  example	  proteins	  are	  shown,	  ELP3	  
(Elongator	  complex	  protein	  3)	  and	  OGFOD1	  (2-­‐oxoglutarate	  and	  iron-­‐dependent	  
oxygenase	  domain-­‐containing	  protein	  1).	  The	  graphs	  on	  the	  left	  show	  peptide	  count	  (Y	  
axis)	  versus	  gel	  slice	  (X	  axis)	  as	  an	  aggregate	  for	  the	  whole	  cell,	  indicating	  that	  both	  
ELP3	  and	  OGFOD1	  migrate	  at	  two	  separate	  gel	  slices,	  indicating	  two	  isoforms.	  The	  
cytoplasmic	  graph	  (top-­‐middle-­‐right)	  and	  nuclear	  graph	  (top-­‐right)	  for	  ELP3	  indicate	  
that	  only	  one	  isoform	  is	  present	  in	  the	  Cytoplasm	  (A’),	  whereas	  both	  isoforms	  are	  
detected	  in	  the	  Nucleus	  (A	  and	  A’).	  The	  turnover	  graph	  (top-­‐middle-­‐left),	  showing	  the	  
turnover	  values	  detected	  (Y	  axis)	  in	  each	  gel	  slice	  (X	  axis),	  indicates	  that	  both	  isoforms	  
of	  ELP3	  have	  a	  different	  turnover,	  i.e.	  6	  hours	  (A)	  and	  28	  hours	  (A’)	  respectively.	  In	  
relation	  to	  OGFOD,	  the	  cytoplasmic	  graph	  (bottom-­‐middle-­‐right)	  and	  nuclear	  graph	  
(bottom-­‐right)	  show	  the	  isoform	  A	  is	  found	  in	  both	  the	  cytoplasm	  and	  nucleus,	  however	  
isoform	  A’	  is	  only	  found	  in	  the	  cytoplasm.	  The	  turnover	  graph	  (bottom-­‐middle-­‐left),	  
showing	  the	  turnover	  values	  detected	  (Y	  axis)	  in	  each	  gel	  slice	  (X	  axis),	  indicates	  that	  
the	  two	  forms	  of	  the	  OGFOD1	  protein	  at	  the	  different	  gel	  slices	  have	  different	  
turnovers,	  i.e.	  18.18	  hours	  (A)	  and	  37.49	  hours	  (A’).	  
By	   independently	  evaluating	   the	  SILAC	  data	   reflecting	   subcellular	  protein	   localisation	  
and	  turnover	  (Boisvert	  et	  al.,	  2011)	  for	  the	  separate	  sets	  of	  unique	  peptides	  found	  in	  
different	   gel	   slices,	   it	   can	   thus	   be	   predicted	   whether	   the	   different	   protein	  
isoforms/processed	   forms	   differ	   in	   their	   properties.	   This	   is	   illustrated	   for	   proteins	  
Elongator	  complex	  protein	  3	  (ELP3)	  and	  2-­‐oxoglutarate	  and	  iron-­‐dependent	  oxygenase	  
domain-­‐containing	  protein	   1	   (OGFOD1),	   both	  of	  which	   are	  detected	   in	   two	  peaks	  of	  
unique	  peptide	  abundance	  in	  SDS	  PAGE	  (see	  Figure	  53B).	  In	  the	  case	  of	  ELP3,	  the	  larger	  
(A)	  isoform	  has	  a	  turnover	  value	  of	  ~5	  hours	  and	  is	  detected	  specifically	  in	  the	  nucleus.	  
In	   contrast,	   the	   smaller	   (A’)	   isoform	   has	   an	   apparent	   turnover	   more	   than	   five	   fold	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slower	  (~27	  hours)	  and	  is	  detected	  equally	  in	  the	  nucleus	  and	  cytoplasm.	  In	  the	  case	  of	  
protein	   OGFOD1,	   the	   two	   isoforms	   detected	   also	   differ	   in	   both	   turnover	   and	   in	  
subcellular	   distribution.	   The	   larger	   (A)	   OGFOD1	   isoform	   has	   a	   ~50%	   faster	   turnover	  
than	   the	   smaller	   (A’)	   isoform,	   (~18	   hours	   and	   ~37	   hours,	   respectively).	   The	   two	  
isoforms	  are	  differentially	  distributed,	  with	  the	   larger	  A	   isoform	  detected	  in	  both	  the	  
cytoplasm	   and	   nucleus,	   and	   the	   smaller	   A’	   isoform	   concentrated	   specifically	   in	   the	  
cytoplasm.	   It	   was	   concluded	   that	   this	   pre-­‐chromatography	   approach	   can	   reveal	   the	  
presence	  of	  protein	  isoforms	  with	  differential	  properties.	  
7.4.5 Correlating Post-Translational Modification with Protein Properties 
Finally,	   the	   potential	   relationship	   between	   post-­‐translational	   modifications	   and	   the	  
properties	   of	   subcellular	   localisation,	   turnover	   and	   abundance	   measured	   for	   HeLa	  
proteins	  using	  SILAC	  was	  investigated.	  In	  this	  study	  the	  effect	  of	  phosphorylation	  was	  
analysed	  on	  either	  serine,	  threonine	  or	  tyrosine	  residues	  on	  rates	  of	  protein	  turnover	  
in	   each	   of	   the	   cytoplasmic,	   nuclear,	   and	   nucleolar	   compartments	   (see	   Figure	   55).	  
Phosphopeptides	  were	  detected	  and	  quantitated	  for	  the	  HeLa	  protein	  localisation	  and	  
turnover	   SILAC	   data	   set	   using	   MaxQuant.	   Overall,	   2,444	   phosphopeptides	   were	  
detected	  and	  quantitated	  in	  this	  analysis,	  identifying	  phosphorylated	  residues	  in	  ~46%	  
of	  the	  HeLa	  proteins	  (see	  Figure	  54).	  	  
	  
Figure	  54:	  Phosphorylated	  proteins	  correlated	  with	  protein	  properties.	  	  
A)	  Graphs	  show	  bins	  of	  log	  intensity	  (X	  axis)	  against	  the	  number	  of	  proteins	  found	  in	  
each	  bin	  (X	  axis),	  for	  cytoplasm,	  nucleus	  and	  nucleolus.	  The	  graphs	  show	  that	  the	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comparison	  of	  protein	  abundance	  levels	  with	  the	  detection	  of	  phosphorylated	  peptides	  
indicates	  only	  a	  weak	  positive	  correlation.	  This	  shows	  that	  the	  phosphopeptides	  studied	  
are	  representative	  of	  the	  proteome	  and	  not	  reflecting	  the	  properties	  of	  only	  the	  most	  
abundant	  proteins.	  B)	  Graph	  showing	  bins	  of	  peptide	  count	  (X	  axis)	  against	  number	  of	  
proteins	  found	  in	  each	  bin	  (Y	  axis).	  The	  majority	  (53%)	  of	  phosphoproteins	  were	  
identified	  with	  a	  single	  phosphorylated	  residue,	  although	  23%	  had	  two	  phosphorylated	  
peptides	  and	  24%	  had	  three	  or	  more.	  
A	   comparison	   of	   protein	   abundance	   levels	   with	   the	   detection	   of	   phosphorylated	  
peptides	   showed	   only	   a	   weak	   positive	   correlation.	   This	   indicates	   that	   the	  
phosphopeptides	   studied	   are	   representative	   of	   the	   proteome	   and	   not	   reflecting	   the	  
properties	  of	  only	  the	  most	  abundant	  proteins.	  The	  majority	  (53%)	  of	  phosphoproteins	  
were	   identified	   with	   a	   single	   phosphorylated	   residue,	   although	   23%	   had	   two	  
phosphorylated	  peptides	  and	  24%	  had	  three	  or	  more	  (see	  Figure	  54).	  
	  
Figure	  55:	  Phosphorylated	  post	  translation	  modification	  analysis	  with	  turnover.	  
Graphs	  A,	  B	  and	  C	  show	  the	  average	  protein	  turnover	  using	  non-­‐phosphorylated	  
peptides	  (X	  axis)	  against	  average	  protein	  turnover	  using	  both	  phosphorylated	  and	  non-­‐
phosphorylated	  peptides	  in	  each	  of	  the	  cytoplasmic,	  nuclear,	  and	  nucleolar	  
compartments.	  Highlighted	  in	  blue	  are	  phosphorylated	  proteins	  that	  show	  a	  1.5	  fold	  
change	  compared	  to	  the	  non-­‐phosphorylated	  form	  of	  the	  protein.	  Comparison	  of	  
graphs	  A	  (cytoplasm),	  B	  (nucleus)	  and	  C	  (nucleolus)	  show	  that	  the	  nucleolus	  has	  the	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greatest	  number	  of	  phosphorylated	  proteins	  compared	  with	  the	  cytoplasm	  and	  
nucleus.	  The	  pie	  charts	  D,	  E	  and	  F	  show	  the	  gene	  ontology	  analysis	  of	  the	  
phosphorylate	  proteins	  that	  have	  a	  slower	  turnover	  in	  comparison	  with	  phosphorylated	  
from	  and,	  similarly,	  pie	  charts	  G,	  H	  and	  I	  show	  the	  gene	  ontology	  analysis	  of	  the	  
phosphorylate	  proteins	  that	  have	  a	  faster	  turnover	  in	  comparison	  with	  phosphorylated	  
form.	  
For	  proteins	   identified	   in	   the	  respective	  cytoplasmic,	  nuclear	  and	  nucleolar	   fractions,	  
the	   mean	   turnover	   value	   for	   all	   proteins	   assigned	   to	   each	   protein,	   including	   all	  
phosphopeptides	  detected,	  was	  plotted	  on	  the	  y	  axis	  against	  the	  corresponding	  mean	  
turnover	   value	   for	   all	   peptides	   assigned	   to	   the	   same	   protein,	   but	   excluding	  
phosphopeptides,	  plotted	  on	  the	  x	  axis	  (see	  Figure	  55,	  A-­‐C).	  In	  the	  graphs	  any	  protein	  
where	   the	   presence	   of	   phosphopeptides	   either	   increases,	   or	   decreases,	   the	   mean	  
turnover	  value	  by	  1.5	   fold,	  or	  greater,	   is	   coloured	  dark	  blue.	  The	  data	   show	   that	   for	  
most	  HeLa	  proteins	  the	  presence	  of	  one	  or	  more	  phosphorylated	  residues	  has	  little	  or	  
no	   effect	   on	  mean	   turnover	   rate.	  However,	   a	   subset	   of	   proteins	   showed	   changes	   in	  
turnover	   rate	   when	   phosphopeptides	   are	   present.	   Interestingly,	   a	   larger	   fraction	   of	  
nucleolar	   proteins	   showed	   effects	   of	   phosphorylation	   on	   turnover	   rates	   (see	   Figure	  
55C),	  as	  opposed	  to	  either	  cytoplasmic,	  or	  nuclear	  proteins	  (see	  Figure	  55	  A	  &	  B).	  This	  
is	  not	  caused	  by	  the	  subset	  of	  highest	  abundance	  nucleolar	  proteins,	  such	  as	  ribosomal	  
proteins	   and	   nucleophosmin,	   suggesting	   that	   there	   is	   a	   broader	   effect	   of	  
phosphorylation	  on	  modulating	  nucleolar	  protein	  turnover	  rates.	  
Gene	   ontology	   analysis	   was	   carried	   out	   to	   categorise	   the	   phosphorylated	   proteins	  
showing	   the	   greatest	   increase	   (see	   Figure	   55	   D,	   F	   &	   H)	   and	   greatest	   decrease	   in	  
turnover	  (see	  Figure	  55	  E,	  G	  &	  I),	  for	  the	  cytoplasmic	  (see	  Figure	  55	  D	  &	  E),	  nuclear	  (see	  
Figure	  55	  F	  &	  G)	  and	  nucleolar	  (see	  Figure	  55	  H	  &	  I)	  compartments,	  respectively.	  This	  
shows	   specific	   groups	   of	   proteins	   whose	   turnover	   rates	   are	   most	   affected	   by	  
phosphorylation.	  This	  includes	  ATP	  and	  nucleotide	  binding	  proteins,	  multiple	  cell	  cycle	  
regulated	   proteins	   and	   proteins	   involved	   in	   apoptosis	   and	   cell	   death	   response	  
mechanisms.	  
7.5 Discussion 
This	   study	   has	   investigated	   multiple	   data	   analysis	   approaches	   that	   can	   be	   used	   to	  
identify	  the	  expression	  of	  protein	  isoforms	  that	  exhibit	  differential	  localisation	  and/or	  
turnover	   properties.	   Examples	   of	   protein	   phosphorylation	   correlating	   with	   altered	  
turnover	   rates	  were	   identified	   in	  different	   subcellular	   compartments.	  These	  analyses	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are	  performed	  on	  SILAC-­‐based	  quantitative	  mass	  spectrometry	  data	  from	  fractionated	  
HeLa	  cells,	  where	  changes	  in	  isotope	  ratios	  are	  used	  to	  measure	  turnover	  rates	  in	  the	  
separate	   cytoplasmic,	   nuclear	   and	   nucleolar	   compartments	   (Boisvert	   et	   al.,	   2011).	   It	  
has	  been	  shown	  that	  separating	   intact	  proteins	  by	  chromatography,	  prior	   to	  enzyme	  
digestion	   and	   peptide	   identification	   by	   mass	   spectrometry,	   can	   be	   effectively	  
combined	  with	  SILAC	  analysis	  of	  changes	   in	  peptide	   isotope	  ratios	  to	   identify	  protein	  
isoforms	  and	  assess	  whether	  the	  isoforms	  have	  different	  properties.	  Collectively,	  these	  
experimental	  procedures	  and	  data	  analysis	  approaches	  provide	  a	  new	  framework	  for	  
the	   systematic	   detection	   and	   analysis	   of	   protein	   isoforms	   and	   their	   biological	  
properties	  that	  can	  be	  used	  to	  expand	  the	  functional	  annotation	  of	  the	  genome.	  
Differential	  proteomic	  analysis	  using	  SILAC	  involves	  measuring	  differences	  in	  the	  ratio	  
of	  separate	   isotopic	   forms	  of	   the	  same	  peptide,	  which	   in	   turn	   is	   related	  to	  a	  specific	  
biological	  property	  according	  to	  the	  experimental	  design.	  Thus,	  differences	  in	  isotope	  
ratios	  can	  be	  used,	  inter	  alia,	  to	  measure	  changes	  in	  protein	  expression	  levels	  following	  
drug	  treatment,	  to	  discriminate	  between	  specific	  and	  non-­‐specific	  protein	  interaction	  
partners	   or	   to	   compare	   subcellular	   protein	   localisation.	   	   Typically,	   mean	   values	   are	  
calculated	  for	  the	  different	  isotopic	  forms	  of	  all	  of	  the	  peptides	  detected	  that	  map	  to	  a	  
given	  protein,	  as	  deduced	  from	  genomic	  sequence	  information.	  A	  potential	  limitation	  
with	   this	   strategy	  however	   is	   that	   it	  usually	  does	  not	  discriminate	  between	  peptides	  
arising	   from	   functionally	   distinct	   pools	   of	   protein	   encoded	   by	   the	   same	   gene.	   Thus,	  
ensemble	  measurements	  are	  generated	  that	  can	  average	  the	  separate	  properties,	  or	  
responses,	  of	   two	  or	  more	  distinct	  protein	   isoforms.	   It	  has	  been	  shown	  here	  that,	  at	  
least	   in	   part,	   it	   is	   possible	   to	   circumvent	   these	   limitations	   and	   to	   identify	   protein	  
isoforms	   and	   compare	   their	   properties,	   both	  using	   information	  provided	  by	  detailed	  
analysis	  of	  isotope	  ratios	  for	  separate	  peptides	  assigned	  to	  the	  same	  protein	  group	  and	  
by	  incorporating	  information	  from	  protein	  chromatography	  prior	  to	  enzyme	  digestion	  
and	  MS	  analysis.	  
The	   candidate	   peptide	   approach	   is	   conceptually	   simple	   and	   can	   be	   effective,	   as	  
demonstrated	  here	   for	   the	  protein	  NudCD1	   (see	  Figure	  48).	  However,	   it	   is	  often	  not	  
possible	   either	   to	   identify,	   or	   to	   reliably	   detect	   and	   quantitate,	   isoform-­‐specific	  
peptides.	   This	   restricts	   the	  use	  of	   the	   candidate	  peptide	  approach	   to	   the	  analysis	  of	  
protein	   isoforms	  whose	  structures	  are	  already	  characterised	  and	  where	  one	  or	  more	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isoform-­‐specific	  peptides	  have	  been	  identified.	  Even	  in	  these	  cases,	  quantitation	  of	  the	  
isoform	  response	   is	  often	  derived	  from	  analysis	  of	  only	  one	  or	  two	  specific	  peptides,	  
which	  can	  reduce	  the	  overall	  reliability	  of	  the	  measurements.	  It	  has	  been	  shown	  that	  
more	   promising	   general	   approaches	   for	   detecting	   isoforms	   and	   comparing	   their	  
properties	  involve	  the	  systematic	  evaluation	  of	  mean	  isotope	  ratio	  values	  for	  groups	  of	  
peptides	  within	  the	  total	  set	  of	  peptides	  mapped	  to	  a	  specific	  gene.	  Importantly,	  with	  
both	  the	  ‘rule	  of	  thirds’	  and	  ‘three	  peptides	  in	  a	  row’	  approaches,	  analysis	  of	  the	  SILAC	  
data	   can	   predict	   the	   potential	   existence	   of	   either	   isoforms,	   or	   processed	   forms	   of	  
proteins,	   as	   well	   as	   compare	   their	   properties,	   without	   prior	   knowledge	   of	   either	  
isoform	  structures,	  or	  expression.	  In	  each	  case,	  the	  mean	  isotope	  ratio	  values	  of	  sub-­‐
groups	  of	  peptides	  can	  be	  evaluated	  with	  respect	  to	  the	  mean	  value,	  either	  for	  all	  the	  
peptides	   in	   the	   protein,	   or	   for	   values	   for	   neighbouring	   groups	   of	   peptides,	   or	   both.	  
Objective	   statistical	   criteria	   can	   be	   applied	   to	   these	   comparisons	   that	   will	   aid	   the	  
reliable	  detection	  of	  isoforms	  and	  thereby	  help	  to	  annotate	  the	  functional	  expression	  
of	  the	  genome.	  
This	   study	   has	   validated	   the	   effectiveness	   of	   data	   analysis	   strategies	   involving	  
statistical	   comparisons	   of	   isotope	   ratio	   values	   for	   local	   clusters	   of	   peptides	  within	   a	  
protein.	   Several	   ways	   are	   envisioned	   in	   which	   such	   general	   approaches	   can	   be	  
enhanced	   further	   in	   future.	   For	   example,	   using	   filters	   that	   compare	   more	   closely	  
variations	  in	  values	  between	  peptides	  in	  a	  group	  and	  by	  defining	  peptide	  groups	  with	  
reference	   to	   3-­‐D	   crystal	   structure	   information	   on	   proteins.	   Whatever	   future	  
refinements	  are	  made	  to	  the	  data	  analysis	  procedures,	  it	  is	  clear	  that	  a	  critical	  point	  is	  
having	   a	   high	  quality	   SILAC	  data	   set	   for	   the	  proteome	  under	   study	   and	   in	   particular	  
having	  as	  wide	  a	  peptide	  coverage	  as	  possible	  for	  each	  protein.	  The	  HeLa	  SILAC	  data	  
set	  studied	  here	  included	  over	  80,000	  peptides	  from	  ~8,000	  proteins,	  with	  an	  average	  
coverage	  of	  ~10	  peptides	  per	  protein	   identified.	  Recent	  analyses	   indicate	   that	   this	   is	  
already	   a	   large	   enough	   sample	   of	   the	   expressed	   HeLa	   proteome	   to	   be	   highly	  
representative	   of	   the	   general	   behaviour	   of	   cell	   proteins	   (Boisvert	   et	   al.,	   2010).	   In	  
future,	  therefore,	  the	  project	  will	  aim	  to	  expand	  the	  number	  of	  peptides	  analysed,	  not	  
primarily	   to	   increase	   the	   total	   number	   of	   proteins	   identified,	   but	   rather	   seeking	   to	  
enhance	   the	   peptide	   coverage	   for	   each	   protein.	   It	   is	   anticipated	   this	   will	   aid	   the	  
unbiased	  detection	  of	  protein	  isoforms	  and	  their	  properties	  that	  can	  in	  turn	  be	  related	  
to	  biological	  mechanisms	  and	  responses.	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In	   most	   cases,	   differences	   in	   structure	   between	   protein	   isoforms	   alters	   their	   size	  
and/or	   charge,	   which	   in	   turn	   provides	   an	   opportunity	   to	   separate	   them	   by	  
chromatography,	   as	   demonstrated	   here	   using	   1-­‐D	   SDS	   PAGE.	   The	   results	   show	   that	  
independently	   evaluating	   the	   differences	   in	   peptide	   isotope	   ratios	   for	   the	   same	  
peptides	   migrating	   in	   different	   chromatographic	   fractions	   (in	   the	   present	   case	  
different	  gel	  slices),	  provides	  a	  powerful	  approach	  for	  detecting	  protein	  isoforms	  and	  
assessing	   differences	   in	   their	   properties.	   Combining	   fractionation	   of	   protein	   extracts	  
with	   downstream	   enzyme	   cleavage	   and	   MS	   analysis	   thus	   provides	   important	  
information	  that	  is	  lost	  in	  procedures	  where	  entire	  extracts	  are	  digested	  without	  pre-­‐
fractionation	  and	  peptides	  analysed	  en	  masse.	  The	  isoform	  information	  is	  similarly	  lost	  
if	   extract	   fractionation	   is	   performed	   at	   the	   peptide,	   rather	   than	   protein	   level.	   To	  
provide	  higher	  resolution	  separation	  of	   isoforms,	  therefore,	   it	   is	  planned	   in	   future	  to	  
increase	  the	  degree	  of	  protein	  fractionation	  prior	  to	  MS	  analysis.	  For	  example,	  using	  2-­‐
D	  fractionation	  of	  extracts,	  combining	  ion	  exchange	  and	  gel	  filtration	  chromatography.	  
It	   is	   anticipated	   that	   such	   2-­‐D	   protein	   fractionation	   strategies,	   combined	   with	  
increased	  peptide	  coverage,	  will	   further	  enhance	  the	  efficiency	  of	  detecting	   isoforms	  
and	  characterising	  their	  properties.	  
It	  has	  been	  shown	  previously	  that	  the	  subcellular	  distribution	  of	  the	  proteome	  can	  be	  
measured	  using	  a	  SILAC	  strategy	  where	  different	  cell	  compartments	  and	  organelles	  are	  
isotope-­‐encoded	   (Boisvert	   and	   Lamond,	   2010,	   Boisvert	   et	   al.,	   2010,	   Boisvert	   et	   al.,	  
2011).	   It	  has	  been	  shown	  also	  that	  system-­‐wide	  changes	   in	  protein	   localisation	  could	  
be	  measured	  in	  response	  to	  drug	  treatment	  and	  in	  cells	  with	  different	  genotypes.	  Here	  
the	  	  ‘spatial	  proteomics’	  approach	  has	  been	  extended	  to	  detect	  protein	  isoforms	  that	  
are	  differentially	  localised	  within	  the	  cell	  and	  to	  analyse	  differential	  effects	  of	  protein	  
phosphorylation	   on	   turnover	   in	   different	   subcellular	   compartments.	   This	   can	   be	  
developed	  further	  in	  future	  in	  several	  ways.	  First,	  a	  higher	  resolution	  map	  of	  proteome	  
localisation	   can	   be	   derived	   by	   more	   extensive	   cell	   fractionation	   prior	   to	   protein	  
chromatography	  and	  MS	  analysis.	  For	  example,	  the	  cytoplasmic	  compartment	  can	  be	  
sub-­‐fractionated	   into	  plasma	  membrane,	   cytosol	   and	  organelle	   fractions	  and	  work	   is	  
underway	   to	   implement	   this.	   Second,	  many	  other	  post-­‐translational	  modifications	   in	  
addition	   to	   phosphorylation	   can	   be	   analysed	   and	   their	   potential	   effects	   on	   the	  
properties	  of	  specific	  protein	  families	  and	  protein	  isoforms	  evaluated	  and	  compared	  in	  
different	  cellular	  compartments.	  Third,	  the	  analyses	  to	  date	  have	  analysed	  mixtures	  of	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cells	   at	   different	   cell	   cycle	   stages.	  However,	   it	   is	   already	   known	   for	   specific	   proteins	  
that	   their	   expression	   levels	   and	   properties,	   including	   localisation	   and	   PTMs,	   can	  
change	   during	   different	   stages	   of	   interphase	   and	  mitosis.	   It	   is	   therefore	   planned	   to	  
expand	   future	   studies	   to	   encompass	   system-­‐wide,	   quantitative	   analysis	   of	   the	  
properties	  of	  protein	   isoforms	  both	   in	  multiple	   subcellular	   locations	   and	  at	  different	  
cell	  cycle	  stages.	  The	  resulting	  data	  are	  likely	  to	  provide	  a	  major	  source	  of	  information	  
that	  can	  reveal	  unexpected	  and	  novel	  molecular	  relationships	  and	  potential	  regulatory	  
mechanisms	  for	  future	  investigation.	  
7.6 Distribution of Effort 
Lamond	   Laboratory	   biologists,	   primarily	   Francois-­‐Michel	   Boisvert,	   carried	   out	   the	  
experimental	  bench	  work	  during	  this	  study.	  The	  analysis	  described	  in	  this	  chapter	  was	  
a	  joint	  effort	  between	  Yasmeen	  Ahmad	  and	  Francois-­‐Michel	  Boisvert.	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Chapter 8: Discussion 
The	  Human	  Genome	  Project	  was	  a	  major	  international	  endeavour	  aimed	  at	  identifying	  
and	  mapping	  all	  genes,	  which	  control	  hereditary	  characteristics	   in	   living	  organisms.	  A	  
gene	  is	  any	  given	  segment	  along	  a	  DNA	  strand	  that	  encodes	  instructions	  allowing	  a	  cell	  
to	  produce	  a	  specific	  product	   -­‐	   typically	  a	  protein.	  However,	   since	   the	  completion	  of	  
the	  human	  genome	  project	  (2003)	  the	  focus	  of	  research	  has	  changed	  from	  working	  at	  
the	   genome	   level,	   identifying	   and	   mapping	   genes,	   to	   documenting	   the	   function	   of	  
genes	  and	  realising	  how	  changes	   in	  the	  sequence	  relate	  to	  health	  and	  disease	  at	  the	  
cellular	   level.	   By	   researching	   the	   proteins	   expressed	   by	   genes	   under	   various	  
conditions,	   the	   field	   of	   life	   sciences	   has	   made	   significant	   contributions	   to	   the	  
understanding	   of	   how	   the	   human	   body	   functions.	   This	   research	   has	   led	   to	   the	  
definition	  of	  a	  new	   field:	  proteomics,	  which	  aims	   to	  discover,	  annotate	  and	  describe	  
the	  properties	  of	  proteins	  in	  living	  organisms.	  
The	   Lamond	  Laboratory,	  based	   in	   the	  Wellcome	  Trust	  Centre	   for	  Gene	  Regulation	  &	  
Expression	   at	   the	   University	   of	   Dundee,	   is	   playing	   a	   role	   in	   the	   development	   and	  
application	  of	  new	  quantitative	  and	  high	  throughput	  methods	  for	  the	  analysis	  of	  gene	  
expression	  and	  cell	  biology.	  In	  particular	  the	  Lamond	  group	  focus	  on	  how	  cancer	  and	  
other	  diseases	  can	  result	  in	  changes	  in	  the	  spatial	  distribution,	  stability	  and	  function	  of	  
proteins	   in	   human	   cell	   lines.	   These	   studies	   involve	   large-­‐scale	   use	   of	   proteomics	  
technologies,	   including	  novel	  mass	  spectrometry	   (MS)	  approaches	  based	  upon	  stable	  
isotope	  labelling	  (i.e.	  SILAC).	  	  A	  key	  feature	  of	  these	  quantitative	  MS-­‐based	  methods	  is	  
the	   creation	   of	   huge	   volumes	   of	   data	   that	   are	   impossible	   to	   analyse	   by	   manual	  
inspection.	  These	  data	  are	  major	   resources	   that	   require	  new	  approaches	   to	  manage,	  
analyse	  and	  store	  efficiently.	  These	  problems	  are	  further	  enhanced	  by	  the	  complexity	  
of	   the	   data,	   the	   non-­‐consensus	   on	   data	   formats	   and	   non-­‐existent	   data	   standards.	  
Furthermore,	   there	   is	   a	   need	   to	   archive	   these	   data	   in	   accessible	   repositories	   to	  
promote	  sharing	  of	  data.	  Hence,	   it	   is	   imperative	   that	   these	  advancements	   in	   science	  
are	  supported	  by	  adequate	  developments	  in	  the	  field	  of	  computing.	   	  There	  are	  many	  
new	   and	   exciting	   discoveries	   to	   be	   made	   through	   cross	   discipline	   work	   that	   brings	  
together	  life	  sciences	  research	  and	  computing	  in	  a	  usable	  fashion,	  which	  can	  enhance	  
knowledge	  and	  understanding	  in	  both	  fields.	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“The	  mapping	  of	  complex	  proteomics	  data	  to	  biological	  processes	  has	  become	  
impossible	  by	  manual	  means,	  and	  the	  need	  for	  computer-­‐aided	  data	  analysis	  is	  
essential	  for	  further	  progress	  in	  the	  field.”	  (Kumar	  and	  Mann,	  2009)	  
To	  date	   there	   is	  no	  method	   to	   routinely	   capture,	  manage	  and	  archive	  datasets	   from	  
such	   studies.	   Furthermore,	   downstream	   analysis	   is	   a	   major	   challenge	   posed	   by	  
proteomics	  technologies.	  Advances	  in	  technology	  have	  allowed	  for	  more	  sophisticated	  
proteomics	   experiments,	   which	   have	   resulted	   in	   generation	   of	   an	   increased	   volume	  
and	   complexity	   of	   data	   that	   demands	   the	   development	   of	   new	   tools	   due	   to	   the	  
inadequacy	   of	   existing	   software,	   such	   as	   Excel.	   In	   these	   situations,	   biological	  
researchers	   are	  often	   forced	   to	   carry	   out	  minimal	   analysis	  manually	   and	   then	  hand-­‐
over	   their	   datasets	   to	   bioinformaticians	  who	   have	   the	   necessary	   computing	   skills	   to	  
handle	  these	  data.	  This	  is	  frustrating	  as	  the	  biologists	  are	  experts	  in	  how	  the	  data	  are	  
generated	  and	  having	  driven	  the	   formulation	  of	   the	   initial	  hypothesis	   that	   led	   to	   the	  
experiments	  and	  data	  generation,	  they	  are	  more	  acutely	  aware	  of	  how	  they	  would	  like	  
to	  question	  the	  data	  further	  and	   its	  potential.	  Furthermore,	  unless	  there	   is	  extensive	  
interaction	   between	   bioinformaticians	   and	   biologists,	   there	   will	   be	   in	   minimal	  
information	  exchange	  regarding	  the	  context	  of	  the	  data	  and	  the	  processes	  involved	  in	  
generating	  the	  data.	  
“Despite	  our	  reliance	  on	  computation,	  most	  scientists	  are	  not	  capable	  of	  complex	  data	  
storage	  and	  analysis	  computing,	  and	  therefore	  rely	  on	  computer	  programmers	  to	  do	  
this	  for	  us.”	  (Proteomics	  Researcher,	  Lamond	  Laboratory)	  
During	  this	   thesis	  a	  consolidated	  data	  environment	  has	  been	  created	  that	  provides	  a	  
central	   source	   for	  project-­‐wide	  decision-­‐making.	   The	   challenges	  described	  above	  are	  
met	   through	   a	   pipeline	   for	   quantitative	   data	   derived	   from	   proteomics	   experiments.	  
This	   pipeline	   has	   been	   incorporated	   into	   the	   development	   of	   a	   software	   suite:	  
PepTracker	   (http://www.peptracker.com),	   which	   provides	   a	   Laboratory	   Information	  
Management	   System	   (LIMS)	   and	   supports	   the	   upload	   of	   datasets	   processed	   by	  
MaxQuant	   (current,	   future	   and	   legacy	   versions	   of	   3rd	   party	   software).	   PepTracker	  
incorporates	  an	  easily	  accessible	  data	   repository	   that	  allows	  sharing	  of	   the	  uploaded	  
data,	   visualisation	   interfaces	   to	   navigate	   the	   datasets,	   tools	   to	   assess	   quality	   of	  
constituent	   data,	   interactive	   graphical	   control	   of	   basic	   analysis	   and	   more	   advanced	  
features	  for	  global	  analysis.	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Benefits	  of	  having	  a	  repository	  include	  access	  to	  a	  large	  collection	  of	  baseline	  datasets	  
that	  are	  labelled	  with	  detailed	  metadata.	  These	  datasets	  can	  be	  analysed	  together	  to	  
aid	   in	  the	  analysis	  of	  new	  datasets,	  through	  confirmation	  of	  trends	  and	  identification	  
of	   false-­‐positive	   results.	   As	   the	   experimental	   protocols	   and	   analysis	   become	   more	  
complex,	  manual	  analysis	  of	  single	  datasets	  and	  the	  resultant	  observed	  patterns	  give	  
rise	  to	  subjective	  errors.	   In	  addition,	  depending	  on	  the	  experiment	  and	  the	  protocols	  
used	  to	  create	  samples,	  contamination	  may	  creep	   into	  samples	   from	  the	  procedures	  
carried	  out.	  However,	   for	   accurate	   analysis	  MS	  datasets	  must	   be	  of	   high	   confidence	  
and	  users	  must	  be	  sure	  that	  data	  repositories	  sharing	  such	  data	  contain	  similar	  high-­‐
accuracy	  and	  high-­‐confidence	  datasets.	  Through	  automated	  approaches,	  software	  can	  
evaluate	  and	  normalise	  multiple	  datasets	  to	  tackle	  these	  concerns	  and	  then	  allow	  for	  
more	  reliable	  automated	  classification,	  visualisation	  and	  clustering	  of	  datasets,	  leading	  
to	   biologically	   interpretable	   results	   and	   insights.	   The	   work	   in	   this	   thesis	   addresses	  
these	   issues	   and	   enables	   new	   discoveries	   through	   entirely	   novel	   analysis	   strategies	  
which	   take	   full	   benefit	   of	   the	   uniquely	   quantitative	   nature	   of	   the	   proteomics	   data	  
being	  generated.	  	  
Using	  this	  repository	  of	  datasets	  in	  PepTracker,	  this	  thesis	  led	  to	  the	  development	  of	  a	  
specific	  analysis	  tool,	  the	  Protein	  Frequency	  Library	  (PFL),	  in	  order	  to	  tackle	  the	  issue	  of	  
contamination	   within	   samples	   (Boulon	   et	   al.,	   2010a).	   Using	   the	   multi-­‐dimensional	  
datasets	   allowed	   the	   research	   to	   explore	   the	   use	   of	   techniques	   from	   other	   fields,	  
including	  Business	   Intelligence	   (BI),	   to	   tackle	   the	   analysis	   of	   data	   from	  a	   global	   data	  
standpoint	   in	   contrast	   to	   the	   typical	   one	   user	   -­‐	   single	   experiment	   analysis	   approach	  
common	  in	  life	  sciences.	  	  
The	   use	   of	   BI	   is	   not	   previously	   documented	   in	   biology	   or	   proteomics	   and	   is	   rarely	  
found	   in	   research	   science	   in	   general.	  With	   the	   global	   BI	   approach,	   each	  dataset	   can	  
enhance	  the	  analysis	  of	  every	  other	  dataset	  in	  the	  repository,	  allowing	  researchers	  to	  
make	   better,	   informed	   decisions	   that	   result	   in	   improved,	   more	   efficient	   science	   (in	  
terms	   of	   human	   and	   physical	   resources).	   This	   type	   of	   analysis	   has	   been	   coined	   as	  
“super-­‐experiment”	   analysis	   within	   this	   thesis,	   whereby	   datasets	   are	   analysed	  
collectively	  rather	  than	  individually.	  The	  whole	  in	  this	  case	  is	  much	  more	  than	  the	  sum	  
of	  the	  individual	  datasets	  and	  can	  answer	  questions	  that	  were	  not	  conceived	  of	  when	  
the	   original	   experiments	   were	   performed.	   A	   key	   feature	   of	   the	   super	   experiment	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concept	   is	   that	   each	   new	   dataset	   that	   is	   added	   improves	   the	   analysis	   of	   all	   future	  
experiments	   and	   also	   allows	   re-­‐analysis	   of	   previous	   data	   to	   detect	   trends	   and	  
relationships	  not	  apparent	  when	  prior	  experiments	  were	  first	  performed.	  
The	  application	  of	  business	   intelligence	   to	  proteomics	   in	   this	   research	  has	   facilitated	  
reliable	  identification	  of	  protein	  interaction	  partners	  (see	  Chapter	  5:	  Multidimensional	  
Analysis	   with	   IP	   Experiments).	   Techniques	   from	   the	   BI	   field	   were	   used	   to	   perform	  
multidimensional	   data	   analysis,	   in	   order	   to	   improve	   the	   discrimination	   between	  
specific	   and	   non-­‐specific	   protein	   associations	   and	   to	   analyse	   dynamic	   protein	  
complexes.	   These	   strategies	   involved	   annotating	   the	   frequency	   of	   detection	   in	  
immunoprecipitation	  experiments	   for	  all	  proteins	   in	   the	  human	  proteome.	  From	  this	  
annotation,	  the	  likely	  specific	  interaction	  partners	  could	  be	  discerned	  more	  reliably	  as	  
these	   were	   usually	   expected	   to	   have	   a	   low	   frequency.	   This	   list	   of	   proteins	   and	  
annotation	  produced	  a	  Protein	  Frequency	  Library	  (PFL)	  that	  improves	  on	  previous	  use	  
of	   static	   “bead	   proteomes”.	   The	   PFL	   produced	   not	   only	   provides	   a	   flexible	   and	  
objective	   filter	   for	   discriminating	   between	   contaminants	   and	   specifically	   bound	  
proteins	   but	   it	   can	   be	   used	   to	   normalise	   data	   values	   and	   facilitate	   comparisons	  
between	  data	  obtained	  in	  separate	  experiments.	  The	  PFL	  is	  a	  dynamic	  tool	  that	  can	  be	  
filtered	   by	   specific	   experimental	   parameters	   to	   generate	   a	   customised	   library.	  
Furthermore,	  it	  is	  continuously	  updated	  as	  data	  from	  each	  new	  experiment	  are	  added	  
to	  PepTracker	  thereby	  progressively	  enhancing	  its	  utility.	  The	  application	  of	  the	  PFL	  to	  
pull-­‐down	  experiments	   is	  especially	  helpful	   in	   identifying	  either	   lower	  abundance,	  or	  
less	   tightly	  bound,	   specific	  components	  of	  protein	  complexes	   that	  are	  otherwise	   lost	  
amongst	  the	  large,	  non-­‐specific	  background.	  	  
The	   PFL	   has	   been	   fully	   implemented	   in	   a	   PFL	   Viewer	   tool	  
(http://proteinfrequencylibrary.com)	  that	  provides	  an	  intuitive	  graphical	  user	  interface	  
for	   researchers	   wishing	   to	   explore	   the	   PFL	   database,	   which	   is	   implemented	   as	   an	  
OnLine	  Analytical	  Processing	  cube.	  Furthermore,	  the	  PFL	  functionality	  is	  built	  into	  the	  
main	  PepTracker	  suite	  so	  that	  researchers	  can	  integrate	  the	  PFL	  with	  their	  datasets	  to	  
allow	  normalisation	  using	  the	  wealth	  of	  experience	  captured	  by	  the	  PFL.	  
The	   PFL	   Viewer	   is	   one	   tool	   that	   captures	   the	   concept	   of	   super-­‐experiments	   to	  
formulate	   information	   that	   can	   be	   used	   to	   annotate	   proteins	   with	   an	   additional	  
confidence	   score.	   This	   type	   of	   annotation	   is	   valuable	   to	   researchers	   as	   it	   can	   help	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direct	   efforts	   more	   systematically	   to	   proteins	   that	   may	   yield	   interesting	   biological	  
results.	  This	  is	  imperative	  for	  biologists	  before	  they	  follow	  lines	  of	  research,	  which	  may	  
take	   them	   on	   a	   detailed	   and	   costly	   study	   of	   a	   particular	   protein/set	   of	   proteins.	  
Biologists	   will	   focus	   a	   number	   of	   years	   on	   such	   studies,	   hence	   heightening	   the	  
importance	  of	  being	  able	  to	  identify	  research	  worthy	  proteins.	  	  
Within	   the	   Lamond	   Laboratory,	   having	   the	   PepTracker	   system	   in	   place,	   researchers	  
have	   been	   driven	   to	   carry	   out	   larger	   scale	   proteome-­‐wide	   studies	   that	   can	   provide	  
additional	  protein	  annotations	  and	  proteome	  level	  analysis	  capabilities.	  One	  of	  these	  
large-­‐scale	   studies	   has	   been	   the	   study	   of	   global	   proteome	   turnover	   rates	   of	   human	  
proteins,	  conducted	  by	  Francois-­‐Michel	  Boisvert	  and	  Fabien	  Charriere	  (see	  Chapter	  6:	  
Spatial	   Localisation	   &	   Turnover	   Analyses).	   This	   experiment	   collected	   abundance,	  
localisation,	   synthesis,	  degradation	  and	   turnover	  data	  over	   time	   for	  different	  cellular	  
compartments,	  hence	  making	  these	  data	  an	  extremely	  valuable	  resource,	  which	  can	  be	  
mined	   to	   answer	   questions	   such	   as	   the	   variation	   in	   turnover	   trends	   across	   different	  
cellular	  compartments	  (Boisvert	  et	  al.,	  2011).	  These	  data	  can	  also	  be	  of	  worth	  to	  other	  
researchers	  wanting	   to	   gain	   further	   insight	   into	   specific	   proteins	   of	   interest.	   Hence,	  
making	   these	  data	  available	   through	  an	  online	   tool	  would	  benefit	  many	   researchers.	  
The	   Turnover	   Viewer	   was	   created	   as	   a	   practical	   utility	   that	   can	   be	   accessed	   by	  
biologists	   globally.	   It	   documents	   the	   turnover,	   half-­‐life,	   abundance	   and	   localisation	  
information	   collected	   during	   this	   proteome	  wide	   study	   and	   links	   this	   information	   to	  
spatial	   datasets	   to	   provide	   “super-­‐experiment”	   analysis	   that	   could	   add	   further	  
annotation	  to	  the	  human	  proteome.	  
Leading	  on	   from	   this	  work,	  new	  analysis	   approaches	  have	  also	  been	  developed	  with	  
the	  aim	  of	  extracting	  more	  value	  from	  the	  data	  generated.	  Using	  the	  global	  proteome	  
turnover	   and	   localisation	   dataset,	   strategies	   were	   developed	   to	   carry	   out	   more	  
accurate	  protein	  identifications	  by	  applied	  knowledge	  analysis	  (see	  Chapter	  7:	  Protein	  
Isoform,	  Localisation	  and	  Turnover	  Analysis).	  In	  higher	  eukaryotes,	  many	  genes	  encode	  
two	  or	  more	  protein	  isoforms	  and	  the	  properties	  and	  biological	  roles	  of	  these	  separate	  
isoforms	   are	   often	   poorly	   characterised.	   In	   a	   simple	   analysis,	   these	   isoforms	   can	   be	  
overlooked	  and	  misidentified.	  Within	  this	  research,	  using	  a	  multidimensional	  approach	  
to	  the	  analysis	  brought	  together	  various	  dimensions	  in	  the	  study	  to	  accurately	  identify	  
either	   protein	   isoforms	   or	   functionally	   distinct	   pools	   of	   proteins	   that	   differ	   in	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measurable	   properties.	   A	   number	   of	   systematic	   approaches	   were	   developed	   and	  
published	  for	   the	  detection	  of	  protein	   isoforms	  with	  differential	  biological	  properties	  
(Ahmad	  et	  al.,	  2011).	  These	  strategies	  focused	  on	   identifying	  proteins	  that	  contained	  
identified	   peptides	   with	   SILAC	   ratios	   that	   were	   off	   trend.	   Furthermore,	   protein	  
isoforms	  were	   also	  detected	  by	   independently	   evaluating	   gel	   fractionation	  data	   that	  
displayed	  anomalies,	  suggesting	  the	  presence	  of	  multiple	  forms	  of	  a	  protein.	  Examples	  
of	  protein	  phosphorylation	  correlating	  with	  altered	  turnover	  rates	  were	  also	  observed	  
in	   different	   subcellular	   compartments.	   These	   strategies	   validate	   the	   benefits	   of	   a	  
multi-­‐dimensional	   strategy	   to	   data	   analysis.	   Collectively,	   the	   experimental	   and	  
analytical	   approaches	   developed	   here	   provide	   a	   framework	   for	   expanding	   the	  
functional	  annotation	  of	  the	  genome.	  
This	  research	  has	  paved	  the	  way	  for	  novel	  methods	  of	  analysing	  MS	  data.	  Through	  the	  
PepTracker	   suite	   the	   research	   has	   been	   able	   to	   record	   metadata	   and	   capture	   the	  
experimental	   experience	   of	   researchers.	   The	   visualisation	   and	   analysis	   built	   into	  
PepTracker	  allows	  users	  to	  navigate	  datasets	  and	  formulate	  hypotheses	  with	  ease	  –	  a	  
task	  that	  was	  previously	  becoming	   impossible.	  By	  realising	  the	  potential	  of	  collecting	  
proteomics	   datasets,	   this	   thesis	   has	   evidenced	   the	   validity	   of	   analysing	   datasets	  
together	  to	  form	  new	  hypothesis	  that	  span	  the	  whole	  human	  proteome.	  Furthermore,	  
these	   broad	   spanning	   analyses	   have	   provided	   further	   protein	   annotation	   to	   guide	  
research	   activities	   by	   providing	   methods	   of	   accurately	   identifying	   proteins	   and	  
assessing	   genuine	   interaction	   partners,	   as	   well	   as	   building	   up	   a	   dynamic	   picture	   of	  
cellular	  proteomics	  through	  large-­‐scale	  proteome	  studies	  and	  data	  analyses.	  	  
The	   Turnover	   and	   PFL	   Viewers	   are	   already	   available	   online	   for	   the	   benefit	   of	   the	  
academic	   community.	   It	   is	   envisioned	   that	   other	   elements	   of	   this	   pipeline	   and	  
software	  are	  also	  well	  established	  to	  be	  extended	  for	  more	  general	  use	  out	  with	  the	  
Lamond	  Laboratory	  experimental	  protocols.	  
The	   approach	   to	   software	   development	   in	   this	   thesis	   has	   flourished	   due	   to	   clear	  
understanding	   of	   the	   importance	   of	   communication	   between	   end	   users	   and	  myself,	  
the	  developer.	  The	  challenges	  affecting	  a	  software	  development	  project	  in	  life	  sciences	  
centre	  on	  domain	  understanding	  of	  a	  specialised	  science,	  knowledge	  extraction	  from	  
expert	  biologists,	  dealing	  with	   levels	  of	  experience	   in	  computer	   literacy	  and	  analysis,	  
discovery	  of	  unexpected	   requirements	  due	   to	   the	  pioneering	  nature	  of	   the	   field	  and	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the	  risk	  of	  wrong	  decisions.	  So	  far	  I	  have	  worked	  whilst	  being	  embedded	  directly	  in	  the	  
research	   laboratory,	   which	   has	   allowed	   for	   good	   dialogue	   throughout	   the	   software	  
development	   process.	   By	   understanding	   the	   importance	   of	   end	   researchers,	   rapid	  
deployment	  and	  an	   iterative	  process,	   it	  has	  been	  possible	   to	  make	   rapid	  progress	   in	  
both	  the	  computational	  and	  biological	  aspects	  of	  the	  project.	  	  
8.1 Proteomics Data Management and Analysis in the Future 
It	   is	   imperative	  that	  advances	   in	  many	  areas	  of	   life	  sciences	  research,	  especially	  high	  
throughput	   approaches	   that	   generate	   large	   volumes	   of	   data,	   are	   supported	   by	  
adequate	  developments	   in	  the	  field	  of	  computing.	   	  There	  are	  many	  new	  and	  exciting	  
discoveries	  to	  be	  made	  through	  cross	  discipline	  work	  that	  brings	  together	  science	  and	  
computing	  in	  a	  usable	  fashion	  that	  can	  enhance	  knowledge	  and	  understanding	  in	  both	  
fields.	   By	   having	   an	   open	   exchange	   of	   ideas	   and	   close	   collaboration	   between	   cell	  
biologists	   and	   computer	   scientists,	   exciting	   new	   solutions	   can	   be	   created	   that	   are	  
researcher	   friendly	   and	   intuitive,	   whilst	   providing	   researchers	   with	   more	   effective	  
representations	  and	  interpretations	  of	  their	  data.	  	  
Collectively,	   the	   experimental	   procedures	   and	  data	   analysis	   approaches	  described	   in	  
this	   thesis	   provide	   a	   new	   framework	   for	   the	   systematic	   detection	   and	   analysis	   of	  
proteins	   that	  can	  be	  correlated	  with	  biological	  properties	  and	  hence	  used	   to	  expand	  
the	  functional	  annotation	  of	  the	  genome	  and	  take	  it	  to	  the	  next	  level.	  	  
Proteomics	   has	   reached	   a	   critical	   stage	   where	   it	   is	   now	   possible	   to	   produce	   high	  
quality	   datasets	  with	  wide	   peptide	   coverage	   of	   protein	   identifications.	   This	  will	   only	  
continue	   to	   improve	   over	   the	   years	   to	   come,	   with	   data	   growth	   being	   described	   as	  
exponential.	  The	  measurement	  of	  protein	  properties	  for	  whole	  proteomes	  in	  different	  
cell	  types,	  under	  different	  growth	  conditions	  and	  at	  many	  time	  points	  generates	  very	  
large	  volumes	  of	  data.	  This	  allows	  proteomics	  a	  definite	  position	  in	  the	  ‘Big	  Data’	  arena	  
with	  predicted	  sample	  raw	  files	  growing	  towards	  the	  10GB	  size	  in	  the	  next	  2-­‐3	  years,	  
leading	   to	   generation	   of	   terabytes	   if	   not	   petabytes	   of	   data.	   This	   data	   growth	   will	  
require	   further	   sophisticated	   data	  management	   and	   pipelining	   strategies	   to	   prevent	  
researchers	   from	   drowning	   in	   their	   data.	   Storage	   of	   these	   data	   is	   also	   another	  
consideration	  that	  will	  become	  ever	  more	  prevalent.	  A	  subset	  of	  these	  data	  will	  be	  in	  
the	  form	  of	  processed	  and	  annotated	  data	  outputs	  that	  are	  the	  primary	  resource	  used	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by	   the	  biological	   community.	  A	   large	  amount	  of	  data	  will	  be	   in	   the	   form	  of	  archived	  
raw	  files	  that	  must	  be	  stored	  securely	  and	  available	  for	  reference	  if	  called	  upon.	  
There	  is	  further	  development	  work	  that	  can	  be	  carried	  out	  in	  the	  future	  to	  extend	  the	  
core	  functionality	  of	  the	  well-­‐documented	  existing	  code	  base	  of	  the	  PepTracker	  suite,	  
with	   the	   intention	   of	   expanding	   the	   software	   for	   a	   broader	   audience.	   This	   requires	  
further	  attention	  to	  dealing	  with	  a	  larger	  user	  base,	  additional	  levels	  of	  security	  and	  a	  
much	  more	  varied	  experiment	  set.	  The	  software	  has	  been	  created	  with	  the	  intention	  
of	  scalability	  and	  in	  awareness	  of	  the	  fact	  that	  science	  is	  constantly	  advancing.	  Hence	  
the	   metadata	   to	   be	   collected	   regarding	   experiments	   is	   continuously	   evolving.	  
However,	   with	   a	   wider	   user	   base	   the	   experimental	   variety	   increases	   and	   hence	  
resources	   could	   be	   applied	   to	   extending	   the	   software	   to	   deal	   with	   the	   additional	  
requirements	  and	  features	  specific	  to	  other	  laboratories.	  	  
In	   addition,	   the	   current	   web-­‐based	   software	   can	   be	   extended	   to	   run	   as	   a	   cross	  
platform	  enterprise	  desktop	  application.	  With	  the	  increased	  size	  of	  datasets	  it	  is	  more	  
desirable	   for	  users	   to	  have	   the	  ability	   to	   run	   their	  analysis	  on	  a	  desktop	  platform	  as	  
well	   as	   a	   web	   platform.	   This	   provides	   increased	   power	   and	   capabilities	   for	   larger	  
datasets	   that	   are	  more	   difficult	   to	  manipulate	   across	   the	  web.	   Also,	  with	   a	   desktop	  
platform	   combined	   with	   a	   local	   database,	   users	   can	   download	   datasets	   for	   offline	  
access.	  The	  proof	  of	  concept	  and	  suitability	  of	  the	  software	  has	  already	  been	  proven	  
through	  the	  creation	  of	  the	  fully	  functional	  web	  based	  version	  of	  the	  software.	  
Increasingly	  researchers	  are	  demanding	  software	  improvements	  for	  faster	  analytics	  to	  
open	  up	  current	  bottlenecks	  in	  the	  quantitative	  proteomics	  data	  pipeline.	  This	  requires	  
that	  current	  software	  running	  on	  single	  desktops	  be	  scaled	  up	  to	  cluster	   level	  access	  
and	  data	  warehousing	  solutions	  to	  become	  more	  prevalent.	  PepTracker	   is	  one	  of	  the	  
first	   quantitative	   proteomics	   software	   to	   provide	   data	   warehousing	   capabilities.	  
Additionally,	   pipelining	   the	   PepTracker	   workflow	   with	   commercial	   and/or	  
freeware/shareware	  software,	  that	  allows	  MS	  identification	  and	  quantification,	  would	  
provide	  researchers	  with	  a	  smoother	  pipeline	  for	  MS	  analysis.	  
The	  visualization	  and	  analytics	  interfaces	  that	  have	  been	  created	  thus	  far	  have	  already	  
proven	   to	   be	   immensely	   useful.	   However,	   these	   can	   be	   further	   developed	   with	  
concentrated	   effort	   on	   the	   maximisation	   of	   interaction	   with	   data.	   The	   existing	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software	  includes	  charting	  and	  graphing	  capabilities	  that	  integrate	  mouse	  controls	  for	  
zooming,	  scrolling	  and	  hover-­‐over	  tooltips,	  cross	  comparison	  of	  datasets,	  management	  
of	  protein	  groups	  and	  automated	  classification	  and	  filtering	  of	  contaminant	  proteins.	  
By	  extending	   these	  existing	   tools,	   it	   is	  possible	   to	  enable	  more	  enhanced	  analysis	  of	  
datasets.	   One	   way	   in	   which	   this	   can	   be	   implemented	   is	   via	   an	   Application	  
Programming	   Interface	   (API)	   that	  would	  provide	  users,	  who	  are	  proficient	  at	   coding,	  
with	  the	  capability	  of	  building	  their	  own	  plugins	  that	  can	  be	  used	  with	  the	  PepTracker	  
suite.	  This	  API	  would	  provide	  researchers	  with	  programmatic	  access	  to	  their	  datasets,	  
which	  in	  turn	  enables	  novel	  analysis	  possibilities.	  An	  API	  would	  also	  provide	  additional	  
flexibility	   and	   encourage	   users	   to	   take	   part	   in	   the	   development	   efforts.	   Due	   to	   the	  
varied	   nature	   of	   the	   science	   carried	   out	   in	   laboratories	   around	   the	   world,	   it	   is	  
impossible	   to	   cover	   all	   potential	   functionality	   that	   may	   be	   requested	   by	   external	  
researchers,	  hence	  creating	  an	  API	  raises	  the	  prospects	  of	  a	  much	  wider	  user	  base.	  
Using	   the	   PepTracker	   suite,	   the	   work	   in	   this	   thesis	   has	   already	   established	   and	  
validated	   successful	  workflows	   for	   the	   large-­‐scale,	   quantitative	  measurement	   of	   key	  
protein	  properties,	  including	  subcellular	  protein	  localisation,	  the	  reliable	  identification	  
of	   specific	   protein	   interaction	   partners,	   the	   systematic	   identification	   of	   protein	  
isoforms	   and	  protein	   pools,	   the	  measurement	   of	   protein	   synthesis,	   degradation	   and	  
turnover	  rates	  and	  the	   identification	  and	  correlation	  of	  patterns	  of	  post-­‐translational	  
protein	  modifications.	  
Increasingly	   the	   Lamond	   Laboratory	   is	  moving	   from	   studying	   static	   snapshots	   of	   the	  
cell,	  to	  carrying	  out	  experiments	  that	  can	  aid	  in	  the	  development	  of	  a	  dynamic	  picture	  
of	  the	  cell.	  Within	  a	  cell,	  the	  structures	  and	  properties	  of	  proteins	  are	  crucial	  for	  their	  
function	   and	   can	   vary	   greatly.	   Subcellular	   localisation	   patterns,	   post-­‐translational	  
modifications,	   rates	   of	   synthesis	   and	   degradation	   and	   interactions	   with	   partner	  
proteins	  are	  all	   variable.	   Furthermore,	   all	   of	   these	  properties	  not	  only	   vary	  between	  
proteins,	  they	  are	  also	  dynamic	  and	  can	  vary	  for	  the	  same	  protein	  at	  different	  times,	  
depending	   on	   parameters	   such	   as	   cell	   cycle	   progression,	   growth	   rate	   and	   signalling	  
events.	  Proteomes	  are	  thus	   inherently	  complex	  and	  their	  properties	   in	  constant	   flux.	  
This	   is	   the	   challenge	   to	   be	   explored	   in	   future	   proteomic	   studies	  within	   the	   Lamond	  
Laboratory,	  aiming	  to	  ideally	  not	  only	  identify	  which	  proteins	  are	  expressed	  in	  a	  cell	  or	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organelle,	   but	   also	   characterise	   their	   properties	   and	   quantify	   how	   these	   change	   in	  
response	  to	  different	  perturbations	  and	  cell	  cycle	  stages	  etc.	  
Building	   on	   the	   work	   in	   this	   thesis,	   the	   Lamond	   Laboratory	   can	   move	   forward	   and	  
extend	  the	  ‘spatial	  proteomics’	  approach	  by	  compiling	  an	  even	  higher	  resolution	  map	  
of	   proteome	   localisation	   through	   more	   extensive	   cell	   fractionation	   prior	   to	   protein	  
chromatography	  and	  MS	  analysis.	  For	  example,	  the	  cytoplasmic	  compartment	  can	  be	  
further	  sub-­‐fractionated	  into	  cytosol	  and	  organelle	  fractions	  and	  work	  is	  underway	  to	  
implement	  this.	  Furthermore,	  additional	  post-­‐translational	  modifications	  can	  be	  added	  
to	  the	  analysis	  and	  their	  potential	  effects	  on	  the	  properties	  of	  specific	  protein	  families	  
and	   protein	   pools	   evaluated	   and	   compared	   in	   different	   cellular	   compartments.	   In	  
addition,	  the	  analyses	  to	  date	  have	  analysed	  mixtures	  containing	  cells	  at	  different	  cell	  
cycle	   stages.	  However,	   it	   is	   already	  known	   for	   specific	  proteins	   that	   their	   expression	  
levels	   and	   properties,	   including	   localisation	   and	   PTMs,	   can	   change	   during	   different	  
stages	  of	  interphase	  and	  mitosis.	  It	  is	  therefore	  important	  to	  expand	  future	  studies	  to	  
encompass	   system-­‐wide,	   quantitative	   analysis	   of	   the	   properties	   of	   proteins	   both	   in	  
multiple	  subcellular	  locations	  and	  at	  different	  cell	  cycle	  stages.	  The	  resulting	  data	  are	  
likely	  to	  provide	  a	  useful	  source	  of	  information	  that	  can	  reveal	  unexpected	  and	  novel	  
molecular	  relationships	  and	  potential	  regulatory	  mechanisms	  for	  future	  investigation.	  
Over	   recent	  years,	   the	  Lamond	  Laboratory	  has	   shifted	   resources	   to	   increase	  analysis	  
capabilities	   from	   studying	   single	   datasets	   to	   analysing	   the	   global	   proteome	   and	  
system-­‐wide	   changes	   at	   the	   cellular	   level.	   PepTracker	   and	   the	   idea	   of	   super	  
experiments	  have	  thus	  far	  highlighted	  the	  huge	  potential	   for	   further	  development	  of	  
these	  approaches	  in	  the	  field	  of	  proteomics.	  The	  super	  experiment	  concept	  is	  relatively	  
unexplored	  and	  can	  be	  developed	  much	  further	   in	  the	  realm	  of	  biology	  by	  extending	  
the	  work	  described	  whilst	  accessing	  more	  sophisticated	  analysis	   techniques.	  Through	  
focussed	   application	   of	   new	   mass	   spectrometry	   based	   proteomics	   tools,	   study	   and	  
documentation	  of	  dynamic	  protein	  properties	  on	  a	  proteome	  wide	  scale,	  researchers	  
can	  discover	  and	  annotate	  proteins	  with	  information	  that	  can	  eventually	  lead	  to	  major	  
advances	  in	  cell	  biology	  and	  aid	  the	  development	  of	  new	  approaches	  for	  the	  pharma	  
and	   healthcare	   industries	   to	   evaluate	   drug	   toxicity	   and	   reduce	   the	   costs	   inherent	   in	  
bringing	  safe	  new	  drugs	  to	  market.	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Figure	  56:	  Multidimensional	  analytics	  of	  protein	  properties.	  
Due	  to	  the	  highly	  complex	  nature	  of	  the	  new	  types	  of	  data	  being	  gathered,	  there	  is	  a	  
need	   for	   novel	   ways	   to	   visualise	   and	   interface	   with	   this	   biological	   data.	   Traditional	  
software	  approaches	  mainly	  deal	  with	  visualising	  data	  using	  two	  or	  three	  dimensions	  
at	  any	  one	  time.	  In	  the	  future,	  PepTracker	  can	  be	  expanded	  to	  explore	  the	  use	  of	  many	  
more	   dimensions	   on	   the	   same	   visualisations,	   including	   shape,	   colour,	   size,	   labels,	  
gradients	   etc.	   Each	   dimension	   in	   a	   dataset	   can	   have	   different	   characteristics,	   which	  
defines	   their	   suitability	   for	   visualisation	   using	   various	   techniques.	   This	   would	   be	  
particularly	  useful	  for	  displaying	  complex	  multidimensional	  datasets	  in	  a	  format	  that	  is	  
easy	   for	   researchers	   to	   rapidly	   assimilate	   and	   interpret.	   Through	   extending	  
multidimensional	  analytics	  it	  will	  be	  possible	  to	  uncover	  new	  trends	  and	  relationships	  
within	  the	  data.	  
There	  is	  also	  a	  huge	  potential	  for	  integrating	  the	  proteomics	  data	  with	  other	  forms	  of	  
biological	  data	   (e.g.	   sequence	  data	  and	   imaging	  data)	   to	  expand	   further	   the	  value	  of	  
the	  information	  recorded	  in	  each	  proteomics	  experiment.	  Dealing	  with	  heterogeneous	  
data	  will	   also	  mean	   developing	   automated	   quality	   control.	   It	   is	   anticipated	   that	   the	  
techniques	   developed	   here	   will	   be	   researched	   and	   developed	   further	   to	   allow	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evaluation	   of	   datasets	   based	   upon	   the	   similarities/dissimilarities	   found	   in	   a	   vast	  
collection	  of	  historical	  data.	  	  
The	   PepTracker	   data	  warehouse	   is	   continuing	   to	   grow	   in	   the	   Lamond	   Laboratory	   as	  
further	  datasets	  are	  added	  to	  the	  data	  warehouse,	  both	  those	  generated	  in-­‐house	  and	  
datasets	  obtained	  from	  collaborators.	  Thanks	  to	  the	  variety	  of	  the	  experiments	  carried	  
out	  in	  the	  Lamond	  Laboratory,	  PepTracker	  is	  accumulating	  and	  recording	  diverse	  types	  
of	   experimental	   data	   that	   could	   be	   used	   to	   test	   new	   mining	   techniques	   as	   they	  
become	  available.	  This	  data	  collation	  can	  be	  further	  improved	  with	  data	  from	  external	  
laboratories.	   Future	   directions	   involve	   supporting	   a	   larger	   group	   of	   researchers	   and	  
sharing	  the	  resources	  and	  data	  outputs	  with	  the	  international	  community.	  	  
The	   PepTracker	   environment	   is	   in	   daily	   use	   and	   in	   active	   development	   within	   the	  
Lamond	  Laboratory,	  however	  there	  is	  growing	  demand	  for	  access	  to	  PepTracker	  from	  
the	   wider	   international	   research	   community,	   both	   in	   Dundee	   and	   globally	   from	  
academia	  and	  pharma	   industry.	   Interest	  has	  been	  registered	   from	   institutes	  globally,	  
who	  would	  like	  to	  be	  involved	  in	  the	  development	  work	  through	  contribution	  of	  data	  
and/or	  use	  of	  our	  current	  and	  proposed	  analysis	  and	  visualisation	  tools.	  There	  has	  also	  
been	   interest	   and	   dialogue	   with	   the	   pharma	   industry	   who	   have	   expressed	   their	  
interest	  in	  making	  use	  of	  the	  proposed	  tools	  and	  data	  to	  make	  the	  arduous	  process	  of	  
developing	  new	  medicines	  much	   cheaper	   and	   safer	   in	   the	   future.	  Moving	   forward	   a	  
major	  aim	  could	  be	  to	  expand	  PepTracker	  to	  support	  a	  larger	  group	  of	  users	  and	  share	  
the	   resources	   and	   data	   outputs	   with	   the	   international	   community,	   including	  
commercial	  companies.	  Currently	  PepTracker	   is	  deigned	  to	  run	   locally,	  by	  developing	  
the	   application	   further,	   it	   would	   be	   possible	   to	   make	   it	   more	   distributable	   with	   a	  
‘download	   and	   install’	   version	   of	   the	   PepTracker	   software	   and	   tools,	   which	   can	   be	  
made	  available	  to	  the	  academic	  community	  and	  licensed	  commercially.	  	  
Through	   the	   already	   implemented	   accurate	   tagging	   and	   aggregation	   of	   complex	  
quantitative	   data,	   this	   thesis	   provides	   the	   basis	   for	   developing	   pioneering	   new	  
approaches	   that	   allow	   biologists	   to	   carry	   out	  multi	   dimensional	   analysis,	   benefitting	  
both	  basic	  and	  advanced	  biomedical	  projects	  around	  the	  world.	  PepTracker	  is	  already	  
collecting	  vast	  amounts	  of	  data,	  which	  can	  be	  used	  as	  a	  test	  bed	  for	  mining.	  This	  thesis	  
has	  highlighted	  the	  benefits	  of	  focusing	  on	  data	  management	  and	  visualisation	  tools	  to	  
aid	   access,	   interpretation	   and	   manipulation	   of	   the	   large	   volumes	   of	   data	   being	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generated	  by	   cell	   biologists.	  With	   the	   focus	  on	  enhanced	  user	   interaction	  with	  data,	  
this	  thesis	  is	  aiding	  in	  the	  concerted,	  large-­‐scale	  characterisation	  of	  cell	  proteomes	  by	  
the	   Lamond	   Laboratory.	   The	   analytical	   techniques	   developed	   in	   this	   thesis	   will	   be	  
transferrable	  to	  many	  more	  types	  of	  data.	  In	  the	  future	  it	  is	  possible	  for	  the	  PepTracker	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Appendices 
A. Cairngorm Framework 
The	   following	   class	   diagram	   depicts	   the	   Cairngorm	   Framework.	   This	   framework	  
describes	  how	  to	  design	  and	  implement	  solutions.	  Hence	  it	  allows	  developers	  to	  easily	  
analyse	   and	   understand	   code	   written	   by	   other	   developers.	   Furthermore,	   this	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B. Metadata Definition 
The	  following	  metadata	  is	  collected	  with	  regards	  to	  mass	  spectrometry	  submissions.	  
General	  Details	  
Field	   Definition	  
Keywords	   Specify	  up	  to	  three	  words	  associated	  with	  the	  experiment.	  
Cost	  Centre	   Cost	  centre	  number	  to	  be	  used	  by	  MS	  facility	  for	  billing.	  
Organism	   Organism	  of	  the	  cell	  type	  used	  in	  the	  experiment.	  
Cell	  Type	   Main	  cell	  type	  used	  in	  the	  experiment.	  
Treatment	  Type	   Specify	  whether	  drug	  or	  stress	  treatment(s)	  were	  used.	  
Treatment	   Details	  of	  treatment(s)	  applied	  to	  cells.	  
Enzyme	   Enzyme	  used	  in	  the	  experiment.	  
Digestion	   Type	  of	  digestion	  used	  in	  the	  experiment.	  
Additional	  
Information	  
Any	  additional	  details	  that	  a	  user	  may	  want	  to	  specify.	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Mass	  Spectrometry	  Details	  
Field	   Definition	  
Instrument	   The	  instrument	  you	  would	  like	  your	  samples	  to	  be	  run	  on.	  
Reagent	   Reagent	  used	  during	   alkylation	   to	   reduce	  proteins,	   e.g.	   IAA.	  
Note	  this	  will	  change	  the	  mass	  of	  your	  peptides.	  
Sample	  Composition	   Solution	  used	   to	  purify	  peptides,	  e.g.	  1%	  FA.	  This	   should	  be	  
an	  analytical	  grade	  acid	  solution,	   such	  as	  1%	  Formic	  Acid	  or	  
0.1%	  Trifluoroacetic	  Acid.	  Please	  consult	  the	  MS	  facility	  if	  you	  
intend	  to	  use	  a	  different	  solution.	  
Peptide	  Cleanup	   Method	  used	  for	  peptide	  cleanup.	  Peptide	  cleanup	  should	  be	  
carried	  out	  on	  ALL	  samples.	  
Sample	  Volume	   Total	  volume	  of	  sample	  being	  submitted	  to	  the	  MS	  facility	  in	  
microlitres.	  
Injection	  Volume	   Volume	   of	   sample	   to	   inject	   on	   the	   mass	   spectrometer	   in	  
microlitres.	  
Analysis	  Type	   Type	  of	  MS	  analysis.	  
Quant	  Type	   Type	  of	  quantification	  used,	  if	  any.	  
Run	  Length	   Length	  of	  run	  for	  each	  MS	  sample.	  Suggested	  times	   include:	  
40mins	   for	   purified,	   simple,	   single	  or	   small	   complex	  protein	  
sample	   ID;	   100	  mins	   for	   complex	   fractionated	   samples;	   and	  
180mins	  for	  complex	  protein	  samples.	  
96	  Well	  Plate	   Indicate	  whether	  a	  96	  well	  plate	  will	  be	  used	  for	  the	  sample	  
submission.	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SILAC	  Details	  
Field	   Definition	  
Medium	  Labels	   The	  labelling	  used	  in	  the	  medium	  SILAC	  label.	  
Heavy	  Labels	   The	  labelling	  used	  in	  the	  heavy	  SILAC	  label.	  
	  
Pull-­‐Down	  Details	  
Field	   Definition	  
Bait	   Type	  of	  target	  protein	  to	  be	  pulled	  down.	  
Tag	  Type	   Labelling	  of	  protein,	  if	  any.	  
Bead	  Type	   Solid	  matrix	  used.	  
Bead	   Bead	  used	  to	  pull-­‐down	  protein,	  if	  any.	  
Antibody	  Type	   Antibody	  used	  in	  experiment.	  
Buffers	   Buffers	   used	   during	   pull	   down	   of	   protein.	   Note:	   IP	   buffer	  
specifics	   affect	   which	   proteins	   are	   pulled	   down	   in	   each	  
experiment,	   i.e.	  high	  salt	  percentage	  will	  mean	   less	  proteins	  
are	  pulled	  down.	  
Pre-­‐Clearing	  Time	   Pre-­‐clearing	  is	  a	  step	  that	  can	  be	  included	  where	  the	  protein	  
solution	   is	   incubated	   for	   a	   short	   time	  with	   beads	   to	   reduce	  
non-­‐specific	  protein	  binding.	  
Incubation	  Time	   Incubation	  time	  with	  the	  antibody.	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Gel	  Lane/Solution	  Sample	  Details	  
Field	   Definition	  
Cell	  Extract	   Specify	  the	  cell	  extract	  of	  the	  lane/samples.	  
Derived	  Cell	  Type	   Relevant	   mutant	   or	   genetically	   modified	   cell	   types	   used	   to	  
express	  a	  specific	  protein.	  
Cell	  Cycle	  Stage	   Specify	  the	  cell	  cycle	  phase	  of	  cells	  in	  the	  lane/samples.	  
Volume	   Micrograms	   per	   microlitre	   of	   protein	   loaded	   onto	   gel/in-­‐
solution.	  
Replicate	   Replicate	  type	  of	  sample,	  if	  applicable.	  
Samples	   Number	  of	  fractions	  the	  gel	  lane	  was	  separated	  into.	  
IP	  Protein	   Protein(s)	  pulled	  down	  in	  lane/sample.	  
Light	  Label	   Description	  of	  the	  lane/samples	  in	  light	  media.	  
Medium	  Label	   Description	  of	  the	  lane/samples	  in	  medium	  media	  
Heavy	  Label	   Description	  of	  the	  lane/samples	  in	  heavy	  media	  
Column	  One	  Type	   Chromatography	  column	  one	  type.	  
Column	  One	  Buffer	   Chromatography	  column	  one	  buffer	  description.	  
Column	  Two	  Type	   Chromatography	  column	  two	  type.	  
Column	  Two	  Buffer	   Chromatography	  column	  two	  buffer	  description.	  
Column	   One	  
Fractions	  
Number	  of	  fractions	  for	  chromatography	  column	  one.	  
Column	   Two	  
Fractions	  
Number	  of	  fractions	  for	  chromatography	  column	  two.	  
Fraction	  Volume	   Volume	  of	  fractions	  on	  microliters.	  
Volume	  Injected	   Volume	  injected	  in	  microliters.	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C. N-End Rule Evaluation 
This	  table	  refers	  to	  data	  generated	  during	  the	  study	  described	  in	  Chapter	  6:	  Spatial	  
Localisation	  &	  Turnover	  Analyses 
Chapter	   6:	   Spatial	   Localisation	   &	   Turnover	   Analyses.	   Analysis	   was	   carried	   out	   to	  
determine	   whether	   the	   amino	   acids	   at	   the	   N-­‐terminus	   or	   C-­‐	   terminus	   of	   a	   protein	  
sequence	  could	  be	  related	  to	  the	  turnover	  or	  half-­‐life	  of	  the	  protein,	  as	  suggested	  by	  
the	  N-­‐end	  rule. 
This	   analysis	   considered	  all	   turnover	  proteins	   that	   start	  with	   a	  methionine	   at	   the	  N-­‐
terminus.	  The	  first	   table	   (see	  Table	  7)	  shows	  the	  average	  half-­‐life	  measured	  for	  each	  
amino	   acid	   at	   the	   first	   ten	   N-­‐terminal	   positions	   and	   Table	   8,	   similarly	   shows	   the	  
average	   half-­‐life	  measured	   for	   each	   amino	   acid	   at	   the	   last	   ten	   C-­‐terminal	   positions.	  
From	   these	   tables	   we	   can	   conclude	   that	   half-­‐life	   is	   not	   affected	   by	   the	   amino	   acid	  
identity	   at	   the	  N-­‐terminus	   or	   C-­‐	   terminus.	   Furthermore,	   Table	   9	   and	   Table	   10	   show	  
that	  the	  average	  turnover	  rate	  is	  also	  not	  affected	  by	  the	  amino	  acid	  identity	  at	  either	  
the	  N-­‐terminus	  or	  C-­‐terminus.	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N	  -­‐	  























A	   	   22.5	   22.4	   22.1	   22.3	   22.7	   22.3	   21.7	   21.7	   22.0	  
R	   	   20.4	   23.0	   21.8	   21.0	   22.1	   21.1	   22.3	   21.7	   22.0	  
N	   	   20.9	   23.0	   20.1	   22.2	   20.6	   22.1	   21.5	   21.3	   21.4	  
D	   	   20.3	   21.9	   22.5	   20.9	   22.0	   22.2	   20.7	   21.9	   21.9	  
C	   	   25.2	   20.8	   22.8	   22.9	   21.9	   21.2	   20.5	   21.5	   22.4	  
Q	   	   20.9	   21.7	   21.8	   21.0	   22.6	   21.9	   22.1	   22.7	   23.8	  
E	   	   19.9	   22.7	   22.0	   21.5	   20.9	   21.0	   20.7	   21.8	   22.7	  
G	   	   21.1	   21.4	   22.4	   21.0	   21.2	   21.6	   22.0	   21.7	   21.9	  
H	   	   21.7	   21.7	   22.0	   23.8	   21.9	   20.5	   19.7	   20.4	   19.2	  
I	   	   22.4	   21.4	   22.0	   21.8	   21.6	   23.7	   22.9	   21.9	   21.5	  
L	   	   24.6	   21.3	   22.7	   23.0	   22.3	   21.7	   23.0	   22.9	   21.9	  
K	   	   21.8	   21.7	   21.5	   21.9	   20.4	   20.7	   21.6	   20.8	   21.4	  
M	   21.8	   20.7	   22.6	   19.9	   20.2	   20.8	   19.2	   21.0	   21.2	   21.6	  
F	   	   22.5	   25.5	   20.0	   21.0	   22.4	   22.1	   22.0	   21.1	   19.7	  
P	   	   22.6	   20.8	   20.9	   20.9	   21.5	   22.3	   21.6	   21.3	   20.9	  
S	   	   21.9	   20.8	   21.9	   21.6	   21.8	   21.9	   21.6	   21.8	   21.7	  
T	   	   20.1	   20.4	   21.4	   21.5	   21.0	   22.0	   21.2	   21.3	   21.8	  
W	   	   19.2	   24.0	   21.1	   21.0	   20.8	   21.3	   21.3	   21.0	   22.7	  
Y	   	   24.4	   21.2	   21.5	   23.6	   23.5	   25.8	   22.1	   21.7	   22.5	  
V	   	   21.9	   20.6	   22.2	   23.6	   22.2	   21.7	   22.1	   22.2	   21.3	  
Table	  7:	  Average	  half-­‐life	  for	  each	  amino	  acid	  at	  the	  first	  ten	  N-­‐terminal	  positions.	  
	  
	   	  
265	  
C	  -­‐	  























A	   22.7	   20.7	   22.8	   21.4	   23.1	   22.1	   21.4	   22.1	   21.3	   21.6	  
R	   21.6	   22.5	   21.4	   21.4	   21.4	   22.2	   22.2	   21.7	   22.2	   21.7	  
N	   22.4	   21.3	   21.1	   21.6	   21.7	   22.4	   22.7	   20.1	   23.3	   22.4	  
D	   21.8	   20.0	   21.0	   21.3	   20.3	   21.9	   20.6	   21.4	   23.5	   21.0	  
C	   21.8	   22.1	   21.3	   18.8	   22.2	   20.1	   20.3	   21.0	   21.0	   18.3	  
Q	   21.3	   22.4	   22.2	   23.6	   22.4	   21.8	   20.7	   21.4	   21.6	   22.2	  
E	   21.6	   22.4	   21.3	   21.6	   23.5	   21.2	   22.6	   21.8	   22.2	   21.6	  
G	   21.8	   21.7	   22.7	   21.1	   22.4	   22.7	   21.7	   23.2	   22.7	   21.7	  
H	   21.9	   21.2	   23.1	   24.3	   22.1	   21.0	   22.8	   20.6	   21.0	   20.9	  
I	   21.1	   21.0	   20.7	   22.4	   23.2	   21.7	   21.5	   21.7	   23.4	   22.1	  
L	   21.2	   21.0	   21.8	   21.7	   22.1	   21.8	   22.4	   22.4	   22.4	   21.2	  
K	   22.6	   22.7	   22.5	   22.2	   21.7	   21.9	   21.9	   21.4	   21.2	   22.6	  
M	   20.5	   24.5	   19.6	   19.1	   20.9	   24.0	   22.2	   21.5	   22.6	   22.0	  
F	   22.5	   23.6	   22.6	   21.3	   21.9	   21.6	   22.8	   21.7	   21.7	   21.0	  
P	   21.9	   22.0	   22.3	   21.8	   20.4	   22.0	   21.9	   22.1	   21.8	   23.0	  
S	   22.0	   21.3	   22.5	   21.6	   21.1	   21.3	   20.9	   21.4	   20.2	   20.9	  
T	   21.1	   22.2	   21.1	   22.7	   21.1	   20.7	   21.5	   22.6	   22.3	   22.5	  
W	   20.3	   22.6	   20.2	   22.1	   21.5	   22.8	   21.2	   20.9	   21.9	   19.4	  
Y	   21.4	   21.9	   21.7	   21.5	   21.6	   22.1	   23.5	   24.3	   19.7	   21.3	  
V	   22.8	   22.5	   21.5	   24.0	   20.8	   22.1	   21.9	   21.8	   20.7	   24.2	  
Table	  8:	  Average	  half-­‐life	  for	  each	  amino	  acid	  at	  the	  last	  ten	  C-­‐terminal	  positions.	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N	  -­‐	  























A	   	   19.7	   19.7	   19.2	   20.0	   19.9	   19.8	   19.6	   19.1	   19.0	  
R	   	   18.5	   19.6	   19.0	   18.6	   19.2	   18.9	   19.4	   19.2	   19.3	  
N	   	   19.0	   18.6	   18.4	   19.3	   19.8	   19.4	   19.7	   19.6	   19.1	  
D	   	   18.3	   18.9	   19.3	   19.3	   19.6	   19.0	   19.0	   19.8	   19.6	  
C	   	   19.2	   18.6	   21.3	   19.8	   18.7	   19.3	   19.4	   18.9	   19.9	  
Q	   	   19.0	   19.0	   19.2	   19.6	   19.5	   18.4	   19.1	   19.0	   19.6	  
E	   	   18.3	   20.3	   19.7	   19.2	   19.0	   19.6	   18.5	   19.7	   19.1	  
G	   	   19.2	   19.7	   19.6	   18.8	   19.1	   19.3	   19.5	   19.5	   19.8	  
H	   	   18.9	   20.0	   20.8	   20.4	   20.2	   20.3	   19.0	   18.8	   18.9	  
I	   	   19.8	   19.6	   19.9	   19.1	   19.3	   20.1	   19.7	   20.0	   19.2	  
L	   	   20.5	   19.5	   20.1	   20.0	   19.6	   19.1	   19.7	   19.5	   19.4	  
K	   	   19.2	   19.4	   19.7	   19.7	   18.6	   19.2	   19.5	   18.8	   19.4	  
M	   19.3	   19.5	   20.1	   18.2	   17.1	   17.8	   19.7	   17.9	   20.6	   17.9	  
F	   	   20.5	   20.4	   18.4	   19.2	   20.3	   18.7	   19.4	   19.4	   18.3	  
P	   	   20.2	   18.5	   19.0	   19.1	   19.0	   19.8	   19.5	   18.7	   19.0	  
S	   	   19.1	   18.6	   19.4	   19.1	   18.9	   19.5	   19.0	   19.2	   19.9	  
T	   	   18.5	   19.0	   19.2	   19.0	   19.4	   19.3	   18.6	   19.5	   19.9	  
W	   	   19.4	   19.5	   18.3	   18.6	   17.5	   17.6	   19.6	   18.4	   20.6	  
Y	   	   22.0	   20.3	   19.1	   20.7	   18.0	   20.1	   19.7	   20.5	   20.1	  
V	   	   19.0	   18.6	   19.1	   19.8	   20.6	   19.4	   19.7	   19.7	   19.0	  
Table	  9:	  Average	  turnover	  for	  each	  amino	  acid	  at	  the	  first	  ten	  N-­‐terminal	  positions.	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A	   19.9	   19.2	   19.8	   19.2	   19.9	   20.2	   19.2	   19.9	   19.3	   19.3	  
R	   19.6	   20.1	   19.3	   19.1	   19.2	   18.9	   19.5	   19.5	   19.1	   19.5	  
N	   19.7	   19.2	   18.6	   19.2	   19.1	   19.6	   19.6	   19.1	   18.7	   19.5	  
D	   19.5	   18.7	   19.9	   19.0	   18.5	   18.6	   19.1	   19.6	   19.9	   18.9	  
C	   19.3	   18.8	   18.7	   17.9	   20.0	   19.0	   19.8	   19.4	   20.1	   17.9	  
Q	   19.0	   19.9	   19.2	   20.0	   20.0	   19.9	   19.5	   19.3	   19.6	   19.3	  
E	   19.4	   19.8	   19.4	   19.9	   19.7	   19.5	   19.9	   19.5	   20.4	   19.5	  
G	   19.4	   18.9	   19.3	   19.1	   20.0	   20.0	   19.0	   19.4	   19.3	   19.3	  
H	   18.8	   18.4	   20.0	   20.0	   19.0	   18.9	   20.2	   19.1	   19.5	   18.1	  
I	   18.9	   19.4	   19.0	   19.5	   20.3	   19.3	   18.8	   18.7	   19.7	   19.1	  
L	   19.3	   19.1	   19.9	   19.5	   19.9	   19.4	   19.7	   19.4	   19.6	   19.0	  
K	   19.7	   19.3	   20.1	   19.6	   19.3	   19.4	   19.9	   19.2	   19.1	   20.1	  
M	   19.1	   21.3	   17.9	   18.2	   19.2	   20.5	   20.3	   20.5	   20.5	   19.6	  
F	   19.4	   20.5	   18.8	   18.8	   19.1	   18.9	   18.9	   19.0	   19.3	   19.5	  
P	   19.1	   19.4	   19.3	   19.3	   18.5	   19.3	   19.1	   19.2	   19.2	   19.3	  
S	   19.2	   19.1	   19.4	   19.2	   18.3	   18.9	   18.7	   19.1	   18.6	   19.0	  
T	   19.3	   19.5	   19.1	   19.1	   19.4	   18.7	   19.2	   19.5	   19.7	   20.0	  
W	   17.9	   18.4	   17.4	   20.6	   19.6	   20.5	   18.7	   19.1	   19.2	   17.2	  
Y	   19.4	   19.6	   19.4	   19.1	   19.9	   19.6	   19.6	   20.4	   17.8	   18.6	  
V	   20.0	   19.5	   19.3	   20.3	   19.2	   19.2	   19.2	   19.2	   19.3	   21.0	  
Table	  10:	  Average	  turnover	  for	  each	  amino	  acid	  at	  the	  last	  ten	  C-­‐terminal	  positions.	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D. Random Protein Sampling Evaluation 
This	   table	   refers	   to	   data	   generated	   during	   the	   study	   described	   in	   Chapter	   6:	   Spatial	  
Localisation	  &	  Turnover	  Analyses.	  	  
In	  order	  to	  evaluate	  the	  random	  sampling	  of	  proteins	  within	  the	  study,	  the	  amino	  acid	  
occurrence	   at	   the	   first	   ten	   N-­‐terminal	   positions	   were	   calculated	   for	   the	   complete	  
human	   proteome	   (see	   Table	   11)	   and	   compared	   with	   the	   matrix	   of	   frequencies	  
calculated	  for	  proteins	  identified	  in	  this	  study	  (see	  Table	  12).	  The	  Pearson	  correlation	  
of	  this	  comparison	  is	  0.99	  indicating	  that	  the	  subset	  of	  human	  proteins	  sampled	  in	  the	  
study	  is	  highly	  representative	  of	  the	  total	  human	  proteome.	  
In	  order	  to	  ensure,	  this	  correlation	  was	  truly	  reflective	  of	  all	  data	  generated	  during	  this	  
study,	   the	   matrix	   of	   frequencies	   was	   calculated	   for	   the	   top	   10%	   fastest	   turnover	  
proteins	   (see	  Table	  13,	  Pearson	  correlation:	  0.99)	  and	   the	   top	  10%	  slowest	   turnover	  
proteins	  (see	  Table	  14,	  Pearson	  correlation:	  0.98).	  The	  high	  correlations	  show	  that	  all	  
sets	   of	   proteins	   within	   this	   study	   are	   highly	   representative	   of	   the	   total	   human	  
proteome.	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A	   0	   14765	   7608	   6822	   6398	   6646	   6405	   6492	   6720	   6371	  
R	   0	   3807	   5514	   5684	   5663	   5910	   5666	   5575	   5286	   5318	  
N	   0	   2605	   2388	   2417	   2403	   2115	   2255	   2101	   2039	   1867	  
D	   0	   4321	   3405	   2568	   2956	   3226	   2822	   2649	   3022	   2955	  
C	   0	   1088	   1584	   1768	   1743	   1884	   1828	   1872	   2000	   2149	  
Q	   0	   2180	   3207	   3353	   3312	   3349	   3393	   3329	   3238	   3132	  
E	   0	   6932	   5245	   5007	   4719	   4635	   4645	   4541	   4417	   4423	  
G	   0	   6153	   5761	   5456	   6729	   6259	   5562	   5983	   5910	   5863	  
H	   0	   1148	   1689	   1676	   1600	   1572	   1688	   1645	   1613	   1579	  
I	   0	   1681	   2131	   2552	   2477	   2472	   2426	   2748	   2667	   2772	  
L	   0	   4961	   7331	   8513	   8006	   8549	   9501	   9597	   9946	   10191	  
K	   0	   3804	   3917	   4211	   4449	   4004	   4079	   3763	   3598	   3491	  
M	   78546	   1426	   1451	   1502	   1470	   1392	   1331	   1574	   1238	   1310	  
F	   0	   1823	   2434	   2727	   2609	   2618	   2687	   2695	   3014	   3108	  
P	   0	   4308	   5616	   5989	   5202	   5438	   5787	   5722	   5307	   5710	  
S	   0	   8157	   8033	   7293	   7107	   7039	   6954	   6361	   6656	   6746	  
T	   0	   3604	   4658	   4088	   3996	   4033	   4189	   4121	   4023	   3955	  
W	   0	   1226	   1347	   1334	   1462	   1341	   1335	   1383	   1318	   1370	  
Y	   0	   1015	   1151	   1413	   1383	   1498	   1488	   1457	   1509	   1391	  
V	   0	   3540	   4075	   4163	   4844	   4534	   4461	   4889	   4964	   4758	  
Table	  11:	  Analysis	  of	  amino	  acid	  occurrence	  of	  complete	  human	  proteome.	  
Amino	  acid	  occurrence	  at	  first	  ten	  N-­‐terminal	  positions	  of	  all	  human	  proteins.	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A	   0	   1866	   908	   706	   658	   623	   607	   597	   656	   603	  
R	   0	   234	   447	   475	   481	   494	   519	   492	   489	   513	  
N	   0	   172	   177	   196	   160	   166	   199	   180	   157	   154	  
D	   0	   292	   373	   217	   259	   296	   245	   219	   267	   265	  
C	   0	   46	   94	   104	   85	   93	   114	   105	   117	   115	  
Q	   0	   141	   236	   291	   235	   281	   267	   253	   269	   262	  
E	   0	   529	   491	   426	   417	   426	   401	   433	   392	   378	  
G	   0	   441	   509	   457	   658	   538	   466	   514	   544	   538	  
H	   0	   46	   109	   98	   99	   99	   120	   116	   111	   103	  
I	   0	   92	   111	   213	   206	   181	   184	   204	   217	   230	  
L	   0	   297	   513	   592	   612	   627	   729	   706	   762	   739	  
K	   0	   200	   334	   333	   407	   360	   395	   358	   333	   352	  
M	   6402	   101	   98	   121	   128	   113	   95	   103	   91	   102	  
F	   0	   125	   145	   238	   177	   182	   204	   194	   216	   178	  
P	   0	   375	   383	   491	   357	   416	   455	   470	   414	   480	  
S	   0	   823	   639	   567	   560	   560	   540	   497	   487	   485	  
T	   0	   261	   357	   298	   290	   294	   313	   309	   281	   269	  
W	   0	   84	   82	   92	   79	   94	   68	   95	   77	   98	  
Y	   0	   50	   73	   133	   94	   121	   112	   124	   112	   118	  
V	   0	   227	   323	   354	   440	   438	   369	   433	   410	   420	  
Table	  12:	  Analysis	  of	  amino	  acid	  occurrence	  of	  turnover	  proteins.	  
Amino	  acid	  occurrence	  at	  the	  first	  ten	  N-­‐terminal	  positions	  of	  proteins	  found	  in	  this	  
study.	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A	   0	   140	   67	   68	   52	   42	   46	   39	   57	   58	  
R	   0	   35	   39	   47	   53	   51	   54	   42	   52	   49	  
N	   0	   15	   16	   17	   18	   16	   18	   13	   9	   13	  
D	   0	   23	   33	   20	   19	   23	   17	   22	   23	   16	  
C	   0	   7	   10	   5	   8	   11	   12	   10	   9	   5	  
Q	   0	   9	   29	   36	   19	   28	   30	   22	   28	   19	  
E	   0	   49	   24	   25	   38	   37	   40	   51	   29	   37	  
G	   0	   48	   36	   41	   54	   37	   41	   38	   44	   46	  
H	   0	   2	   8	   6	   6	   6	   7	   9	   9	   10	  
I	   0	   10	   11	   17	   15	   21	   15	   18	   16	   24	  
L	   0	   21	   51	   37	   51	   59	   58	   61	   68	   65	  
K	   0	   18	   27	   26	   29	   32	   30	   25	   35	   33	  
M	   558	   8	   7	   15	   15	   15	   8	   15	   3	   16	  
F	   0	   13	   10	   24	   16	   10	   15	   20	   17	   17	  
P	   0	   29	   42	   47	   32	   45	   42	   41	   42	   35	  
S	   0	   73	   59	   47	   49	   56	   45	   44	   46	   49	  
T	   0	   25	   36	   26	   34	   30	   24	   28	   16	   16	  
W	   0	   7	   6	   9	   7	   10	   11	   7	   9	   8	  
Y	   0	   2	   5	   11	   7	   14	   12	   13	   7	   7	  
V	   0	   24	   42	   34	   36	   15	   33	   40	   39	   35	  
Table	  13:	  Analysis	  of	  amino	  acid	  occurrence	  of	  fastest	  turnover	  proteins.	  
Amino	  acid	  occurrence	  for	  the	  top	  10%	  fastest	  turnover	  proteins	  in	  this	  study.	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A	   0	   156	   88	   69	   66	   57	   56	   48	   57	   59	  
R	   0	   24	   41	   36	   31	   44	   44	   41	   45	   40	  
N	   0	   9	   10	   12	   13	   14	   15	   19	   13	   8	  
D	   0	   13	   21	   12	   22	   24	   17	   14	   26	   26	  
C	   0	   5	   7	   10	   7	   8	   11	   12	   13	   10	  
Q	   0	   11	   16	   27	   18	   24	   16	   18	   17	   20	  
E	   0	   32	   51	   30	   37	   29	   41	   30	   38	   30	  
G	   0	   34	   50	   47	   47	   42	   36	   41	   41	   58	  
H	   0	   4	   12	   11	   10	   11	   13	   6	   6	   10	  
I	   0	   10	   10	   25	   14	   14	   20	   21	   22	   16	  
L	   0	   42	   46	   53	   64	   61	   49	   71	   65	   76	  
K	   0	   21	   28	   23	   30	   30	   32	   30	   25	   31	  
M	   536	   9	   8	   12	   6	   9	   8	   10	   8	   8	  
F	   0	   15	   20	   16	   12	   22	   11	   20	   18	   13	  
P	   0	   38	   26	   37	   30	   37	   46	   44	   31	   33	  
S	   0	   66	   36	   40	   45	   41	   56	   28	   34	   39	  
T	   0	   18	   30	   28	   27	   22	   24	   22	   21	   18	  
W	   0	   4	   11	   5	   4	   1	   3	   9	   4	   9	  
Y	   0	   8	   6	   12	   8	   3	   8	   10	   13	   6	  
V	   0	   17	   19	   31	   45	   43	   30	   42	   39	   26	  
Table	  14:	  Analysis	  of	  amino	  acid	  occurrence	  of	  slowest	  turnover	  proteins.	  
Amino	  acid	  occurrence	  for	  the	  top	  10%	  slowest	  turnover	  proteins	  in	  this	  study.	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E. LabTracker: iPad Based Laboratory Management Software 
The	  LabTracker	  project	  was	  an	  extension	  to	  the	  main	  PepTracker	  work	  discussed	  in	  this	  
thesis.	  An	  honours	  project	  student,	  Yasir	  Ahmad	  -­‐	  whom	  I	  supervised,	  carried	  out	  this	  
project.	  The	  software	  was	  then	   integrated	   into	  PepTracker	  and	  further	  developed	  by	  
myself.	  	  
	  
The	   LabTracker	   software	   aims	   to	   provide	   an	   online	   electronic	   laboratory	   book	   and	  
associated	   tools	   for	   researchers	   working	   at	   a	   laboratory	   bench.	   The	   need	   for	   this	  
software	   arose	   as	   a	   direct	   result	   of	   the	   common	   problems	   encountered	   with	  
traditional	   paper	   based	   laboratory	   books.	   Traditional	   laboratory	   books	   suffer	   from	  
many	  issues	  including:	  
• Inefficient	  recording	  of	  laboratory	  activities,	  	  
• Keeping	  the	  laboratory	  book	  up-­‐to-­‐date,	  
• Keeping	  track	  of	  reagents,	  
• Lack	  of	  ability	  to	  search	  for	  data,	  
• Data	  can	  become	  easily	  unorganised,	  
• Legibility	  of	  written	  laboratory	  books,	  and	  
• Potential	  of	  loss	  and/or	  damage	  to	  the	  laboratory	  book.	  
All	  of	  these	  issues	  highlight	  the	  need	  to	  move	  to	  an	  electronic	  based	  system	  that	  can	  
record	   the	   everyday	   work	   carried	   out	   by	   a	   researcher,	   as	   well	   as	   provide	   added	  
security	  that	  the	  data	  is	  backed	  up	  and	  protected.	  Furthermore,	  having	  this	  data	  in	  an	  
electronic	  format	  means	  it	  can	  be	  easily	  searched	  and	  organised,	  is	  available	  from	  any	  
computer	   connected	   to	   the	   web	   and	   it	   is	   legible	   and	   structured.	   Furthermore,	   by	  
recording	   protocols	   and	   experiments	   on	   a	   web	   server	   means	   duplication	   can	   be	  
avoided	  as	  protocols	  can	  be	  easily	  shared	  and	  kept	  consistent.	  
In	  order	  to	  implement	  a	  portable	  electronic	  notebook,	  an	  appropriate	  device	  had	  to	  be	  
selected.	   For	   this	   work,	   the	   iPad	   was	   chosen	   as	   the	   platform	   of	   choice	   due	   to	   its	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popularity	  in	  the	  scientific	  community	  and	  its	  ease	  of	  use.	  The	  iPad	  device	  is	  intuitive	  
to	  use,	   lightweight	  and	  very	  portable,	  making	  an	   ideal	  option	  as	  a	   replacement	   for	  a	  
traditional	  laboratory	  book	  in	  a	  science	  environment.	  Hence,	  the	  LabTracker	  software	  
was	  developed	  as	  an	  Apple	  app	  that	  runs	  on	  iPad/iPhone	  devices.	  
It	  was	  decided	  that	  user	  laboratory	  data	  collected	  via	  the	  application	  should	  be	  stored	  
on	  a	  central	  database	  server	  from	  where	   it	   is	  backed	  up.	  Each	  researcher	  can	  use	  an	  
iPad	   with	   the	   LabTracker	   software	   installed	   to	   access	   their	   laboratory	   book	   on	   the	  
server.	   This	   also	   provides	   the	   option	   of	   extending	   the	   application	   in	   the	   future	   to	   a	  
web-­‐based	  platform	  that	  can	  be	  accessed	  from	  any	  web	  browser	  on	  any	  device.	  
Shown	  below	   is	   the	  LabTracker	  homepage,	  
which	  has	  links	  to	  all	  of	  the	  main	  sections	  in	  
LabTracker:	   Lab	   Book,	   Reagents	   Database,	  
Timers,	   Calculators,	   Molecule	   Viewer,	  






The	   main	   component	   within	  
LabTracker	   is	   the	   ‘Lab	   Book’.	   The	  
‘Lab	   Book’	   provides	   researchers	  
with	   a	   diary	   interface,	   allowing	  
them	  to	  record	  the	  experiments	  they	  carry	  out	  on	  a	  daily	  basis,	  maintain	  a	  task	  list	  for	  
each	   day,	   upload	   images	   from	   the	   in-­‐built	   camera	   on	   the	   iPad	   2	   and	   setup	   alerts.	  
When	   recording	   experiments	   being	   carried	   out,	   a	   researcher	   has	   the	   option	   of	  
selecting	   from	   a	   library	   of	   standard	   protocols.	   This	   library	   is	   editable	   so	   that	   new	  
protocols	   can	  be	  added	  and	  existing	  protocols	  updated.	   	   This	  ensures	   that	  protocols	  
can	  be	  easily	  managed	  and	  maintained.	  
As	   a	   researcher	   carries	   out	   the	   steps	   within	   a	   protocol,	   they	   have	   the	   option	   of	  
marking	  the	   individual	  steps	  as	  being	  complete,	  as	  well	  as	  adding	  notes	  to	  each	  step	  
for	  future	  reference.	  With	  the	  iPad	  2	  allowing	  photo	  acquisitions,	  researchers	  can	  also	  
take	  photographs	  of	  gels	  etc.,	   at	   their	   laboratory	  bench,	  and	  have	   these	   stored	  with	  
protocols.	  
Reagents	  Database	  
LabTracker	   also	   implements	   access	   to	   the	   reagents	   database	   held	   by	   PepTracker.	  
LabTracker	  allows	  researchers	  to	  search	  for	  reagents	  from	  the	  reagent	  database.	  This	  
is	   a	   particularly	   useful	   feature	   for	   researchers	  working	   at	   a	   laboratory	   bench.	   In	   the	  
future	   this	   functionality	   could	   be	   extended	   to	   link	   up	   with	   the	   University	   ordering	  
system	  to	  allow	  reagents	  to	  be	  ordered	  via	  the	  LabTracker	  software.	  
Timers	  
One	   of	   the	   useful	   tools	   for	   a	   researcher	   working	   on	   experiments	   at	   the	   laboratory	  
bench	  is	  their	  timer.	  The	  LabTracker	  software	  implements	  the	  possibility	  of	  setting	  up	  
electronic	  timers.	  Researchers	  can	  use	  this	  functionality	  to	  time	  different	  experimental	  
stages,	   furthermore	   this	   functionality	  can	  be	  used	   to	  setup	   timer	  alerts	   for	  meetings	  
etc.	  Researchers	  have	  the	  option	  of	  either	  visual	  and/or	  sound	  alerts.	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Calculators	  
LabTracker	  also	   includes	  a	   series	  of	   scientific	   calculators.	   These	   include	  molarity	   and	  
DNA/RNA	   conversion	   calculators.	   Without	   this	   functionality	   being	   at	   hand	   at	   the	  
laboratory	  bench,	  researchers	  would	  have	  to	  return	  to	  their	  office	  computer	  to	  carry	  
out	  these	  calculations.	  
Molecule	  Viewer	  
The	   3D	   molecule	   viewer	   provides	   researchers	   with	   an	   interactive	   interface	   to	   view	  
different	   molecule	   structures.	   Currently	   this	   includes	   all	   amino	   acid	   structures	   but	  
could	  be	  extended	   in	   the	   future	   to	  other	   structures,	   for	   example	  protein	   structures.	  
Researchers	  have	  the	  option	  of	  rotating	  molecules	  in	  the	  x,	  y	  and	  z	  planes,	  alternating	  
between	  ball	  and	  stick	  and	   letter	   representations,	  as	  well	  as	   free	   rotation	  with	  hand	  
gestures.	  
Periodic	  Table	  
An	   interactive	   periodic	   table	   of	   elements	   is	   implemented,	   providing	   easy	   to	   access	  
information	  on	  all	  elements	  in	  a	  pop-­‐up	  style	  window.	  	  
Health	  and	  Safety	  Regulations	  
It	  is	  imperative	  health	  and	  safety	  regulations	  are	  followed	  within	  a	  laboratory	  setting.	  
In	  order	  to	  make	  this	  easier	  for	  researcher,	  health	  and	  safety	  documentation	  is	  made	  
available	   via	   the	   LabTracker	   application	   for	   easy	   access.	   This	   information	   includes	  
guidance	  on	  radioactive	  substances,	  risk	  assessments,	  fume	  hood	  operation	  etc.	  
The	   LabTracker	   software	   is	   under	   continued	   development	   and	   evaluation	   by	  
researchers	   in	   the	   Lamond	   Laboratory.	   The	   tools	   and	   feature	   sets	   available	   via	   the	  
application	   are	   being	   updated	   and	   reviewed	   to	   ensure	   they	   are	   effective	   in	   their	  
purpose	   and	   usable.	   It	   is	   intended	   that	   this	   software	   could	   be	   extended	   to	   other	  
platforms	   in	  the	  future	  via	  a	  web	   interface	  that	  communicates	  data	   from	  the	  central	  
LabTracker	  database.	  
	  
	  	  
	  
